Mycobacterium abscessus subsp. abscessus L948 is a Gram-positive, rod-shaped human pathogen of the family Mycobacteriaceae.
Gram-positive rod-shaped human pathogen genome sequence 16S sequence Bacteria
SI-ID 92877
| @ref 20215 |
Last LPSN update
2026-05-29 08:26:51 |
| Domain Bacteria |
| Phylum Actinomycetota |
| Class Actinomycetes |
| Order Mycobacteriales |
| Family Mycobacteriaceae |
| Genus Mycobacterium |
| Species Mycobacterium abscessus subsp. abscessus |
| Full scientific name Mycobacterium abscessus subsp. abscessus (Moore and Frerichs 1953) Leao et al. 2011 |
| Synonyms (1) |
| BacDive ID | Other strains from Mycobacterium abscessus subsp. abscessus (3) | Type strain |
|---|---|---|
| 8415 | M. abscessus subsp. abscessus 9404L, DSM 43507, SN 589 | |
| 8417 | M. abscessus subsp. abscessus B98-10.22.0168, DSM 44567 | |
| 169509 | M. abscessus subsp. abscessus 20004864, DSM 113269 |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 11592 | MIDDLEBROOK MEDIUM (DSMZ Medium 645) | Medium recipe at MediaDive  | Name: MIDDLEBROOK MEDIUM (DSMZ Medium 645) Composition: Bacto Middlebrook 7H10 agar 20.9945 g/l Glycerol Distilled water | ||
| 19848 | BUG | ||||
| 19848 | 5006 | Medium: 5006 Name: Composition (g/l) Sucrose 3,0 Dextrin 15,0 Meat extract 1,0 Yeast extract 2,0 Tryptone soy broth (Oxoid) 5,0 NaCl 0,5 K2HPO4 0,5 MgSO4 x 7 H2O 0,5 FeSO4 x 7 H2O 0,01 Agar 20,0 Preparation: Sterilisation: 20 minutes at 121°C pH before sterilisation: 7,3 Usage: Maintenance Organisms: All Actinomycetes | |||
| 19848 | MB7H9 | Name: Middlebrook 7H9 (MB7H9) Broth Base Composition: Middelbrook 7H9 Broth Base 4.7 g/l Glycerol 2.0 g/l Casaminoacids 11.0 g/l Yeast extract 5.5 g/l Tween80 (20%) 2.5 g/l OADC-Enrichment 100 ml Agar 15.0 g/l Preparation: Dissolve in Milli-Q-H2O. Before Use add 10% OADC stock solution Sterilisation: 20 minutes at 121°C pH before sterilisation: Usage: Maintenance and revitalization Organisms: Mycobacteria OADC stock solution old broth-name: OADC-Stock Composition: Bovine Serum Albumin, fraction V 5 % 1% Oleic Acid in 0.2N NaOH 5ml Glucose 2 % NaCl 0.85 % Comments: Melt 1% Oleic Acid in 65°C water bath. Dissolve all ingredients in 700ml of ddH2O. Adjust volume to 1L. Filter sterilize and store at 4°C. -To make 1% Oleic Acid in 0.2N NaOH: Dissolve 5g oleic acid (ampule) in 500ml 0.2N NaOH (300ml ddH2O + 20ml NaOH + adjust volume to 500ml). Heat solution to 55°C for oleic acid to melt. Store at -20°C in 50ml aliquots. There is no need to sterilize this. Sterilisation: 20 minutes Temperature:121°C PH before: PH after: Biological details Culture type: suitable for: Mycobacteria | |||
| 37180 | MEDIUM 55 - for Mycobacterium |
| @ref | Oxygen tolerance | Confidence | |
|---|---|---|---|
| 125439 | obligate aerobe | 97.208 |
| @ref | Spore formation | Confidence | |
|---|---|---|---|
| 125439 | 94.705 |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68379 | 17634 ChEBI | D-glucose | - | fermentation | from API Coryne |
| 68379 | 16899 ChEBI | D-mannitol | - | fermentation | from API Coryne |
| 68379 | 16988 ChEBI | D-ribose | - | fermentation | from API Coryne |
| 68379 | 65327 ChEBI | D-xylose | - | fermentation | from API Coryne |
| 68379 | 4853 ChEBI | esculin | + | hydrolysis | from API Coryne |
| 68379 | 5291 ChEBI | gelatin | - | hydrolysis | from API Coryne |
| 68379 | 28087 ChEBI | glycogen | - | fermentation | from API Coryne |
| 68379 | 17716 ChEBI | lactose | - | fermentation | from API Coryne |
| 68379 | 17306 ChEBI | maltose | - | fermentation | from API Coryne |
| 68379 | 17632 ChEBI | nitrate | - | reduction | from API Coryne |
| 68379 | 17992 ChEBI | sucrose | - | fermentation | from API Coryne |
| 68379 | 16199 ChEBI | urea | + | hydrolysis | from API Coryne |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 68382 | alkaline phosphatase | - | 3.1.3.1 | from API zym |
| 68379 | alkaline phosphatase | - | 3.1.3.1 | from API Coryne |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | + | 3.2.1.20 | from API zym |
| 68379 | alpha-glucosidase | + | 3.2.1.20 | from API Coryne |
| 68382 | alpha-mannosidase | + | 3.2.1.24 | from API zym |
| 68382 | beta-galactosidase | + | 3.2.1.23 | from API zym |
| 68379 | beta-galactosidase | - | 3.2.1.23 | from API Coryne |
| 68382 | beta-glucosidase | + | 3.2.1.21 | from API zym |
| 68379 | beta-glucosidase | + | 3.2.1.21 | from API Coryne |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 68379 | beta-glucuronidase | - | 3.2.1.31 | from API Coryne |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 68379 | gelatinase | - | from API Coryne | |
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 68382 | lipase (C 14) | - | from API zym | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68379 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API Coryne |
| 68382 | naphthol-AS-BI-phosphohydrolase | - | from API zym | |
| 68379 | pyrazinamidase | - | 3.5.1.B15 | from API Coryne |
| 68379 | pyrrolidonyl arylamidase | + | 3.4.19.3 | from API Coryne |
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 68379 | urease | + | 3.5.1.5 | from API Coryne |
| 68382 | valine arylamidase | - | from API zym |
Global distribution of 16S sequence AF480592 (>99% sequence identity) for Mycobacteroides from Microbeatlas 
 Aquatic Samples |
6199 |
 Soil Samples |
7046 |
 Animal Samples |
7007 |
 Plant Samples |
1742 |
| Total Samples | 21994 |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | ASM6918v1 assembly for Mycobacteroides abscessus ATCC 19977 | complete | GCA_000069185   | 36809.5  | 641522641  | 561007 | 98.98 | |
| 67770 | 46941_C01 assembly for Mycobacteroides abscessus NCTC13031 | contig | GCA_900453225 | 36809.556 | 2916644324 | 36809 | 78.91 | |
| 66792 | Mycobacteroides abscessus subsp. abscessus strain 2572-15 | contig | 1185650.997 | 1185650 | 73.2 | | ||
| 66792 | Mycobacteroides abscessus subsp. massiliense strain 10003-15 | contig | 1962118.376 | 1962118 | 72.6 | | ||
| 66792 | ASM194250v1 assembly for Mycobacteroides abscessus ATCC 19977 | contig | GCA_001942505 | 1185650.503 | 2916649437 | 561007 | 71.98 | |
| 66792 | Mycobacteroides abscessus subsp. bolletii strain 7742-15 | contig | 319705.143 | 319705 | 71 | | ||
| 66792 | Mycobacteroides abscessus subsp. massiliense strain 10896-16 | contig | 1962118.378 | 1962118 | 71 | | ||
| 66792 | Mycobacteroides abscessus subsp. abscessus strain 3563-15 | contig | 1185650.1000 | 1185650 | 70.2 | | ||
| 66792 | Mycobacteroides abscessus subsp. bolletii strain 11702-16 | contig | 319705.144 | 319705 | 70 | | ||
| 66792 | Mycobacteroides abscessus subsp. bolletii strain 13116-16 | contig | 319705.141 | 319705 | 69.6 | | ||
| 66792 | Mycobacteroides abscessus subsp. abscessus strain 12389-15 | contig | 1185650.999 | 1185650 | 69 | | ||
| 66792 | Mycobacteroides abscessus subsp. abscessus strain 4549-15 | contig | 1185650.1002 | 1185650 | 68.6 | | ||
| 66792 | Mycobacteroides abscessus subsp. abscessus strain 8844-15 | contig | 1185650.1001 | 1185650 | 68.2 | | ||
| 66792 | Mycobacteroides abscessus subsp. bolletii strain 713-16 | contig | 319705.142 | 319705 | 67.8 | | ||
| 66792 | Mycobacteroides abscessus subsp. massiliense strain 14479-15 | contig | 1962118.377 | 1962118 | 67.6 | | ||
| 66792 | Mycobacteroides abscessus subsp. abscessus strain 2677-16 | contig | 1185650.998 | 1185650 | 66.2 | | ||
| 66792 | Mycobacteroides abscessus subsp. abscessus strain 11351-15 | contig | 1185650.1003 | 1185650 | 65.4 | | ||
| 66792 | Mycobacteroides abscessus subsp. massiliense strain 16155-15 | contig | 1962118.375 | 1962118 | 65 | |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 20218 | Mycobacterium abscessus DNA, 16S-23S ribosomal RNA intergenic spacer, partial sequence, strain: JCM 13569 | AB548596 | 297 | | 36809 | |
| 20218 | Mycobacterium abscessus gene for 16S ribosomal RNA, partial sequence, strain: JCM 13569 | AB548599 | 1468 |  | 36809 | |
| 20218 | Mycobacterium abscessus 16S ribosomal RNA gene, partial sequence | AF480592 | 1441 | | 561007 | |
| 20218 | Mycobacterium abscessus strain CIP 104536 16S ribosomal RNA gene, partial sequence | AF547892 | 540 | | 36809 | |
| 20218 | Mycobacterium abscessus 16S rRNA gene | AJ536038 | 1455 | | 36809 | |
| 20218 | Mycobacteroides abscessus strain CIP 104536 16S ribosomal RNA gene, partial sequence | AY457071 | 1481 | | 36809 | |
| 20218 | Mycobacterium abscessus 16S ribosomal RNA gene and 16S-23S intergenic spacer, partial sequence | AY498740 | 253 | | 561007 | |
| 20218 | Mycobacterium abscessus 16S-23S ribosomal RNA intergenic spacer, partial sequence | AY593976 | 257 | | 36809 | |
| 20218 | M.chelonei 16S ribosomal RNA | M29559 | 1355 | | 1774 | |
| 20218 | M.abscessus 16S rRNA gene | X82235 | 1071 | | 561007 | |
| 20218 | Mycobacterium abscessus murA and 16S rRNA gene | Y13910 | 1025 | | 561007 | |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Biofilm prevention concentration of clarithromycin against clinically relevant species of nontuberculous mycobacteria. | Senhaji-Kacha A, Akir A, Broncano-Lavado A, Esteban J. | Rev Esp Quimioter | 10.37201/req/014.2024 | 2024 | | |
| Pathogenicity | Antimicrobial Treatment Provides a Competitive Advantage to Mycobacterium abscessus in a Dual-Species Biofilm with Pseudomonas aeruginosa. | Rodriguez-Sevilla G, Crabbe A, Garcia-Coca M, Aguilera-Correa JJ, Esteban J, Perez-Jorge C. | Antimicrob Agents Chemother | 10.1128/aac.01547-19 | 2019 | |
| Genetics | Genetic diversification of persistent Mycobacterium abscessus within cystic fibrosis patients. | Lewin A, Kamal E, Semmler T, Winter K, Kaiser S, Schafer H, Mao L, Eschenhagen P, Grehn C, Bender J, Schwarz C. | Virulence | 10.1080/21505594.2021.1959808 | 2021 | |
| Clinical Evaluation of Nontuberculous Mycobacteria (NTM) Elite Agar, a New Medium for the Isolation of NTM: a Multicenter Study. | Broncano-Lavado A, Barrado L, Lopez-Roa P, Cacho J, Domingo D, Hernandez S, Garcia-Martinez J, Millan MR, Perez-Cecilia E, Ruiz-Serrano MJ, Salso S, Simon M, Tato M, Toro C, Valverde-Canovas JF, Esteban J. | J Clin Microbiol | 10.1128/jcm.00036-23 | 2023 | | |
| Mycobacterium abscessus subsp. abscessus Is Capable of Degrading Pseudomonas aeruginosa Quinolone Signals. | Birmes FS, Wolf T, Kohl TA, Ruger K, Bange F, Kalinowski J, Fetzner S. | Front Microbiol | 10.3389/fmicb.2017.00339 | 2017 | | |
| Autofluorescence as a tool for structural analysis of biofilms formed by nonpigmented rapidly growing mycobacteria. | Munoz-Egea MC, Garcia-Pedrazuela M, Mahillo I, Garcia MJ, Esteban J. | Appl Environ Microbiol | 10.1128/aem.03149-12 | 2013 | | |
| Phylogeny | Intra- and interpatient variability of the hsp65 and 16S-23S intergenic gene region in Mycobacterium abscessus strains from patients with cystic fibrosis. | Konig B, Tammer I, Sollich V, Konig W. | J Clin Microbiol | 10.1128/jcm.43.7.3500-3503.2005 | 2005 | |
| Pathogenicity | In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria. | Fernandez-Roblas R, Martin-de-Hijas NZ, Fernandez-Martinez AI, Garcia-Almeida D, Gadea I, Esteban J. | Antimicrob Agents Chemother | 10.1128/aac.00695-08 | 2008 | |
| Phylogeny | Phylogenomics and Comparative Genomic Studies Robustly Support Division of the Genus Mycobacterium into an Emended Genus Mycobacterium and Four Novel Genera. | Gupta RS, Lo B, Son J. | Front Microbiol | 10.3389/fmicb.2018.00067 | 2018 | |
| Pathogenicity | Effect of ciprofloxacin in the ultrastructure and development of biofilms formed by rapidly growing mycobacteria. | Munoz-Egea MC, Garcia-Pedrazuela M, Mahillo I, Esteban J. | BMC Microbiol | 10.1186/s12866-015-0359-y | 2015 | |
| Metabolism | Signal Synthase-Type versus Catabolic Monooxygenases: Retracing 3-Hydroxylation of 2-Alkylquinolones and Their N-Oxides by Pseudomonas aeruginosa and Other Pulmonary Pathogens. | Ritzmann NH, Drees SL, Fetzner S. | Appl Environ Microbiol | 10.1128/aem.02241-20 | 2021 | |
| Enzymology | Evaluation of the invader assay with the BACTEC MGIT 960 system for prompt isolation and identification of mycobacterial species from clinical specimens. | Ichimura S, Nagano M, Ito N, Shimojima M, Egashira T, Miyamoto C, Ohkusu K, Ezaki T. | J Clin Microbiol | 10.1128/jcm.02289-06 | 2007 | |
| Novel mass spectrometry-based tool for genotypic identification of mycobacteria. | Lefmann M, Honisch C, Bocker S, Storm N, von Wintzingerode F, Schlotelburg C, Moter A, van den Boom D, Gobel UB. | J Clin Microbiol | 10.1128/jcm.42.1.339-346.2004 | 2004 | | |
| Pharmacodynamic assessment of apramycin against Mycobacterium abscessus in a hollow fibre infection model. | Singh N, Dangi B, Johnson JJ, Louie A, Karunanidhi A, Curry BN, Mitarai S, Daley CL, Hobbie SN, Bulman ZP. | J Antimicrob Chemother | 10.1093/jac/dkaf073 | 2025 | | |
| In vitro Activity of the Novel Tetracyclines Derivative, Zifanocycline Against Mycobacterium abscessus. | Yu Q, Niu X, Hou B, Mao M, Zhu L, Shen W, Wang W. | Infect Drug Resist | 10.2147/idr.s538789 | 2025 | | |
| Characterization of new mouse models of acute and chronic Mycobacterium abscessus infection for antimicrobial drug screening. | Alshiraihi IM, Lam H, Troyer BT, Tran KN, Zohaib Ali M, Conner DK, Godelfer A, Pearce C, Jackson M, Henao-Tamayo M, Norcross SEM, Meibohm B, Lee RE, Gonzalez-Juarrero M, Obregon-Henao A. | Antimicrob Agents Chemother | 10.1128/aac.00475-25 | 2025 | | |
| Repression of mab_1999 impairs growth and alters cellular morphology of Mycobacterium abscessus. | Ilmi AFN, Kaewsapsak P, Rotcheewaphan S. | BMC Microbiol | 10.1186/s12866-025-04319-3 | 2025 | | |
| In Vitro Activity of Imipenem/Relebactam Alone and in Combination Against Cystic Fibrosis Isolates of Mycobacterium abscessus. | Sanders M, Kim SW, Shinde A, Fletcher-Williams D, Quach E, Beringer P. | Antibiotics (Basel) | 10.3390/antibiotics14050486 | 2025 | | |
| Enzymology | An enoyl-ACP reductase inhibitor, NITD-916, expresses anti-Mycobacterium abscessus activity. | Jia Y, Fan J, Tan Z, Li A, He S, Lin Y, Li J, Zhang Z, Li B, Chu H. | Antimicrob Agents Chemother | 10.1128/aac.00249-25 | 2025 | |
| Genetics | Ultra-high field strength electroporation enables efficient DNA transformation and genome editing in nontuberculous mycobacteria. | Tang D, Wang M, Wang D, Yang D, Cai Y, Luo T, He J, Wang Q. | Microbiol Spectr | 10.1128/spectrum.01944-25 | 2025 | |
| Heterologous expression of the M. abscessus CBASS system confers phage TM4 resistance in M. smegmatis. | Wang CL, Duan AF, Pan DM, Zhao YO, Yang J, Sun YC. | BMC Microbiol | 10.1186/s12866-025-04214-x | 2025 | | |
| Mycobacterium abscessus strain variability in preclinical drug development: does it really matter? | Mudde SE, Meliefste HM, Ammerman NC, de Steenwinkel JEM, Bax HI. | J Antimicrob Chemother | 10.1093/jac/dkae336 | 2024 | | |
| Novel C5alpha-substituted carbapenems enhance Mycobacterium abscessus killing via selective target binding and reduced hydrolysis by BlaMab. | Shin E, Taracila MA, Quan P, Khan MMK, Cox J, Patel D, Dousa KM, Parmar A, Nantongo M, Nguyen DC, Rubin EJ, Holland SM, Kreiswirth BN, Buynak JD, Bonomo RA. | Antimicrob Agents Chemother | 10.1128/aac.00170-25 | 2025 | | |
| The addition of amoxicillin improves the efficacy of the imipenem-avibactam combination against Mycobacterium abscessus in a mouse model of infection. | Le Moigne V, Bitar M, Arthur M, Mainardi J-L, Herrmann J-L. | Antimicrob Agents Chemother | 10.1128/aac.00534-25 | 2025 | | |
| Novel mutations in the marR gene (MAB_2648c) modify nitroxoline activity in Mycobacterium abscessus. | Xu P, Li Y, Xu B, Cao D, Dong X, Xiang Y, Jiang X, Yuan X, Qiu Y, Zhang Y. | Antimicrob Agents Chemother | 10.1128/aac.01744-24 | 2025 | | |
| Preparation of Agar Bead Embedded Mycobacterium abscessus to Inoculate Immunocompetent Mice Intratracheally. | Proietto J, Tatek B, Folvar C, Jimenez DC, Alshiraihi IM, Gonzalez-Juarrero M, Saliu F, Vacca F, Cirillo DM, Lore N, Dick T, Dartois V, Aragaw WW. | J Vis Exp | 10.3791/67602 | 2025 | | |
| Mutations in the transcriptional regulator MAB_2885 confer tedizolid and linezolid resistance through the MmpS-MmpL efflux pump MAB_2302-MAB_2303 in Mycobacterium abscessus. | Zhang H, Wang S, Zhang Y, Hua W, Lin S, Chen X, Xu T, Chen J, Zhang W. | PLoS Pathog | 10.1371/journal.ppat.1013190 | 2025 | | |
| Toward a Bactericidal Oral Drug Combination for the Treatment of Mycobacterium abscessus Lung Disease. | Sarathy JP, Xie M, Wong CF, Negatu DA, Rodriguez S, Zimmerman MD, Jimenez DC, Alshiraihi IM, Gonzalez-Juarrero M, Dartois V, Dick T. | ACS Infect Dis | 10.1021/acsinfecdis.4c00948 | 2025 | | |
| Ivacaftor affects the susceptibility of standard-of-care drugs used to treat Mycobacterium abscessus lung disease. | Shrivastava A, Singh S, Boorgula GD, Galvez R-A, Srivastava S. | Antimicrob Agents Chemother | 10.1128/aac.00030-25 | 2025 | | |
| Genetics | Transposon-sequencing across multiple Mycobacterium abscessus isolates reveals significant functional genomic diversity among strains. | Akusobi C, Choudhery S, Benghomari BS, Wolf ID, Singhvi S, Ioerger TR, Rubin EJ. | mBio | 10.1128/mbio.03376-24 | 2025 | |
| Genetics | A CRISPR/Cas9-based system using dual-sgRNAs for efficient gene deletion in Mycobacterium abscessus. | Li L, Hu Y, Wang D, Li X, Bao S, Deng T, Wang Q. | Front Microbiol | 10.3389/fmicb.2025.1608274 | 2025 | |
| A BALB/c mouse model of Mycobacterium abscessus lung infection based on once-weekly cyclophosphamide administration. | Rimal B, Panthi CM, Howe RA, Lamichhane G. | Dis Model Mech | 10.1242/dmm.052310 | 2025 | | |
| TBAJ-587, a novel diarylquinoline, is active against Mycobacterium abscessus. | Fan J, Tan Z, He S, Li A, Jia Y, Li J, Zhang Z, Li B, Chu H. | Antimicrob Agents Chemother | 10.1128/aac.00945-24 | 2024 | | |
| Poor efficacy of the combination of clarithromycin, amikacin, and cefoxitin against Mycobacterium abscessus in the hollow fiber infection model. | Vignaud E, Goutelle S, Genestet C, Guitton J, Cohen S, Bourg C, Durand A, Lebouteiller L, Bernard A, Richet C, Dumitrescu O, Hodille E. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-025-00776-w | 2025 | | |
| VLX600, an anticancer iron chelator, exerts antimicrobial effects on Mycobacterium abscessus infections. | Oh J, Choi S, Seo H, Kim DH, Kim H, Lee D, Jang J, Jung S, Lee J-Y, Kim Z, Yim J-J, Kwak N, Kim B-J. | Microbiol Spectr | 10.1128/spectrum.00719-25 | 2025 | | |
| Multidrug tolerance conferred by loss-of-function mutations in anti-sigma factor RshA of Mycobacterium abscessus. | Aragaw WW, Gebresilase TT, Negatu DA, Dartois V, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.01051-24 | 2024 | | |
| Durlobactam to boost the clinical utility of standard of care beta-lactams against Mycobacterium abscessus lung disease. | Negatu DA, Aragaw WW, Gebresilase TT, Paruchuri S, Kaya F, Shin SJ, Sander P, Dartois V, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.01046-24 | 2025 | | |
| Metabolism | Microbial metabolism disrupts cytokine activity to impact host immune response. | Marshall EKP, Nunes C, Burbaud S, Vincent CM, Munroe NO, Simoes da Silva CJ, Wadhawan A, Pearson WH, Sangen J, Boeck L, Floto RA, S Dionne M. | Proc Natl Acad Sci U S A | 10.1073/pnas.2405719121 | 2024 | |
| The role of colony morphotype in shaping gene essentiality in Mycobacteroides abscessus. | Ross BN, Evans E, Diggle F, Briaud P, Whiteley M. | Proc Natl Acad Sci U S A | 10.1073/pnas.2500719122 | 2025 | | |
| A Multiplexed, Target-Based Phenotypic Screening Platform Using CRISPR Interference in Mycobacterium abscessus. | Neo DM, Ben-Zion I, Bagnall J, Solomon MY, Bond AN, Gath E, Zhang S, Shoresh N, Gomez J, Hung DT. | ACS Infect Dis | 10.1021/acsinfecdis.5c00623 | 2025 | | |
| Ceftaroline pharmacokinetics/pharmacodynamics in the hollow-fibre model of Mycobacterium abscessus lung disease. | Ferro BE, Srivastava S, Gumbo T. | IJTLD Open | 10.5588/ijtldopen.25.0173 | 2025 | | |
| Pathogenicity | Phosphatidylinositol 5-Phosphate-Loaded Apoptotic Body-Like Liposomes for Mycobacterium abscessus Infection Management in Patients With Cystic Fibrosis. | Olimpieri T, Poerio N, Saliu F, Lore NI, Ciciriello F, Ponsecchi G, D'Andrea MM, Alghisi F, Cirillo DM, Fraziano M. | J Infect Dis | 10.1093/infdis/jiaf124 | 2025 | |
| Oral oxaborole MRX-5 exhibits efficacy against pulmonary Mycobacterium abscessus in mouse. | Rimal B, Howe RA, Panthi CM, Wang W, Lamichhane G. | Antimicrob Agents Chemother | 10.1128/aac.01351-24 | 2024 | | |
| Culture conversion and macrolide resistance in Mycobacterium abscessus complex pulmonary disease. | Chen S, Bao S, Zheng J, Jiang G, Duan H, Huang H. | Microbiol Spectr | 10.1128/spectrum.01274-25 | 2025 | | |
| Combinations comprising dual beta-lactams and a beta-lactamase inhibitor achieve optimal synergistic inhibition of Mycobacterium abscessus growth. | Rimal B, Xie Y, Panthi CM, Devlin KL, Beatty KE, Lamichhane G. | Antimicrob Agents Chemother | 10.1128/aac.00127-25 | 2025 | | |
| Novel Synthetic Peptide Agelaia-12 Has Improved Activity Against Mycobacterium abscessus Complex. | Coelho AA, Barbosa LCS, da Costa AC, Kipnis A, Junqueira-Kipnis AP. | Pathogens | 10.3390/pathogens13110994 | 2024 | | |
| Pathogenicity | Host Cell-Derived Extracellular Vesicles Regulate Iron Uptake in Recipient Macrophages during Mycobacterium abscessus Infection. | Ramos-Wolfley AD, Speelmon CA, Zhang J, Guthrie CM, Clark OL, Hartson SD, Liu L, Tan X, Cheng Y. | J Proteome Res | 10.1021/acs.jproteome.5c00399 | 2025 | |
| Dual beta-lactams for the treatment of Mycobacterium abscessus: a review of the evidence and a call to act against an antibiotic nightmare. | Longo BM, Trunfio M, Calcagno A. | J Antimicrob Chemother | 10.1093/jac/dkae288 | 2024 | | |
| Preclinical model of Mycobacteroides abscessus lung disease by nose-only exposure of mice to bacterial powder aerosol. | Verma K, Garg T, Singh S, Deivreddy VSR, Raman SK, Bharti R, Sofi HS, Singh K, Shaik M, Dasgupta A, Mugale MN, Misra A. | Tuberculosis (Edinb) | 10.1016/j.tube.2025.102606 | 2025 | | |
| Durlobactam in combination with beta-lactams to combat Mycobacterium abscessus. | Shin E, Dousa KM, Taracila MA, Bethel CR, Nantongo M, Nguyen DC, Akusobi C, Kurz SG, Plummer MS, Daley CL, Holland SM, Rubin EJ, Bulitta JB, Boom WH, Kreiswirth BN, Bonomo RA. | Antimicrob Agents Chemother | 10.1128/aac.01174-24 | 2025 | | |
| Sulbactam-durlobactam improves cephalosporin and carbapenem susceptibility and time-kill effect against Mycobacterium abscessus. | Shrivastava A, Boorgula GD, Singh S, Stiles D, McShane PJ, Devine M, Gumbo T, Srivastava S. | Microbiol Spectr | 10.1128/spectrum.01492-25 | 2025 | | |
| Efficacy of epetraborole against Mycobacteroides abscessus in a mouse model of lung infection. | Rimal B, Lippincott CK, Panthi CM, Xie Y, Keepers TR, Alley M, Lamichhane G. | Antimicrob Agents Chemother | 10.1128/aac.00648-24 | 2024 | | |
| Lipoarabinomannan modification as a source of phenotypic heterogeneity in host-adapted Mycobacterium abscessus isolates. | De K, Belardinelli JM, Pandurangan AP, Ehianeta T, Lian E, Palcekova Z, Lam H, Gonzalez-Juarrero M, Bryant JM, Blundell TL, Parkhill J, Floto RA, Lowary TL, Wheat WH, Jackson M. | Proc Natl Acad Sci U S A | 10.1073/pnas.2403206121 | 2024 | | |
| Antimicrobial and Antibiofilm Effects of Bithionol against Mycobacterium abscessus | Cao D, Yuan X, Jiang X, Wu T, Xiang Y, Ji Z, Liu J, Dong X, Bi K, Tonjum T, Xu K, Zhang Y. | Antibiotics (Basel) | 2024 | | ||
| Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against Mycobacterium abscessus. | Dousa KM, Shin E, Kurz SG, Plummer M, Nantongo M, Bethel CR, Taracila MA, Nguyen DC, Kreiswith BN, Daley CL, Remy KE, Holland SM, Bonomo RA. | mBio | 10.1128/mbio.00609-24 | 2024 | | |
| In Vitro Susceptibility to Imipenem/Relebactam and Comparators in a Multicentre Collection of Mycobacterium abscessus Complex Isolates. | Seoane-Estevez A, Aja-Macaya P, Garcia-Pose A, Lopez-Roa P, Ruedas-Lopez A, Gonzalez-Galan V, Esteban J, Arca-Suarez J, Pampin M, Beceiro A, Oviano M, Bou G, On Behalf Of The Geim-Seimc Study Group. | Antibiotics (Basel) | 10.3390/antibiotics14070682 | 2025 | | |
| Defining the mechanism of action of the nitrofuranyl piperazine HC2210 against Mycobacterium abscessus. | Eke IE, Abdalla BJ, Soverina S, Olive AJ, Cicchetti N, Carey AF, Abramovitch RB. | NPJ Antimicrob Resist | 10.1038/s44259-025-00124-0 | 2025 | | |
| In vitro activity of cefoxitin, imipenem, meropenem, and ceftaroline in combination with vaborbactam against Mycobacterium abscessus. | Chen L, Shashkina E, Kurepina N, Calado Nogueira de Moura V, Daley CL, Kreiswirth BN. | Antimicrob Agents Chemother | 10.1128/aac.00174-24 | 2024 | | |
| Genetics | Limited predictive power of known resistance genes for phenotypic drug resistance in clinical Mycobacterium abscessus complex from Beijing in China. | Hou Y, Pi R, Jia J, Wu Z, Huo F, Zhou Y, Jiang H, Takiff HE, Zhu C, Wang W, Li W. | Antimicrob Agents Chemother | 10.1128/aac.01847-24 | 2025 | |
| Genetics | Genomic-enabled classification of three Mycobacteroides abscessus subspecies and an effective subspecies-specific identification method. | Yu Z, Wang R. | J Clin Microbiol | 10.1128/jcm.00697-25 | 2025 | |
| Broad-Spectrum In Vitro Activity of Nalpha-Aroyl-N-Aryl-Phenylalanine Amides against Non-Tuberculous Mycobacteria and Comparative Analysis of RNA Polymerases. | Lang M, Ganapathy US, Abdelaziz R, Dick T, Richter A. | Antibiotics (Basel) | 10.3390/antibiotics13050404 | 2024 | | |
| Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations. | Dartois V, Bonfield TL, Boyce JP, Daley CL, Dick T, Gonzalez-Juarrero M, Gupta S, Kramnik I, Lamichhane G, Laughon BE, Lore NI, Malcolm KC, Olivier KN, Tuggle KL, Jackson M. | Tuberculosis (Edinb) | 10.1016/j.tube.2024.102503 | 2024 | | |
| Activity of combinations of bactericidal and bacteriostatic compounds in Mycobacterium abscessus-infected mice: an overview. | Lanni A, Iona E, Fattorini L, Giannoni F, Iacobino A. | Front Microbiol | 10.3389/fmicb.2025.1616149 | 2025 | | |
| Pharmacological validation of dihydrofolate reductase as a drug target in Mycobacterium abscessus. | Aragaw WW, Negatu DA, Bungard CJ, Dartois VA, Marrouni AE, Nickbarg EB, Olsen DB, Warrass R, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.00717-23 | 2024 | | |
| Heme alters biofilm formation in Mycobacterium abscessus. | Aftab H, Samudio J, Wang G, Le L, Soni RK, Donegan RK. | Microbiol Spectr | 10.1128/spectrum.02415-24 | 2025 | | |
| High rate of macrolide resistance and closely genetically related Mycobacterium abscessus complex strains identified among both cystic fibrosis and non-cystic fibrosis patients within two countries. | Dohal M, Dvorakova V, Hromadkova M, Pinkova M, Amlerova J, Schwarz M, Spitaleri A, di Marco F, Hnilicova J, Gondas E, Rasmussen ME, Porvaznik I, Solovic I, Cirillo DM, Mokry J. | Microbiol Spectr | 10.1128/spectrum.01056-24 | 2024 | | |
| In vitro effects of the new oral beta-lactamase inhibitor xeruborbactam in combination with oral beta-lactams against clinical Mycobacterium abscessus isolates. | Yamatani I, Aono A, Fujiwara K, Asami T, Kamada K, Morishige Y, Igarashi Y, Chikamatsu K, Murase Y, Yamada H, Takaki A, Komiya K, Mitarai S. | Microbiol Spectr | 10.1128/spectrum.00084-24 | 2024 | | |
| Next-generation rifamycins for the treatment of mycobacterial infections. | Dartois V, Lan T, Ganapathy US, Wong CF, Sarathy JP, Jimenez DC, Alshiraihi IM, Lam H, Rodriguez S, Xie M, Soto-Ojeda M, Jackson M, Wheat W, Dillman NC, Kostenkova K, Schmitt J, Mann L, Richter A, Imming P, Sarathy J, Kaya F, Paruchuri S, Tatek B, Folvar C, Proietto J, Zimmerman M, Gonzalez-Juarrero M, Aldrich CC, Dick T. | Proc Natl Acad Sci U S A | 10.1073/pnas.2423842122 | 2025 | | |
| Evaluation of omadacycline against intracellular Mycobacterium abscessus in an infection model in human macrophages. | Jahanbakhsh S, Howland J, Ndayishimiye Uwineza MO, Thwaites MT, Pillar CM, Serio AW, Anastasiou DM, Hufnagel DA. | JAC Antimicrob Resist | 10.1093/jacamr/dlad104 | 2023 | | |
| Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus. | Negatu DA, Aragaw WW, Dartois V, Dick T. | Microbiol Spectr | 10.1128/spectrum.02199-23 | 2023 | | |
| A Novel Inhibitor against the Biofilms of Non-Tuberculous Mycobacteria. | Kaur P, Krishnamurthy RV, Shandil RK, Mohan R, Narayanan S. | Pathogens | 10.3390/pathogens13010040 | 2023 | | |
| The in vitro effect of new combinations of carbapenem-beta-lactamase inhibitors for Mycobacterium abscessus. | Froberg G, Ahmed A, Chryssanthou E, Davies Forsman L. | Antimicrob Agents Chemother | 10.1128/aac.00528-23 | 2023 | | |
| Mycobacterium abscessus extracellular vesicles increase mycobacterial resistance to clarithromycin in vitro. | Vermeire CA, Tan X, Liang Y, Kotey SK, Rogers J, Hartson SD, Liu L, Cheng Y. | Proteomics | 10.1002/pmic.202300332 | 2024 | | |
| Intrapulmonary Treatment with Mycobacteriophage LysB Rapidly Reduces Mycobacterium abscessus Burden. | Hurst-Hess K, Walz A, Yang Y, McGuirk H, Gonzalez-Juarrero M, Hatfull GF, Ghosh P, Ojha AK. | Antimicrob Agents Chemother | 10.1128/aac.00162-23 | 2023 | | |
| Investigating the role of MAB_1915 in intrinsic resistance to multiple drugs in Mycobacterium abscessus. | Yusuf B, Wang S, Alam MS, Zhang J, Liu Z, Lu Z, Ding J, Chiwala G, Gao Y, Fang C, Khan SA, Tian X, Islam MM, Hameed HMA, Maslov DA, Zhong N, Hu J, Zhang T. | Microbiol Spectr | 10.1128/spectrum.03974-23 | 2024 | | |
| Mutation rates and the molecular epidemiology of Mycobacterium abscessus. | Harrison LB, Behr MA. | Proc Natl Acad Sci U S A | 10.1073/pnas.2307499120 | 2023 | | |
| Efficacy of carbonyl cyanide-3-chlorophenylhydrazone in combination with antibiotics against Mycobacterium abscessus. | Zheng J, Liu Q, Wang H, Huo F, Jia J, Huang H, Chen S. | Microbiol Spectr | 10.1128/spectrum.01777-24 | 2025 | | |
| Macrolide resistance in Mycobacterium abscessus: current insights and future perspectives. | Nguyen VL, Eick KL, Gan M, Miner TA, Friedland AE, Carey AF, Olivier KN, Liu Q. | JAC Antimicrob Resist | 10.1093/jacamr/dlaf047 | 2025 | | |
| Hierarchy and interconnected networks in the WhiB7 mediated transcriptional response to antibiotic stress in Mycobacterium abscessus. | Hurst-Hess K, McManaman C, Yang Y, Gupta S, Ghosh P. | PLoS Genet | 10.1371/journal.pgen.1011060 | 2023 | | |
| Isoleucyl-tRNA synthetase depletion reveals vulnerabilities in Mycobacterium abscessus and Mycobacterium marinum. | Luo D, Xie W, Wang C, Sun Y, Zhang L, Qian L, Zhang J, Dang G, Liu S, Wang Z. | Commun Biol | 10.1038/s42003-025-08841-y | 2025 | | |
| Pathogenicity | Dual spatial host-bacterial gene expression in Mycobacterium abscessus respiratory infections. | Di Marco F, Nicola F, Giannese F, Saliu F, Tonon G, de Pretis S, Cirillo DM, Lore NI. | Commun Biol | 10.1038/s42003-024-06929-5 | 2024 | |
| Natural Products Lysobactin and Sorangicin A Show In Vitro Activity against Mycobacterium abscessus Complex. | Sullivan JR, Yao J, Courtine C, Lupien A, Herrmann J, Muller R, Behr MA. | Microbiol Spectr | 10.1128/spectrum.02672-22 | 2022 | | |
| Transcriptome | Computational drug repositioning identifies niclosamide and tribromsalan as inhibitors of Mycobacterium tuberculosis and Mycobacterium abscessus. | Yang JJ, Goff A, Wild DJ, Ding Y, Annis A, Kerber R, Foote B, Passi A, Duerksen JL, London S, Puhl AC, Lane TR, Braunstein M, Waddell SJ, Ekins S. | Tuberculosis (Edinb) | 10.1016/j.tube.2024.102500 | 2024 | |
| Characterization of novel double-reporter strains of Mycobacterium abscessus for drug discovery: a study in mScarlet. | Bento CM, van Calster K, Piller T, Oliveira GS, de Vooght L, Cappoen D, Cos P, Gomes MS, Silva T. | Microbiol Spectr | 10.1128/spectrum.00362-24 | 2024 | | |
| Isoegomaketone exhibits potential as a new Mycobacterium abscessus inhibitor. | Kim HW, Lee JW, Yu AR, Yoon HS, Kang M, Lee BS, Park HW, Lee SK, Whang J, Kim JS. | Front Microbiol | 10.3389/fmicb.2024.1344914 | 2024 | | |
| Rifaximin potentiates clarithromycin against Mycobacterium abscessus in vitro and in zebrafish. | Goh BC, Larsson S, Dam LC, Ling YHS, Chua WLP, Abirami R, Singh S, Ong JLE, Teo JWP, Ho P, Ingham PW, Pethe K, Dedon PC. | JAC Antimicrob Resist | 10.1093/jacamr/dlad052 | 2023 | | |
| Cell envelope polysaccharide modifications alter the surface properties and interactions of Mycobacterium abscessus with innate immune cells in a morphotype-dependent manner. | Lian E, Belardinelli JM, De K, Pandurangan AP, Angala SK, Palcekova Z, Grzegorzewicz AE, Bryant JM, Blundell TL, Parkhill J, Floto RA, Wheat WH, Jackson M. | mBio | 10.1128/mbio.00322-25 | 2025 | | |
| High efficacy of the F-ATP synthase inhibitor TBAJ-5307 against nontuberculous mycobacteria in vitro and in vivo. | Ragunathan P, Sae-Lao P, Hamela C, Alcaraz M, Krah A, Poh WH, Ern Pee CJ, Hou Lim AY, Rice SA, Pethe K, Bond PJ, Dick T, Kremer L, Bates RW, Gruber G. | J Biol Chem | 10.1016/j.jbc.2023.105618 | 2024 | | |
| Novel Synergies and Isolate Specificities in the Drug Interaction Landscape of Mycobacterium abscessus. | Van N, Degefu YN, Leus PA, Larkins-Ford J, Klickstein J, Maurer FP, Stone D, Poonawala H, Thorpe CM, Smith TC, Aldridge BB. | Antimicrob Agents Chemother | 10.1128/aac.00090-23 | 2023 | | |
| Blocking ADP-ribosylation expands the anti-mycobacterial spectrum of rifamycins. | Ganapathy US, Lan T, Dartois V, Aldrich CC, Dick T. | Microbiol Spectr | 10.1128/spectrum.01900-23 | 2023 | | |
| Disulfiram Is Effective against Drug-Resistant Mycobacterium abscessus in a Zebrafish Embryo Infection Model. | Winters CG, Basnet RM, Faasuamalie PE, Shallom SJ, Zelazny AM, Gupta S, Olivier KN. | Antimicrob Agents Chemother | 10.1128/aac.00539-22 | 2022 | | |
| Impact on Macrolide Resistance of Genetic Diversity of Mycobacterium abscessus Species. | Jong BE, Wu TS, Chen NY, Yang CH, Shu CC, Wang LS, Wu TL, Lu JJ, Chiu CH, Lai HC, Chung WH. | Microbiol Spectr | 10.1128/spectrum.02749-22 | 2022 | | |
| Glycopeptidolipid Defects Leading to Rough Morphotypes of Mycobacterium abscessus Do Not Confer Clinical Antibiotic Resistance. | Hershko Y, Adler A, Barkan D, Meir M. | Microbiol Spectr | 10.1128/spectrum.05270-22 | 2023 | | |
| Bacteriophage infection and killing of intracellular Mycobacterium abscessus. | Schmalstig AA, Wiggins A, Badillo D, Wetzel KS, Hatfull GF, Braunstein M. | mBio | 10.1128/mbio.02924-23 | 2024 | | |
| Synthesis and Biological Assessment of New Thiazoles for Mycobacterial Infections and Biofilm Disruption. | Folquitto LRDS, Siqueira FDS, Nunes TR, de Souza TB, Carvalho DT, Machado RP, Doriguetto AC, Campos MMA, Diniz LF, Soares MG, Chagas de Paula DA, Dias DF. | ACS Omega | 10.1021/acsomega.5c06421 | 2025 | | |
| Pathological granuloma fibrosis induced by agar-embedded Mycobacterium abscessus in C57BL/6JNarl mice. | Yang SJ, Hsu CH, Lai CY, Tsai PC, Song YD, Yeh CC, Chen YY, Dou HY. | Front Immunol | 10.3389/fimmu.2023.1277745 | 2023 | | |
| New Streptomyces-Derived Antibacterial Compounds Targeting Gram-Positive Bacteria: A Systematic Review. | Ait Assou S, El Hassouni M. | ScientificWorldJournal | 10.1155/tswj/6659874 | 2025 | | |
| Nitric oxide-releasing prodrug for the treatment of complex Mycobacterium abscessus infections. | McDonald RA, Nagy SG, Chambers M, Broberg CA, Ahonen MJR, Schoenfisch MH. | Antimicrob Agents Chemother | 10.1128/aac.01327-23 | 2024 | | |
| Genetics | Mycobacteroides abscessus subspecies: a comparative genomic analysis reveals unique metabolic activities and drug resistance patterns. | Wang X, Dai Y, Wang X, Li L, Feng Y, Liu S, Kou Z, Wang L, Wang F, Chen Y, Lei X. | BMC Microbiol | 10.1186/s12866-025-04010-7 | 2025 | |
| Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus In Vitro. | Sarathy JP, Zimmerman MD, Gengenbacher M, Dartois V, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.01237-22 | 2022 | | |
| Zafirlukast induces DNA condensation and has bactericidal effect on replicating Mycobacterium abscessus. | Niet Svd, Green KD, Schimmel IM, Bakker Jd, Lodder B, Reits EA, Garneau-Tsodikova S, van der Wel NN. | Antimicrob Agents Chemother | 10.1128/aac.00029-24 | 2024 | | |
| Infection model of THP-1 cells, growth dynamics, and antimicrobial susceptibility of clinical Mycobacterium abscessus isolates from cystic fibrosis patients: Results from a multicentre study. | Ruedas-Lopez A, Tato M, Lerma L, Esteban J, Munoz-Egea MC, Toro C, Domingo D, Prados-Rosales R, Lopez-Roa P. | PLoS One | 10.1371/journal.pone.0319710 | 2025 | | |
| Biofilm formation and polar lipid biosynthesis in Mycobacterium abscessus are inhibited by naphthylmethylpiperazine. | Faboro T, Daniel J. | PLoS One | 10.1371/journal.pone.0311669 | 2024 | | |
| A Simple In Vitro Method to Determine Bactericidal Activity Against Mycobacterium abscessus Under Hypoxic Conditions. | Feilcke R, Eckenstaler R, Lang M, Richter A, Imming P. | Antibiotics (Basel) | 10.3390/antibiotics14030299 | 2025 | | |
| In Vitro Profiling of the Synthetic RNA Polymerase Inhibitor MMV688845 against Mycobacterium abscessus. | Mann L, Ganapathy US, Abdelaziz R, Lang M, Zimmerman MD, Dartois V, Dick T, Richter A. | Microbiol Spectr | 10.1128/spectrum.02760-22 | 2022 | | |
| A potent phenylalkylamine disrupts mycobacterial membrane bioenergetics and augments bactericidal activity of bedaquiline. | Phua ZY, Li M, Ali A, Cheong CCS, Goh KJ, Seto MYK, Ng ASY, Sarathy JP, Goh BC, Go ML, Chui WK, Dick T, Lam Y. | iScience | 10.1016/j.isci.2025.112915 | 2025 | | |
| Strongly Bactericidal All-Oral beta-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease. | Negatu DA, Zimmerman MD, Dartois V, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.00790-22 | 2022 | | |
| Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus. | Madani A, Negatu DA, El Marrouni A, Miller RR, Boyce CW, Murgolo N, Bungard CJ, Zimmerman MD, Dartois V, Gengenbacher M, Olsen DB, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.00669-22 | 2022 | | |
| Interplay of Mycobacterium abscessus and Pseudomonas aeruginosa in experimental models of coinfection: Biofilm dynamics and host immune response. | Campo-Perez V, Julian E, Torrents E. | Virulence | 10.1080/21505594.2025.2493221 | 2025 | | |
| Targeted Chromosomal Barcoding Establishes Direct Genotype-Phenotype Associations for Antibiotic Resistance in Mycobacterium abscessus. | Calvet-Seral J, Crespo-Yuste E, Mathys V, Rodriguez-Villalobos H, Ceyssens PJ, Martin A, Gonzalo-Asensio J. | Microbiol Spectr | 10.1128/spectrum.05344-22 | 2023 | | |
| CRISPR Inhibition of Essential Peptidoglycan Biosynthesis Genes in Mycobacterium abscessus and Its Impact on beta-Lactam Susceptibility. | Kurepina N, Chen L, Composto K, Rifat D, Nuermberger EL, Kreiswirth BN. | Antimicrob Agents Chemother | 10.1128/aac.00093-22 | 2022 | | |
| In vitro and intracellular inhibitory activities of nosiheptide against Mycobacterium abscessus. | Zhu R, Yu X, Zhang T, Kong Y, Wang F, Jia J, Xue Y, Huang H. | Front Microbiol | 10.3389/fmicb.2022.926361 | 2022 | | |
| ENaC is a host susceptibility factor to bacterial infections in cystic fibrosis context. | Toure H, Durand N, Orgeur M, Galindo LA, Girard-Misguich F, Guenal I, Herrmann JL, Szuplewski S. | Commun Biol | 10.1038/s42003-025-07877-4 | 2025 | | |
| Noncanonical Mismatch Repair Protein NucS Modulates the Emergence of Antibiotic Resistance in Mycobacterium abscessus. | Fressatti Cardoso R, Martin-Blecua I, Pietrowski Baldin V, Meneguello JE, Valverde JR, Blazquez J, Castaneda-Garcia A. | Microbiol Spectr | 10.1128/spectrum.02228-22 | 2022 | | |
| Aortic endograft infection by Mycobacterium abscessus subsp. massiliense with acquired clarithromycin resistance: a case report. | Akiyama Y, Iwamoto N, Kamada K, Yoshida A, Osugi A, Mitarai S, Suzuki T, Yamamoto K, Nagashima M, Horai T, Ohmagari N. | BMC Infect Dis | 10.1186/s12879-023-08702-1 | 2023 | | |
| Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro. | Li A, He S, Li J, Zhang Z, Li B, Chu H. | Microbiol Spectr | 10.1128/spectrum.00718-23 | 2023 | | |
| Mab2780c, a TetV-like efflux pump, confers high-level spectinomycin resistance in mycobacterium abscessus. | Hurst-Hess KR, Phelps GA, Wilt LA, Lee RE, Ghosh P. | Tuberculosis (Edinb) | 10.1016/j.tube.2022.102295 | 2023 | | |
| Pathogenicity | Mycobacterium abscessus VapC5 toxin potentiates evasion of antibiotic killing by ribosome overproduction and activation of multiple resistance pathways. | Troian EA, Maldonado HM, Chauhan U, Barth VC, Woychik NA. | Nat Commun | 10.1038/s41467-023-38844-4 | 2023 | |
| Development of 2nd generation aminomethyl spectinomycins that overcome native efflux in Mycobacterium abscessus. | Phelps GA, Cheramie MN, Fernando DM, Selchow P, Meyer CJ, Waidyarachchi SL, Dharuman S, Liu J, Meuli M, Molin MD, Killam BY, Murphy PA, Reeve SM, Wilt LA, Anderson SM, Yang L, Lee RB, Temrikar ZH, Lukka PB, Meibohm B, Polikanov YS, Hobbie SN, Bottger EC, Sander P, Lee RE. | Proc Natl Acad Sci U S A | 10.1073/pnas.2314101120 | 2024 | | |
| A dual-plasmid CRISPR/Cas9-based method for rapid and efficient genetic disruption in Mycobacterium abscessus. | Neo DM, Clatworthy AE, Hung DT. | J Bacteriol | 10.1128/jb.00335-23 | 2024 | | |
| Mycobacterium abscessus pulmonary infection and associated respiratory function in cystic fibrosis-like betaENaC mice. | Pearce CM, Shaw TD, Podell B, Jackson M, Henao-Tamayo M, Obregon-Henao A, Lam H, Alshiraihi IM, O'Neal W, Livraghi-Butrico A, Hickey AJ, Meibohm B, Gonzalez-Juarrero M. | Front Tuberc | 10.3389/ftubr.2024.1473341 | 2024 | | |
| Metabolism | Characterization of Exosomes Released from Mycobacterium abscessus-Infected Macrophages. | Vermeire CA, Tan X, Ramos-Leyva A, Wood A, Kotey SK, Hartson SD, Liang Y, Liu L, Cheng Y. | Proteomics | 10.1002/pmic.202400181 | 2025 | |
| Pathogenicity | Phosphatidylserine liposomes induce a phagosome acidification-dependent and ROS-mediated intracellular killing of Mycobacterium abscessus in human macrophages. | Olimpieri T, Poerio N, Ponsecchi G, Di Lallo G, D'Andrea MM, Fraziano M. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1443719 | 2024 | |
| Loss of allosteric regulation in alpha-isopropylmalate synthase identified as an antimicrobial resistance mechanism. | Sullivan JR, Courtine C, Taylor L, Solomon O, Behr MA. | NPJ Antimicrob Resist | 10.1038/s44259-023-00005-4 | 2023 | | |
| Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection. | Negatu DA, Gonzalez Del Rio R, Cacho-Izquierdo M, Barros-Aguirre D, Lelievre J, Rullas J, Casado P, Ganapathy US, Zimmerman MD, Gengenbacher M, Dartois V, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.01459-22 | 2023 | | |
| Global prevalence of Mycobacterium massiliense strains with recombinant rpoB genes (Rec-Mas) horizontally transferred from Mycobacterium abscessus: two major types, dominant circulating clone 7 and MLST ST46 sequence type. | Kim DH, Seo H, Jung S, Kim B-J. | Microbiol Spectr | 10.1128/spectrum.01935-24 | 2024 | | |
| Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice. | Aragaw WW, Roubert C, Fontaine E, Lagrange S, Zimmerman MD, Dartois V, Gengenbacher M, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.01400-21 | 2022 | | |
| 2-Aminoimidazoles Inhibit Mycobacterium abscessus Biofilms in a Zinc-Dependent Manner. | Belardinelli JM, Li W, Martin KH, Zeiler MJ, Lian E, Avanzi C, Wiersma CJ, Nguyen TV, Angala B, de Moura VCN, Jones V, Borlee BR, Melander C, Jackson M. | Int J Mol Sci | 10.3390/ijms23062950 | 2022 | | |
| Evolution toward extremely high imipenem resistance in Mycobacterium abscessus outbreak strains. | Le Run E, Tettelin H, Holland SM, Zelazny AM. | Antimicrob Agents Chemother | 10.1128/aac.00673-24 | 2024 | | |
| Genetics | Genomic Analysis of Mycobacterium abscessus Complex Isolates from Patients with Pulmonary Infection in China. | Jin P, Dai J, Guo Y, Wang X, Lu J, Zhu Y, Yu F. | Microbiol Spectr | 10.1128/spectrum.00118-22 | 2022 | |
| In Vitro Bedaquiline and Clofazimine Susceptibility Testing in Mycobacterium abscessus. | Schulthess B, Akdogan Kittana FN, Homke R, Sander P. | Antimicrob Agents Chemother | 10.1128/aac.02346-21 | 2022 | | |
| C25-modified rifamycin derivatives with improved activity against Mycobacterium abscessus. | Paulowski L, Beckham KSH, Johansen MD, Berneking L, Van N, Degefu Y, Staack S, Sotomayor FV, Asar L, Rohde H, Aldridge BB, Aepfelbacher M, Parret A, Wilmanns M, Kremer L, Combrink K, Maurer FP. | PNAS Nexus | 10.1093/pnasnexus/pgac130 | 2022 | | |
| Prodrug florfenicol amine is activated by intrinsic resistance to target Mycobacterium abscessus. | Phelps GA, Kurt S, Jenner AR, Anderson SM, Jayasinghe TD, Griffith EC, Thompson CW, Yang L, Wicki B, Bright FK, Loudon V, Wright WC, Srivastava A, Singh A, Thalluri B, Park H, Lee RB, Wright AK, Grant-Chapman O, Conner DK, Troyer BT, Iverson A, Ochoado J, Pagala VR, Wu L, Byrum S, Fu Y, Yuan ZF, High AA, Schulthess B, Rosch JW, Geeleher P, Hobbie SN, Boeck L, Meibohm B, Obregon-Henao A, Sander P, Lee RE. | Nat Microbiol | 10.1038/s41564-025-02147-9 | 2025 | | |
| A Novel Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Expresses Anti-Mycobacterium abscessus Activity In Vitro and In Vivo. | Wu W, He S, Li A, Guo Q, Tan Z, Liu S, Wang X, Zhang Z, Li B, Chu H. | Antimicrob Agents Chemother | 10.1128/aac.00601-22 | 2022 | | |
| Analysis of Phenotypic and Genotypic Susceptibility to Clarithromycin and Amikacin of Mycobacterium abscessus Complex Strains Isolated from Cystic Fibrosis Patients. | Cao Yao JC, Navas Mendez J, Tortola Fernandez MT. | Microorganisms | 10.3390/microorganisms11122897 | 2023 | | |
| A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity In Vitro. | Guo Q, Xu L, Tan F, Zhang Y, Fan J, Wang X, Zhang Z, Li B, Chu H. | Antimicrob Agents Chemother | 10.1128/aac.00889-21 | 2021 | | |
| MarR-Dependent Transcriptional Regulation of mmpSL5 Induces Ethionamide Resistance in Mycobacterium abscessus. | Rodriguez R, Campbell-Kruger N, Gonzalez Camba J, Berude J, Fetterman R, Stanley S. | Antimicrob Agents Chemother | 10.1128/aac.01350-22 | 2023 | | |
| Genetic Determinants of Tigecycline Resistance in Mycobacteroides abscessus. | Ng HF, Ngeow YF. | Antibiotics (Basel) | 10.3390/antibiotics11050572 | 2022 | | |
| In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria. | Zhang T, Du J, Dong L, Wang F, Zhao L, Jia J, Wang C, Cheng M, Yu X, Huang H. | Microbiol Spectr | 10.1128/spectrum.03238-22 | 2023 | | |
| Enzymology | Inactivation kinetics of 280 nm UV-LEDs against Mycobacterium abscessus in water. | Song JJX, Oguma K, Takizawa S. | Sci Rep | 10.1038/s41598-023-29338-w | 2023 | |
| Genetics | Characterization of the cluster MabR prophages of Mycobacterium abscessus and Mycobacterium chelonae. | Cote J, Welch C, Kimble M, Archambault D, Ross JC, Orellana H, Amero K, Bourett C, Daigle A, Hutchison KW, Molloy SD. | G3 (Bethesda) | 10.1093/g3journal/jkac188 | 2022 | |
| Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus. | Belardinelli JM, Verma D, Li W, Avanzi C, Wiersma CJ, Williams JT, Johnson BK, Zimmerman M, Whittel N, Angala B, Wang H, Jones V, Dartois V, de Moura VCN, Gonzalez-Juarrero M, Pearce C, Schenkel AR, Malcolm KC, Nick JA, Charman SA, Wells TNC, Podell BK, Vennerstrom JL, Ordway DJ, Abramovitch RB, Jackson M. | Sci Transl Med | 10.1126/scitranslmed.abj3860 | 2022 | | |
| Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of M. abscessus lung disease. | Ignatius EH, Rimal B, Panthi CM, Belz DC, Lippincott CK, Deck DH, Serio AW, Lamichhane G. | mSphere | 10.1128/msphere.00381-24 | 2024 | | |
| A Pivotal Role for Mycobactin/mbtE in Growth and Adaptation of Mycobacterium abscessus. | Foreman M, Kolodkin-Gal I, Barkan D. | Microbiol Spectr | 10.1128/spectrum.02623-22 | 2022 | | |
| Enzymology | Crystal structure of MAB_4123, a putative flavin-dependent monooxygenase from Mycobacterium abscessus. | Ung KL, Poussineau C, Couston J, Alsarraf HMAB, Blaise M. | Acta Crystallogr F Struct Biol Commun | 10.1107/s2053230x2300345x | 2023 | |
| Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease. | Rimal B, Nicklas DA, Panthi CM, Lippincott CK, Belz DC, Ignatius EH, Deck DH, Serio AW, Lamichhane G. | mSphere | 10.1128/msphere.00665-22 | 2023 | | |
| Dynamic 11C-Para-Aminobenzoic Acid Positron Emission Tomography/Computed Tomography for Visualizing Pulmonary Mycobacteroides abscessus Infections. | Masias-Leon Y, Ruiz-Gonzalez CE, Nino-Meza OJ, Singh M, Sarhan MO, Chen X, Flavahan K, Kronenberg A, Tucker EW, Freundlich JS, Lodge MA, Carroll LS, Parrish N, Lechtzin N, Jain SK. | Am J Respir Crit Care Med | 10.1164/rccm.202409-1792oc | 2025 | | |
| Pathogenicity | Combined Host- and Pathogen-Directed Therapy for the Control of Mycobacterium abscessus Infection. | Poerio N, Riva C, Olimpieri T, Rossi M, Lore NI, De Santis F, Henrici De Angelis L, Ciciriello F, D'Andrea MM, Lucidi V, Cirillo DM, Fraziano M. | Microbiol Spectr | 10.1128/spectrum.02546-21 | 2022 | |
| A laboratory perspective on Mycobacterium abscessus biofilm culture, characterization and drug activity testing. | Meliefste HM, Mudde SE, Ammerman NC, de Steenwinkel JEM, Bax HI. | Front Microbiol | 10.3389/fmicb.2024.1392606 | 2024 | | |
| Enzymology | Mycothione reductase as a potential target in the fight against Mycobacterium abscessus infections. | Piller T, De Vooght L, Gansemans Y, Van Nieuwerburgh F, Cos P. | mSphere | 10.1128/msphere.00669-23 | 2024 | |
| Anti-Mycobacterium abscessus Activity of Tuberculosis F-ATP Synthase Inhibitor GaMF1. | Ragunathan P, Dick T, Gruber G. | Antimicrob Agents Chemother | 10.1128/aac.00018-22 | 2022 | | |
| Lsr2, a pleiotropic regulator at the core of the infectious strategy of Mycobacterium abscessus. | Gerges E, Rodriguez-Ordonez MdP, Durand N, Herrmann J-L, Cremazy F. | Microbiol Spectr | 10.1128/spectrum.03528-23 | 2024 | | |
| In Vitro Activity of Bedaquiline and Imipenem against Actively Growing, Nutrient-Starved, and Intracellular Mycobacterium abscessus. | Martins O, Lee J, Kaushik A, Ammerman NC, Dooley KE, Nuermberger EL. | Antimicrob Agents Chemother | 10.1128/aac.01545-21 | 2021 | | |
| Sudapyridine (WX-081) antibacterial activity against Mycobacterium avium, Mycobacterium abscessus, and Mycobacterium chelonae in vitro and in vivo. | Zheng L, Wang H, Qi X, Zhang W, Wang B, Fu L, Chen X, Chen X, Lu Y. | mSphere | 10.1128/msphere.00518-23 | 2024 | | |
| MAB_2355c Confers Macrolide Resistance in Mycobacterium abscessus by Ribosome Protection. | Guo Q, Zhang Y, Fan J, Zhang H, Zhang Z, Li B, Chu H. | Antimicrob Agents Chemother | 10.1128/aac.00330-21 | 2021 | | |
| The unusual convergence of steroid catabolic pathways in Mycobacterium abscessus. | Crowe AM, Krekhno JMC, Brown KL, Kulkarni JA, Yam KC, Eltis LD. | Proc Natl Acad Sci U S A | 10.1073/pnas.2207505119 | 2022 | | |
| Sitafloxacin Expresses Potent Anti-Mycobacterium abscessus Activity. | He S, Guo Q, Zhao L, Xu L, Fan J, Wu W, Zhang Z, Li B, Chu H. | Front Microbiol | 10.3389/fmicb.2021.779531 | 2021 | | |
| Enzymology | Time-dependent pharmacodynamics of amikacin on Mycobacterium abscessus growth and resistance emergence. | Gibson JE, Nandanwar N, Neely MN. | Microbiol Spectr | 10.1128/spectrum.03222-23 | 2024 | |
| Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus. | Negatu DA, Beuchel A, Madani A, Alvarez N, Chen C, Aragaw WW, Zimmerman MD, Laleu B, Gengenbacher M, Dartois V, Imming P, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.00676-21 | 2021 | | |
| A Rough Colony Morphology of Mycobacterium abscessus Is Associated With Cavitary Pulmonary Disease and Poor Clinical Outcome. | Hedin W, Froberg G, Fredman K, Chryssanthou E, Selmeryd I, Gillman A, Orsini L, Runold M, Jonsson B, Schon T, Davies Forsman L. | J Infect Dis | 10.1093/infdis/jiad007 | 2023 | | |
| Polymicrobial interactions influence Mycobacterium abscessus co-existence and biofilm forming capabilities. | Nandanwar N, Gu G, Gibson JE, Neely MN. | Front Microbiol | 10.3389/fmicb.2024.1484510 | 2024 | | |
| The cell envelope of Mycobacterium abscessus and its role in pathogenesis. | Parmar S, Tocheva EI. | PLoS Pathog | 10.1371/journal.ppat.1011318 | 2023 | | |
| Unusually high clarithromycin resistance in Mycobacterium abscessus subsp. abscessus isolated from human gastric epithelium. | Chouhan D, Retnakumar RJ, Devi TB, Dharmaseelan S, Alexander SM, Devadas K, Chattopadhyay S, Nair GB, Pillai MR. | Front Microbiol | 10.3389/fmicb.2023.1193380 | 2023 | | |
| Phenylacetic acid metabolic genes are associated with Mycobacteroides abscessus dominant circulating clone 1. | Ross BN, Evans E, Whiteley M. | Microbiol Spectr | 10.1128/spectrum.01330-24 | 2024 | | |
| Genetics | Functional (re)annotation of Mycobacteroides abscessus proteome using integrative sequence and AI-based structural approaches. | Gnanasekar P, Gambhir S, Kinatukara P, Bhardwaj A. | Curr Res Struct Biol | 10.1016/j.crstbi.2025.100172 | 2025 | |
| Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options. | Recchia D, Stelitano G, Stamilla A, Gutierrez DL, Degiacomi G, Chiarelli LR, Pasca MR. | Int J Mol Sci | 10.3390/ijms24054635 | 2023 | | |
| A Genome-Wide Screen in Macrophages Defines Host Genes Regulating the Uptake of Mycobacterium abscessus. | Gilliland HN, Beckman OK, Olive AJ. | mSphere | 10.1128/msphere.00663-22 | 2023 | | |
| Development of tetracycline analogues with increased aqueous stability for the treatment of mycobacterial infections. | Liu J, Phelps GA, Dunn CM, Murphy PA, Wilt LA, Loudon V, Lee RB, Fernando D, Yang L, Tran KN, Troyer BT, Obregon-Henao A, Lee RE. | Tuberculosis (Edinb) | 10.1016/j.tube.2024.102592 | 2025 | | |
| Epetraborole Is Active against Mycobacterium abscessus. | Ganapathy US, Gengenbacher M, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.01156-21 | 2021 | | |
| Inducible Resistance to Amikacin in Mycobacterium abscessus Isolated in Beijing, China. | Zhang Z, Wang W, Wang Y, Xue Z, Li S, Pang Y. | Infect Drug Resist | 10.2147/idr.s357887 | 2022 | | |
| Antimicrobial Effect of Oxazolidinones and Its Synergistic Effect with Bedaquiline Against Mycobacterium abscessus Complex. | Gao T, Yao C, Shang Y, Su R, Zhang X, Ren W, Li S, Shu W, Pang Y, Li Q. | Infect Drug Resist | 10.2147/idr.s395750 | 2023 | | |
| Surface Dependent Inhibition of Mycobacterium abscessus by Diverse Pseudomonas aeruginosa Strains. | Idosa AW, Wozniak DJ, Hall-Stoodley L. | Microbiol Spectr | 10.1128/spectrum.02471-22 | 2022 | | |
| A glycosylated lipooctapeptide promotes uptake and growth of Mycobacterium abscessus in the host. | Leclercq LD, Le Moigne V, Daher W, Cortes M, Viljoen B, Tasrini Y, Trivelli X, Lavanant H, Schmitz-Afonso I, Durand N, Biet F, Guerardel Y, Kremer L, Herrmann JL. | Nat Commun | 10.1038/s41467-025-58455-5 | 2025 | | |
| Dectin-1-Independent Macrophage Phagocytosis of Mycobacterium abscessus. | Ochoa AE, Congel JH, Corley JM, Janssen WJ, Nick JA, Malcolm KC, Hisert KB. | Int J Mol Sci | 10.3390/ijms241311062 | 2023 | | |
| An Improved Method for Rapid Detection of Mycobacterium abscessus Complex Based on Species-Specific Lipid Fingerprint by Routine MALDI-TOF. | Jia Khor M, Broda A, Kostrzewa M, Drobniewski F, Larrouy-Maumus G. | Front Chem | 10.3389/fchem.2021.715890 | 2021 | | |
| Apramycin Overcomes the Inherent Lack of Antimicrobial Bactericidal Activity in Mycobacterium abscessus. | Selchow P, Ordway DJ, Verma D, Whittel N, Petrig A, Hobbie SN, Bottger EC, Sander P. | Antimicrob Agents Chemother | 10.1128/aac.01510-21 | 2022 | | |
| Pathogenicity | Efficacy of epetraborole against Mycobacterium abscessus is increased with norvaline. | Sullivan JR, Lupien A, Kalthoff E, Hamela C, Taylor L, Munro KA, Schmeing TM, Kremer L, Behr MA. | PLoS Pathog | 10.1371/journal.ppat.1009965 | 2021 | |
| Phenotype | The ability to detach from biofilms in the lung airways prior to transmission to another host is associated with the infectious phenotype of Mycobacterium abscessus. | Keefe B, Leestemaker-Palmer A, Bermudez LE. | Front Immunol | 10.3389/fimmu.2025.1508584 | 2025 | |
| Pathogenicity | The polyamino-isoprenyl enhancer NV716 enables the antibacterial activity of two families of multi-target inhibitors against the ESKAPEE bacterium Enterobacter cloacae. | Forest E, Lehoux J, Guy A, Durand T, Audebert S, Camoin L, Spilling CD, Crauste C, Canaan S, Brunel JM, Bolla JM, Cavalier JF. | mLife | 10.1002/mlf2.70014 | 2025 | |
| Glby, Encoded by MAB_3167c, Is Required for In Vivo Growth of Mycobacteroides abscessus and Exhibits Mild beta-Lactamase Activity. | Galanis C, Maggioncalda EC, Kumar P, Lamichhane G. | J Bacteriol | 10.1128/jb.00046-22 | 2022 | | |
| Metabolism | In Mycobacterium abscessus, the Stringent Factor Rel Regulates Metabolism but Is Not the Only (p)ppGpp Synthase. | Hunt-Serracin AC, Kazi MI, Boll JM, Boutte CC. | J Bacteriol | 10.1128/jb.00434-21 | 2022 | |
| Pathogenicity | In Vitro Resistance against DNA Gyrase Inhibitor SPR719 in Mycobacterium avium and Mycobacterium abscessus. | Aragaw WW, Cotroneo N, Stokes S, Pucci M, Critchley I, Gengenbacher M, Dick T. | Microbiol Spectr | 10.1128/spectrum.01321-21 | 2022 | |
| Antibacterial activity of the novel compound Sudapyridine (WX-081) against Mycobacterium abscessus. | Nie W, Gao S, Su L, Liu L, Geng R, You Y, Chu N. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1217975 | 2023 | | |
| Enzymology | Blocking Bacterial Naphthohydroquinone Oxidation and ADP-Ribosylation Improves Activity of Rifamycins against Mycobacterium abscessus. | Ganapathy US, Lan T, Krastel P, Lindman M, Zimmerman MD, Ho H, Sarathy JP, Evans JC, Dartois V, Aldrich CC, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.00978-21 | 2021 | |
| In Vitro Synergistic Effects of Omadacycline with Other Antimicrobial Agents against Mycobacterium abscessus. | Fujiwara K, Aono A, Asami T, Morimoto K, Kamada K, Morishige Y, Igarashi Y, Chikamatsu K, Murase Y, Yamada H, Takaki A, Mitarai S. | Antimicrob Agents Chemother | 10.1128/aac.01579-22 | 2023 | | |
| Clinically relevant mutations in the PhoR sensor kinase of host-adapted Mycobacterium abscessus isolates impact response to acidic pH and virulence. | Belardinelli JM, Arora D, Avanzi C, Wheat WH, Bryant JM, Spencer JS, Blundell TL, Parkhill J, Floto RA, Jackson M. | Microbiol Spectr | 10.1128/spectrum.01588-23 | 2023 | | |
| Microevolution, reinfection and highly complex genomic diversity in patients with sequential isolates of Mycobacterium abscessus. | Buenestado-Serrano S, Martinez-Lirola M, Herranz-Martin M, Esteban J, Broncano-Lavado A, Molero-Salinas A, Sanz-Perez A, Blazquez J, Ruedas-Lopez A, Toro C, Lopez-Roa P, Domingo D, Zamarron E, Ruiz Serrano MJ, Munoz P, Perez-Lago L, Garcia de Viedma D. | Nat Commun | 10.1038/s41467-024-46552-w | 2024 | | |
| Antibacterial activity of the novel oxazolidinone contezolid (MRX-I) against Mycobacterium abscessus. | Gao S, Nie W, Liu L, Su L, You Y, Geng R, Chu N. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1225341 | 2023 | | |
| First Penicillin-Binding Protein Occupancy Patterns for 15 beta-Lactams and beta-Lactamase Inhibitors in Mycobacterium abscessus. | Sayed ARM, Shah NR, Basso KB, Kamat M, Jiao Y, Moya B, Sutaria DS, Lang Y, Tao X, Liu W, Shin E, Zhou J, Werkman C, Louie A, Drusano GL, Bulitta JB. | Antimicrob Agents Chemother | 10.1128/aac.01956-20 | 2020 | | |
| Comparative survival of environmental and clinical Mycobacterium abscessus isolates in a variety of diverse host cells. | Vang CK, Dawrs SN, Oberlag NM, Gilmore AE, Hasan NA, Honda JR. | J Appl Microbiol | 10.1111/jam.15416 | 2022 | | |
| Predominantly Orphan Secretome in the Lung Pathogen Mycobacterium abscessus Revealed by a Multipronged Growth-Phase-Driven Strategy. | Chandra H, Gupta MK, Lam YW, Yadav JS. | Microorganisms | 10.3390/microorganisms12020378 | 2024 | | |
| In vitro Susceptibility of Nontuberculous Mycobacteria to Tedizolid. | Zhang H, Hua W, Lin S, Zhang Y, Chen X, Wang S, Chen J, Zhang W. | Infect Drug Resist | 10.2147/idr.s362583 | 2022 | | |
| Mycobacterium abscessus HelR interacts with RNA polymerase to confer intrinsic rifamycin resistance. | Hurst-Hess KR, Saxena A, Rudra P, Yang Y, Ghosh P. | Mol Cell | 10.1016/j.molcel.2022.06.034 | 2022 | | |
| T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with beta-Lactams Imipenem and Cefditoren. | Rimal B, Batchelder HR, Story-Roller E, Panthi CM, Tabor C, Nuermberger EL, Townsend CA, Lamichhane G. | Antimicrob Agents Chemother | 10.1128/aac.00536-22 | 2022 | | |
| Structural and Mechanistic Insights into Mycobacterium abscessus Aspartate Decarboxylase PanD and a Pyrazinoic Acid-Derived Inhibitor. | Saw WG, Leow CY, Harikishore A, Shin J, Cole MS, Aragaw WW, Ragunathan P, Hegde P, Aldrich CC, Dick T, Gruber G. | ACS Infect Dis | 10.1021/acsinfecdis.2c00133 | 2022 | | |
| Synthesis and Characterization of Phenylalanine Amides Active against Mycobacterium abscessus and Other Mycobacteria. | Lang M, Ganapathy US, Mann L, Abdelaziz R, Seidel RW, Goddard R, Sequenzia I, Hoenke S, Schulze P, Aragaw WW, Csuk R, Dick T, Richter A. | J Med Chem | 10.1021/acs.jmedchem.3c00009 | 2023 | | |
| In Vitro and In Vivo Activity of Gepotidacin against Drug-Resistant Mycobacterial Infections. | Ahmad MN, Garg T, Singh S, Shukla R, Malik P, Krishnamurthy RV, Kaur P, Chopra S, Dasgupta A. | Antimicrob Agents Chemother | 10.1128/aac.00564-22 | 2022 | | |
| Genetics | Molecular Epidemiology of Mycobacterium abscessus Isolates Recovered from German Cystic Fibrosis Patients. | Wetzstein N, Diricks M, Kohl TA, Wichelhaus TA, Andres S, Paulowski L, Schwarz C, Lewin A, Kehrmann J, Kahl BC, Dichtl K, Hugel C, Eickmeier O, Smaczny C, Schmidt A, Zimmermann S, Nahrlich L, Hafkemeyer S, Niemann S, Maurer FP, Hogardt M. | Microbiol Spectr | 10.1128/spectrum.01714-22 | 2022 | |
| AR-12 Exhibits Direct and Host-Targeted Antibacterial Activity toward Mycobacterium abscessus. | Zhang S, Zou Y, Guo Q, Chen J, Xu L, Wan X, Zhang Z, Li B, Chu H. | Antimicrob Agents Chemother | 10.1128/aac.00236-20 | 2020 | | |
| Biotechnology | Targeted labeling and depletion of alveolar macrophages using VeDTR mouse technology. | Nakayama Y, Sasai M, Kuratani A, Okamoto M, Okuzaki D, Yamamoto K, Ono C, Yamaguchi M, Kawabata S, Shinjyo N, Okabe Y, Matsuura Y, Ato M, Yamamoto M. | iScience | 10.1016/j.isci.2025.111975 | 2025 | |
| Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections. | Negatu DA, Aragaw WW, Cangialosi J, Dartois V, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.01655-22 | 2023 | | |
| The Prophage and Plasmid Mobilome as a Likely Driver of Mycobacterium abscessus Diversity. | Dedrick RM, Aull HG, Jacobs-Sera D, Garlena RA, Russell DA, Smith BE, Mahalingam V, Abad L, Gauthier CH, Hatfull GF. | mBio | 10.1128/mbio.03441-20 | 2021 | | |
| Detection of Mtb and NTM: preclinical validation of a new asymmetric PCR-binary deoxyribozyme sensor assay. | Neves YCd, Reis AJ, Rodrigues MA, Chimara E, da Silva Lourenco MC, Fountain J, Ramis IB, von Groll A, Gerasimova Y, Rohde KH, Almeida da Silva PE. | Microbiol Spectr | 10.1128/spectrum.03506-23 | 2024 | | |
| Genetics | Molecular epidemiology and phylogenomic analysis of Mycobacterium abscessus clinical isolates in an Asian population. | Chew KL, Octavia S, Jureen R, Ng OT, Marimuthu K, Lin RTP, Teo JWP. | Microb Genom | 10.1099/mgen.0.000708 | 2021 | |
| Carbonyl Cyanide 3-Chlorophenylhydrazone (CCCP) Exhibits Direct Antibacterial Activity Against Mycobacterium abscessus. | Chen S, Teng T, Zhang Z, Shang Y, Xiao H, Jiang G, Wang F, Jia J, Dong L, Zhao L, Chu N, Huang H. | Infect Drug Resist | 10.2147/idr.s303113 | 2021 | | |
| Ribosome Protection as a Mechanism of Lincosamide Resistance in Mycobacterium abscessus. | Hurst-Hess KR, Rudra P, Ghosh P. | Antimicrob Agents Chemother | 10.1128/aac.01184-21 | 2021 | | |
| Unveiling the Biosynthetic Pathway for Short Mycolic Acids in Nontuberculous Mycobacteria: Mycobacterium smegmatis MSMEG_4301 and Its Ortholog Mycobacterium abscessus MAB_1915 Are Essential for the Synthesis of alpha'-Mycolic Acids. | Di Capua CB, Belardinelli JM, Carignano HA, Buchieri MV, Suarez CA, Morbidoni HR. | Microbiol Spectr | 10.1128/spectrum.01288-22 | 2022 | | |
| Genetics | A Simplified and Efficient Method for Himar-1 Transposon Sequencing in Bacteria, Demonstrated by Creation and Analysis of a Saturated Transposon-Mutant Library in Mycobacterium abscessus. | Foreman M, Gershoni M, Barkan D. | mSystems | 10.1128/msystems.00976-20 | 2020 | |
| Redesign of Rifamycin Antibiotics to Overcome ADP-Ribosylation-Mediated Resistance. | Lan T, Ganapathy US, Sharma S, Ahn YM, Zimmerman M, Molodtsov V, Hegde P, Gengenbacher M, Ebright RH, Dartois V, Freundlich JS, Dick T, Aldrich CC. | Angew Chem Int Ed Engl | 10.1002/anie.202211498 | 2022 | | |
| Genomic epidemiology of Mycobacterium abscessus in a Canadian cystic fibrosis centre. | Waglechner N, Tullis E, Stephenson AL, Waters V, McIntosh F, Ma J, Jamieson FB, Behr MA, Batt J, Lee RS. | Sci Rep | 10.1038/s41598-022-19666-8 | 2022 | | |
| Reduced Sphingosine in Cystic Fibrosis Increases Susceptibility to Mycobacterium abscessus Infections. | Schnitker F, Liu Y, Keitsch S, Soddemann M, Verhasselt HL, Kehrmann J, Grassme H, Kamler M, Gulbins E, Wu Y. | Int J Mol Sci | 10.3390/ijms241814004 | 2023 | | |
| Increased Virulence of Outer Membrane Porin Mutants of Mycobacterium abscessus. | de Moura VCN, Verma D, Everall I, Brown KP, Belardinelli JM, Shanley C, Stapleton M, Parkhill J, Floto RA, Ordway DJ, Jackson M. | Front Microbiol | 10.3389/fmicb.2021.706207 | 2021 | | |
| Genetics | Host DNA depletion can increase the sensitivity of Mycobacterium spp. detection through shotgun metagenomics in sputum. | Kok NA, Peker N, Schuele L, de Beer JL, Rossen JWA, Sinha B, Couto N. | Front Microbiol | 10.3389/fmicb.2022.949328 | 2022 | |
| Mycobacterium abscessus DosRS two-component system controls a species-specific regulon required for adaptation to hypoxia. | Simcox BS, Tomlinson BR, Shaw LN, Rohde KH. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1144210 | 2023 | | |
| Polysaccharide Succinylation Enhances the Intracellular Survival of Mycobacterium abscessus. | Palcekova Z, Gilleron M, Angala SK, Belardinelli JM, McNeil M, Bermudez LE, Jackson M. | ACS Infect Dis | 10.1021/acsinfecdis.0c00361 | 2020 | | |
| Genetics | Genomic Analyses of Longitudinal Mycobacterium abscessus Isolates in a Multicenter Cohort Reveal Parallel Signatures of In-Host Adaptation. | Choi J, Keen EC, Wallace MA, Fishbein S, Prusa J, Zimbric M, Mejia-Chew CR, Mehta SB, Bailey TC, Caverly LJ, Burnham CD, Dantas G. | J Infect Dis | 10.1093/infdis/jiad187 | 2023 | |
| The risk of pulmonary NTM infections and water-quality constituents among persons with cystic fibrosis in the United States, 2010-2019. | Lipner EM, French JP, Mercaldo RA, Nelson S, Zelazny AM, Marshall JE, Strong M, Falkinham JO, Prevots DR. | Environ Epidemiol | 10.1097/ee9.0000000000000266 | 2023 | | |
| Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance. | Dedrick RM, Smith BE, Garlena RA, Russell DA, Aull HG, Mahalingam V, Divens AM, Guerrero-Bustamante CA, Zack KM, Abad L, Gauthier CH, Jacobs-Sera D, Hatfull GF. | mBio | 10.1128/mbio.03431-20 | 2021 | | |
| "One-Two Punch": Synergistic ß-Lactam Combinations for Mycobacterium abscessus and Target Redundancy in the Inhibition of Peptidoglycan Synthesis Enzymes. | Nguyen DC, Dousa KM, Kurz SG, Brown ST, Drusano G, Holland SM, Kreiswirth BN, Boom WH, Daley CL, Bonomo RA. | Clin Infect Dis | 10.1093/cid/ciab535 | 2021 | | |
| Pathogenicity | In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of Mycobacterium abscessus. | Kaushik A, Ammerman NC, Martins O, Parrish NM, Nuermberger EL. | Antimicrob Agents Chemother | 10.1128/aac.00470-19 | 2019 | |
| ALA_PDT Promotes Ferroptosis-Like Death of Mycobacterium abscessus and Antibiotic Sterilization via Oxidative Stress. | Wang X, Wan M, Zhang L, Dai Y, Hai Y, Yue C, Xu J, Ding Y, Wang M, Xie J, Lei X, Zhong JL. | Antioxidants (Basel) | 10.3390/antiox11030546 | 2022 | | |
| Human pluripotent stem cell-derived macrophages host Mycobacterium abscessus infection. | Sun S, See M, Nim HT, Strumila K, Ng ES, Hidalgo A, Ramialison M, Sutton P, Elefanty AG, Sarkar S, Stanley EG. | Stem Cell Reports | 10.1016/j.stemcr.2022.07.013 | 2022 | | |
| Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates In Vitro and in a Mouse Model of Pulmonary Infection. | Nicklas DA, Maggioncalda EC, Story-Roller E, Eichelman B, Tabor C, Serio AW, Keepers TR, Chitra S, Lamichhane G. | Antimicrob Agents Chemother | 10.1128/aac.01704-21 | 2022 | | |
| Mycobacterium abscessus Opsonization Allows an Escape from the Defensin Bactericidal Action in Drosophila. | Toure H, Durand N, Guenal I, Herrmann JL, Girard-Misguich F, Szuplewski S. | Microbiol Spectr | 10.1128/spectrum.00777-23 | 2023 | | |
| Pathogenicity | Biofilms of Mycobacterium abscessus Complex Can Be Sensitized to Antibiotics by Disaggregation and Oxygenation. | Kolpen M, Jensen PO, Qvist T, Kragh KN, Ravnholt C, Fritz BG, Johansen UR, Bjarnsholt T, Hoiby N. | Antimicrob Agents Chemother | 10.1128/aac.01212-19 | 2020 | |
| Metabolism | The Antimalarial Mefloquine Shows Activity against Mycobacterium abscessus, Inhibiting Mycolic Acid Metabolism. | Degiacomi G, Chiarelli LR, Recchia D, Petricci E, Gianibbi B, Fiscarelli EV, Fattorini L, Manetti F, Pasca MR. | Int J Mol Sci | 10.3390/ijms22168533 | 2021 | |
| Highly Discriminative Genotyping of Mycobacterium abscessus Complex Using a Set of Variable Number Tandem Repeats in China. | Huang L, Li H, Ren W, Zhang X, Shang Y, Liu Y, Liu A, Pang Y. | Front Microbiol | 10.3389/fmicb.2021.802133 | 2021 | | |
| Genetics | Genomic Analysis of Mycobacterium abscessus Complex Isolates Collected in Ireland between 2006 and 2017. | Redondo N, Mok S, Montgomery L, Flanagan PR, McNamara E, Smyth EG, O'Sullivan N, Schaffer K, Rogers TR, Fitzgibbon MM. | J Clin Microbiol | 10.1128/jcm.00295-20 | 2020 | |
| Genetics | Whole-Genome Sequencing and Drug-Susceptibility Analysis of Serial Mycobacterium abscessus Isolates from Thai Patients. | Kaewprasert O, Nonghanphithak D, Chetchotisakd P, Namwat W, Ong RT, Faksri K. | Biology (Basel) | 10.3390/biology11091319 | 2022 | |
| Rifabutin Suppresses Inducible Clarithromycin Resistance in Mycobacterium abscessus by Blocking Induction of whiB7 and erm41. | Aziz DB, Go ML, Dick T. | Antibiotics (Basel) | 10.3390/antibiotics9020072 | 2020 | | |
| Differential In Vitro Activities of Individual Drugs and Bedaquiline-Rifabutin Combinations against Actively Multiplying and Nutrient-Starved Mycobacterium abscessus. | Lee J, Ammerman N, Agarwal A, Naji M, Li SY, Nuermberger E. | Antimicrob Agents Chemother | 10.1128/aac.02179-20 | 2021 | | |
| Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane beta-Lactamase Inhibitor To Augment beta-Lactam Action. | Dousa KM, Nguyen DC, Kurz SG, Taracila MA, Bethel CR, Schinabeck W, Kreiswirth BN, Brown ST, Boom WH, Hotchkiss RS, Remy KE, Jacono FJ, Daley CL, Holland SM, Miller AA, Bonomo RA. | mBio | 10.1128/mbio.03529-21 | 2022 | | |
| Mycobacterium abscessus pathogenesis identified by phenogenomic analyses. | Boeck L, Burbaud S, Skwark M, Pearson WH, Sangen J, Wuest AW, Marshall EKP, Weimann A, Everall I, Bryant JM, Malhotra S, Bannerman BP, Kierdorf K, Blundell TL, Dionne MS, Parkhill J, Andres Floto R. | Nat Microbiol | 10.1038/s41564-022-01204-x | 2022 | | |
| Short Signature rpoB Gene Sequence to Differentiate Species in Mycobacterium abscessus Group. | Bao JR, Shier KL, Master RN, Jones RS, Clark RB. | Microbiol Spectr | 10.1128/spectrum.02534-21 | 2022 | | |
| Delineating Mycobacterium abscessus population structure and transmission employing high-resolution core genome multilocus sequence typing. | Diricks M, Merker M, Wetzstein N, Kohl TA, Niemann S, Maurer FP. | Nat Commun | 10.1038/s41467-022-32122-5 | 2022 | | |
| Development of Inhibitors of SAICAR Synthetase (PurC) from Mycobacterium abscessus Using a Fragment-Based Approach. | Charoensutthivarakul S, Thomas SE, Curran A, Brown KP, Belardinelli JM, Whitehouse AJ, Acebron-Garcia-de-Eulate M, Sangan J, Gramani SG, Jackson M, Mendes V, Floto RA, Blundell TL, Coyne AG, Abell C. | ACS Infect Dis | 10.1021/acsinfecdis.1c00432 | 2022 | | |
| Mycobacterium abscessus resists the innate cellular response by surviving cell lysis of infected phagocytes. | Toure H, Galindo LA, Lagune M, Glatigny S, Waterhouse RM, Guenal I, Herrmann JL, Girard-Misguich F, Szuplewski S. | PLoS Pathog | 10.1371/journal.ppat.1011257 | 2023 | | |
| Itaconic acid inhibits nontuberculous mycobacterial growth in pH dependent manner while 4-octyl-itaconic acid enhances THP-1 clearance of nontuberculous mycobacteria in vitro. | Breen P, Zimbric M, Caverly LJ. | PLoS One | 10.1371/journal.pone.0303516 | 2024 | | |
| Pathogenicity | In Vitro Activity of the New beta-Lactamase Inhibitors Relebactam and Vaborbactam in Combination with beta-Lactams against Mycobacterium abscessus Complex Clinical Isolates. | Kaushik A, Ammerman NC, Lee J, Martins O, Kreiswirth BN, Lamichhane G, Parrish NM, Nuermberger EL. | Antimicrob Agents Chemother | 10.1128/aac.02623-18 | 2019 | |
| Improving Protection to Prevent Bacterial Infections: Preliminary Applications of Reverse Vaccinology against the Main Cystic Fibrosis Pathogens. | Cocorullo M, Chiarelli LR, Stelitano G. | Vaccines (Basel) | 10.3390/vaccines11071221 | 2023 | | |
| Pathogenicity | Children With Cystic Fibrosis Are Infected With Multiple Subpopulations of Mycobacterium abscessus With Different Antimicrobial Resistance Profiles. | Shaw LP, Doyle RM, Kavaliunaite E, Spencer H, Balloux F, Dixon G, Harris KA. | Clin Infect Dis | 10.1093/cid/ciz069 | 2019 | |
| Metabolism | Phagosome Escape of Rough Mycobacterium abscessus Strains in Murine Macrophage via Phagosomal Rupture Can Lead to Type I Interferon Production and Their Cell-To-Cell Spread. | Kim BR, Kim BJ, Kook YH, Kim BJ. | Front Immunol | 10.3389/fimmu.2019.00125 | 2019 | |
| A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus. | Ganapathy US, Del Rio RG, Cacho-Izquierdo M, Ortega F, Lelievre J, Barros-Aguirre D, Aragaw WW, Zimmerman MD, Lindman M, Dartois V, Gengenbacher M, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.01514-21 | 2021 | | |
| Pathogenicity | Novel Mutations Associated with Clofazimine Resistance in Mycobacterium abscessus. | Chen Y, Chen J, Zhang S, Shi W, Zhang W, Zhu M, Zhang Y. | Antimicrob Agents Chemother | 10.1128/aac.00544-18 | 2018 | |
| An Antibody-Recruiting Molecule Enhances Fcgamma Receptor-Mediated Uptake and Killing of Mycobacterial Pathogens by Macrophages. | Dzigba P, Dekhtyar GAT, Hartman MJ, Winstead-Leroy KJ, Greenlee-Wacker MC, Swarts BM. | ACS Infect Dis | 10.1021/acsinfecdis.5c00097 | 2025 | | |
| 3-[(Benzo-1,3-dioxol-5-yl)amino]-4-methoxycyclobut-3-ene-1,2-dione: polymorphism and twinning of a precursor to an antimycobacterial squaramide. | Palme PR, Goddard R, Richter A, Imming P, Seidel RW. | Acta Crystallogr C Struct Chem | 10.1107/s2053229624006211 | 2024 | | |
| Pathogenicity | Antimicrobial peptides against drug resistant Mycobacterium abscessus. | da Silva JL, Gupta S, Olivier KN, Zelazny AM. | Res Microbiol | 10.1016/j.resmic.2020.03.001 | 2020 | |
| Mycobacterium tuberculosis Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 Compound. | Recchia D, Stelitano G, Egorova A, Batisti Biffignandi G, Savkova K, Kafkova R, Huszar S, Marino Cerrato A, Slayden RA, Cummings JE, Whittel N, Bauman AA, Robertson GT, Rank L, Urbina F, Lane TR, Ekins S, Riabova O, Kazakova E, Mikusova K, Sassera D, Degiacomi G, Chiarelli LR, Makarov V, Pasca MR. | ACS Infect Dis | 10.1021/acsinfecdis.4c01030 | 2025 | | |
| Genetics | Mutation rates and adaptive variation among the clinically dominant clusters of Mycobacterium abscessus. | Commins N, Sullivan MR, McGowen K, Koch EM, Rubin EJ, Farhat M. | Proc Natl Acad Sci U S A | 10.1073/pnas.2302033120 | 2023 | |
| Pathogenicity | Mycobacterium abscessus drug discovery using machine learning. | Schmalstig AA, Zorn KM, Murcia S, Robinson A, Savina S, Komarova E, Makarov V, Braunstein M, Ekins S. | Tuberculosis (Edinb) | 10.1016/j.tube.2022.102168 | 2022 | |
| High-Throughput Screening Identifies Synthetic Peptides with Antibacterial Activity against Mycobacterium abscessus and Serum Stability. | Iannuzo N, Haller YA, McBride M, Mehari S, Lainson JC, Diehnelt CW, Haydel SE. | ACS Omega | 10.1021/acsomega.2c02844 | 2022 | | |
| Efficacy of PBTZ169 and pretomanid against Mycobacterium avium, Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum in BALB/c mice models. | Zheng L, Qi X, Zhang W, Wang H, Fu L, Wang B, Chen X, Chen X, Lu Y. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1115530 | 2023 | | |
| Genetics | Cross-transmission Is Not the Source of New Mycobacterium abscessus Infections in a Multicenter Cohort of Cystic Fibrosis Patients. | Doyle RM, Rubio M, Dixon G, Hartley J, Klein N, Coll P, Harris KA. | Clin Infect Dis | 10.1093/cid/ciz526 | 2020 | |
| Synthesis and antibacterial action of 3',6'-disubstituted spectinomycins. | Dharuman S, Phelps GA, Dunn CM, Wilt LA, Murphy PA, Lee RB, Snoke HE, Selchow P, Haldimann K, Bottger EC, Hobbie SN, Sander P, Lee RE. | J Antibiot (Tokyo) | 10.1038/s41429-024-00750-2 | 2024 | | |
| Pathogenicity | Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination. | Pryjma M, Burian J, Thompson CJ. | Antimicrob Agents Chemother | 10.1128/aac.00283-18 | 2018 | |
| Pathogenicity | Synergistic Efficacy of beta-Lactam Combinations against Mycobacterium abscessus Pulmonary Infection in Mice. | Story-Roller E, Maggioncalda EC, Lamichhane G. | Antimicrob Agents Chemother | 10.1128/aac.00614-19 | 2019 | |
| Comparing the Utilities of Different Multilocus Sequence Typing Schemes for Identifying Outbreak Strains of Mycobacterium abscessus subsp. massiliense. | Cheng A, Sun HY, Tsai YT, Chang SY, Wu UI, Hsueh PR, Sheng WH, Chen YC, Chang SC. | J Clin Microbiol | 10.1128/jcm.01304-19 | 2019 | | |
| The small non-coding RNA B11 regulates multiple facets of Mycobacterium abscessus virulence. | Bar-Oz M, Martini MC, Alonso MN, Meir M, Lore NI, Miotto P, Riva C, Angala SK, Xiao J, Masiello CS, Misiakou MA, Sun H, Moy JK, Jackson M, Johansen HK, Cirillo DM, Shell SS, Barkan D. | PLoS Pathog | 10.1371/journal.ppat.1011575 | 2023 | | |
| Insights into the l,d-Transpeptidases and d,d-Carboxypeptidase of Mycobacterium abscessus: Ceftaroline, Imipenem, and Novel Diazabicyclooctane Inhibitors. | Dousa KM, Kurz SG, Taracila MA, Bonfield T, Bethel CR, Barnes MD, Selvaraju S, Abdelhamed AM, Kreiswirth BN, Boom WH, Kasperbauer SH, Daley CL, Bonomo RA. | Antimicrob Agents Chemother | 10.1128/aac.00098-20 | 2020 | | |
| Pathogenicity | Development of a penem antibiotic against Mycobacteroides abscessus. | Batchelder HR, Story-Roller E, Lloyd EP, Kaushik A, Bigelow KM, Maggioncalda EC, Nuermberger EL, Lamichhane G, Townsend CA. | Commun Biol | 10.1038/s42003-020-01475-2 | 2020 | |
| Arabinosyltransferase C Mediates Multiple Drugs Intrinsic Resistance by Altering Cell Envelope Permeability in Mycobacterium abscessus. | Wang S, Cai X, Yu W, Zeng S, Zhang J, Guo L, Gao Y, Lu Z, Hameed HMA, Fang C, Tian X, Yusuf B, Chhotaray C, Alam MDS, Zhang B, Ge H, Maslov DA, Cook GM, Peng J, Lin Y, Zhong N, Zhang G, Zhang T. | Microbiol Spectr | 10.1128/spectrum.02763-21 | 2022 | | |
| Challenges and a potential solution to perform drug susceptibility testing of omadacycline against nontuberculous mycobacteria. | Shankar P, Singh S, Boorgula GD, Gumbo T, Heysell SK, Srivastava S. | Tuberculosis (Edinb) | 10.1016/j.tube.2022.102269 | 2022 | | |
| Structural Characterization of Mycobacterium abscessus Phosphopantetheine Adenylyl Transferase Ligand Interactions: Implications for Fragment-Based Drug Design. | Thomas SE, McCarthy WJ, El Bakali J, Brown KP, Kim SY, Blaszczyk M, Mendes V, Abell C, Floto RA, Coyne AG, Blundell TL. | Front Mol Biosci | 10.3389/fmolb.2022.880432 | 2022 | | |
| Association between mutations in a thyX-hsdS.1 region and para-aminosalicylic acid resistance in Mycobacterium tuberculosis clinical isolates. | Zeng R, He L, Zhang B, Hu Y, Yu J, Yang S, Gu J, Wu Z, Deng J. | Emerg Microbes Infect | 10.1080/22221751.2023.2276339 | 2023 | | |
| Disruption of nontuberculous mycobacteria biofilms induces a highly vulnerable to antibiotic killing phenotype. | Kurbatfinski N, Hill PJ, Tobin N, Kramer CN, Wickham J, Goodman SD, Hall-Stoodley L, Bakaletz LO. | Biofilm | 10.1016/j.bioflm.2023.100166 | 2023 | | |
| Zinc Chelator N,N,N',N'-Tetrakis(2-Pyridylmethyl)Ethylenediamine Reduces the Resistance of Mycobacterium abscessus to Imipenem. | He S, Zou Y, Zhan M, Guo Q, Zhang Y, Zhang Z, Li B, Zhang S, Chu H. | Infect Drug Resist | 10.2147/idr.s267552 | 2020 | | |
| Subspecies-specific sequence detection for differentiation of Mycobacterium abscessus complex. | Minias A, Zukowska L, Lach J, Jagielski T, Strapagiel D, Kim SY, Koh WJ, Adam H, Bittner R, Truden S, Zolnir-Dovc M, Dziadek J. | Sci Rep | 10.1038/s41598-020-73607-x | 2020 | | |
| Pathogenicity | Indole-2-Carboxamides Are Active against Mycobacterium abscessus in a Mouse Model of Acute Infection. | Pandya AN, Prathipati PK, Hegde P, Li W, Graham KF, Mandal S, Drescher KM, Destache CJ, Ordway D, Jackson M, North EJ. | Antimicrob Agents Chemother | 10.1128/aac.02245-18 | 2019 | |
| Pathogenicity | A novel DNA chromatography method to discriminate Mycobacterium abscessus subspecies and macrolide susceptibility. | Yoshida M, Sano S, Chien JY, Fukano H, Suzuki M, Asakura T, Morimoto K, Murase Y, Miyamoto S, Kurashima A, Hasegawa N, Hsueh PR, Mitarai S, Ato M, Hoshino Y. | EBioMedicine | 10.1016/j.ebiom.2020.103187 | 2021 | |
| beta-Lactam Combinations That Exhibit Synergy against Mycobacteroides abscessus Clinical Isolates. | Story-Roller E, Galanis C, Lamichhane G. | Antimicrob Agents Chemother | 10.1128/aac.02545-20 | 2021 | | |
| Development of a loop-mediated isothermal amplification coupled lateral flow dipstick targeting erm(41) for detection of Mycobacterium abscessus and Mycobacterium massiliense. | Liu D, He W, Jiang M, Zhao B, Ou X, Liu C, Xia H, Zhou Y, Wang S, Song Y, Zheng Y, Chen Q, Fan J, He G, Zhao Y. | AMB Express | 10.1186/s13568-019-0734-4 | 2019 | | |
| Establishment and Validation of Galleria mellonella as a Novel Model Organism To Study Mycobacterium abscessus Infection, Pathogenesis, and Treatment. | Meir M, Grosfeld T, Barkan D. | Antimicrob Agents Chemother | 10.1128/aac.02539-17 | 2018 | | |
| A comprehensive evaluation of a novel targeted-sequencing workflow for Mycobacterium species identification and anti-tuberculosis drug-resistance detection. | Ou X, Pei S, Li H, Qin Z, Anthony R, Wang J, Song Z, Xing R, Zhang L, Teng C, Xia H, Zhou Y, Song Y, Zheng Y, Wang S, Zhao B, Zhao Y. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1584237 | 2025 | | |
| Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis. | Malcolm KC, Wheeler EA, Calhoun K, Lenhart-Pendergrass PM, Rysavy N, Poch KR, Caceres SM, Saavedra MT, Nick JA. | Microbiol Spectr | 10.1128/spectrum.01874-22 | 2022 | | |
| Pathogenicity | Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro. | Mukherjee D, Wu ML, Teo JWP, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.01298-17 | 2017 | |
| Phylogeny | Genome reorganization during emergence of host-associated Mycobacterium abscessus. | Bohr LL, Youngblom MA, Eldholm V, Pepperell CS. | Microb Genom | 10.1099/mgen.0.000706 | 2021 | |
| Pathogenicity | TBAJ-876, a 3,5-Dialkoxypyridine Analogue of Bedaquiline, Is Active against Mycobacterium abscessus. | Sarathy JP, Ganapathy US, Zimmerman MD, Dartois V, Gengenbacher M, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.02404-19 | 2020 | |
| In vivo screening for toxicity-modulating drug interactions identifies antagonism that protects against ototoxicity in zebrafish. | Bustad E, Mudrock E, Nilles EM, Mcquate A, Bergado M, Gu A, Galitan L, Gleason N, Ou HC, Raible DW, Hernandez RE, Ma S. | Front Pharmacol | 10.3389/fphar.2024.1363545 | 2024 | | |
| Pathogenicity | Mycobacterium abscessus WhiB7 Regulates a Species-Specific Repertoire of Genes To Confer Extreme Antibiotic Resistance. | Hurst-Hess K, Rudra P, Ghosh P. | Antimicrob Agents Chemother | 10.1128/aac.01347-17 | 2017 | |
| Pathogenicity | Select beta-Lactam Combinations Exhibit Synergy against Mycobacterium abscessus In Vitro. | Story-Roller E, Maggioncalda EC, Lamichhane G. | Antimicrob Agents Chemother | 10.1128/aac.02613-18 | 2019 | |
| A New Model of Chronic Mycobacterium abscessus Lung Infection in Immunocompetent Mice. | Riva C, Tortoli E, Cugnata F, Sanvito F, Esposito A, Rossi M, Colarieti A, Canu T, Cigana C, Bragonzi A, Lore NI, Miotto P, Cirillo DM. | Int J Mol Sci | 10.3390/ijms21186590 | 2020 | | |
| Teicoplanin - Tigecycline Combination Shows Synergy Against Mycobacterium abscessus. | Aziz DB, Teo JWP, Dartois V, Dick T. | Front Microbiol | 10.3389/fmicb.2018.00932 | 2018 | | |
| Enzymology | Rational Exploration of 2,4-Diaminopyrimidines as DHFR Inhibitors Active against Mycobacterium abscessus and Mycobacterium avium, Two Emerging Human Pathogens. | Andrade Meirelles M, Almeida VM, Sullivan JR, de Toledo I, Dos Reis CV, Cunha MR, Zigweid R, Shim A, Sankaran B, Woodward EL, Seibold S, Liu L, Mian MR, Battaile KP, Riley J, Duncan C, Simeons FRC, Ferguson L, Joji H, Read KD, Lovell S, Staker BL, Behr MA, Pilli RA, Counago RM. | J Med Chem | 10.1021/acs.jmedchem.4c01594 | 2024 | |
| Pathogenicity | Ex vivo infection of murine precision-cut lung tissue slices with Mycobacterium abscessus: a model to study antimycobacterial agents. | Molina-Torres CA, Flores-Castillo ON, Carranza-Torres IE, Guzman-Delgado NE, Viveros-Valdez E, Vera-Cabrera L, Ocampo-Candiani J, Verde-Star J, Castro-Garza J, Carranza-Rosales P. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-020-00399-3 | 2020 | |
| Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection. | Nick JA, Dedrick RM, Gray AL, Vladar EK, Smith BE, Freeman KG, Malcolm KC, Epperson LE, Hasan NA, Hendrix J, Callahan K, Walton K, Vestal B, Wheeler E, Rysavy NM, Poch K, Caceres S, Lovell VK, Hisert KB, de Moura VC, Chatterjee D, De P, Weakly N, Martiniano SL, Lynch DA, Daley CL, Strong M, Jia F, Hatfull GF, Davidson RM. | Cell | 10.1016/j.cell.2022.04.024 | 2022 | | |
| Pathogenicity | Activity of LCB01-0371, a Novel Oxazolidinone, against Mycobacterium abscessus. | Kim TS, Choe JH, Kim YJ, Yang CS, Kwon HJ, Jeong J, Kim G, Park DE, Jo EK, Cho YL, Jang J. | Antimicrob Agents Chemother | 10.1128/aac.02752-16 | 2017 | |
| What the Hel: recent advances in understanding rifampicin resistance in bacteria. | Sudzinova P, Sanderova H, Koval' T, Skalova T, Borah N, Hnilicova J, Kouba T, Dohnalek J, Krasny L. | FEMS Microbiol Rev | 10.1093/femsre/fuac051 | 2023 | | |
| Ethyl Acetate Fraction of Bixa orellana and Its Component Ellagic Acid Exert Antibacterial and Anti-Inflammatory Properties against Mycobacterium abscessus subsp. massiliense. | Moraes-Neto RN, Coutinho GG, Ataide ACS, de Oliveira Rezende A, Nascimento CEC, de Albuquerque RP, da Rocha CQ, Rego AS, de Sousa Cartagenes MDS, Abreu-Silva AL, Dos Santos IVF, Dos Santos CBR, Guerra RNM, Ribeiro RM, Monteiro-Neto V, de Sousa EM, Carvalho RC. | Antibiotics (Basel) | 10.3390/antibiotics11060817 | 2022 | | |
| Unique Features of Mycobacterium abscessus Biofilms Formed in Synthetic Cystic Fibrosis Medium. | Belardinelli JM, Li W, Avanzi C, Angala SK, Lian E, Wiersma CJ, Palcekova Z, Martin KH, Angala B, de Moura VCN, Kerns C, Jones V, Gonzalez-Juarrero M, Davidson RM, Nick JA, Borlee BR, Jackson M. | Front Microbiol | 10.3389/fmicb.2021.743126 | 2021 | | |
| Pathogenicity | Alternative and Experimental Therapies of Mycobacterium abscessus Infections. | Meir M, Barkan D. | Int J Mol Sci | 10.3390/ijms21186793 | 2020 | |
| Phylogeny | Cas12a/Guide RNA-Based Platform for Rapid and Accurate Identification of Major Mycobacterium Species. | Xiao G, He X, Zhang S, Liu Y, Liang Z, Liu H, Zhang J, Ou M, Cai S, Lai W, Zhang T, Ren L, Zhang G. | J Clin Microbiol | 10.1128/jcm.01368-19 | 2020 | |
| Assessment of antimycobacterial activities of pure compounds extracted from Thai medicinal plants against clarithromycin-resistant Mycobacterium abscessus. | Sirichoat A, Kham-Ngam I, Kaewprasert O, Ananta P, Wisetsai A, Lekphrom R, Faksri K. | PeerJ | 10.7717/peerj.12391 | 2021 | | |
| Pathogenicity | Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus. | Kaushik A, Gupta C, Fisher S, Story-Roller E, Galanis C, Parrish N, Lamichhane G. | Future Microbiol | 10.2217/fmb-2016-0234 | 2017 | |
| Antimicrobial Susceptibility of Mycobacterium abscessus Complex Clinical Isolates from a Chinese Tertiary Hospital. | Guo Y, Cao X, Yu J, Zhan Q, Yang J, Wu X, Wan B, Liu Y, Yu F. | Infect Drug Resist | 10.2147/idr.s252485 | 2020 | | |
| Species-Specific Interferon-Gamma Release Assay for the Diagnosis of Mycobacterium abscessus Complex Infection. | Steindor M, Stehling F, Olivier M, Kehrmann J, Diricks M, Maurer FP, Horn PA, Strassburg S, Welsner M, Sutharsan S, Lindemann M. | Front Microbiol | 10.3389/fmicb.2021.692395 | 2021 | | |
| Unassuming Lichens: Nature's Hidden Antimicrobial Warriors. | Tian H, Lu J, Liang F, Ding H, Xiao C. | Int J Mol Sci | 10.3390/ijms26073136 | 2025 | | |
| Metabolism | A mouse model of pulmonary Mycobacteroides abscessus infection. | Maggioncalda EC, Story-Roller E, Mylius J, Illei P, Basaraba RJ, Lamichhane G. | Sci Rep | 10.1038/s41598-020-60452-1 | 2020 | |
| Biotin-dependent cell envelope remodelling is required for Mycobacterium abscessus survival in lung infection. | Sullivan MR, McGowen K, Liu Q, Akusobi C, Young DC, Mayfield JA, Raman S, Wolf ID, Moody DB, Aldrich CC, Muir A, Rubin EJ. | Nat Microbiol | 10.1038/s41564-022-01307-5 | 2023 | | |
| Draft Genome Sequence of Mycobacterium abscessus Bamboo. | Yee M, Klinzing D, Wei JR, Gengenbacher M, Rubin EJ, Dick T. | Genome Announc | 10.1128/genomea.00388-17 | 2017 | | |
| Pathogenicity | Lack of association between rrl and erm(41) mutations and clarithromycin resistance in Mycobacterium abscessus complex. | Carneiro MDS, Nunes LS, David SMM, Barth AL. | Mem Inst Oswaldo Cruz | 10.1590/0074-02760170080 | 2017 | |
| In Vitro Activity of the Sudapyridine (WX-081) against Non-Tuberculous Mycobacteria Isolated in Beijing, China. | Zhu R, Shang Y, Chen S, Xiao H, Ren R, Wang F, Xue Y, Li L, Li Y, Chu N, Huang H. | Microbiol Spectr | 10.1128/spectrum.01372-22 | 2022 | | |
| Metabolism | New beta-Lactamase Inhibitors Nacubactam and Zidebactam Improve the In Vitro Activity of beta-Lactam Antibiotics against Mycobacterium abscessus Complex Clinical Isolates. | Kaushik A, Ammerman NC, Parrish NM, Nuermberger EL. | Antimicrob Agents Chemother | 10.1128/aac.00733-19 | 2019 | |
| Pathogenicity | Molecular Analysis of Linezolid-Resistant Clinical Isolates of Mycobacterium abscessus. | Ye M, Xu L, Zou Y, Li B, Guo Q, Zhang Y, Zhan M, Xu B, Yu F, Zhang Z, Chu H. | Antimicrob Agents Chemother | 10.1128/aac.01842-18 | 2019 | |
| Clofazimine as a comparator for preclinical efficacy evaluations of experimental therapeutics against pulmonary M. abscessus infection in mice. | Sriram D, Wahi R, Maggioncalda EC, Panthi CM, Lamichhane G. | Tuberculosis (Edinb) | 10.1016/j.tube.2022.102268 | 2022 | | |
| A Two-Step Real-Time PCR Method To Identify Mycobacterium tuberculosis Infections and Six Dominant Nontuberculous Mycobacterial Infections from Clinical Specimens. | Park J, Kwak N, Chae JC, Yoon EJ, Jeong SH. | Microbiol Spectr | 10.1128/spectrum.01606-23 | 2023 | | |
| Modeling Site-Specific Nucleotide Biases Affecting Himar1 Transposon Insertion Frequencies in TnSeq Data Sets. | Choudhery S, Brown AJ, Akusobi C, Rubin EJ, Sassetti CM, Ioerger TR. | mSystems | 10.1128/msystems.00876-21 | 2021 | | |
| Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo. | Pearce C, Ruth MM, Pennings LJ, Wertheim HFL, Walz A, Hoefsloot W, Ruesen C, Munoz Gutierrez J, Gonzalez-Juarrero M, van Ingen J. | J Antimicrob Chemother | 10.1093/jac/dkaa110 | 2020 | | |
| Genetics | Genetic Correlation of Antibiotic Susceptibility and Resistance Genotyping for the Mycobacterium abscessus Group. | Zheng H, Liu D, Lu J, Song Y, Wang S, Zhao Y, Ni X. | Antimicrob Agents Chemother | 10.1128/aac.01523-18 | 2019 | |
| The ESX-4 substrates, EsxU and EsxT, modulate Mycobacterium abscessus fitness. | Lagune M, Le Moigne V, Johansen MD, Vasquez Sotomayor F, Daher W, Petit C, Cosentino G, Paulowski L, Gutsmann T, Wilmanns M, Maurer FP, Herrmann JL, Girard-Misguich F, Kremer L. | PLoS Pathog | 10.1371/journal.ppat.1010771 | 2022 | | |
| Complete Genome Sequence of a Novel Clinical Isolate, Mycobacterium abscessus Strain NOV0213. | Dymova MA, Alkhovik OI, Evdokimova LS, Cherednichenko AG, Petrenko TI. | Genome Announc | 10.1128/genomea.01407-15 | 2016 | | |
| Calcium carbonate mineralization is essential for biofilm formation and lung colonization. | Cohen-Cymberknoh M, Kolodkin-Gal D, Keren-Paz A, Peretz S, Brumfeld V, Kapishnikov S, Suissa R, Shteinberg M, McLeod D, Maan H, Patrauchan M, Zamir G, Kerem E, Kolodkin-Gal I. | iScience | 10.1016/j.isci.2022.104234 | 2022 | | |
| Metabolism | Mycobacterial HflX is a ribosome splitting factor that mediates antibiotic resistance. | Rudra P, Hurst-Hess KR, Cotten KL, Partida-Miranda A, Ghosh P. | Proc Natl Acad Sci U S A | 10.1073/pnas.1906748117 | 2020 | |
| Metabolism | High Levels of Intrinsic Tetracycline Resistance in Mycobacterium abscessus Are Conferred by a Tetracycline-Modifying Monooxygenase. | Rudra P, Hurst-Hess K, Lappierre P, Ghosh P. | Antimicrob Agents Chemother | 10.1128/aac.00119-18 | 2018 | |
| Mechanical morphotype switching as an adaptive response in mycobacteria. | Eskandarian HA, Chen YX, Toniolo C, Belardinelli JM, Palcekova Z, Hom L, Ashby PD, Fantner GE, Jackson M, McKinney JD, Javid B. | Sci Adv | 10.1126/sciadv.adh7957 | 2024 | | |
| Mycobacterium abscessus Genetic Determinants Associated with the Intrinsic Resistance to Antibiotics. | Gorzynski M, Week T, Jaramillo T, Dzalamidze E, Danelishvili L. | Microorganisms | 10.3390/microorganisms9122527 | 2021 | | |
| Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus. | Quang NT, Jang J. | Front Pharmacol | 10.3389/fphar.2021.724725 | 2021 | | |
| Pathogenicity | The Peroxisome Proliferator-Activated Receptor alpha- Agonist Gemfibrozil Promotes Defense Against Mycobacterium abscessus Infections. | Kim YS, Kim JK, Hanh BTB, Kim SY, Kim HJ, Kim YJ, Jeon SM, Park CR, Oh GT, Park JW, Kim JM, Jang J, Jo EK. | Cells | 10.3390/cells9030648 | 2020 | |
| Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the whiB7 Gene. | Pryjma M, Burian J, Kuchinski K, Thompson CJ. | Antimicrob Agents Chemother | 10.1128/aac.01353-17 | 2017 | | |
| Structural Basis of Cysteine Ligase MshC Inhibition by Cysteinyl-Sulfonamides. | Pang L, Lenders S, Osipov EM, Weeks SD, Rozenski J, Piller T, Cappoen D, Strelkov SV, Van Aerschot A. | Int J Mol Sci | 10.3390/ijms232315095 | 2022 | | |
| Pathogenicity | Discovery of benzothiazole amides as potent antimycobacterial agents. | Graham J, Wong CE, Day J, McFaddin E, Ochsner U, Hoang T, Young CL, Ribble W, DeGroote MA, Jarvis T, Sun X. | Bioorg Med Chem Lett | 10.1016/j.bmcl.2018.08.026 | 2018 | |
| Nontuberculous mycobacteria in China: incidence and antimicrobial resistance spectrum from a nationwide survey. | Liu CF, Song YM, He WC, Liu DX, He P, Bao JJ, Wang XY, Li YM, Zhao YL. | Infect Dis Poverty | 10.1186/s40249-021-00844-1 | 2021 | | |
| Pathogenicity | Mycobacterium abscessus l,d-Transpeptidases Are Susceptible to Inactivation by Carbapenems and Cephalosporins but Not Penicillins. | Kumar P, Chauhan V, Silva JRA, Lameira J, d'Andrea FB, Li SG, Ginell SL, Freundlich JS, Alves CN, Bailey S, Cohen KA, Lamichhane G. | Antimicrob Agents Chemother | 10.1128/aac.00866-17 | 2017 | |
| Pathogenicity | In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates. | Kim DH, Jhun BW, Moon SM, Kim SY, Jeon K, Kwon OJ, Huh HJ, Lee NY, Shin SJ, Daley CL, Koh WJ. | Antimicrob Agents Chemother | 10.1128/aac.00665-19 | 2019 | |
| Metabolism | Mycobacterium abscessus Cells Have Altered Antibiotic Tolerance and Surface Glycolipids in Artificial Cystic Fibrosis Sputum Medium. | Hunt-Serracin AC, Parks BJ, Boll J, Boutte CC. | Antimicrob Agents Chemother | 10.1128/aac.02488-18 | 2019 | |
| Pathogenicity | Mycobacterium abscessus: It's Complex. | Abdelaal HFM, Chan ED, Young L, Baldwin SL, Coler RN. | Microorganisms | 10.3390/microorganisms10071454 | 2022 | |
| Pathogenicity | Mycobacterium abscessus Clearance by Neutrophils Is Independent of Autophagy. | Pohl K, Grimm XA, Caceres SM, Poch KR, Rysavy N, Saavedra M, Nick JA, Malcolm KC. | Infect Immun | 10.1128/iai.00024-20 | 2020 | |
| Phylogeny | Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Mycobacterium abscessus Subspecies According to Whole-Genome Sequencing. | Luo L, Liu W, Li B, Li M, Huang D, Jing L, Chen H, Yang J, Yue J, Wang F, Chu H, Zhang Z. | J Clin Microbiol | 10.1128/jcm.01151-16 | 2016 | |
| Pathogenicity | In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium abscessus Complex. | Brown-Elliott BA, Wallace RJ. | Antimicrob Agents Chemother | 10.1128/aac.01919-18 | 2019 | |
| Structural Determinants of Indole-2-carboxamides: Identification of Lead Acetamides with Pan Antimycobacterial Activity. | Bhattarai P, Hegde P, Li W, Prathipati PK, Stevens CM, Yang L, Zhou H, Pandya A, Cunningham K, Grissom J, Roman Sotelo M, Sowards M, Calisto L, Destache CJ, Rocha-Sanchez S, Gumbart JC, Zgurskaya HI, Jackson M, North EJ. | J Med Chem | 10.1021/acs.jmedchem.2c00352 | 2023 | | |
| Antimicrobial Susceptibility and Phylogenetic Relations in a German Cohort Infected with Mycobacterium abscessus. | Wetzstein N, Kohl TA, Schultze TG, Andres S, Bellinghausen C, Hugel C, Kempf VAJ, Lehn A, Hogardt M, Serve H, Vehreschild MJGT, Wolf T, Niemann S, Maurer FP, Wichelhaus TA. | J Clin Microbiol | 10.1128/jcm.01813-20 | 2020 | | |
| Mycobacterium abscessus and beta-Lactams: Emerging Insights and Potential Opportunities. | Story-Roller E, Maggioncalda EC, Cohen KA, Lamichhane G. | Front Microbiol | 10.3389/fmicb.2018.02273 | 2018 | | |
| Genetic Evolution of Mycobacterium abscessus Conferring Clarithromycin Resistance during Long-Term Antibiotic Therapy. | Li B, Guo Q, Mao Y, Zou Y, Zhang Y, Zhang Z, Chu H. | Can Respir J | 10.1155/2020/7623828 | 2020 | | |
| Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates. | Kim SY, Kim DH, Moon SM, Song JY, Huh HJ, Lee NY, Shin SJ, Koh WJ, Jhun BW. | Sci Rep | 10.1038/s41598-021-85721-5 | 2021 | | |
| Phylogeny | Global phylogenomic analyses of Mycobacterium abscessus provide context for non cystic fibrosis infections and the evolution of antibiotic resistance. | Bronson RA, Gupta C, Manson AL, Nguyen JA, Bahadirli-Talbott A, Parrish NM, Earl AM, Cohen KA. | Nat Commun | 10.1038/s41467-021-25484-9 | 2021 | |
| Pathogenicity | In vitro activity of SPR719 against Mycobacterium ulcerans, Mycobacterium marinum and Mycobacterium chimaera. | Pidot SJ, Porter JL, Lister T, Stinear TP. | PLoS Negl Trop Dis | 10.1371/journal.pntd.0009636 | 2021 | |
| Phylogenetic analysis and interactomics study unveil gene co-optive evolution of LysR-type transcription regulators across non-pathogenic, opportunistic, and pathogenic mycobacteria. | Tyagi E, Singhvi N, Keshavam CC, Sangwan N, Gupta V, Bhimwal T, Seth R, Seth RK, Singh Y. | 3 Biotech | 10.1007/s13205-023-03583-2 | 2023 | | |
| Sulfonamides complexed with metals as mycobacterial biofilms inhibitors. | Bonez PC, Agertt VA, Rossi GG, Dos Santos Siqueira F, Siqueira JD, Marques LL, de Oliveira GNM, Santos RCV, de Campos MMA. | J Clin Tuberc Other Mycobact Dis | 10.1016/j.jctube.2021.100217 | 2021 | | |
| Whole-Genome Sequence of Mycobacterium abscessus Clinical Strain V06705. | Pang S, Renvoise A, Perret C, Guinier M, Chelghoum N, Brossier F, Capton E, Jarlier V, Sougakoff W. | Genome Announc | 10.1128/genomea.00690-13 | 2013 | | |
| Pathogenicity | Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies. | Mougari F, Bouziane F, Crockett F, Nessar R, Chau F, Veziris N, Sapriel G, Raskine L, Cambau E. | Antimicrob Agents Chemother | 10.1128/aac.00943-16 | 2017 | |
| Pathogenicity | Racemization-free synthesis of Nalpha-2-thiophenoyl-phenylalanine-2-morpholinoanilide enantiomers and their antimycobacterial activity. | Mann L, Lang M, Schulze P, Halz JH, Csuk R, Hoenke S, Seidel RW, Richter A. | Amino Acids | 10.1007/s00726-021-03044-1 | 2021 | |
| Pathogenicity | Application of Precision-Cut Lung Slices as an In Vitro Model for Research of Inflammatory Respiratory Diseases. | Liu Y, Wu P, Wang Y, Liu Y, Yang H, Zhou G, Wu X, Wen Q. | Bioengineering (Basel) | 10.3390/bioengineering9120767 | 2022 | |
| Pathogenicity | Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus. | Kaushik A, Makkar N, Pandey P, Parrish N, Singh U, Lamichhane G. | Antimicrob Agents Chemother | 10.1128/aac.01158-15 | 2015 | |
| Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection. | Ferro BE, Srivastava S, Deshpande D, Pasipanodya JG, van Soolingen D, Mouton JW, van Ingen J, Gumbo T. | Antimicrob Agents Chemother | 10.1128/aac.00990-16 | 2016 | | |
| Pathogenicity | Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus. | Li B, Ye M, Guo Q, Zhang Z, Yang S, Ma W, Yu F, Chu H. | Antimicrob Agents Chemother | 10.1128/aac.00175-18 | 2018 | |
| Mycobacterium abscessus biofilms produce an extracellular matrix and have a distinct mycolic acid profile. | Dokic A, Peterson E, Arrieta-Ortiz ML, Pan M, Di Maio A, Baliga N, Bhatt A. | Cell Surf | 10.1016/j.tcsw.2021.100051 | 2021 | | |
| Pathogenicity | Pathogen Box screening for hit identification against Mycobacterium abscessus. | Jeong J, Kim G, Moon C, Kim HJ, Kim TH, Jang J. | PLoS One | 10.1371/journal.pone.0195595 | 2018 | |
| Tedizolid Activity Against Clinical Mycobacterium abscessus Complex Isolates-An in vitro Characterization Study. | Tang YW, Cheng B, Yeoh SF, Lin RTP, Teo JWP. | Front Microbiol | 10.3389/fmicb.2018.02095 | 2018 | | |
| Phylogeny | Molecular typing of Mycobacterium abscessus based on tandem-repeat polymorphism. | Wong YL, Ong CS, Ngeow YF. | J Clin Microbiol | 10.1128/jcm.00753-12 | 2012 | |
| Phylogeny | Whole-genome sequence of the emerging pathogen Mycobacterium abscessus strain 47J26. | Chan J, Halachev M, Yates E, Smith G, Pallen M. | J Bacteriol | 10.1128/jb.06440-11 | 2012 | |
| Transcriptome | Genome sequence of Mycobacterium abscessus strain M152. | Ngeow YF, Wong YL, Tan JL, Ong CS, Ng KP, Choo SW. | J Bacteriol | 10.1128/jb.01846-12 | 2012 | |
| Pathogenicity | Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach. | Liu Y, Tan Y, Islam MM, Cao Y, Lu X, Zeng S, Hameed HMA, Zhou P, Cai X, Wang S, Mugweru JN, Zhang G, Yin H, Liu J, Nuermberger E, Zhang T. | Antimicrob Agents Chemother | 10.1128/aac.01881-19 | 2020 | |
| Genome Sequence of an Epidemic Isolate of Mycobacterium abscessus subsp. bolletii from Rio de Janeiro, Brazil. | Davidson RM, Reynolds PR, Farias-Hesson E, Duarte RS, Jackson M, Strong M. | Genome Announc | 10.1128/genomea.00617-13 | 2013 | | |
| Transcriptome | Analysis of the genome of Mycobacterium abscessus strain M94 reveals an uncommon cluster of tRNAs. | Choo SW, Wong YL, Leong ML, Heydari H, Ong CS, Ng KP, Ngeow YF. | J Bacteriol | 10.1128/jb.01407-12 | 2012 | |
| The DosR regulon of Mycobacterium avium and adaptation to hypoxia. | Belardinelli JM, Avanzi C, Martin KE, Lam H, Dragset MS, Wheat WH, Podell BK, Gonzalez-Juarrero M, Jackson M. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1545856 | 2025 | | |
| A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case Study. | Kaya F, Ernest JP, LoMauro K, Gengenbacher M, Madani A, Aragaw WW, Zimmerman MD, Sarathy JP, Alvarez N, Daudelin I, Wang H, Lanni F, Weiner DM, Via LE, Barry CE, Olivier KN, Dick T, Podell BK, Savic RM, Dartois V. | Antimicrob Agents Chemother | 10.1128/aac.02212-21 | 2022 | | |
| Phylogeny | Devising Isolation Forest-Based Method to Investigate the sRNAome of Mycobacterium tuberculosis Using sRNA-seq Data. | Maity U, Aggarwal R, Balasubramanian R, Venkatraman DL, R Hegde S. | Bioinform Biol Insights | 10.1177/11779322241263674 | 2024 | |
| Pipeline of anti-Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities. | Egorova A, Jackson M, Gavrilyuk V, Makarov V. | Med Res Rev | 10.1002/med.21798 | 2021 | | |
| In Vitro Susceptibility Testing of Omadacycline against Nontuberculous Mycobacteria. | Brown-Elliott BA, Wallace RJ. | Antimicrob Agents Chemother | 10.1128/aac.01947-20 | 2021 | | |
| Genetics | Genome sequence of the Mycobacterium abscessus strain M93. | Choo SW, Wong YL, Yusoff AM, Leong ML, Wong GJ, Ong CS, Ng KP, Ngeow YF. | J Bacteriol | 10.1128/jb.00492-12 | 2012 | |
| Mycobacterium abscessus infection leads to enhanced production of type 1 interferon and NLRP3 inflammasome activation in murine macrophages via mitochondrial oxidative stress. | Kim BR, Kim BJ, Kook YH, Kim BJ. | PLoS Pathog | 10.1371/journal.ppat.1008294 | 2020 | | |
| Prevalence of nontuberculous mycobacteria and high efficacy of d-cycloserine and its synergistic effect with clarithromycin against Mycobacterium fortuitum and Mycobacterium abscessus. | Khosravi AD, Mirsaeidi M, Farahani A, Tabandeh MR, Mohajeri P, Shoja S, Hoseini Lar KhosroShahi SR. | Infect Drug Resist | 10.2147/idr.s187554 | 2018 | | |
| MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections. | Li W, Yazidi A, Pandya AN, Hegde P, Tong W, Calado Nogueira de Moura V, North EJ, Sygusch J, Jackson M. | Front Microbiol | 10.3389/fmicb.2018.01547 | 2018 | | |
| Pathogenicity | In vitro activity of bedaquiline against rapidly growing nontuberculous mycobacteria. | Aguilar-Ayala DA, Cnockaert M, Andre E, Andries K, Gonzalez-Y-Merchand JA, Vandamme P, Palomino JC, Martin A. | J Med Microbiol | 10.1099/jmm.0.000537 | 2017 | |
| Identification of genes required for Mycobacterium abscessus growth in vivo with a prominent role of the ESX-4 locus. | Laencina L, Dubois V, Le Moigne V, Viljoen A, Majlessi L, Pritchard J, Bernut A, Piel L, Roux AL, Gaillard JL, Lombard B, Loew D, Rubin EJ, Brosch R, Kremer L, Herrmann JL, Girard-Misguich F. | Proc Natl Acad Sci U S A | 10.1073/pnas.1713195115 | 2018 | | |
| Genetics | GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance. | Huh HJ, Kim SY, Shim HJ, Kim DH, Yoo IY, Kang OK, Ki CS, Shin SY, Jhun BW, Shin SJ, Daley CL, Koh WJ, Lee NY. | J Clin Microbiol | 10.1128/jcm.00516-19 | 2019 | |
| Pathogenicity | Mutations in the MAB_2299c TetR Regulator Confer Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus. | Richard M, Gutierrez AV, Viljoen A, Rodriguez-Rincon D, Roquet-Baneres F, Blaise M, Everall I, Parkhill J, Floto RA, Kremer L. | Antimicrob Agents Chemother | 10.1128/aac.01316-18 | 2019 | |
| Whole-Genome Shotgun Sequencing of Mycobacterium abscessus M156, an Emerging Clinical Pathogen in Malaysia. | Choo SW, Wong YL, Beh CY, Lokanathan N, Leong ML, Ong CS, Ng KP, Ngeow YF. | Genome Announc | 10.1128/genomea.00063-12 | 2013 | | |
| Pathogenicity | Rocket-miR, a translational launchpad for miRNA-based antimicrobial drug development. | Neff SL, Hampton TH, Koeppen K, Sarkar S, Latario CJ, Ross BD, Stanton BA. | mSystems | 10.1128/msystems.00653-23 | 2023 | |
| Transcriptome | Genomic analysis of Mycobacterium abscessus strain M139, which has an ambiguous subspecies taxonomic position. | Ngeow YF, Wee WY, Wong YL, Tan JL, Ongi CS, Ng KP, Choo SW. | J Bacteriol | 10.1128/jb.01455-12 | 2012 | |
| Metabolism | Comprehensive Comparative Analysis of Cholesterol Catabolic Genes/Proteins in Mycobacterial Species. | van Wyk R, van Wyk M, Mashele SS, Nelson DR, Syed K. | Int J Mol Sci | 10.3390/ijms20051032 | 2019 | |
| Mycobacterium abscessus Displays Fitness for Fomite Transmission. | Malcolm KC, Caceres SM, Honda JR, Davidson RM, Epperson LE, Strong M, Chan ED, Nick JA. | Appl Environ Microbiol | 10.1128/aem.00562-17 | 2017 | | |
| Phylogeny | Efficient differentiation of Mycobacterium abscessus complex isolates to the species level by a novel PCR-based variable-number tandem-repeat assay. | Choi GE, Chang CL, Whang J, Kim HJ, Kwon OJ, Koh WJ, Shin SJ. | J Clin Microbiol | 10.1128/jcm.02318-10 | 2011 | |
| Metabolism | Advances in Research on Bioactivity, Toxicity, Metabolism, and Pharmacokinetics of Usnic Acid In Vitro and In Vivo. | Wang H, Xuan M, Huang C, Wang C. | Molecules | 10.3390/molecules27217469 | 2022 | |
| Bedaquiline for treatment of non-tuberculous mycobacteria (NTM): a systematic review and meta-analysis. | Omar S, Whitfield MG, Nolan MB, Ngom JT, Ismail N, Warren RM, Klopper M. | J Antimicrob Chemother | 10.1093/jac/dkad372 | 2024 | | |
| Pathogenicity | A Rapid Unraveling of the Activity and Antibiotic Susceptibility of Mycobacteria. | Mustazzolu A, Venturelli L, Dinarelli S, Brown K, Floto RA, Dietler G, Fattorini L, Kasas S, Girasole M, Longo G. | Antimicrob Agents Chemother | 10.1128/aac.02194-18 | 2019 | |
| Genetics | Annotated genome sequence of Mycobacterium massiliense strain M154, belonging to the recently created taxon Mycobacterium abscessus subsp. bolletii comb. nov. | Choo SW, Wong YL, Tan JL, Ong CS, Wong GJ, Ng KP, Ngeow YF. | J Bacteriol | 10.1128/jb.01043-12 | 2012 | |
| Phylogeny | Phylogenomics of Brazilian epidemic isolates of Mycobacterium abscessus subsp. bolletii reveals relationships of global outbreak strains. | Davidson RM, Hasan NA, de Moura VC, Duarte RS, Jackson M, Strong M. | Infect Genet Evol | 10.1016/j.meegid.2013.09.012 | 2013 | |
| A Leucyl-tRNA Synthetase Inhibitor with Broad-Spectrum Anti-Mycobacterial Activity. | Ganapathy US, Del Rio RG, Cacho-Izquierdo M, Ortega F, Lelievre J, Barros-Aguirre D, Lindman M, Dartois V, Gengenbacher M, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.02420-20 | 2023 | | |
| Phylogeny | Genomic insights into the emerging human pathogen Mycobacterium massiliense. | Tettelin H, Sampaio EP, Daugherty SC, Hine E, Riley DR, Sadzewicz L, Sengamalay N, Shefchek K, Su Q, Tallon LJ, Conville P, Olivier KN, Holland SM, Fraser CM, Zelazny AM. | J Bacteriol | 10.1128/jb.01200-12 | 2012 | |
| Pathogenicity | Dissecting the antibacterial activity of oxadiazolone-core derivatives against Mycobacterium abscessus. | Madani A, Mallick I, Guy A, Crauste C, Durand T, Fourquet P, Audebert S, Camoin L, Canaan S, Cavalier JF. | PLoS One | 10.1371/journal.pone.0238178 | 2020 | |
| MGIT Enriched Shotgun Metagenomics for Routine Identification of Nontuberculous Mycobacteria: a Route to Personalized Health Care. | Schildkraut JA, Coolen JPM, Severin H, Koenraad E, Aalders N, Melchers WJG, Hoefsloot W, Wertheim HFL, van Ingen J. | J Clin Microbiol | 10.1128/jcm.01318-22 | 2023 | | |
| Genetics | MycoBASE: expanding the functional annotation coverage of mycobacterial genomes. | Garcia BJ, Datta G, Davidson RM, Strong M. | BMC Genomics | 10.1186/s12864-015-2311-9 | 2015 | |
| Genetics | The Clarithromycin Susceptibility Genotype Affects the Treatment Outcome of Patients with Mycobacterium abscessus Lung Disease. | Guo Q, Chu H, Ye M, Zhang Z, Li B, Yang S, Ma W, Yu F. | Antimicrob Agents Chemother | 10.1128/aac.02360-17 | 2018 | |
| Stepwise pathogenic evolution of Mycobacterium abscessus. | Bryant JM, Brown KP, Burbaud S, Everall I, Belardinelli JM, Rodriguez-Rincon D, Grogono DM, Peterson CM, Verma D, Evans IE, Ruis C, Weimann A, Arora D, Malhotra S, Bannerman B, Passemar C, Templeton K, MacGregor G, Jiwa K, Fisher AJ, Blundell TL, Ordway DJ, Jackson M, Parkhill J, Floto RA. | Science | 10.1126/science.abb8699 | 2021 | | |
| Pathogenicity | Inhibition of the beta-Lactamase BlaMab by Avibactam Improves the In Vitro and In Vivo Efficacy of Imipenem against Mycobacterium abscessus. | Lefebvre AL, Le Moigne V, Bernut A, Veckerle C, Compain F, Herrmann JL, Kremer L, Arthur M, Mainardi JL. | Antimicrob Agents Chemother | 10.1128/aac.02440-16 | 2017 | |
| Demonstration of plasmid-mediated drug resistance in Mycobacterium abscessus. | Matsumoto CK, Bispo PJ, Santin K, Nogueira CL, Leao SC. | J Clin Microbiol | 10.1128/jcm.00032-14 | 2014 | | |
| Genetics | Mycobacterial genomics and structural bioinformatics: opportunities and challenges in drug discovery. | Waman VP, Vedithi SC, Thomas SE, Bannerman BP, Munir A, Skwark MJ, Malhotra S, Blundell TL. | Emerg Microbes Infect | 10.1080/22221751.2018.1561158 | 2019 | |
| Phylogeny | Whole-genome sequencing and epidemiological analysis do not provide evidence for cross-transmission of mycobacterium abscessus in a cohort of pediatric cystic fibrosis patients. | Harris KA, Underwood A, Kenna DT, Brooks A, Kavaliunaite E, Kapatai G, Tewolde R, Aurora P, Dixon G. | Clin Infect Dis | 10.1093/cid/ciu967 | 2015 | |
| Enzymology | The Role of Antibiotic-Target-Modifying and Antibiotic-Modifying Enzymes in Mycobacterium abscessus Drug Resistance. | Luthra S, Rominski A, Sander P. | Front Microbiol | 10.3389/fmicb.2018.02179 | 2018 | |
| Biochemical and microbiological evaluation of N-aryl urea derivatives against mycobacteria and mycobacterial hydrolases. | Vartak A, Goins C, de Moura VCN, Schreidah CM, Landgraf AD, Lin B, Du J, Jackson M, Ronning DR, Sucheck SJ. | Medchemcomm | 10.1039/c9md00122k | 2019 | | |
| Genetics | MabsBase: a Mycobacterium abscessus genome and annotation database. | Heydari H, Wee WY, Lokanathan N, Hari R, Mohamed Yusoff A, Beh CY, Yazdi AH, Wong GJ, Ngeow YF, Choo SW. | PLoS One | 10.1371/journal.pone.0062443 | 2013 | |
| In Vitro Activity of Rifamycin Derivatives against Nontuberculous Mycobacteria, including Macrolide-/Amikacin-Resistant Clinical Isolates. | Kim DH, Kim SY, Huh HJ, Lee NY, Koh WJ, Jhun BW. | Antimicrob Agents Chemother | 10.1128/aac.02611-20 | 2023 | | |
| Genomic epidemiology of a national outbreak of post-surgical Mycobacterium abscessus wound infections in Brazil. | Everall I, Nogueira CL, Bryant JM, Sanchez-Buso L, Chimara E, Duarte RDS, Ramos JP, Lima KVB, Lopes ML, Palaci M, Kipnis A, Monego F, Floto RA, Parkhill J, Leao SC, Harris SR. | Microb Genom | 10.1099/mgen.0.000111 | 2017 | | |
| Metabolism | Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification. | Thomas SE, Whitehouse AJ, Brown K, Burbaud S, Belardinelli JM, Sangen J, Lahiri R, Libardo MDJ, Gupta P, Malhotra S, Boshoff HIM, Jackson M, Abell C, Coyne AG, Blundell TL, Floto RA, Mendes V. | Nucleic Acids Res | 10.1093/nar/gkaa539 | 2020 | |
| Phylogeny | Molecular fingerprinting of Mycobacterium abscessus strains in a cohort of pediatric cystic fibrosis patients. | Harris KA, Kenna DT, Blauwendraat C, Hartley JC, Turton JF, Aurora P, Dixon GL. | J Clin Microbiol | 10.1128/jcm.00155-12 | 2012 | |
| Transcriptome | Functional characterization of the Mycobacterium abscessus genome coupled with condition specific transcriptomics reveals conserved molecular strategies for host adaptation and persistence. | Miranda-CasoLuengo AA, Staunton PM, Dinan AM, Lohan AJ, Loftus BJ. | BMC Genomics | 10.1186/s12864-016-2868-y | 2016 | |
| Genetics | Detection of Bacterial Pathogens from Broncho-Alveolar Lavage by Next-Generation Sequencing. | Leo S, Gaia N, Ruppe E, Emonet S, Girard M, Lazarevic V, Schrenzel J. | Int J Mol Sci | 10.3390/ijms18092011 | 2017 | |
| Metabolism | Transcriptional Response of Respiratory Epithelium to Nontuberculous Mycobacteria. | Matsuyama M, Martins AJ, Shallom S, Kamenyeva O, Kashyap A, Sampaio EP, Kabat J, Olivier KN, Zelazny AM, Tsang JS, Holland SM. | Am J Respir Cell Mol Biol | 10.1165/rcmb.2017-0218oc | 2018 | |
| Potentiation of high hydrostatic pressure inactivation of Mycobacterium by combination with physical and chemical conditions. | de Souza AR, da Costa Demonte AL, de Araujo Costa K, Faria MA, Duraes-Carvalho R, Lancellotti M, Bonafe CF. | Appl Microbiol Biotechnol | 10.1007/s00253-013-5067-7 | 2013 | | |
| Genetics | Complete genome sequence and comparative genomic analysis of Mycobacterium massiliense JCM 15300 in the Mycobacterium abscessus group reveal a conserved genomic island MmGI-1 related to putative lipid metabolism. | Sekizuka T, Kai M, Nakanaga K, Nakata N, Kazumi Y, Maeda S, Makino M, Hoshino Y, Kuroda M. | PLoS One | 10.1371/journal.pone.0114848 | 2014 | |
| Transcriptome | Genome analysis of Mycobacterium massiliense strain M172, which contains a putative mycobacteriophage. | Choo SW, Yusoff AM, Wong YL, Wee WY, Ong CS, Ng KP, Ngeow YF. | J Bacteriol | 10.1128/jb.01096-12 | 2012 | |
| Genetics | Genome analysis reveals three genomospecies in Mycobacterium abscessus. | Sassi M, Drancourt M. | BMC Genomics | 10.1186/1471-2164-15-359 | 2014 | |
| Pathogenicity | Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease. | Ferro BE, Srivastava S, Deshpande D, Pasipanodya JG, van Soolingen D, Mouton JW, van Ingen J, Gumbo T. | Antimicrob Agents Chemother | 10.1128/aac.03112-15 | 2016 | |
| Aspergillus fumigatus Preexposure Worsens Pathology and Improves Control of Mycobacterium abscessus Pulmonary Infection in Mice. | Monin L, Mehta S, Elsegeiny W, Gopal R, McAleer JP, Oury TD, Kolls J, Khader SA. | Infect Immun | 10.1128/iai.00859-17 | 2018 | | |
| Metabolism | Macrophage Signaling Pathways in Pulmonary Nontuberculous Mycobacteria Infections. | Prasla Z, Sutliff RL, Sadikot RT. | Am J Respir Cell Mol Biol | 10.1165/rcmb.2019-0241tr | 2020 | |
| Protective effects of a traditional herbal extract from Stellaria dichotoma var. lanceolata against Mycobacterium abscessus infections. | Bae SJ, Choi JW, Park BJ, Lee J, Jo EK, Lee YH, Kim SB, Yuk JM. | PLoS One | 10.1371/journal.pone.0207696 | 2018 | | |
| Identification of nontuberculous mycobacteria species by multiplex real-time PCR with high-resolution melting. | Peixoto ADS, Montenegro LML, Lima AS, Melo FL, Barbosa Junior WL, Neves MMC, Ramos JP, Schindler HC, Medeiros ZM. | Rev Soc Bras Med Trop | 10.1590/0037-8682-0211-2020 | 2020 | | |
| Transcriptome | Draft genome sequence of Mycobacterium bolletii strain M24, a rapidly growing mycobacterium of contentious taxonomic status. | Wong YL, Choo SW, Tan JL, Ong CS, Ng KP, Ngeow YF. | J Bacteriol | 10.1128/jb.00916-12 | 2012 | |
| Pathogenicity | In Vitro Activity of Clofazimine against Nontuberculous Mycobacteria Isolated in Beijing, China. | Luo J, Yu X, Jiang G, Fu Y, Huo F, Ma Y, Wang F, Shang Y, Liang Q, Xue Y, Huang H. | Antimicrob Agents Chemother | 10.1128/aac.00072-18 | 2018 | |
| Metabolism | Mycobacterial SigA and SigB Cotranscribe Essential Housekeeping Genes during Exponential Growth. | Hurst-Hess K, Biswas R, Yang Y, Rudra P, Lasek-Nesselquist E, Ghosh P. | mBio | 10.1128/mbio.00273-19 | 2019 | |
| Differential Responses by Human Macrophages to Infection With Mycobacterium tuberculosis and Non-tuberculous Mycobacteria. | Feng Z, Bai X, Wang T, Garcia C, Bai A, Li L, Honda JR, Nie X, Chan ED. | Front Microbiol | 10.3389/fmicb.2020.00116 | 2020 | | |
| Phylogeny | Multilocus sequence typing scheme versus pulsed-field gel electrophoresis for typing Mycobacterium abscessus isolates. | Machado GE, Matsumoto CK, Chimara E, Duarte Rda S, de Freitas D, Palaci M, Hadad DJ, Lima KV, Lopes ML, Ramos JP, Campos CE, Caldas PC, Heym B, Leao SC. | J Clin Microbiol | 10.1128/jcm.00688-14 | 2014 | |
| Enzymology | Discovery of substituted benzyloxy-benzylamine inhibitors of acetyltransferase Eis and their anti-mycobacterial activity. | Pang AH, Green KD, Chandrika NT, Garzan A, Punetha A, Holbrook SYL, Willby MJ, Posey JE, Tsodikov OV, Garneau-Tsodikova S. | Eur J Med Chem | 10.1016/j.ejmech.2022.114698 | 2022 | |
| Pathogenicity | Impact of Chlorine and Chloramine on the Detection and Quantification of Legionella pneumophila and Mycobacterium Species. | Donohue MJ, Vesper S, Mistry J, Donohue JM. | Appl Environ Microbiol | 10.1128/aem.01942-19 | 2019 | |
| Gene replacement in Mycobacterium chelonae: application to the construction of porin knock-out mutants. | Calado Nogueira de Moura V, Gibbs S, Jackson M. | PLoS One | 10.1371/journal.pone.0094951 | 2014 | | |
| Pathogenicity | Mycobacterium abscessus Smooth and Rough Morphotypes Form Antimicrobial-Tolerant Biofilm Phenotypes but Are Killed by Acetic Acid. | Clary G, Sasindran SJ, Nesbitt N, Mason L, Cole S, Azad A, McCoy K, Schlesinger LS, Hall-Stoodley L. | Antimicrob Agents Chemother | 10.1128/aac.01782-17 | 2018 | |
| Enzymology | Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens. | Ruger K, Hampel A, Billig S, Rucker N, Suerbaum S, Bange FC. | J Clin Microbiol | 10.1128/jcm.01249-13 | 2014 | |
| Identification and characterization of potential therapeutic candidates in emerging human pathogen Mycobacterium abscessus: a novel hierarchical in silico approach. | Shanmugham B, Pan A. | PLoS One | 10.1371/journal.pone.0059126 | 2013 | | |
| Metabolism | MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections. | Sethiya JP, Sowards MA, Jackson M, North EJ. | Int J Mol Sci | 10.3390/ijms21176202 | 2020 | |
| Phylogeny | Discrimination of Mycobacterium abscessus subsp. massiliense from Mycobacterium abscessus subsp. abscessus in clinical isolates by multiplex PCR. | Nakanaga K, Sekizuka T, Fukano H, Sakakibara Y, Takeuchi F, Wada S, Ishii N, Makino M, Kuroda M, Hoshino Y. | J Clin Microbiol | 10.1128/jcm.01327-13 | 2014 | |
| Pathogenicity | Therapeutic Potential of Curcumin as an Antimycobacterial Agent. | Barua N, Buragohain AK. | Biomolecules | 10.3390/biom11091278 | 2021 | |
| Pathogenicity | Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models. | Obregon-Henao A, Arnett KA, Henao-Tamayo M, Massoudi L, Creissen E, Andries K, Lenaerts AJ, Ordway DJ. | Antimicrob Agents Chemother | 10.1128/aac.00459-15 | 2015 | |
| Interaction of Mycobacteria With Host Cell Inflammasomes. | Rastogi S, Briken V. | Front Immunol | 10.3389/fimmu.2022.791136 | 2022 | | |
| Genetics | Genome-wide mosaicism within Mycobacterium abscessus: evolutionary and epidemiological implications. | Sapriel G, Konjek J, Orgeur M, Bouri L, Frezal L, Roux AL, Dumas E, Brosch R, Bouchier C, Brisse S, Vandenbogaert M, Thiberge JM, Caro V, Ngeow YF, Tan JL, Herrmann JL, Gaillard JL, Heym B, Wirth T. | BMC Genomics | 10.1186/s12864-016-2448-1 | 2016 | |
| Genetics | Genomic reconnaissance of clinical isolates of emerging human pathogen Mycobacterium abscessus reveals high evolutionary potential. | Choo SW, Wee WY, Ngeow YF, Mitchell W, Tan JL, Wong GJ, Zhao Y, Xiao J. | Sci Rep | 10.1038/srep04061 | 2014 | |
| Metabolism | Intrabacterial lipid inclusion-associated proteins: a core machinery conserved from saprophyte Actinobacteria to the human pathogen Mycobacterium tuberculosis. | Dargham T, Mallick I, Kremer L, Santucci P, Canaan S. | FEBS Open Bio | 10.1002/2211-5463.13721 | 2023 | |
| Enzymology | Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease. | Ferro BE, Srivastava S, Deshpande D, Pasipanodya JG, van Soolingen D, Mouton JW, van Ingen J, Gumbo T. | Antimicrob Agents Chemother | 10.1128/aac.02821-15 | 2016 | |
| Neutrophil killing of Mycobacterium abscessus by intra- and extracellular mechanisms. | Malcolm KC, Caceres SM, Pohl K, Poch KR, Bernut A, Kremer L, Bratton DL, Herrmann JL, Nick JA. | PLoS One | 10.1371/journal.pone.0196120 | 2018 | | |
| Enzymology | Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses. | Checkley AM, Wyllie DH, Scriba TJ, Golubchik T, Hill AV, Hanekom WA, McShane H. | PLoS One | 10.1371/journal.pone.0026434 | 2011 | |
| Pathogenicity | Analysis of a panel of rapidly growing mycobacteria for resistance to aldehyde-based disinfectants. | De Groote MA, Gibbs S, de Moura VC, Burgess W, Richardson K, Kasperbauer S, Madinger N, Jackson M. | Am J Infect Control | 10.1016/j.ajic.2014.05.014 | 2014 | |
| Phylogeny | High-throughput transcriptomics reveals common and strain-specific responses of human macrophages to infection with Mycobacterium abscessus Smooth and Rough variants. | Aulicino A, Dinan AM, Miranda-CasoLuengo AA, Browne JA, Rue-Albrecht K, MacHugh DE, Loftus BJ. | BMC Genomics | 10.1186/s12864-015-2246-1 | 2015 | |
| Pathogenicity | In Vitro Activities of Bedaquiline and Delamanid against Nontuberculous Mycobacteria Isolated in Beijing, China. | Yu X, Gao X, Li C, Luo J, Wen S, Zhang T, Ma Y, Dong L, Wang F, Huang H. | Antimicrob Agents Chemother | 10.1128/aac.00031-19 | 2019 | |
| Case series of mycobacterium abscessus infections associated with a trigger point injection and epidural block at a rural clinic. | Song JY, Son JB, Lee MK, Gwack J, Lee KS, Park JY. | Epidemiol Health | 10.4178/epih/e2012001 | 2012 | | |
| Enzymology | Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model. | Ferro BE, Srivastava S, Deshpande D, Sherman CM, Pasipanodya JG, van Soolingen D, Mouton JW, van Ingen J, Gumbo T. | Antimicrob Agents Chemother | 10.1128/aac.02282-15 | 2015 | |
| Phylogeny | Evaluation of the VITEK MS knowledge base version 3.0 for the identification of clinically relevant Mycobacterium species. | Luo L, Cao W, Chen W, Zhang R, Jing L, Chen H, Yu F, Yue J. | Emerg Microbes Infect | 10.1038/s41426-018-0120-3 | 2018 | |
| Pathogenicity | New Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design. | Kazakova O, Racoviceanu R, Petrova A, Mioc M, Militaru A, Udrescu L, Udrescu M, Voicu A, Cummings J, Robertson G, Ordway DJ, Slayden RA, Soica C. | Int J Mol Sci | 10.3390/ijms222212542 | 2021 | |
| Enzymology | Mycobacterium abscessus isolated from municipal water - a potential source of human infection. | Thomson R, Tolson C, Sidjabat H, Huygens F, Hargreaves M. | BMC Infect Dis | 10.1186/1471-2334-13-241 | 2013 | |
| Desymmetrization of Cyclopropenes via the Potassium-Templated Diastereoselective 7- exo- trig Cycloaddition of Tethered Amino Alcohols toward Enantiopure Cyclopropane-Fused Oxazepanones with Antimycobacterial Activity. | Maslivetc VA, Turner DN, McNair KN, Frolova L, Rogelj S, Maslivetc AA, Aksenov NA, Rubina M, Rubin M. | J Org Chem | 10.1021/acs.joc.8b00640 | 2018 | | |
| Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples. | Caverly LJ, Carmody LA, Haig SJ, Kotlarz N, Kalikin LM, Raskin L, LiPuma JJ. | PLoS One | 10.1371/journal.pone.0153876 | 2016 | | |
| Pathogenicity | An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria. | Kaushik A, Heuer AM, Bell DT, Culhane JC, Ebner DC, Parrish N, Ippoliti JT, Lamichhane G. | Bioorg Med Chem Lett | 10.1016/j.bmcl.2016.06.019 | 2016 | |
| Pathogenicity | Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus. | Choules MP, Wolf NM, Lee H, Anderson JR, Grzelak EM, Wang Y, Ma R, Gao W, McAlpine JB, Jin YY, Cheng J, Lee H, Suh JW, Duc NM, Paik S, Choe JH, Jo EK, Chang CL, Lee JS, Jaki BU, Pauli GF, Franzblau SG, Cho S. | Antimicrob Agents Chemother | 10.1128/aac.02204-18 | 2019 | |
| Performance Evaluation of the PowerChek MERS (upE & ORF1a) Real-Time PCR Kit for the Detection of Middle East Respiratory Syndrome Coronavirus RNA. | Huh HJ, Kim JY, Kwon HJ, Yun SA, Lee MK, Ki CS, Lee NY, Kim JW. | Ann Lab Med | 10.3343/alm.2017.37.6.494 | 2017 | | |
| Comparative analyses of nonpathogenic, opportunistic, and totally pathogenic mycobacteria reveal genomic and biochemical variabilities and highlight the survival attributes of Mycobacterium tuberculosis. | Rahman SA, Singh Y, Kohli S, Ahmad J, Ehtesham NZ, Tyagi AK, Hasnain SE. | mBio | 10.1128/mbio.02020-14 | 2014 | | |
| Enzymology | Acute respiratory failure involving an R variant of Mycobacterium abscessus. | Catherinot E, Roux AL, Macheras E, Hubert D, Matmar M, Dannhoffer L, Chinet T, Morand P, Poyart C, Heym B, Rottman M, Gaillard JL, Herrmann JL. | J Clin Microbiol | 10.1128/jcm.01478-08 | 2009 | |
| MiR-144-3p is associated with pathological inflammation in patients infected with Mycobacteroides abscessus. | Kim HJ, Kim IS, Lee SG, Kim YJ, Silwal P, Kim JY, Kim JK, Seo W, Chung C, Cho HK, Huh HJ, Shim SC, Park C, Jhun BW, Jo EK. | Exp Mol Med | 10.1038/s12276-020-00552-0 | 2021 | | |
| Enzymology | Culture-Independent Detection of Nontuberculous Mycobacteria in Clinical Respiratory Samples. | Scoleri GP, Choo JM, Leong LE, Goddard TR, Shephard L, Burr LD, Bastian I, Thomson RM, Rogers GB. | J Clin Microbiol | 10.1128/jcm.01410-16 | 2016 | |
| Pathogenicity | Modification at the 2'-Position of the 4,5-Series of 2-Deoxystreptamine Aminoglycoside Antibiotics To Resist Aminoglycoside Modifying Enzymes and Increase Ribosomal Target Selectivity. | Sati GC, Sarpe VA, Furukawa T, Mondal S, Mantovani M, Hobbie SN, Vasella A, Bottger EC, Crich D. | ACS Infect Dis | 10.1021/acsinfecdis.9b00128 | 2019 | |
| The detection and sequencing of a broad-host-range conjugative IncP-1beta plasmid in an epidemic strain of Mycobacterium abscessus subsp. bolletii. | Leao SC, Matsumoto CK, Carneiro A, Ramos RT, Nogueira CL, Lima JD, Lima KV, Lopes ML, Schneider H, Azevedo VA, da Costa da Silva A. | PLoS One | 10.1371/journal.pone.0060746 | 2013 | | |
| Molecular longitudinal tracking of Mycobacterium abscessus spp. during chronic infection of the human lung. | Kreutzfeldt KM, McAdam PR, Claxton P, Holmes A, Seagar AL, Laurenson IF, Fitzgerald JR. | PLoS One | 10.1371/journal.pone.0063237 | 2013 | | |
| Structural Elements Involved in ATP Hydrolysis Inhibition and ATP Synthesis of Tuberculosis and Nontuberculous Mycobacterial F-ATP Synthase Decipher New Targets for Inhibitors. | Wong CF, Saw WG, Basak S, Sano M, Ueno H, Kerk HW, Litty D, Ragunathan P, Dick T, Muller V, Noji H, Gruber G. | Antimicrob Agents Chemother | 10.1128/aac.01056-22 | 2022 | | |
| Evybactin is a DNA gyrase inhibitor that selectively kills Mycobacterium tuberculosis. | Imai Y, Hauk G, Quigley J, Liang L, Son S, Ghiglieri M, Gates MF, Morrissette M, Shahsavari N, Niles S, Baldisseri D, Honrao C, Ma X, Guo JJ, Berger JM, Lewis K. | Nat Chem Biol | 10.1038/s41589-022-01102-7 | 2022 | | |
| Enzymology | Development of a One-Step Multiplex PCR Assay for Differential Detection of Major Mycobacterium Species. | Chae H, Han SJ, Kim SY, Ki CS, Huh HJ, Yong D, Koh WJ, Shin SJ. | J Clin Microbiol | 10.1128/jcm.00549-17 | 2017 | |
| Pathogenicity | Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing. | Bastian S, Veziris N, Roux AL, Brossier F, Gaillard JL, Jarlier V, Cambau E. | Antimicrob Agents Chemother | 10.1128/aac.00861-10 | 2011 | |
| Metabolism | Regulation of gamma-Aminobutyrate (GABA) Utilization in Corynebacterium glutamicum by the PucR-Type Transcriptional Regulator GabR and by Alternative Nitrogen and Carbon Sources. | Zhu L, Mack C, Wirtz A, Kranz A, Polen T, Baumgart M, Bott M. | Front Microbiol | 10.3389/fmicb.2020.544045 | 2020 | |
| Phylogeny | A High-Throughput Approach for Identification of Nontuberculous Mycobacteria in Drinking Water Reveals Relationship between Water Age and Mycobacterium avium. | Haig SJ, Kotlarz N, LiPuma JJ, Raskin L. | mBio | 10.1128/mbio.02354-17 | 2018 | |
| Phylogeny | Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. | Jonsson BE, Gilljam M, Lindblad A, Ridell M, Wold AE, Welinder-Olsson C. | J Clin Microbiol | 10.1128/jcm.02592-06 | 2007 | |
| Phylogeny | LightCycler-based differentiation of Mycobacterium abscessus and Mycobacterium chelonae. | Sedlacek L, Rifai M, Feldmann K, Bange FC. | J Clin Microbiol | 10.1128/jcm.42.7.3284-3287.2004 | 2004 | |
| Pathogenicity | Transposon mutagenesis in Mycobacterium kansasii links a small RNA gene to colony morphology and biofilm formation and identifies 9,885 intragenic insertions that do not compromise colony outgrowth. | Budell WC, Germain GA, Janisch N, McKie-Krisberg Z, Jayaprakash AD, Resnick AE, Quadri LEN. | Microbiologyopen | 10.1002/mbo3.988 | 2020 | |
| Design, synthesis and evaluation of indole-2-carboxamides with pan anti-mycobacterial activity. | Franz ND, Belardinelli JM, Kaminski MA, Dunn LC, Calado Nogueira de Moura V, Blaha MA, Truong DD, Li W, Jackson M, North EJ. | Bioorg Med Chem | 10.1016/j.bmc.2017.05.015 | 2017 | | |
| Metabolism | Aggregation of Nontuberculous Mycobacteria Is Regulated by Carbon-Nitrogen Balance. | DePas WH, Bergkessel M, Newman DK. | mBio | 10.1128/mbio.01715-19 | 2019 | |
| Genetics | Comprehensive essentiality analysis of the Mycobacterium kansasii genome by saturation transposon mutagenesis and deep sequencing. | Levendosky K, Janisch N, Quadri LEN. | mBio | 10.1128/mbio.00573-23 | 2023 | |
| Metabolism | Development of Inhibitors against Mycobacterium abscessus tRNA (m1G37) Methyltransferase (TrmD) Using Fragment-Based Approaches. | Whitehouse AJ, Thomas SE, Brown KP, Fanourakis A, Chan DS, Libardo MDJ, Mendes V, Boshoff HIM, Floto RA, Abell C, Blundell TL, Coyne AG. | J Med Chem | 10.1021/acs.jmedchem.9b00809 | 2019 | |
| Metabolism | Discovery of a novel hsp65 genotype within Mycobacterium massiliense associated with the rough colony morphology. | Kim BJ, Yi SY, Shim TS, Do SY, Yu HK, Park YG, Kook YH, Kim BJ. | PLoS One | 10.1371/journal.pone.0038420 | 2012 | |
| Identifying Corneal Infections in Formalin-Fixed Specimens Using Next Generation Sequencing. | Li Z, Breitwieser FP, Lu J, Jun AS, Asnaghi L, Salzberg SL, Eberhart CG. | Invest Ophthalmol Vis Sci | 10.1167/iovs.17-21617 | 2018 | | |
| Enzymology | Identification of Key Residues for Enzymatic Carboxylate Reduction. | Stolterfoht H, Steinkellner G, Schwendenwein D, Pavkov-Keller T, Gruber K, Winkler M. | Front Microbiol | 10.3389/fmicb.2018.00250 | 2018 | |
| Genetics | Prevalence of nontuberculous mycobacteria among extrapulmonary tuberculosis cases in tertiary care centers in Northern India. | Maurya AK, Nag VL, Kant S, Kushwaha RA, Kumar M, Singh AK, Dhole TN. | Biomed Res Int | 10.1155/2015/465403 | 2015 | |
| Phylogeny | Mycobacterial Pan-Genome Analysis Suggests Important Role of Plasmids in the Radiation of Type VII Secretion Systems. | Dumas E, Christina Boritsch E, Vandenbogaert M, Rodriguez de la Vega RC, Thiberge JM, Caro V, Gaillard JL, Heym B, Girard-Misguich F, Brosch R, Sapriel G. | Genome Biol Evol | 10.1093/gbe/evw001 | 2016 | |
| Genetics | MycoRRdb: a database of computationally identified regulatory regions within intergenic sequences in mycobacterial genomes. | Midha M, Prasad NK, Vindal V. | PLoS One | 10.1371/journal.pone.0036094 | 2012 | |
| Diving into drug-screening: zebrafish embryos as an in vivo platform for antimicrobial drug discovery and assessment. | Habjan E, Schouten GK, Speer A, van Ulsen P, Bitter W. | FEMS Microbiol Rev | 10.1093/femsre/fuae011 | 2024 | | |
| Enzymology | Mycobacterium massiliense bacteremia as a consequence of M. massiliense pneumonia in a patient with acute lymphoblastic leukemia. | Kim J, Park JS, Jeong YS, Kim DY, Sung H, Kim MN. | J Clin Microbiol | 10.1128/jcm.03543-13 | 2014 | |
| Comparative Study of Eis-like Enzymes from Pathogenic and Nonpathogenic Bacteria. | Green KD, Pricer RE, Stewart MN, Garneau-Tsodikova S. | ACS Infect Dis | 10.1021/acsinfecdis.5b00036 | 2015 | | |
| Phylogeny | Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. | Zelazny AM, Root JM, Shea YR, Colombo RE, Shamputa IC, Stock F, Conlan S, McNulty S, Brown-Elliott BA, Wallace RJ, Olivier KN, Holland SM, Sampaio EP. | J Clin Microbiol | 10.1128/jcm.01688-08 | 2009 | |
| The recombination-cold region as an epidemiological marker of recombinogenic opportunistic pathogen Mycobacterium avium. | Yano H, Suzuki H, Maruyama F, Iwamoto T. | BMC Genomics | 10.1186/s12864-019-6078-2 | 2019 | | |
| Genetics | Complete genome sequence analysis of Nocardia brasiliensis HUJEG-1 reveals a saprobic lifestyle and the genes needed for human pathogenesis. | Vera-Cabrera L, Ortiz-Lopez R, Elizondo-Gonzalez R, Ocampo-Candiani J. | PLoS One | 10.1371/journal.pone.0065425 | 2013 | |
| Galleria mellonella-intracellular bacteria pathogen infection models: the ins and outs. | Asai M, Li Y, Newton SM, Robertson BD, Langford PR. | FEMS Microbiol Rev | 10.1093/femsre/fuad011 | 2023 | | |
| Enzymology | Direct detection of Mycobacterium tuberculosis complex in bovine and bubaline tissues through nested-PCR. | Araujo CP, Osorio AL, Jorge KS, Ramos CA, Souza Filho AF, Vidal CE, Vargas AP, Roxo E, Rocha AS, Suffys PN, Fonseca AA, Silva MR, Barbosa Neto JD, Cerqueira VD, Araujo FR. | Braz J Microbiol | 10.1590/s1517-83822014000200035 | 2014 | |
| In Vitro Antimicrobial Susceptibility of Mycobacterium massiliense Recovered from Wound Samples of Patients Submitted to Arthroscopic and Laparoscopic Surgeries. | Cardoso AM, Junqueira-Kipnis AP, Kipnis A. | Minim Invasive Surg | 10.1155/2011/724635 | 2011 | | |
| Pathogenicity | Novel Antimicrobials from Uncultured Bacteria Acting against Mycobacterium tuberculosis. | Quigley J, Peoples A, Sarybaeva A, Hughes D, Ghiglieri M, Achorn C, Desrosiers A, Felix C, Liang L, Malveira S, Millett W, Nitti A, Tran B, Zullo A, Anklin C, Spoering A, Ling LL, Lewis K. | mBio | 10.1128/mbio.01516-20 | 2020 | |
| Metabolism | Mycobacterium abscessus activates the NLRP3 inflammasome via Dectin-1-Syk and p62/SQSTM1. | Lee HM, Yuk JM, Kim KH, Jang J, Kang G, Park JB, Son JW, Jo EK. | Immunol Cell Biol | 10.1038/icb.2011.72 | 2012 | |
| Genetics | Structural diversity in the Mycobacteria DUF3349 superfamily. | Buchko GW, Abendroth J, Robinson JI, Phan IQ, Myler PJ, Edwards TE. | Protein Sci | 10.1002/pro.3758 | 2020 | |
| Phylogeny | Efficient differentiation of Mycobacterium avium complex species and subspecies by use of five-target multiplex PCR. | Shin SJ, Lee BS, Koh WJ, Manning EJ, Anklam K, Sreevatsan S, Lambrecht RS, Collins MT. | J Clin Microbiol | 10.1128/jcm.00904-10 | 2010 | |
| Mycobacterium tuberculosis pili (MTP), a putative biomarker for a tuberculosis diagnostic test. | Naidoo N, Ramsugit S, Pillay M. | Tuberculosis (Edinb) | 10.1016/j.tube.2014.03.004 | 2014 | | |
| dndDB: a database focused on phosphorothioation of the DNA backbone. | Ou HY, He X, Shao Y, Tai C, Rajakumar K, Deng Z. | PLoS One | 10.1371/journal.pone.0005132 | 2009 | | |
| Phylogeny | Comparison of DNA pyrosequencing with alternative methods for identification of mycobacteria. | Heller LC, Jones M, Widen RH. | J Clin Microbiol | 10.1128/jcm.02001-07 | 2008 | |
| Enzymology | Detection of Tropheryma whipplei DNA in clinical specimens by LightCycler real-time PCR. | Sloan LM, Rosenblatt JE, Cockerill FR. | J Clin Microbiol | 10.1128/jcm.43.7.3516-3518.2005 | 2005 | |
| Phylogeny | Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates. | Kim HY, Kook Y, Yun YJ, Park CG, Lee NY, Shim TS, Kim BJ, Kook YH. | J Clin Microbiol | 10.1128/jcm.00319-08 | 2008 | |
| Phylogeny | Molecular characterization of Mycobacterium massiliense and Mycobacterium bolletii in isolates collected from outbreaks of infections after laparoscopic surgeries and cosmetic procedures. | Viana-Niero C, Lima KV, Lopes ML, Rabello MC, Marsola LR, Brilhante VC, Durham AM, Leao SC. | J Clin Microbiol | 10.1128/jcm.02052-07 | 2008 | |
| Pathogenicity | In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials. | Fernandez-Roblas R, Esteban J, Cabria F, Lopez JC, Jimenez MS, Soriano F. | Antimicrob Agents Chemother | 10.1128/aac.44.1.181-182.2000 | 2000 | |
| Metabolism | Gene cluster encoding cholate catabolism in Rhodococcus spp. | Mohn WW, Wilbrink MH, Casabon I, Stewart GR, Liu J, van der Geize R, Eltis LD. | J Bacteriol | 10.1128/jb.01169-12 | 2012 | |
| Enzymology | Outbreak of Mycobacterium massiliense infection associated with intramuscular injections. | Kim HY, Yun YJ, Park CG, Lee DH, Cho YK, Park BJ, Joo SI, Kim EC, Hur YJ, Kim BJ, Kook YH. | J Clin Microbiol | 10.1128/jcm.00608-07 | 2007 | |
| Pathogenicity | Multidrug-resistant nontuberculous mycobacteria isolated from cystic fibrosis patients. | Candido PH, Nunes Lde S, Marques EA, Folescu TW, Coelho FS, de Moura VC, da Silva MG, Gomes KM, Lourenco MC, Aguiar FS, Chitolina F, Armstrong DT, Leao SC, Neves FP, Mello FC, Duarte RS. | J Clin Microbiol | 10.1128/jcm.00549-14 | 2014 | |
| Computational genomics-proteomics and Phylogeny analysis of twenty one mycobacterial genomes (Tuberculosis & non Tuberculosis strains). | Zakham F, Aouane O, Ussery D, Benjouad A, Ennaji MM. | Microb Inform Exp | 10.1186/2042-5783-2-7 | 2012 | | |
| Genetics | HGA: de novo genome assembly method for bacterial genomes using high coverage short sequencing reads. | Al-Okaily AA. | BMC Genomics | 10.1186/s12864-016-2515-7 | 2016 | |
| Metabolism | Mycobacterium abscessus and M. avium trigger Toll-like receptor 2 and distinct cytokine response in human cells. | Sampaio EP, Elloumi HZ, Zelazny A, Ding L, Paulson ML, Sher A, Bafica AL, Shea YR, Holland SM. | Am J Respir Cell Mol Biol | 10.1165/rcmb.2007-0413oc | 2008 | |
| Detection of Mycobacterium bovis in bovine and bubaline tissues using nested-PCR for TbD1. | Araujo CP, Osorio AL, Jorge KS, Ramos CA, Filho AF, Vidal CE, Roxo E, Nishibe C, Almeida NF, Junior AA, Silva MR, Neto JD, Cerqueira VD, Zumarraga MJ, Araujo FR. | PLoS One | 10.1371/journal.pone.0091023 | 2014 | | |
| Pathogenicity | Gut Microbiota Metabolite Indole Propionic Acid Targets Tryptophan Biosynthesis in Mycobacterium tuberculosis. | Negatu DA, Yamada Y, Xi Y, Go ML, Zimmerman M, Ganapathy U, Dartois V, Gengenbacher M, Dick T. | mBio | 10.1128/mbio.02781-18 | 2019 | |
| Phylogeny | Identification of Mycobacterium species by comparative analysis of the dnaA gene. | Mukai T, Miyamoto Y, Yamazaki T, Makino M. | FEMS Microbiol Lett | 10.1111/j.1574-6968.2005.00031.x | 2006 | |
| Mycobacterium tuberculosis and Paracoccidioides brasiliensis Formation and Treatment of Mixed Biofilm In Vitro. | Medina-Alarcon KP, Tobias da Silva IP, Ferin GG, Pereira-da-Silva MA, Marcos CM, Dos Santos MB, Regasini LO, Chorilli M, Mendes-Giannini MJS, Pavan FR, Fusco-Almeida AM. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.681131 | 2021 | | |
| Enzymology | Epidemic of postsurgical infections caused by Mycobacterium massiliense. | Duarte RS, Lourenco MC, Fonseca Lde S, Leao SC, Amorim Ede L, Rocha IL, Coelho FS, Viana-Niero C, Gomes KM, da Silva MG, Lorena NS, Pitombo MB, Ferreira RM, Garcia MH, de Oliveira GP, Lupi O, Vilaca BR, Serradas LR, Chebabo A, Marques EA, Teixeira LM, Dalcolmo M, Senna SG, Sampaio JL. | J Clin Microbiol | 10.1128/jcm.00027-09 | 2009 | |
| Phylogeny | Mycobacterial phylogenomics: an enhanced method for gene turnover analysis reveals uneven levels of gene gain and loss among species and gene families. | Librado P, Vieira FG, Sanchez-Gracia A, Kolokotronis SO, Rozas J. | Genome Biol Evol | 10.1093/gbe/evu117 | 2014 | |
| Integrative immunoinformatics for Mycobacterial diseases in R platform. | Chaudhuri R, Kulshreshtha D, Raghunandanan MV, Ramachandran S. | Syst Synth Biol | 10.1007/s11693-014-9135-9 | 2014 | | |
| Metabolism | Biochemical and structural analysis of aminoglycoside acetyltransferase Eis from Anabaena variabilis. | Pricer RE, Houghton JL, Green KD, Mayhoub AS, Garneau-Tsodikova S. | Mol Biosyst | 10.1039/c2mb25341k | 2012 | |
| Metabolism | Pathogenic nontuberculous mycobacteria resist and inactivate cathelicidin: implication of a novel role for polar mycobacterial lipids. | Honda JR, Hess T, Malcolm KC, Ovrutsky AR, Bai X, Irani VR, Dobos KM, Chan ED, Flores SC. | PLoS One | 10.1371/journal.pone.0126994 | 2015 | |
| Metabolism | Rapid and specific labeling of single live Mycobacterium tuberculosis with a dual-targeting fluorogenic probe. | Cheng Y, Xie J, Lee KH, Gaur RL, Song A, Dai T, Ren H, Wu J, Sun Z, Banaei N, Akin D, Rao J. | Sci Transl Med | 10.1126/scitranslmed.aar4470 | 2018 | |
| Pathogenicity | Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection. | Kim YJ, Lee JY, Lee JJ, Jeon SM, Silwal P, Kim IS, Kim HJ, Park CR, Chung C, Han JE, Choi JW, Tak EJ, Yoo JH, Jeong SW, Kim DY, Ketphan W, Kim SY, Jhun BW, Whang J, Kim JM, Eoh H, Bae JW, Jo EK. | Gut Microbes | 10.1080/19490976.2022.2073132 | 2022 | |
| Genetics | Characterization of the genome of the polyvalent lytic bacteriophage GTE2, which has potential for biocontrol of Gordonia-, Rhodococcus-, and Nocardia-stabilized foams in activated sludge plants. | Petrovski S, Seviour RJ, Tillett D. | Appl Environ Microbiol | 10.1128/aem.00025-11 | 2011 | |
| Phylogeny | Direct detection of nasal Staphylococcus aureus carriage via helicase-dependent isothermal amplification and chip hybridization. | Frech GC, Munns D, Jenison RD, Hicke BJ. | BMC Res Notes | 10.1186/1756-0500-5-430 | 2012 | |
| DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus. | Wallace RJ, Zhang Y, Brown BA, Fraser V, Mazurek GH, Maloney S. | J Clin Microbiol | 10.1128/jcm.31.10.2697-2701.1993 | 1993 | | |
| Genetics | A genome-wide identification analysis of small regulatory RNAs in Mycobacterium tuberculosis by RNA-Seq and conservation analysis. | Pellin D, Miotto P, Ambrosi A, Cirillo DM, Di Serio C. | PLoS One | 10.1371/journal.pone.0032723 | 2012 | |
| Towards a more accurate annotation of tyrosine-based site-specific recombinases in bacterial genomes. | Van Houdt R, Leplae R, Lima-Mendez G, Mergeay M, Toussaint A. | Mob DNA | 10.1186/1759-8753-3-6 | 2012 | | |
| Pathogenicity | antibacTR: dynamic antibacterial-drug-target ranking integrating comparative genomics, structural analysis and experimental annotation. | Panjkovich A, Gibert I, Daura X. | BMC Genomics | 10.1186/1471-2164-15-36 | 2014 | |
| Phylogeny | Lack of usefulness of carbon utilization tests for identification of Mycobacterium mucogenicum. | Conville PS, Witebsky FG. | J Clin Microbiol | 10.1128/jcm.39.7.2725-2728.2001 | 2001 | |
| Phylogeny | Variables affecting results of sodium chloride tolerance test for identification of rapidly growing mycobacteria. | Conville PS, Witebsky FG. | J Clin Microbiol | 10.1128/jcm.36.6.1555-1559.1998 | 1998 | |
| Metabolism | Multiplicity of 3-Ketosteroid-9alpha-Hydroxylase enzymes in Rhodococcus rhodochrous DSM43269 for specific degradation of different classes of steroids. | Petrusma M, Hessels G, Dijkhuizen L, van der Geize R. | J Bacteriol | 10.1128/jb.00274-11 | 2011 | |
| Metabolism | Mycobacterium tuberculosis Is a Natural Ornithine Aminotransferase (rocD) Mutant and Depends on Rv2323c for Growth on Arginine. | Hampel A, Huber C, Geffers R, Spona-Friedl M, Eisenreich W, Bange FC. | PLoS One | 10.1371/journal.pone.0136914 | 2015 | |
| Phylogeny | Rapid identification of mycobacterial whole cells in solid and liquid culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry. | Lotz A, Ferroni A, Beretti JL, Dauphin B, Carbonnelle E, Guet-Revillet H, Veziris N, Heym B, Jarlier V, Gaillard JL, Pierre-Audigier C, Frapy E, Berche P, Nassif X, Bille E. | J Clin Microbiol | 10.1128/jcm.01397-10 | 2010 | |
| Heterologous expression of mycobacterial Esx complexes in Escherichia coli for structural studies is facilitated by the use of maltose binding protein fusions. | Arbing MA, Chan S, Harris L, Kuo E, Zhou TT, Ahn CJ, Nguyen L, He Q, Lu J, Menchavez PT, Shin A, Holton T, Sawaya MR, Cascio D, Eisenberg D. | PLoS One | 10.1371/journal.pone.0081753 | 2013 | | |
| Genetics | GAGE-B: an evaluation of genome assemblers for bacterial organisms. | Magoc T, Pabinger S, Canzar S, Liu X, Su Q, Puiu D, Tallon LJ, Salzberg SL. | Bioinformatics | 10.1093/bioinformatics/btt273 | 2013 | |
| Pathogenicity | QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity. | Gomes MN, Braga RC, Grzelak EM, Neves BJ, Muratov E, Ma R, Klein LL, Cho S, Oliveira GR, Franzblau SG, Andrade CH. | Eur J Med Chem | 10.1016/j.ejmech.2017.05.026 | 2017 | |
| Redox homeostasis in Mycobacterium tuberculosis is modulated by a novel actinomycete-specific transcription factor. | Khan MZ, Singha B, Ali MF, Taunk K, Rapole S, Gourinath S, Nandicoori VK. | EMBO J | 10.15252/embj.2020106111 | 2021 | | |
| Enzymology | Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens. | Lin SY, Rodwell TC, Victor TC, Rider EC, Pham L, Catanzaro A, Desmond EP. | J Clin Microbiol | 10.1128/jcm.01821-13 | 2014 | |
| Genetics | Genome sequence and characterization of the Tsukamurella bacteriophage TPA2. | Petrovski S, Seviour RJ, Tillett D. | Appl Environ Microbiol | 10.1128/aem.01938-10 | 2011 | |
| Diverse alkane hydroxylase genes in microorganisms and environments. | Nie Y, Chi CQ, Fang H, Liang JL, Lu SL, Lai GL, Tang YQ, Wu XL. | Sci Rep | 10.1038/srep04968 | 2014 | | |
| Pathogenicity | Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria. | Brown BA, Wallace RJ, Onyi G. | Antimicrob Agents Chemother | 10.1128/aac.40.4.874 | 1996 | |
| Pathogenicity | Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis. | Chopra S, Matsuyama K, Tran T, Malerich JP, Wan B, Franzblau SG, Lun S, Guo H, Maiga MC, Bishai WR, Madrid PB. | J Antimicrob Chemother | 10.1093/jac/dkr449 | 2012 | |
| Phylogeny | Biochip system for rapid and accurate identification of mycobacterial species from isolates and sputum. | Zhu L, Jiang G, Wang S, Wang C, Li Q, Yu H, Zhou Y, Zhao B, Huang H, Xing W, Mitchelson K, Cheng J, Zhao Y, Guo Y. | J Clin Microbiol | 10.1128/jcm.00158-10 | 2010 | |
| Pathogenicity | Non-classical transpeptidases yield insight into new antibacterials. | Kumar P, Kumar P, Kaushik A, Lloyd EP, Li SG, Mattoo R, Ammerman NC, Bell DT, Perryman AL, Zandi TA, Ekins S, Ginell SL, Townsend CA, Freundlich JS, Lamichhane G. | Nat Chem Biol | 10.1038/nchembio.2237 | 2017 | |
| Pathogenicity | Rapid detection of rpoB gene mutations conferring rifampin resistance in Mycobacterium tuberculosis. | Ao W, Aldous S, Woodruff E, Hicke B, Rea L, Kreiswirth B, Jenison R. | J Clin Microbiol | 10.1128/jcm.00208-12 | 2012 | |
| Metabolism | A walk into the LuxR regulators of Actinobacteria: phylogenomic distribution and functional diversity. | Santos CL, Correia-Neves M, Moradas-Ferreira P, Mendes MV. | PLoS One | 10.1371/journal.pone.0046758 | 2012 | |
| Metabolism | Adaptation to environmental stimuli within the host: two-component signal transduction systems of Mycobacterium tuberculosis. | Bretl DJ, Demetriadou C, Zahrt TC. | Microbiol Mol Biol Rev | 10.1128/mmbr.05004-11 | 2011 | |
| Pathogenicity | The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo. | Gao W, Kim JY, Anderson JR, Akopian T, Hong S, Jin YY, Kandror O, Kim JW, Lee IA, Lee SY, McAlpine JB, Mulugeta S, Sunoqrot S, Wang Y, Yang SH, Yoon TM, Goldberg AL, Pauli GF, Suh JW, Franzblau SG, Cho S. | Antimicrob Agents Chemother | 10.1128/aac.04054-14 | 2015 | |
| Phylogeny | Rapid-cycle PCR and fluorimetry for detection of mycobacteria. | Lachnik J, Ackermann B, Bohrssen A, Maass S, Diephaus C, Puncken A, Stermann M, Bange FC. | J Clin Microbiol | 10.1128/jcm.40.9.3364-3373.2002 | 2002 | |
| Comparative phylogenomics of pathogenic and non-pathogenic mycobacterium. | Prasanna AN, Mehra S. | PLoS One | 10.1371/journal.pone.0071248 | 2013 | | |
| Pathogenicity | A Novel Small-Molecule Inhibitor of the Mycobacterium tuberculosis Demethylmenaquinone Methyltransferase MenG Is Bactericidal to Both Growing and Nutritionally Deprived Persister Cells. | Sukheja P, Kumar P, Mittal N, Li SG, Singleton E, Russo R, Perryman AL, Shrestha R, Awasthi D, Husain S, Soteropoulos P, Brukh R, Connell N, Freundlich JS, Alland D. | mBio | 10.1128/mbio.02022-16 | 2017 | |
| Phylogeny | Comparative sequence analysis of Mycobacterium leprae and the new leprosy-causing Mycobacterium lepromatosis. | Han XY, Sizer KC, Thompson EJ, Kabanja J, Li J, Hu P, Gomez-Valero L, Silva FJ. | J Bacteriol | 10.1128/jb.00762-09 | 2009 | |
| Mycobacterial biomaterials and resources for researchers. | Hazbon MH, Rigouts L, Schito M, Ezewudo M, Kudo T, Itoh T, Ohkuma M, Kiss K, Wu L, Ma J, Hamada M, Strong M, Salfinger M, Daley CL, Nick JA, Lee JS, Rastogi N, Couvin D, Hurtado-Ortiz R, Bizet C, Suresh A, Rodwell T, Albertini A, Lacourciere KA, Deheer-Graham A, Alexander S, Russell JE, Bradford R, Riojas MA. | Pathog Dis | 10.1093/femspd/fty042 | 2018 | | |
| Phylogeny | Differential identification of Mycobacterium fortuitum and Mycobacterium chelonei. | David HL, Traore I, Feuillet A. | J Clin Microbiol | 10.1128/jcm.13.1.6-9.1981 | 1981 | |
| Annotation of Protein Domains Reveals Remarkable Conservation in the Functional Make up of Proteomes Across Superkingdoms. | Nasir A, Naeem A, Khan MJ, Nicora HD, Caetano-Anolles G. | Genes (Basel) | 10.3390/genes2040869 | 2011 | | |
| Metabolism | Co-opting sulphur-carrier proteins from primary metabolic pathways for 2-thiosugar biosynthesis. | Sasaki E, Zhang X, Sun HG, Lu MY, Liu TL, Ou A, Li JY, Chen YH, Ealick SE, Liu HW. | Nature | 10.1038/nature13256 | 2014 | |
| Enzymology | Detection and identification of mycobacteria in formalin-fixed, paraffin-embedded tissues by nested PCR and restriction enzyme analysis. | Bascunana CR, Belak K. | J Clin Microbiol | 10.1128/jcm.34.10.2351-2355.1996 | 1996 | |
| Genetic heterogeneity within Mycobacterium fortuitum complex species: genotypic criteria for identification. | Kirschner P, Kiekenbeck M, Meissner D, Wolters J, Bottger EC. | J Clin Microbiol | 10.1128/jcm.30.11.2772-2775.1992 | 1992 | | |
| Pathogenicity | Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR. | Wada T, Maeda S, Tamaru A, Imai S, Hase A, Kobayashi K. | J Clin Microbiol | 10.1128/jcm.42.11.5277-5285.2004 | 2004 | |
| Analysis of genetic polymorphism in the phospholipase region of Mycobacterium tuberculosis. | Vera-Cabrera L, Howard ST, Laszlo A, Johnson WM. | J Clin Microbiol | 10.1128/jcm.35.5.1190-1195.1997 | 1997 | | |
| Phylogeny | Phylogenetic framework and molecular signatures for the main clades of the phylum Actinobacteria. | Gao B, Gupta RS. | Microbiol Mol Biol Rev | 10.1128/mmbr.05011-11 | 2012 | |
| P3MA: A Promising Mycobacteriophage Infecting Mycobacterium abscessus | Broncano-Lavado A, Aguilera-Correa J, Roquet-Baneres F, Kremer L, Mediero A, Seoane-Blanco M, van Raaij M, Pagan I, Esteban J, Garcia-Quintanilla M. | Antibiotics (Basel) | 2025 | | ||
| Cultivation | Contribution of machine learning for subspecies identification from Mycobacterium abscessus with MALDI-TOF MS in solid and liquid media. | Godmer A, Bigey L, Giai-Gianetto Q, Pierrat G, Mohammad N, Mougari F, Piarroux R, Veziris N, Aubry A. | Microb Biotechnol | 10.1111/1751-7915.14545 | 2024 | |
| Promising antibacterial efficacy of arenicin peptides against the emerging opportunistic pathogen Mycobacterium abscessus. | Casanova M, Maresca M, Poncin I, Point V, Olleik H, Boidin-Wichlacz C, Tasiemski A, Mabrouk K, Cavalier JF, Canaan S. | J Biomed Sci | 10.1186/s12929-024-01007-8 | 2024 | | |
| Immune defects in patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis. | Schuurbiers MMF, Bruno M, Zweijpfenning SMH, Magis-Escurra C, Boeree M, Netea MG, van Ingen J, van de Veerdonk F, Hoefsloot W. | ERJ Open Res | 10.1183/23120541.00590-2020 | 2020 | | |
| Pathogenicity | Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease. | Ruth MM, Sangen JJN, Pennings LJ, Schildkraut JA, Hoefsloot W, Magis-Escurra C, Wertheim HFL, van Ingen J. | Antimicrob Agents Chemother | 10.1128/aac.01208-18 | 2018 | |
| Subtle immunodeficiencies in nodular-bronchiectatic Mycobacterium avium complex lung disease. | Bruno M, Zweijpfenning SMH, Verhoeven J, Boeree MJ, Netea MG, van de Veerdonk FL, van Ingen J, Hoefsloot W. | ERJ Open Res | 10.1183/23120541.00548-2020 | 2020 | | |
| Enzymology | Preclinical Pharmacokinetic and Pharmacodynamic Data To Support Cefoxitin Nebulization for the Treatment of Mycobacterium abscessus. | Mehta S, Aranzana-Climent V, Rammaert B, Gregoire N, Marchand S, Couet W, Buyck JM. | Antimicrob Agents Chemother | 10.1128/aac.02651-18 | 2019 | |
| Pathogenicity | Thiostrepton: A Novel Therapeutic Drug Candidate for Mycobacterium abscessus Infection. | Kim TH, Hanh BTB, Kim G, Lee DG, Park JW, Lee SE, Kim JS, Kim BS, Ryoo S, Jo EK, Jang J. | Molecules | 10.3390/molecules24244511 | 2019 | |
| Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease? | Ruth MM, Koeken VACM, Pennings LJ, Svensson EM, Wertheim HFL, Hoefsloot W, van Ingen J. | J Antimicrob Chemother | 10.1093/jac/dkz511 | 2020 | | |
| Pathogenicity | Rifamycin O, An Alternative Anti-Mycobacterium abscessus Agent. | Hanh BTB, Park JW, Kim TH, Kim JS, Yang CS, Jang K, Cui J, Oh DC, Jang J. | Molecules | 10.3390/molecules25071597 | 2020 | |
| Exploring antibiotic resistance mechanisms in Mycobacterium abscessus for enhanced therapeutic approaches. | Nguyen TQ, Heo BE, Jeon S, Ash A, Lee H, Moon C, Jang J. | Front Microbiol | 10.3389/fmicb.2024.1331508 | 2024 | | |
| Pathogenicity | Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus. | Bax HI, de Vogel CP, Mouton JW, de Steenwinkel JEM. | J Antimicrob Chemother | 10.1093/jac/dkz267 | 2019 | |
| Pathogenicity | Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin. | Ferro BE, Meletiadis J, Wattenberg M, de Jong A, van Soolingen D, Mouton JW, van Ingen J. | Antimicrob Agents Chemother | 10.1128/aac.02615-15 | 2016 | |
| Pathogenicity | Sirtuin 3 is essential for host defense against Mycobacterium abscessus infection through regulation of mitochondrial homeostasis. | Kim YJ, Lee SH, Jeon SM, Silwal P, Seo JY, Hanh BTB, Park JW, Whang J, Lee MJ, Heo JY, Kim SH, Kim JM, Song GY, Jang J, Jo EK. | Virulence | 10.1080/21505594.2020.1809961 | 2020 | |
| Phylogeny | Classification algorithm for subspecies identification within the Mycobacterium abscessus species, based on matrix-assisted laser desorption ionization-time of flight mass spectrometry. | Fangous MS, Mougari F, Gouriou S, Calvez E, Raskine L, Cambau E, Payan C, Hery-Arnaud G. | J Clin Microbiol | 10.1128/jcm.00788-14 | 2014 | |
| ATG7 in innate immune cells is required for host defense against nontuberculous mycobacterial pulmonary infections. | Jeon SM, Lee YJ, Lee SH, Kim SI, Lee B, Roh T, Kim YJ, Kim HJ, Kim IS, Whang J, Kim SY, Jhun BW, Chung C, Kang DH, Yeo MK, Kim JM, Jang J, Min JJ, Komatsu M, Kim JK, Park WY, Jo EK. | Nat Commun | 10.1038/s41467-025-61791-1 | 2025 | | |
| Enzymology | Sacroiliitis secondary to catheter-related bacteremia due to Mycobacterium abscessus (sensu stricto). | Laurens C, Hery-Arnaud G, Chiron R, Oziol E, Jean-Pierre H, Bouzinbi N, Vande Perre P, Banuls AL, Godreuil S. | Ann Clin Microbiol Antimicrob | 10.1186/1476-0711-13-9 | 2014 | |
| Phylogeny | Phylogenetic analysis of Mycobacterium massiliense strains having recombinant rpoB gene laterally transferred from Mycobacterium abscessus. | Kim BJ, Kim GN, Kim BR, Shim TS, Kook YH, Kim BJ. | PLoS One | 10.1371/journal.pone.0179237 | 2017 | |
| Enzymology | Tenosynovitis caused by a novel nontuberculous Mycobacterium species initially misidentified as a member of the Mycobacterium tuberculosis complex. | Simner PJ, Hyle EP, Buckwalter SP, Branda JA, Brown-Elliott BA, Franklin J, Toney NC, de Man TJ, Wallace RJ, Vasireddy R, Gandhi RT, Wengenack NL. | J Clin Microbiol | 10.1128/jcm.00967-14 | 2014 | |
| Metabolism | Comparative functional pan-genome analyses to build connections between genomic dynamics and phenotypic evolution in polycyclic aromatic hydrocarbon metabolism in the genus Mycobacterium. | Kweon O, Kim SJ, Blom J, Kim SK, Kim BS, Baek DH, Park SI, Sutherland JB, Cerniglia CE. | BMC Evol Biol | 10.1186/s12862-015-0302-8 | 2015 | |
| Genetics | Genomic basis for natural product biosynthetic diversity in the actinomycetes. | Nett M, Ikeda H, Moore BS. | Nat Prod Rep | 10.1039/b817069j | 2009 | |
| One-step loop-mediated isothermal amplification system for Mycobacterium marinum detection. | Okumura K, Miyamoto Y, Mitarai S, Ato M. | Microbiol Spectr | 10.1128/spectrum.02906-24 | 2025 | | |
| Cystic fibrosis sputum media induces an overall loss of antibiotic susceptibility in Mycobacterium abscessus. | Baker EJ, Allcott G, Molloy A, Cox JAG. | NPJ Antimicrob Resist | 10.1038/s44259-024-00054-3 | 2024 | | |
| Manuka honey in combination with azithromycin shows potential for improved activity against Mycobacterium abscessus. | Nolan VC, Harrison J, Cox JAG. | Cell Surf | 10.1016/j.tcsw.2022.100090 | 2022 | | |
| In vitro efficacy of relebactam versus avibactam against Mycobacterium abscessus complex. | Harrison J, Weaver JA, Desai M, Cox JAG. | Cell Surf | 10.1016/j.tcsw.2021.100064 | 2021 | | |
| Indole-containing arene-ruthenium complexes with broad spectrum activity against antibiotic-resistant bacteria. | Nolan VC, Rafols L, Harrison J, Soldevila-Barreda JJ, Crosatti M, Garton NJ, Wegrzyn M, Timms DL, Seaton CC, Sendron H, Azmanova M, Barry NPE, Pitto-Barry A, Cox JAG. | Curr Res Microb Sci | 10.1016/j.crmicr.2021.100099 | 2022 | | |
| Mycobactin analogue interacting with siderophore efflux-pump protein: insights from molecular dynamics simulations and whole-cell assays. | Shyam M, Thakur A, Velez C, Daniel C, Acevedo O, Bhakta S, Jayaprakash V. | Front Antibiot | 10.3389/frabi.2024.1362516 | 2024 | | |
| Pathogenicity | Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus. | Lopeman RC, Harrison J, Rathbone DL, Desai M, Lambert PA, Cox JAG. | Sci Rep | 10.1038/s41598-020-57844-8 | 2020 | |
| Application of Monoclonal Anti-Mycolate Antibodies in Serological Diagnosis of Tuberculosis. | Truyts A, Du Preez I, Maesela EM, Scriba MR, Baillie L, Jones AT, Land KJ, Verschoor JA, Lemmer Y. | Trop Med Infect Dis | 10.3390/tropicalmed9110269 | 2024 | | |
| In Vitro Antibacterial Activity of Myxin Against Mycobacterium abscessus. | Liu Z, Wan X, Li A, Tan Z, He S, Jia Y, Lin Y, Li R, Qian Y, Xu L, Li B. | Clin Exp Pharmacol Physiol | 10.1111/1440-1681.70091 | 2026 | | |
| Clinical emergence of inducible macrolide resistance mediated by acquired erm(41) C28T mutation in Mycobacterium abscessus. | He G, Zeng S, Banki LT, Zhou W, Zheng Q, Chen Q, Yang X, Luo J, Pan J, Luo T. | Antimicrob Agents Chemother | 10.1128/aac.01153-25 | 2025 | | |
| The MAB_3513c gene plays a key role in intrinsic resistance of Mycobacterium abscessus to isoniazid and ethionamide. | Wang S, Zhang X, Fang X, Hameed HMA, Malik A, Long L, Gao Y, Fang C, Tian X, Hu J, Wang X, Feng L, Zhang T. | Microbiol Spectr | 10.1128/spectrum.02889-25 | 2025 | | |
| Distribution, prevalence of non-tuberculous mycobacteria on Hainan Island and antibiotic resistance of Mycobacterium abscessus. | Xu X, Huang J, Wang H, Xiang T, Liu J, Zheng L. | Microbiol Spectr | 10.1128/spectrum.01134-25 | 2025 | | |
| Pathogenicity | Punicalagin Enhances Autophagy Through Sirtuin 1/FoxO3a Axis to Inhibit Intracellular Mycobacterium Abscessus Infection. | Bi K, Xu B, Cao D, Xu K, Zhang Y. | Adv Sci (Weinh) | 10.1002/advs.202511734 | 2025 | |
| The use of double-reporter Mycobacterium abscessus strains to improve anti-biofilm drug screening. | Bento CM, Gomes MS, Silva T. | J Microbiol Methods | 10.1016/j.mimet.2025.107290 | 2025 | | |
| Physical compatibility of omadacycline with intravenous agents used in the treatment of Mycobacteroides abscessus pulmonary disease. | Butler DA, Moolick K. | Am J Health Syst Pharm | 10.1093/ajhp/zxaf299 | 2025 | | |
| Preclinical evaluation of epetraborole in the hollow fibre system model of Mycobacterium abscessus lung disease. | Singh S, Boorgula GD, Nguyen MH, Daley CL, Gumbo T, Srivastava S. | J Antimicrob Chemother | 10.1093/jac/dkaf405 | 2025 | | |
| Evaluation of the interaction and synergy potential of bedaquiline and clarithromycin in combination with efflux pump inhibitors in clinical isolates of Mycobacterium abscessus complex. | Tursun EG, Bozok T, Bicmen C, Aslan G. | Folia Microbiol (Praha) | 10.1007/s12223-025-01357-2 | 2025 | | |
| Antimicrobial susceptibility patterns and genotypic characteristics of Mycobacterium marinum and Mycobacterium abscessus isolated from cutaneous infections: A retrospective study. | Peng J, Zhang W, Shi Y, Jiang H, Xiong J, Mei Y, Gan T, Wang H. | J Glob Antimicrob Resist | 10.1016/j.jgar.2025.10.001 | 2025 | | |
| Mycobacteriumabscessus CYP123 is a steroid hydroxylase with an implication in host infection. | Brixius B, Aziz O, Shao A, Bocquillon E, Mirtchev A, Ross BN, Brixius-Anderko S. | Drug Metab Dispos | 10.1016/j.dmd.2025.100193 | 2025 | | |
| PrrAB is a Selective Therapeutic Target and Regulator of Respiration in Mycobacterium tuberculosis. | Haller YA, Aguilera Olvera R, Yakimovich L, Anderson L, Heiligenstein P, Haydel SE. | ACS Infect Dis | 10.1021/acsinfecdis.5c00563 | 2025 | | |
| The Role of beta-Lactam Antibiotics in Treating Mycobacterium abscessus: From Laboratory Insights to Clinical Applications and the Case for Clinical Trials. | Dousa KM, Shin E, Kurz SG, Rubin EJ, Holland SM, Olivier KN, Daley CL, Kreiswirth BN, Pottinger PS, Bonomo RA. | Clin Infect Dis | 10.1093/cid/ciaf547 | 2025 | | |
| Case Report: Mycobacterium abscessus knee joint infection following herbal steam bath: successful short-course oral therapy in an immunocompetent patient. | Ye J, Hao J, Zheng C, Song M, Zhang C, Gao W, Guo Y, Zhang L. | Front Immunol | 10.3389/fimmu.2025.1618830 | 2025 | | |
| Characteristics and prognosis of intractable otomastoiditis caused by nontuberculous mycobacteria. | Zhang BY, Wu CC, Liu TC, Yang TH. | Am J Otolaryngol | 10.1016/j.amjoto.2025.104728 | 2025 | | |
| A Rare Case of Refractory Mycobacteroides Abscessus Otomastoiditis in an Immunocompetent Child: A Multidisciplinary Treatment Approach. | Patel R, Wong E, Nashid N, You P. | Ear Nose Throat J | 10.1177/01455613251392104 | 2025 | | |
| Longitudinal epidemiology of pulmonary nontuberculous mycobacteria and tuberculosis in Singapore (2006-2024): Emerging dominance of Mycobacterium abscessus. | Pereira JV, Wong CYX, Sng LH, Low JGH, Ng DHL. | Int J Infect Dis | 10.1016/j.ijid.2025.108054 | 2025 | | |
| Genetics | Genomic analysis of Mycobacterium abscessus isolates from non-cystic fibrosis patients in Thailand: phylogeny, subspecies distribution, and antimicrobial resistance profiles. | Prommi A, Sawaswong V, Petsong S, Wongjarit K, Somsukpiroh U, Payungporn S, Rotcheewaphan S. | J Microbiol Immunol Infect | 10.1016/j.jmii.2025.08.003 | 2025 | |
| [Nontuberculous Mycobacteria: Diagnostic Challenges and Individualized Therapeutic Approaches]. | Terhalle E, Rademacher J. | Dtsch Med Wochenschr | 10.1055/a-2502-6525 | 2025 | | |
| The Rough Morphotype of Mycobacterium abscessus Enhances Its Virulence Through ROS/p65/NLRP3/GSDMD-Mediated Macrophage Pyroptosis. | Li J, Li J, Li A, Tan Z, Fan J, He S, Guo Q, Xu L, Chu H. | Clin Exp Pharmacol Physiol | 10.1111/1440-1681.70034 | 2025 | | |
| Enzymology | Identification of a potential anti-nontuberculous mycobacterial drug candidate targeting a mycothiol disulfide reductase. | Liu T, Nian Y, Liu Y, Xu S, Lu C, Yang W, Chen W, Lin W. | Bioorg Chem | 10.1016/j.bioorg.2025.108981 | 2025 | |
| Baicalein of Scutellaria baicalensis inhibits Mycobacterium abscessus biofilm formation to restore the antibiotics susceptibility. | Zhang X, Dong B, He Q, Tan X, Li Y, Zhao K, Xu X, Zeng J. | Biofouling | 10.1080/08927014.2025.2531139 | 2025 | | |
| P3MA: A Promising Mycobacteriophage Infecting Mycobacterium abscessus. | Broncano-Lavado A, Aguilera-Correa JJ, Roquet-Baneres F, Kremer L, Mediero A, Seoane-Blanco M, van Raaij MJ, Pagan I, Esteban J, Garcia-Quintanilla M. | Antibiotics (Basel) | 10.3390/antibiotics14080801 | 2025 | | |
| Imipenem Pharmacokinetics/Pharmacodynamics in Preclinical Hollow Fiber Model, Dose Finding in Virtual Patients, and Clinical Evidence of Efficacy for Mycobacterium abscessus Lung Disease. | Singh S, Gumbo T, Wang JY, Boorgula GD, Burke A, Huang HL, McShane PJ, Amaro-Galvez R, Gross JE, Aryal S, Heysell SK, Srivastava S. | J Infect Dis | 10.1093/infdis/jiae601 | 2025 | | |
| In vitro, intracellular and in vivo synergy between amoxicillin, imipenem and relebactam against Mycobacterium abscessus. | Bitar M, Le Moigne V, Herrmann JL, Arthur M, Mainardi JL. | J Antimicrob Chemother | 10.1093/jac/dkaf101 | 2025 | | |
| Pathogenicity | The sesquiterpene lactone estafiatin exerts an anti-inflammatory effect against Mycobacterium abscessus infection by regulating interleukin-1 beta production. | Jung DH, Jung SE, Lee TS, Kim YJ, Lee YJ, Seo IS, Kim WG, Kim JY, Ahn SY, Shin SJ, Jang AR, Cho ES, Cho JY, Park JH. | Phytomedicine | 10.1016/j.phymed.2025.157080 | 2025 | |
| Adverse Drug Reactions During Nontuberculous Mycobacterial Pulmonary Disease Treatment: A Systematic Review and Meta-analysis. | Kim J, Oh J, Kang YA, Jung I, Shin JI, Park Y. | Ann Am Thorac Soc | 10.1513/annalsats.202412-1307oc | 2025 | | |
| ABP-Xplorer: A Machine Learning Approach for Prediction of Antibacterial Peptides Targeting Mycobacterium abscessus-tRNA-Methyltransferase (TrmD). | Abbas M, Sahibzada KI, Shahid S, Yousaf N, Hu Y, Wei DQ. | J Chem Inf Model | 10.1021/acs.jcim.5c00663 | 2025 | | |
| Nitric Oxide-Releasing Liposomes for Treatment of Mycobacterium abscessus Infections. | Nagy SG, Metiva JJ, Schoenfisch MH. | ACS Appl Bio Mater | 10.1021/acsabm.5c00218 | 2025 | | |
| In vitro and in vivo antibacterial activity of sudapyridine (WX-081) combined with other drugs against Mycobacterium abscessus. | Wang H, Zheng L, Fu L, Zhang W, Dong S, Chen X, Lu Y. | Tuberculosis (Edinb) | 10.1016/j.tube.2025.102655 | 2025 | | |
| Genetics | Pathogen genotypes and host phenotypes of Mycobacterium abscessus pulmonary disease in Taiwan. | Chiang YH, Feng JY, Shu CC, Chang CJ, Pan SW, Su WJ. | J Infect Public Health | 10.1016/j.jiph.2025.102899 | 2025 | |
| A post-surgical case of rib osteomyelitis and pleural abscess caused by mycobacterium abscessus after 6 years of lung cancer surgery. | Mutoh Y, Sato T, Oya Y, Umemura T, Hioki T, Yamano Y, Kataoka K, Matsuda T, Kimura T, Ichihara T, Kondoh Y. | Oxf Med Case Reports | 10.1093/omcr/omaf212 | 2025 | | |
| Genetics | Genomic insights into persistent infections, reinfections, and subspecies diversity of Mycobacteroides abscessus: A whole-genome sequencing study of Thai and global isolates. | Trisakul K, Sirichoat A, Nithichanon A, Rotcheewaphan S, Phelan J, Clark TG, Faksri K. | Infect Genet Evol | 10.1016/j.meegid.2025.105838 | 2025 | |
| A Unique Combination of Heterozygous | Lemson A, Lemson A, Bosteels C, van Ingen J, Reijers M, Westra D, Hoefsloot W. | Respiration | 10.1159/000545552 | 2025 | | |
| The promise and pitfalls: interpreting dual beta-lactam success in Mycobacterium abscessus with caution. | Mejia-Chew C. | ASM Case Rep | 10.1128/asmcr.00084-25 | 2025 | | |
| LeuRS-Targeting Prodrug, MRX-5, Expresses Anti-Mycobacterium abscessus Activity. | Li A, He S, Jia Y, Fan J, Liu S, Wang X, Zhang Z, Chu H. | Clin Exp Pharmacol Physiol | 10.1111/1440-1681.70024 | 2025 | | |
| Curcumin enhances bedaquiline's efficacy against Mycobacterium abscessus: in vitro and in vivo evidence. | Luo D, Xie W, Wang Z. | Microbiol Spectr | 10.1128/spectrum.02295-24 | 2025 | | |
| Enzymology | Whole-Cell Study Unveils Critical Mechanistic Elements, Regulatory Elements, and Inhibitor Targets of the Mycobacterium abscessus Cytochrome bd Oxidase. | Mathiyazakan V, Kathalingam SS, Pok WN, Sorayah R, Pethe K, Gruber G. | ACS Infect Dis | 10.1021/acsinfecdis.5c00092 | 2025 | |
| The evaluation of Phenylalanine-tRNA ligase beta unit (PheT), as a potential target in Mycobacterium abscessus. | Xie W, Luo D, Wu M, Sun Y, Wang Z. | Tuberculosis (Edinb) | 10.1016/j.tube.2025.102626 | 2025 | | |
| A systematic review of tetracyclines for nontuberculous mycobacteria: focus on rapidly growing mycobacteria. | Daley CL, Flume PA, van Ingen J, Khare R, Mingora CM, Nguyen MH, Winthrop KL, Zha BS. | Eur Respir Rev | 10.1183/16000617.0038-2025 | 2025 | | |
| Metabolism | Mapping of Mycobacterial Enzymes Involved in Triacylglycerol Accumulation as Intrabacterial Lipid Inclusions Using Activity-Based Multitarget Inhibitor Probes. | Avellan R, Lehoux J, Francis T, Dargham T, Celik L, Guy A, Poncin I, Point V, Kremer L, Durand T, Audebert S, Camoin L, Spilling C, Santucci P, Crauste C, Canaan S, Cavalier JF. | ACS Infect Dis | 10.1021/acsinfecdis.5c00127 | 2025 | |
| Mycobacterium abscessus group pulmonary disease. | Griffith DE. | Curr Opin Infect Dis | 10.1097/qco.0000000000001101 | 2025 | | |
| Distribution and epidemiological characteristics of nontuberculous mycobacterium species in jianghan plain. | Li J, Chen H, Liu J, Yang S, Wang X, Zhang Y, Yuan X, Wang Q, Zhang Y. | Sci Rep | 10.1038/s41598-025-24583-7 | 2025 | | |
| Clinical Characteristics and Prognosis of Patients with Severe Pneumonia with Neurological Dysfunction: A Regional Multicenter Retrospective Study in Mainland China. | Zhu Y, Jia Y, Zhang C, Li H, Ding P, Huang L, Wang G, Cai H, Yu W. | Infect Drug Resist | 10.2147/idr.s537406 | 2025 | | |
| Mycobacterium abscessus resides within lipid droplets and acquires a dormancy-like phenotype in adipocytes. | Kurihara Y, Shimizu A, Ozuru R, Yoshimura M, Chou B, Itoh R, Ishii K, Hirota Y, Takagi S, Fujita M, Inoue M, Hiromatsu K. | Biochem Biophys Res Commun | 10.1016/j.bbrc.2025.151645 | 2025 | | |
| Infection by Clonally Related Mycobacterium abscessus Isolates: The Role of Drinking Water. | Thomson RM, Wheeler N, Stockwell RE, Bryant J, Taylor SL, Leong LEX, Le T, Rogers GB, Carter R, Sherrard LJ, Powell H, Simpson G, Patterson-Fahy K, Wainwright CE, Floto RA, Parkhill J, Bell SC. | Am J Respir Crit Care Med | 10.1164/rccm.202409-1824oc | 2025 | | |
| [Report of two cases of Mycobacterium abscessus infection: clinical and therapeutic challenges]. | Sandoval Guggia M, Montaldi M, Aguila D, Lerman D. | Medicina (B Aires) | 2025 | | ||
| Genetics | Subspecies distribution and drug-resistance characteristics of Mycobacterium abscessus complex clinical isolates in South China. | Wang X, Su B, Chen P, Kuang H, Guan P, Zhang C, Pan L, Zhu J, Tan Y. | Microbiol Spectr | 10.1128/spectrum.04103-23 | 2025 | |
| Microvesicles Derived from Human Bronchial Epithelial Cells Regulate Macrophage Activation During Mycobacterium abscessus Infection. | Guthrie CM, Meeker AC, Self AE, Ramos-Leyva A, Clark OL, Kotey SK, Hartson SD, Liang Y, Liu L, Tan X, Cheng Y. | J Proteome Res | 10.1021/acs.jproteome.4c00827 | 2025 | | |
| An immunocompetent rat model of Mycobacterium abscessus multinodular granulomatous lung infection. | Feizi S, Cooksley CM, Reyne N, Boog B, Finnie J, Shaghayegh G, Hon K, Ramezanpour M, Psaltis AJ, Wormald PJ, Cmielewski P, McCarron A, Donnelley M, Parsons D, Vreugde S. | Tuberculosis (Edinb) | 10.1016/j.tube.2025.102629 | 2025 | | |
| Combined dual beta-lactams and diazabicyclooctane beta-lactamase inhibitor is highly effective against Mycobacterium abscessus species in vitro. | Misawa K, Nishimura T, Yoshikawa M, Shimamura R, Kashimura S, Enoki Y, Taguchi K, Matsumoto K, Hasegawa N. | J Glob Antimicrob Resist | 10.1016/j.jgar.2025.02.015 | 2025 | | |
| Pathogenicity | Mechanisms of Virulence of Mycobacterium abscessus and Interaction with the Host Immune System. | Zakhareva EV, Martini BA, Salina EG. | Biochemistry (Mosc) | 10.1134/s0006297924603496 | 2025 | |
| Pathogenicity | Construction of a Subcutaneous Fat Transplantation Model Infected with Mycobacterium. | Diao W, Hu Y, Chen X, Li W, Kpegah JKSK, Chen X, Wang M, Zhou J, Li P. | Curr Med Chem | 10.2174/0109298673345671250114235930 | 2025 | |
| Curcumin-mediated antimicrobial photodynamic therapy for inactivating Mycobacterium abscessus: a promising approach for non-tuberculous mycobacterial skin infections. | Dang Y, Yang R, Jia T, Liu C, Geng S. | Lasers Med Sci | 10.1007/s10103-024-04263-0 | 2025 | | |
| Clinical Trials involving Mycobacterium abscessus: An update. | Moore JE, Millar BC. | Ulster Med J | 2025 | | ||
| Management of tattoo-associated Mycobacterium abscessus skin infections by surgery and observation. | Radu LM, Edwards BD, Kanji JN, Jarand J, Arlette J. | J Assoc Med Microbiol Infect Dis Can | 10.3138/jammi-2025-0004 | 2025 | | |
| Mycobacterium abscessus biofilm cleared from murine lung by monoclonal antibody against bacterial DNABII proteins. | Jurcisek JA, Kurbatfinski N, Wilbanks KQ, Rhodes JD, Goodman SD, Bakaletz LO. | J Cyst Fibros | 10.1016/j.jcf.2025.01.013 | 2025 | | |
| Correlation between rrs gene mutations and amikacin resistance in Mycobacterium abscessus: implications for fitness cost and clinical prevalence. | Ding J, Hameed HMA, Long L, Zhang J, Fang C, Tian X, Zhang H, Li L, Li C, Yang R, Gao Y, Wang S, Zhang T. | J Antimicrob Chemother | 10.1093/jac/dkae468 | 2025 | | |
| Functional characterization of MMAR_1296 in Mycobacterium marinum and its potential as a vaccine candidate. | Xie W, Luo D, Soni V, Wang Z. | Vaccine | 10.1016/j.vaccine.2025.126720 | 2025 | | |
| [How to Avoid Reoperation for Complications Associated with Durable Mechanical Circulatory Support Therapy]. | Ooka T, Minamida T, Sugiki H, Shingu Y, Wakasa S. | Kyobu Geka | 2025 | | ||
| Successful treatment of infections caused by mycobacterium abscessus complex following aesthetic procedures: A case series in China. | Zhu J, Ying M, Zhao R, Yu Z. | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2024.116621 | 2025 | | |
| FL058, a novel beta-lactamase inhibitor, increases the anti-Mycobacterium abscessus activity of imipenem. | Tan Z, Lin Y, Fan J, Jia Y, Zheng S, Wang X, Gao C, Zhang Z, Li B, Chu H. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2024.107414 | 2025 | | |
| Skin Ultrasound Findings of Mycobacterium abscessus After Cosmetic Procedures: The Four Stages of Evolution. | Riedel L, Sarli A, Martins DP, Almeida Issa MC. | J Cosmet Dermatol | 10.1111/jocd.70466 | 2025 | | |
| Nontuberculous scrofuloderma with sweet syndrome leading to anti-interferon-gamma autoantibody-associated adult-onset immunodeficiency: A case report. | Nutthapan N. | JAAD Case Rep | 10.1016/j.jdcr.2025.05.029 | 2025 | | |
| Promoting the Efficacy of Deferiprone-Gallium-Protoporphyrin (IX) against Mycobacterium abscessus Intracellular Infection with Lipid Liquid Crystalline Nanoparticles. | Feizi S, Awad M, Ramezanpour M, Cooksley C, Murphy W, Prestidge CA, Psaltis AJ, Wormald PJ, Barry S, Vreugde S. | ACS Appl Mater Interfaces | 10.1021/acsami.4c15843 | 2024 | | |
| A cationic main-chain poly(carbonate-imidazolium) potent against Mycobacterium abscessus and other resistant bacteria in mice. | Si Z, Sun Y, Tan C, Ooi YJ, Li M, Raju C, Shubi J, Gan YH, Zhu Y, Li P, Chan-Park MB, Pethe K. | Biomaterials | 10.1016/j.biomaterials.2024.123003 | 2025 | | |
| Inked and infected: A case that highlights the emerging concern of tattoo-associated Mycobacterium abscessus. | Tory S, Neena E, Anastasia C, Jill B, Katherine B. | JAAD Case Rep | 10.1016/j.jdcr.2025.05.031 | 2025 | | |
| Case report of peritoneal dialysis-associated peritonitis caused by Mycobacterium abscessus in a child, successfully treated with dual beta-lactam combination therapy. | Shirley DA, Maurtua-Neumann P, Shoemaker L, DeSear K, Dousa KM. | ASM Case Rep | 10.1128/asmcr.00056-25 | 2025 | | |
| Chronic dacryocystitis due to Mycobacterium abscessus. | Solbes-Gochicoa MM, Shoji MK, Chen JS, Al-Sharif E, Kikkawa DO, Korn BS, Liu CY. | Orbit | 10.1080/01676830.2024.2412121 | 2025 | | |
| Optimal incubation duration of liquid cultures for assessing culture negative conversion in patients with Mycobacterium avium complex and Mycobacterium abscessus pulmonary diseases. | Uwamino Y, Hasegawa N, Kamoshita Y, Inose R, Aoki W, Nagata M, Namkoong H, Nishimura T, Matsushita H. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-024-04973-x | 2025 | | |
| A single upstream mutation of whiB7 underlies amikacin and clarithromycin resistance in Mycobacterium abscessus. | De Boeck N, Villellas C, Crespo-Yuste E, Gonzalo-Asensio J, Buckley PT, Thys K, Vuong C, Lounis N, Verstraeten N, Michiels J. | J Appl Microbiol | 10.1093/jambio/lxae286 | 2024 | | |
| EccC3 is essential for pathogenesis of rough Mycobacterium abscessus in zebrafish. | Tasrini Y, Daher W, Kremer L. | Microbiol Spectr | 10.1128/spectrum.01949-25 | 2025 | | |
| MtrAB two-component system is crucial for the intrinsic resistance and virulence of Mycobacterium abscessus. | Zhang J, Ju Y, Li L, Hameed HMA, Yusuf B, Gao Y, Fang C, Tian X, Ding J, Ma W, Chen X, Wang S, Zhang T. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2024.107442 | 2025 | | |
| Evaluation of mlstverse system for accurate subspecies identification and drug resistance prediction in Mycobacterium abscessus species. | Arakaki W, Kinjo T, Kami W, Hashioka H, Nabeya D, Nagano H, Yoshida S, Tsuyuguchi K, Matsumoto Y, Nakamura S, Fujita J, Yamamoto K. | Microbiol Spectr | 10.1128/spectrum.00643-25 | 2025 | | |
| Metabolism | Atypical Mycobacterium abscessus BlaRI Ortholog Mediates Regulation of Energy Metabolism but Not beta-Lactam Resistance. | Bonefont LE, Davenport HC, Chaton CT, Korotkov KV, Rohde KH. | Mol Microbiol | 10.1111/mmi.15314 | 2024 | |
| Reassessment of the relevance between microbiological macrolide-induced resistance and diagnosis and treatment outcome of Mycobacterium abscessus-related pulmonary disease. | Yoshida S, Tsuyuguchi K, Kobayashi T, Kurahara Y, Shimatani Y, Arai T. | Respir Investig | 10.1016/j.resinv.2024.09.012 | 2024 | | |
| Disseminated Mycobacterium abscessus Infection in a Three-Year-Old Girl With CHARGE Syndrome: A Case Report and Literature Review. | Hiruma Y, Orimoto R, Sato L, Tagashira Y, Takasawa K. | Cureus | 10.7759/cureus.88327 | 2025 | | |
| Demographic and clinical features of nontuberculous mycobacteria infection resulting from cosmetic procedures: a systematic review. | Ma X, Li XY, Liu JW. | Int J Infect Dis | 10.1016/j.ijid.2024.107259 | 2024 | | |
| A feasibility study for personalized phage therapy against drug-resistant bacteria in Japan. | Hayakawa K, Kiga K, Ojima S, Chihara K, Tamura A, Yamashita W, Nakamura T, Azam AH, Nie W, Sato Y, Sakai J, Kondo K, Takahashi Y, Watashi K, Saito S, Moriyama Y, Kurokawa M, Mezaki K, Ohashi H, Ohashi Y, Nishimura T, Shinohara K, Yamagishi Y, Doi Y, Ohmagari N. | J Infect Chemother | 10.1016/j.jiac.2025.102770 | 2025 | | |
| Mycobacterium Infection of Abscess with Hemoptysis as the Initial Manifestation. | Bai J, Xu W, Li W, Zhang X, Li K, Zhou Y. | Clin Lab | 10.7754/clin.lab.2024.240209 | 2024 | | |
| Determination of bactericidal activity against 3HC-2-Tre-labelled Mycobacterium abscessus (Mycobacteroides abscessus) by automated fluorescence microscopy. | Mann L, Siersleben F, Lang M, Richter A. | J Microbiol Methods | 10.1016/j.mimet.2024.107002 | 2024 | | |
| Non-Tuberculous Mycobacterial Infections of the Skin and Soft Tissue in a Chinese Population: A Retrospective Analysis of 15 Cases. | Tao H, Zheng W. | Infect Drug Resist | 10.2147/idr.s540147 | 2025 | | |
| Atypical mycobacteria infections of surgical sites: a case series. | Ramachar SM, Shetty N, D Y C. | Wounds | 10.25270/wnds/24008 | 2025 | | |
| JIB-04, an inhibitor of Jumonji histone demethylase as a potent antitubercular agent against Mycobacterium tuberculosis. | Li P, Huang Q, Xie Y, Zhu Z, Zhan S, Meng J, Liu H. | Arch Microbiol | 10.1007/s00203-024-04197-9 | 2024 | | |
| Design, Synthesis, and Anti-Mycobacterial Evaluation of Triclosan-Isoniazid Hybrids. | Gupta N, Chowdhary S, Roquet-Baneres F, Kremer L, Kumar V. | Chem Biodivers | 10.1002/cbdv.202401967 | 2025 | | |
| Severe lactic acidosis associated with oral linezolid. | Ertmann A, Thompson RE, Hoo ZH, Edenborough FP. | BMJ Case Rep | 10.1136/bcr-2024-261989 | 2024 | | |
| In vitro and intracellular activity of vaborbactam combined with beta-lactams against Mycobacterium abscessus. | Sanchez L, Bitar M, Herail Q, Dorchene D, Hugonnet JE, Arthur M, Mainardi JL. | J Antimicrob Chemother | 10.1093/jac/dkae181 | 2024 | | |
| In vitro antimicrobial activity of doxycycline, minocycline, and tigecycline against Mycobacterium abscessus complex: A meta-analysis study. | Zhang W, Dong L, Men P, Jiang G, Wang F, Wang C, Cheng M, Huang H, Yu X. | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2024.116435 | 2024 | | |
| Optimizing macrolide resistance detection for Mycobacterium abscessus: a potential low-cost, time-saving alternative. | Hwang L-E, Cheng A, Sun H-Y, Chien J-Y, Hsueh P-R, Sheng W-H. | Microbiol Spectr | 10.1128/spectrum.00942-25 | 2025 | | |
| Pathogenicity | The Crosstalk Between Mycobacterium abscessus and Immune Cells: Exploring Novel Interaction Modalities. | Mendoza-Trujillo I, Diez-Echave P, Tontini C, Bulfone-Paus S. | Cells | 10.3390/cells14221829 | 2025 | |
| Genetics | Genomic Analysis of Global Mycobacterium abscessus Isolates Reveals Ongoing Evolution of Drug Resistance-Associated Genes. | Yang T, Beach KE, Zhu C, Gan M, Wang W, Zhou H, Peng L, Wang S, Cai L, Li W, Davis JB, Cicchetti N, Slechta ES, Barker A, Shakir SM, Carey AF, Liu Q. | J Infect Dis | 10.1093/infdis/jiae580 | 2025 | |
| First Case Report of Successful Treatment of Mycobacterium abscessus Infection in a Cat in Thailand. | Chuenngam T, Chermprapai S. | Animals (Basel) | 10.3390/ani15070925 | 2025 | | |
| Orbital Cellulitis Associated with Scleral Buckle Infection Caused by Macrolide-Resistant Mycobacterium abscessus Complex: A Case Report and Literature Review. | Rujkorakarn P, Patamatamkul S. | Infect Drug Resist | 10.2147/idr.s516451 | 2025 | | |
| Genetics | Genomic Epidemiology of Extrapulmonary Nontuberculous Mycobacteria Isolates at Emerging Infections Program Sites-United States, 2019-2020. | Masters TL, Toney NC, Ewing TO, McAllister GA, Mathis MH, Grigg C, Magill SS, Jackson KA, Byram R, See I, Salfinger M, Barter D, Johnston H, Lynfield R, Vagnone PS, Tourdot L, Anderson BJ, Dumyati G, Pierce R, Lutgring JD, Gargis A, McKay SL. | J Infect Dis | 10.1093/infdis/jiae488 | 2025 | |
| Transcriptome | Transcriptome profiles of macrophages upon infection by morphotypic smooth and rough variants of Mycobacterium abscessus. | Nandanwar N, Gibson JE, Neely MN. | Microbes Infect | 10.1016/j.micinf.2024.105367 | 2024 | |
| Mycobacterium abscessus Hand Infection Mimicking Dactylitis Due to Spondyloarthritis: A Case Report. | Aung T, Celestin M. | Cureus | 10.7759/cureus.80740 | 2025 | | |
| Cochlear Implant Complicated by Nontuberculous Mycobacteria Infection: Report and Literature Review. | Chen H, Vanstrum EB, Santuray R, Xiao A, Ishiyama A. | Case Rep Otolaryngol | 10.1155/crot/5973005 | 2025 | | |
| Changes in skin discoloration according to clofazimine dosage in nontuberculous mycobacterial pulmonary disease. | Kurahara Y, Tanaka Y, Kobayashi T, Yoshida S, Tsuyuguchi K. | J Infect Chemother | 10.1016/j.jiac.2024.06.004 | 2025 | | |
| Unusual Presentation of Mycobacteroides abscessus Thigh Mass: A Case Report. | Blake RJ, McChesney GR, Williams HJ, Holland SM, Lastinger AM. | Case Rep Infect Dis | 10.1155/crdi/6970929 | 2025 | | |
| Genetics | Unlocking the Mycobacteroides abscessus pan-genome using computational tools: insights into evolutionary dynamics and lifestyle. | Karmakar M, Sur S. | Antonie Van Leeuwenhoek | 10.1007/s10482-024-02042-z | 2024 | |
| Gene knock-out in Mycobacterium abscessus using Streptococcus thermophilus CRISPR/Cas. | Akter S, Kamal E, Schwarz C, Lewin A. | J Microbiol Methods | 10.1016/j.mimet.2024.106924 | 2024 | | |
| Laryngitis Caused by Mycobacterium abscessus Subspecies massiliense Infection. | Kurahara Y, Shimatani Y. | JMA J | 10.31662/jmaj.2023-0202 | 2024 | | |
| Mycobacterium abscessus infection of uncertain etiology following lumbar spine decompression and instrumentation: illustrative case. | Rhodes SV, Nawabi NLA, Saway BF, Triano MJ, Varma AK. | J Neurosurg Case Lessons | 10.3171/case24891 | 2025 | | |
| Antimicrobial and Antibiofilm Effects of Bithionol against Mycobacterium abscessus. | Cao D, Yuan X, Jiang X, Wu T, Xiang Y, Ji Z, Liu J, Dong X, Bi K, Tonjum T, Xu K, Zhang Y. | Antibiotics (Basel) | 10.3390/antibiotics13060529 | 2024 | | |
| The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division. | Degiacomi G, Chiarelli LR, Riabova O, Lore NI, Munoz-Munoz L, Recchia D, Stelitano G, Postiglione U, Saliu F, Griego A, Scoffone VC, Kazakova E, Scarpa E, Ezquerra-Aznarez JM, Stamilla A, Buroni S, Tortoli E, Rizzello L, Sassera D, Ramon-Garcia S, Cirillo DM, Makarov V, Pasca MR. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2024.107278 | 2024 | | |
| Repurposing of FDA-Approved Drugs to Disrupt Iron Uptake in Mycobacterium abscessus: Targeting Salicylate Synthase as a Novel Approach. | Stelitano G, Bettoni C, Mori M, Cocorullo M, Tresoldi A, Meneghetti F, Villa S, Chiarelli LR. | Chem Biol Drug Des | 10.1111/cbdd.70162 | 2025 | | |
| Cultivation | Comparative Analysis of the Mass Spectra of Mycobacterium abscessus Complex Strains Isolated on Various Nutrient Media. | Vyzhigina EV, Kovalyov AM, Kokorev DA, Borodulina EA, Ismatullin DD, Lyamin AV. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_135_24 | 2024 | |
| Genetics | Genomic and epidemiologic investigation of Mycobacterium abscessus isolates in a cystic fibrosis center to determine potential routes of transmission. | Gross JE, Fullmer J, McClelland G, Caceres SM, Poch KR, Hasan NA, Jia F, Epperson LE, Lipner EM, Vang CK, Honda JR, Strand MJ, de Moura VCN, Daley CL, Strong M, Nick JA. | J Cyst Fibros | 10.1016/j.jcf.2025.07.003 | 2025 | |
| SQ31f is a potent non-tuberculous mycobacteria antibiotic by specifically targeting the mycobacterial F-ATP synthase. | Ragunathan P, Sae-Lao P, Harikishore A, Daher W, Roquet-Baneres F, Kremer L, Bates RW, Gruber G. | J Antimicrob Chemother | 10.1093/jac/dkae406 | 2025 | | |
| Mycobacteroides abscessus ability to interact with the host mucosal cells plays an important role in pathogenesis of the infection. | Leestemaker-Palmer A, Bermudez LE. | Crit Rev Microbiol | 10.1080/1040841x.2024.2418130 | 2025 | | |
| Biofilm Formation in Mycobacterial Genus; Mechanism of Biofilm Formation and Anti-mycobacterial Biofilm Agents. | Nasrollahian S, Pourmoshtagh H, Sabour S, Hadi N, Azimi T, Soleiman-Meigooni S. | Curr Pharm Biotechnol | 10.2174/0113892010277107240227054933 | 2025 | | |
| Disseminated Mycobacterium abscessus with endocarditis. | Chue AL, Braganza Menezes D, Bhabra M, Dedicoat M. | BMJ Case Rep | 10.1136/bcr-2023-255390 | 2024 | | |
| Utility of microbial cell-free DNA sequencing in the diagnosis of mycobacterial infections in a quaternary care center. | Centeno FH, Lasco T, Hamdi AM, Al Mohajer M. | Antimicrob Steward Healthc Epidemiol | 10.1017/ash.2025.10057 | 2025 | | |
| Outbreak of infections by Mycobacterium abscessus subsp. abscessus associated with cosmetic surgeries in the Brazil/Paraguay border: a binational cohort study, 2021-2022. | Glehn MPV, Salcedo G, Batista TGDS, Caballero LER, Frank CHM, Cunha EAT, Souza AS, Moraes C, Ribeiro IG. | Epidemiol Serv Saude | 10.1590/s2237-96222025v34e20250516.en | 2025 | | |
| Trial design of bacteriophage therapy for nontuberculous mycobacteria pulmonary disease in cystic fibrosis: The POSTSTAMP study. | Nick JA, Martiniano SL, Lovell VK, Vestal B, Poch K, Caceres SM, Rysavy NM, de Moura VC, Gilick JJ, Malcolm KC, Pacheco J, Amin AG, Chatterjee D, Daley CL, Kasperbauer S, Gross JE, Armantrout E, Cohen KA, Keck A, Vandalfsen JM, Magaret AS, Midamba N, Chapdu C, Gao A, Hill JE, Freeman KG, Cristinziano M, Guerrero C, Jacobs-Sera D, Lauer MJ, Viland M, Hatfull GF, Investigators of the Cystic Fibrosis NTM Consortium. | J Cyst Fibros | 10.1016/j.jcf.2025.03.669 | 2025 | | |
| Pathogenicity | Colony morphotype governs innate and adaptive pulmonary immune responses to Mycobacterium abscessus infection in C3HeB/FeJ mice. | Ferrell KC, Stewart EL, Counoupas C, Triccas JA. | Eur J Immunol | 10.1002/eji.202350610 | 2024 | |
| In vitro susceptibility of 147 international clinical Mycobacterium abscessus isolates to epetraborole and comparators by broth microdilution. | Nguyen MH, Calado Nogueira de Moura V, Keepers TR, van Ingen J, Daley CL. | J Antimicrob Chemother | 10.1093/jac/dkae461 | 2025 | | |
| From M. chelonae to M. immunogenum: A rare case of dual nontuberculous mycobacterial infection. | Uche IK, Simonetti N, Murina A. | JAAD Case Rep | 10.1016/j.jdcr.2025.04.036 | 2025 | | |
| Pathogenicity | Impact of IL-1beta on lung pathology caused by Mycobacterium abscessus infection and its association with IL-17 production. | Ahn JH, Jung DH, Kim DY, Lee TS, Kim YJ, Lee YJ, Seo IS, Kim WG, Cho YJ, Shin SJ, Park JH. | Microbes Infect | 10.1016/j.micinf.2024.105351 | 2024 | |
| Noncanonical mutations in ribosome nascent peptide exit tunnel confer clarithromycin resistance in Mycobacterium abscessus complex. | Liao W, Wang X, Wang Y, Ma P, Chen K, Ge L, Yang X, Zeng S, Gao W, Zhang S, Wang H, Jia X, Luo T. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2024.107223 | 2024 | | |
| Genetics | Whole-genome recombination and dynamic accessory genomes drive the phenotypic diversity of Mycobacterium abscessus subspecies. | Chen Y, Bao R, Li N, Fang T, Yin X, Qin L, Hu B, Miao Q. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-025-00804-9 | 2025 | |
| Exploring the Role of a Putative Secondary Metabolite Biosynthesis Pathway in Mycobacterium abscessus Pathogenesis Using a Xenopus laevis Tadpole Model. | Miller NJ, Dimitrakopoulou D, Baglia LA, Pavelka MS, Robert J. | Microorganisms | 10.3390/microorganisms12061120 | 2024 | | |
| Construction of Composite Correlation Index Matrix and Analysis of Cultural Properties of Representatives of Mycobacterium abscessus Complex Isolated from Patients with Cystic Fibrosis. | Kaiumov KA, Marchenko VV, Kokorev DA, Borodulina EA, Ismatullin DD, Lyamin AV. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_70_24 | 2024 | | |
| Psoralea corylifolia L. and its active component isobavachalcone demonstrate antibacterial activity against Mycobacterium abscessus. | Cao D, Zhang Z, Jiang X, Wu T, Xiang Y, Ji Z, Guo J, Zhang X, Xu K, Liu Z, Zhang Y. | J Ethnopharmacol | 10.1016/j.jep.2024.118142 | 2024 | | |
| Disseminated Mycobacterium abscessus infection with idiopathic CD4+ T-lymphocytopenia: a case report and review of the literature. | Wu X, Zhai M, Xu A, Zheng Y. | J Med Case Rep | 10.1186/s13256-024-05009-w | 2024 | | |
| Clinical characteristics and antimicrobial susceptibility profiles of Mycobacterium abscessus and Mycobacterium massiliense pulmonary infection. | Guo W, Shangguan Y, Ji Z, Hu M, Li X, Hu W, Zheng L, Huang S, Wang Y, Xia J, Jiang L, Xu K. | J Glob Antimicrob Resist | 10.1016/j.jgar.2024.04.004 | 2024 | | |
| Successful treatment of macrolide-resistant Mycobacterium abscessus infection using multi-drug regimens including dual beta-lactams and phage therapy: case reports in two children. | Shimamura M, Becken B, Tansmore J, Cristinziano M, Abad L, Dedrick RM, Jacobs-Sera D, Hatfull GF, Bonomo RA, Dousa KM. | ASM Case Rep | 10.1128/asmcr.00087-24 | 2025 | | |
| The epidemiology of pulmonary Mycobacterium abscessus species in Japanese population. | Ihara H, Kondo K, Muto Y, Haba M, Nakazawa H, Handoh T, Arai Y, Shibayama K, Sumiyoshi I, Ochi Y, Watanabe J, Takei S, Nakamura A, Fujimoto Y, Togo S, Takahashi K. | J Infect Chemother | 10.1016/j.jiac.2024.02.018 | 2024 | | |
| Phylogeny | Development of a silkworm infection model for evaluating the virulence of Mycobacterium intracellulare subspecies estimated using phylogenetic tree analysis based on core gene data. | Matsumoto Y, Fukano H, Komine T, Hoshino Y, Sugita T. | Drug Discov Ther | 10.5582/ddt.2024.01043 | 2024 | |
| Development of narrow-spectrum topoisomerase-targeting antibacterials against mycobacteria. | Sterle M, Habjan E, Piga M, Persolja P, Durcik M, Dernovsek J, Szili P, Czikkely MS, Zidar N, Janez I, Pal C, Accetto T, Pardo LA, Kikelj D, Peterlin Masic L, Tomasic T, Bitter W, Cotman AE, Speer A, Zega A. | Eur J Med Chem | 10.1016/j.ejmech.2024.116693 | 2024 | | |
| Polyinfection secondary to exogenous lipoid pneumonia caused by aspiration of paraffin oil: a Case Report. | Yan X, Chen X, Zhu Y, Chen S, Meng X, Li J, Tang Y, Zhang W, Yi L, Fu Y. | Front Med (Lausanne) | 10.3389/fmed.2025.1555471 | 2025 | | |
| Subcutaneous infection caused by Mycobacterium abscessus following botulinum toxin injections: A case report and literature review. | Ou Y, Liu D, Feng J, Xu X, Lin T, Zhang Y, Luo L, Wu M, Cui Y. | J Cosmet Dermatol | 10.1111/jocd.16170 | 2024 | | |
| High-Throughput Sequencing of Nontuberculous Mycobacterial Flora and Mycobacterium abscessus in Cattle. | Chen S, Liu M, Li Y, Zhang J, Li Y, Liang Y, Fan X, Qu Y. | Vet Sci | 10.3390/vetsci12030275 | 2025 | | |
| Clofazimine serum concentration and safety/efficacy in nontuberculous mycobacterial pulmonary disease treatment. | Watanabe F, Fujiwara K, Furuuchi K, Ito M, Hanada K, Kodama T, Aono A, Mitarai S, Yoshiyama T, Kurashima A, Ohta K, Morimoto K. | Respir Med | 10.1016/j.rmed.2024.107718 | 2024 | | |
| Clinical characterization of immunocompetent patients with Scedosporium detected in respiratory samples: A case series. | Ito Y, Miwa S, Watanabe A, Shirai M. | Respir Med Case Rep | 10.1016/j.rmcr.2025.102256 | 2025 | | |
| [A pharmacologic approach to treatment of Mycobacterium abscessus pulmonary disease]. | Kassegne L, Veziris N, Fraisse P. | Rev Mal Respir | 10.1016/j.rmr.2023.10.010 | 2024 | | |
| Persistent Pathogens Following Minimally Invasive Surgery: Is It Time to Rethink Aldehyde-Based Disinfection? | Nalawade K, Kalikar V, Supe A, Patankar R. | Cureus | 10.7759/cureus.93682 | 2025 | | |
| [Solitary pulmonary nodule as an unusual presentation of infection by Mycobacterium abscessus. Report of a clinical case]. | Gutierrez J, Yumay P, Schiappacasse G, Raimundo S, Valenzuela H, Cabello H. | Rev Med Chil | 10.4067/s0034-98872023001201636 | 2023 | | |
| High-resolution 2D solid-state NMR provides insights into nontuberculous mycobacteria. | Byeon CH, Hansen KH, DePas W, Akbey U. | Solid State Nucl Magn Reson | 10.1016/j.ssnmr.2024.101970 | 2024 | | |
| Luciferase reporter mycobacteriophage (TM4::GeNL) enables rapid assessment of drug susceptibilities and inducible macrolide resistance in Mycobacterium abscessus complex. | Rajagopalan S, Das L, Kohlerschmidt DJ, Rourke AK, Shakir SM, Larsen MH, O'Donnell MR, Szymczak WA, Escuyer VE, Thwe PM, Jacobs WR. | J Clin Microbiol | 10.1128/jcm.00841-25 | 2025 | | |
| Investigating a pulmonary Mycobacterium abscessus infection outbreak among elderly inpatients in the intensive care ward. | Hua W, Wu K, Zhu Y, Liu Z, Zhang Y, Chen J. | J Infect Dev Ctries | 10.3855/jidc.17395 | 2023 | | |
| An anti-mycobacterial conjugated oligoelectrolyte effective against Mycobacterium abscessus. | Zhang K, Limwongyut J, Moreland AS, Wei SCJ, Jim Jia Min T, Sun Y, Shin SJ, Kim SY, Jhun BW, Pethe K, Bazan GC. | Sci Transl Med | 10.1126/scitranslmed.adi7558 | 2024 | | |
| Anterior and posterior surgical approach for vertebral lumbar Mycobacterium abscessus osteomyelitis. | Patel J, Malkoc A, Ghauri MS, Amin L, Petersen M, Cochrane J, Hopkins G, Schwartz S. | J Surg Case Rep | 10.1093/jscr/rjae521 | 2024 | | |
| Concurrent Coccidioidomycosis and Mycobacterium abscessus Infection in Chronic Obstructive Pulmonary Disease. | Kattamuri L, Zambrano A, Duvvuru SR, Sharma K, Deoker A. | J Investig Med High Impact Case Rep | 10.1177/23247096251334229 | 2025 | | |
| [Gastric Ulcer Bleeding Caused by Systemic Inflammatory Response to Mycobacterial Bacteremia]. | Synn SB, Kim SJ. | Korean J Helicobacter Up Gastrointest Res | 10.7704/kjhugr.2024.0064 | 2024 | | |
| Alternative therapies against Mycobacterium abscessus infections. | Palucci I, Delogu G. | Clin Microbiol Infect | 10.1016/j.cmi.2023.10.001 | 2024 | | |
| Disinfectant and antibiotic resistance in Mycobacterium abscessus water isolates. | Patterson-Fahy K, Carter R, Taylor SL, Guo J, Thomson RM. | Microbiol Spectr | 10.1128/spectrum.03374-24 | 2025 | | |
| Case Commentary: Dual beta-lactam as part of regimen to treat Mycobacterium abscessus lung disease. | Lippincott CK, Lamichhane G. | Antimicrob Agents Chemother | 10.1128/aac.00585-24 | 2024 | | |
| The effects of silver nitrate on Mycobacterium abscessus biofilms in a simulated antimicrobial showerhead environment. | Pitell S, Woo C, Millstone J, Stout J, Gilbertson L, Haig SJ. | Front Public Health | 10.3389/fpubh.2025.1572869 | 2025 | | |
| Variations of the Mycobacterium abscessus F-ATP synthase subunit a-c interface alter binding and potency of the anti-TB drug bedaquiline. | Krah A, Ragunathan P, Bond PJ, Gruber G. | Biochem Biophys Res Commun | 10.1016/j.bbrc.2023.149249 | 2024 | | |
| Transcriptome | Single-cell transcriptomics of blood identified IFIT1+ neutrophil subcluster expansion in NTM-PD patients. | Wang P, Yang GL, He YF, Shen YH, Hao XH, Liu HP, Shen HB, Wang L, Sha W. | Int Immunopharmacol | 10.1016/j.intimp.2024.112412 | 2024 | |
| Mycobacteroides abscessus outbreak and mitigation in a cardiothoracic transplant population: the problem with tap water. | Rathod SN, Weber RT, Salim AA, Tanna SD, Stosor V, Malczynski M, O'Boye A, Hoke K, Landon J, McCarthy S, Qi C, Angarone MP, Ison MG, Williams JL, Zembower TR, Bolon MK. | J Hosp Infect | 10.1016/j.jhin.2024.10.016 | 2025 | | |
| The timing of intravenous antibiotics and clinical outcomes of Mycobacterium abscessus complex lung diseases. | Pang AH, Lin SW, Yang JH, Wang PH, Pan SW, Wei YF, Chen CY, Lee HS, Wu TS, Chang CH, Shu CC. | Int J Tuberc Lung Dis | 10.5588/ijtld.23.0086 | 2024 | | |
| Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus. | Mori M, Cocorullo M, Tresoldi A, Cazzaniga G, Gelain A, Stelitano G, Chiarelli LR, Tomaiuolo M, Delre P, Mangiatordi GF, Garofalo M, Cassetta A, Covaceuszach S, Villa S, Meneghetti F. | Eur J Med Chem | 10.1016/j.ejmech.2023.116073 | 2024 | | |
| [Clinical characteristics of 42 patients with different subspecies of Mycobacterium abscessus complex pulmonary disease]. | He SQ, Chen PR, Chen H. | Zhonghua Jie He He Hu Xi Za Zhi | 10.3760/cma.j.cn112147-20230921-00185 | 2023 | | |
| Case Report: Anti-interferon-gamma autoantibodies in an adolescent with disseminated Talaromyces marneffei and mycobacterial co-infections. | Li B, Li T, Huang Q, Mo N, He X, Jiang Z, Li X, Huang X, Zhang X, Cao C. | Front Pediatr | 10.3389/fped.2025.1552469 | 2025 | | |
| Clinical correlation study of non-tuberculous mycobacterial isolates from bronchoalveolar lavage fluid. | Ning H, He G, Mei Y, Yu J, Shi J, Cui X, Qiu C, Jiang X. | AMB Express | 10.1186/s13568-025-01842-4 | 2025 | | |
| Bilateral Jaw Mycobacterium Abscessus Mimicking Actinomycosis: A Postoperative Complication of Wisdom Teeth Extraction. | Johanis M, Cheema KS, Young PA, Bae GH. | Cureus | 10.7759/cureus.62336 | 2024 | | |
| The Advance and Clinical Practice on Lung Disease Caused by Mycobacterium abscessus. | Zhang L, Rao Y, Li Z, Fan M, Xiang Z, Wang J. | Infect Drug Resist | 10.2147/idr.s524214 | 2025 | | |
| Genetic stability of Mycobacterium abscessus during antibiotic treatment. | Kwak N, Park J, Kim SJ, Kim JY, Kim TS, Yoon JK, Whang J, Lee W, Shin SJ, Yim JJ. | J Glob Antimicrob Resist | 10.1016/j.jgar.2023.12.004 | 2024 | | |
| Peritoneal Dialysis Catheter-Associated Peritonitis Caused by Mycobacterium abscessus: A True Infection? | Khin E, Rodriguez R, Walker SK, Handal G. | Cureus | 10.7759/cureus.68721 | 2024 | | |
| MAB_0676c-induced enhanced IL-10 production inhibits the autophagic flux via the MTOR/RUBCN pathway. | Kim DH, Woo K, Park HS, Park HS, Kim HJ, Choi CH. | Virulence | 10.1080/21505594.2025.2529493 | 2025 | | |
| Microbiological persistence in patients with Mycobacterium abscessus complex lung disease: The prevalence, predictors, and the impact on progression. | Chang LK, Wang PH, Lee TF, Huang YT, Shu CC, Wang HC, Yu CJ. | Int J Infect Dis | 10.1016/j.ijid.2023.11.018 | 2024 | | |
| Mycobacterium fortuitum Infection Mimicking an Odontogenic Abscess: Report of a Pediatric Case with Relevant Literature Analysis. | Barile G, Limongelli L, Forte M, Corsalini T, Capodiferro S, Corsalini M. | Pathogens | 10.3390/pathogens14060513 | 2025 | | |
| Drug susceptibility profiles of Mycobacterium abscessus isolated in the state of São Paulo, 2008-2024. | Pedace CS, Arbeit RD, Dos Santos Simeao FC, Gallo JF, de Souza AR, Chimara E. | J Med Microbiol | 10.1099/jmm.0.002005 | 2025 | | |
| Three Cases of Non-Tuberculosis Mycobacterium Skin Infection Outbreak in Beauty Institutions. | Xing Y, Li M, Jiang Y, Zhong Q. | Clin Lab | 10.7754/clin.lab.2024.240101 | 2024 | | |
| Analysis of non-tuberculous mycobacteria types in high tuberculosis endemic areas. | Li NN, Gao LL, Liu M, Zhang WM, Zhang XK, Chen L, Zong Z, Lan Y. | J Health Popul Nutr | 10.1186/s41043-025-00765-x | 2025 | | |
| Therapeutic Management Strategies Among Immunocompetent Infants with Nontuberculous Mycobacterial Pulmonary Infection. | Bai A, Dandapani H, Dosanjh A. | Pediatric Health Med Ther | 10.2147/phmt.s513904 | 2025 | | |
| Dual beta-lactam for treatment of pulmonary Mycobacterium abscessus in a child. | Becken B, Dousa KM, Johnson JL, Holland SM, Bonomo RA. | Antimicrob Agents Chemother | 10.1128/aac.00319-24 | 2024 | | |
| Mycobacterium abscessus, a complex of three fast-growing subspecies sharing virulence traits with slow-growing mycobacteria. | Lagune M, Kremer L, Herrmann JL. | Clin Microbiol Infect | 10.1016/j.cmi.2023.08.036 | 2024 | | |
| Epidemiology of Mycobacterium abscessus. | Cristancho-Rojas C, Varley CD, Lara SC, Kherabi Y, Henkle E, Winthrop KL. | Clin Microbiol Infect | 10.1016/j.cmi.2023.08.035 | 2024 | | |
| Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease. | Rimal B, Panthi CM, Xie Y, Belz DC, Ignatius EH, Lippincott CK, Deck DH, Serio AW, Lamichhane G. | Tuberculosis (Edinb) | 10.1016/j.tube.2024.102482 | 2024 | | |
| Distinct Effects of Moxifloxacin and Bedaquiline on Growing and 'Non-Culturable' Mycobacterium abscessus. | Mulyukin AL, Recchia D, Kostrikina NA, Artyukhina MV, Martini BA, Stamilla A, Degiacomi G, Salina EG. | Microorganisms | 10.3390/microorganisms11112690 | 2023 | | |
| Genetics | Genomic Epidemiology of Mycobacterium abscessus on the Island of Montréal Is Not Suggestive of Health Care-Associated Person-to-Person Transmission. | Olawoye IB, Waglechner N, McIntosh F, Akochy PM, Cloutier N, Grandjean Lapierre S, Tannir B, Greenaway C, Matouk E, Poirier L, Levesque RC, Boyle B, Quach C, Soualhine H, Batt J, Behr MA, Lee RS, Guthrie JL. | J Infect Dis | 10.1093/infdis/jiae407 | 2025 | |
| [In vitro Activity of Rifabutin and Clofazimine to Macrolide-Resistant Mycobacterium abscessus Complex Clinical Isolates]. | Surucuoglu S, Ozkutuk N, Gazi H, Cavusoglu C. | Mikrobiyol Bul | 10.5578/mb.20239951 | 2023 | | |
| Metabolism | GlnR activated transcription of nitrogen metabolic pathway genes facilitates biofilm formation by mycobacterium abscessus. | Fan J, Jia Y, He S, Tan Z, Li A, Li J, Zhang Z, Li B, Chu H. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2023.107025 | 2024 | |
| MALDI-TOF mass spectrometry discriminates drug-susceptible and -resistant strains in Mycobacterium abscessus. | Thai TD, Nithimongkolchai N, Kaewseekhao B, Samarnjit J, Sukkasem C, Wonglakorn L, Sirichoat A, Nithichanon A, Faksri K. | PLoS One | 10.1371/journal.pone.0319809 | 2025 | | |
| Differences in sputum microbiota based on cure status of patients with nontuberculous mycobacterial pulmonary disease. | Kang N, Kim SY, Kim DH, Jhun BW. | Korean J Intern Med | 10.3904/kjim.2024.209 | 2025 | | |
| Application of FT-IR Spectroscopy for Mycobacterium abscessus complex subspecies differentiation. | Curtoni A, Cordovana M, Bondi A, Scaiola F, Criscione G, Ghibaudo D, Pastrone L, Zanotto E, Camaggi A, Caroppo MS, Kostrzewa M, Cavallo R, Costa C. | J Microbiol Methods | 10.1016/j.mimet.2023.106792 | 2023 | | |
| Mycobacterial Spindle Cell Pseudotumor Presenting as a Pancreatic Head Mass: A Case Report. | Cusimano FA, Herrera T, Brust D, Montgomery E, Amin S, Ayoade F. | Pathogens | 10.3390/pathogens14090889 | 2025 | | |
| Enzymology | Identification of novel inhibitors targeting Mycobacterium abscessus InhA through virtual screening, docking, and molecular dynamic simulations. | Abbas M, Alanzi AR, Sahibzada KI, Nawaz M, Fatima G, Wei DQ. | Sci Rep | 10.1038/s41598-025-97513-2 | 2025 | |
| Delineation of transcriptional regulators involve in biofilm formation cycle of Mycobacterium abscessus. | Veigyabati Devi M, Singh AK. | Gene | 10.1016/j.gene.2023.147644 | 2023 | | |
| Lenvatinib-Associated Non-Tuberculous Mycobacterial Pulmonary Disease: A Case Report. | Wang Q, Du L, Wang Y, Zhang L. | Respirol Case Rep | 10.1002/rcr2.70316 | 2025 | | |
| An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection. | Sun Y, Zhang K, Delos Santos M, Pee CJE, Yang Y, Kang M, Shin SJ, Chan-Park MB, Pethe K. | Antimicrob Agents Chemother | 10.1128/aac.01520-23 | 2024 | | |
| Evaluation of the cross-immunity between Mycobacterium tuberculosis and Mycobacterium abscessus in vitro. | Xu D, Gu Y, Li G, Wang R, Xiao S, Duan H, Jiang J, Zhao X, Wan K, He X, Liu H, Lou Y. | BMC Microbiol | 10.1186/s12866-024-03724-4 | 2025 | | |
| Antimicrobial susceptibility of Mycobacterium abscessus and treatment of pulmonary and extra-pulmonary infections. | Tunesi S, Zelazny A, Awad Z, Mougari F, Buyck JM, Cambau E. | Clin Microbiol Infect | 10.1016/j.cmi.2023.09.019 | 2024 | | |
| Mycobacterium abscessus Complex-Associated Chronic Meningitis: Time to Think Beyond Tuberculosis. | Sharma K, Sharma M, Shree R, Sehgal V, Sharma A, Sharma N, Goyal M, Ray P, Singh A, Modi M. | Neurol India | 10.4103/0028-3886.388095 | 2023 | | |
| Multidrug-resistant Mycobacterium abscessus infection in an anophthalmic socket treated with bedaquiline on a compassionate use basis: A case report. | Galindo-Rodriguez D, Moreno Hijazo M, Balint Ilie C, Rubio Castro D, Valles Tormo I, Alias Alegre EG. | Am J Ophthalmol Case Rep | 10.1016/j.ajoc.2024.102139 | 2024 | | |
| Secondary Mycobacterium abscessus Infection after Debridement in Child with Dog Bite: a Case Report. | Li L, Yu JY, Shi YL, Dai ZQ, Dai Y. | Clin Lab | 10.7754/clin.lab.2022.221213 | 2023 | | |
| Evaluation of the In Vitro Activity of Bedaquiline, Delamanid, and Clofazimine Against Mycobacterium abscessus Complex and Their Antibiofilm Potential. | Kania K, Wojcik K, Skorkowska A, Klesiewicz K. | Pathogens | 10.3390/pathogens14060582 | 2025 | | |
| [A Case of Mycobacterium abscessus Identified by Suspicious Gram Staining in the Blood Culture of a Patient with Chronic Renal Failure]. | Adaleti R, Kansak N, Arici N, Balikci A, Uzunoner Y, Aksaray S. | Mikrobiyol Bul | 10.5578/mb.20239956 | 2023 | | |
| Cryo-EM structure of the Mycobacterium abscessus F1-ATPase. | Wong CF, Leow CY, Gruber G. | Biochem Biophys Res Commun | 10.1016/j.bbrc.2023.05.095 | 2023 | | |
| A CRISPR-nonhomologous end-joining-based strategy for rapid and efficient gene disruption in Mycobacterium abscessus. | Zeng S, Ju Y, Alam MS, Lu Z, Hameed HMA, Li L, Tian X, Fang C, Fang X, Ding J, Wang X, Hu J, Wang S, Zhang T. | mLife | 10.1002/mlf2.70007 | 2025 | | |
| Histopathological analysis revealed that Mycobacterium abscessus proliferates in the fat bodies of silkworms. | Matsumoto Y, Fukano H, Katano H, Hoshino Y, Sugita T. | Drug Discov Ther | 10.5582/ddt.2023.01014 | 2023 | | |
| Metabolism | Deferiprone-gallium-protoporphyrin (IX): A promising treatment modality against Mycobacterium abscessus. | Feizi S, Awad M, Nepal R, Cooksley CM, Psaltis AJ, Wormald PJ, Vreugde S. | Tuberculosis (Edinb) | 10.1016/j.tube.2023.102390 | 2023 | |
| Eradication of Mycobacterium abscessus infection in cystic fibrosis with initiation of Elexacaftor/Tezacaftor/Ivacaftor. | McParland C, Nunn M, Marras TK, Chiasson M. | J Cyst Fibros | 10.1016/j.jcf.2023.03.021 | 2024 | | |
| In vitro susceptibility testing of imipenem-relebactam and tedizolid against 102 Mycobacterium abscessus isolates. | Burke A, Carter R, Tolson C, Congdon J, Duplancic C, Bursle E, Bell SC, Roberts JA, Thomson R. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2023.106938 | 2023 | | |
| Structure of MltG from Mycobacterium abscessus reveals structural plasticity between composed domains. | Lee GH, Kim S, Kim DY, Han JH, Lee SY, Lee JH, Lee CS, Park HH. | IUCrJ | 10.1107/s2052252524008443 | 2024 | | |
| Screening, epidemic trends and drug sensitivity analysis of nontuberculous mycobacteria in a local area of China. | Lin WH, Yao C, Mei L, Wang DP, Bao XD, Liu SS. | Am J Transl Res | 10.62347/majy5046 | 2024 | | |
| Cumulative antimicrobial susceptibilities for respiratory clinical isolates of Mycobacterium avium Complex, Mycobacterium kansasii, and Mycobacterium abscessus from Pakistan 2018 to 2022. | Shakoor S, Shafiq S, Shahid A, Mir F, Ali R, Hasan R. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_136_23 | 2023 | | |
| Effective killing of Mycobacterium abscessus biofilm by nanoemulsion delivery of plant phytochemicals. | Albano C, Nabawy A, Tran WC, Prithviraj M, Kado T, Hassan MA, Makabenta JMV, Rotello VM, Morita YS. | Microbiol Spectr | 10.1128/spectrum.02166-24 | 2025 | | |
| Combination of Imipenem-Cilastatin-Relebactam and Amoxicillin in the Antibiotic Regimen in Two Cases of Mycobacterium abscessus Lung Infection. | Vogiatzoglou AI, Hadji Mitrova M, Papadaki E, Sionidou M, Nikopoulou A, Kontos F, Papaventsis D, Papavasileiou A, Manika K. | Cureus | 10.7759/cureus.65112 | 2024 | | |
| Consequences of Climate Change on the Emergence of Pathogenic, Environmentally Acquired Nontuberculous Mycobacteria. | Koch TN, Banta JA, Wilsey RN, Chan ED, Crooks JL, Honda JR. | Open Forum Infect Dis | 10.1093/ofid/ofaf232 | 2025 | | |
| Nontuberculous mycobacterial myositis in dermatomyositis with long-term use of immunosuppressant: a case report. | Kim J, Kim YJ, Park H, Lee S, Yoo DH. | Skeletal Radiol | 10.1007/s00256-023-04444-y | 2024 | | |
| Antimicrobial susceptibility analysis of isepamicin combination treatments in Mycobacterium abscessus species. | Kato Y, Ihara H, Takei S, Nakamura A, Fujimoto Y, Handoh T, Kurokawa K, Arai Y, Shibayama K, Sumiyoshi I, Ochi Y, Watanabe J, Hoshi K, Misawa S, Togo S, Naito T, Tabe Y, Miida T, Takahashi K. | J Clin Tuberc Other Mycobact Dis | 10.1016/j.jctube.2024.100464 | 2024 | | |
| Epidemiology and Drug Susceptibility of Nontuberculous Mycobacteria in the Province of Pavia (Northern Italy): An Overview. | Siciliano M, Amisano F, Bagnarino J, Grassia G, Cambieri P, Baldanti F, Monzillo V, Barbarini D. | Microorganisms | 10.3390/microorganisms13112547 | 2025 | | |
| Metabolism | Impaired ESX-3 Induces Bedaquiline Persistence in Mycobacterium abscessus Growing Under Iron-Limited Conditions. | Li B, He S, Tan Z, Li A, Fan J, Zhao L, Zhang Z, Chu H. | Small Methods | 10.1002/smtd.202300183 | 2023 | |
| Pharmacokinetic and Pharmacodynamic Modeling Analysis of Delpazolid (LCB01-0371) in Adult Patients with Pulmonary Tuberculosis. | Lee SM, Choi SC, Mun KR, Seo JY, Cho YL, Shim TS, Lim HS. | J Clin Pharmacol | 10.1002/jcph.2424 | 2024 | | |
| [Chinese expert consensus on diagnosis and treatment of non-tuberculous mycobacterial pulmonary disease complicated with bronchiectasis]. | Chinese Society of Tuberculosis, Chinese Medical Association, Chinese Throacic Society, Chinese Medical Association. | Zhonghua Jie He He Hu Xi Za Zhi | 10.3760/cma.j.cn112147-20240808-00471 | 2025 | | |
| A viable but nonculturable state of Mycobacterium avium in response to macrolide antibiotics: a recipe for relapses? | Schuiermanni I, Terschlusen E, de Man H, Raaijmakers J, Salillas S, Schildkraut JA, van Ingen J. | J Med Microbiol | 10.1099/jmm.0.002072 | 2025 | | |
| New therapeutic strategies for Mycobacterium abscessus pulmonary diseases - untapping the mycolic acid pathway. | Alcaraz M, Edwards TE, Kremer L. | Expert Rev Anti Infect Ther | 10.1080/14787210.2023.2224563 | 2023 | | |
| Fullertubes inhibit mycobacterial viability and prevent biofilm formation by disrupting the cell wall. | Shenoy V, Gunda R, Noble C, Haraguchi A, Stevenson S, Daniel J. | Cell Biochem Funct | 10.1002/cbf.3963 | 2024 | | |
| GplR1, an unusual TetR-like transcription factor in Mycobacterium abscessus, controls the production of cell wall glycopeptidolipids, colony morphology, and virulence. | Shell SS, Bar-Oz M, Xiao J, Pandey M, Bellardinelli J, Ibitoye OI, Jackson M, Oehlers SH, Barkan D, Meir M. | mSystems | 10.1128/msystems.00872-25 | 2025 | | |
| Prevalence and epidemiologic features of nontuberculous mycobacteria causing persistent surgical site infections in Bangladesh. | Nahar MR, Nasreen SA, Paul SK, Hoque MA, Aung MS, Haque N, Hossain T, Tasnim SA, Tuly SJ, Ishi NS, Ifa IA, Mamun AA, Arafa P, Kobayashi N. | IJID Reg | 10.1016/j.ijregi.2025.100714 | 2025 | | |
| Pathogenicity | Ouabain alleviates Mycobacterium abscessus-triggered inflammatory responses through dual regulation of NLRP3 inflammasome activity and M1 macrophage polarization. | Li N, Huang S, Shi X, Lu K, Yu X, Qiu C, Chen R. | Front Immunol | 10.3389/fimmu.2025.1633882 | 2025 | |
| The In vitro activity of carbapenems alone and in combination with beta-lactamase inhibitors against difficult-to-treat mycobacteria; Mycobacterium tuberculosis, Mycobacterium abscessus, and Mycobacterium avium complex: A systematic review. | Andersson V, Froberg G, Dahl VN, Chryssanthou E, Giske C, Schon T, Forsman LD. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_131_23 | 2023 | | |
| Peritoneal dialysis-associated infection caused by Mycobacterium abscessus in a pediatric patient on continuous peritoneal dialysis without switching to hemodialysis. | Takata K, Omae T, Hamano Y, Ishikawa T, Nogami K. | CEN Case Rep | 10.1007/s13730-024-00875-1 | 2024 | | |
| Induction-free recombineering for simple targeted gene-deletions in various mycobacteria. | Bracha Y, Barkan D. | Microbiol Spectr | 10.1128/spectrum.01897-25 | 2025 | | |
| Iatrogenically Acquired Mycobacterium abscessus Infection in an Indwelling Intercostal Drainage In Situ in a Patient With Alcoholic Liver Disease and Bilateral Hepatic Hydrothorax: A Report of a Rare Case. | Ranjan R, Gunasekaran J, Bir R, Kumar U, Gupta RM. | Cureus | 10.7759/cureus.59626 | 2024 | | |
| Omadacycline therapy for Mycobacterium abscessus species infections. | Ingram PR, Jones EE, Allen B, Murray RJ, Keehner TJ, Whitmore TJ. | Intern Med J | 10.1111/imj.16071 | 2023 | | |
| Identification of Nontuberculous Mycobacteria in Patients with Multidrug-resistant Tuberculosis in Quezon City, Philippines, Using Multiplex PCR. | Cabanatan MM, Bungay AAC, Villanueva SYAM, Tobias-Altura MC, Defensor DD, Lota MMM. | Acta Med Philipp | 10.47895/amp.v59i4.9049 | 2025 | | |
| Transcriptional and cytokine signatures of Mycobacterium abscessus complex pulmonary disease during disease progression and treatment. | Syenina A, Tan YH, Tng DJH, Sim SXQ, Chew VSY, Yee JX, Ong EZ, Ooi EE, Low JGH, Ng DHL. | PLoS Negl Trop Dis | 10.1371/journal.pntd.0012943 | 2025 | | |
| Correlation of Cyclic Threshold Values Generated by GeneXpert Ultra MTB/RIF and Fluorescence Microscopy to Predict Mycobacterial Burden in Suspected Cases of Pulmonary Tuberculosis. | Gota BVA, Shenoy VP, Kamath A. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_199_23 | 2024 | | |
| Primary tuberculous mycobacterial granulomas provide a niche for superinfecting Mycobacterium abscessus. | Wee D, Pandey M, Chen Y, Lorenzini PA, Chow EW, Wang Y, Singhal A, Oehlers SH. | Nat Commun | 10.1038/s41467-025-65797-7 | 2025 | | |
| Recurrent NTM pulmonary disease despite avoidance of hot spring exposure in a plaque psoriasis patient treated with Secukinumab: a case report. | Wei Y, Wang C, Chong L, Cui X. | BMC Infect Dis | 10.1186/s12879-025-10487-4 | 2025 | | |
| Impact of Mycobacteroides abscessus colony morphology on biofilm formation and antimicrobial resistance. | Oschmann-Kadenbach AM, Schaudinn C, Borst L, Schwarz C, Konrat K, Arvand M, Lewin A. | Int J Med Microbiol | 10.1016/j.ijmm.2024.151603 | 2024 | | |
| Pathogenicity | N-Acetylcysteine as a Host-Directed Therapy Against Clarithromycin-Resistant Mycobacterium abscessus. | Yang S, Zhang Y, Xu J, Chen Z, Ren Y, Long Y, Huang X, Liu J, Huang H, Xie S, Ma R, Dong Y, Fan X, Hu Z, Li F. | Pathogens | 10.3390/pathogens14040302 | 2025 | |
| Omadacycline drug susceptibility testing for non-tuberculous mycobacteria using oxyrase to overcome challenges with drug degradation. | Boorgula GD, Gumbo T, Singh S, McShane PJ, Philley JV, Srivastava S. | Tuberculosis (Edinb) | 10.1016/j.tube.2024.102519 | 2024 | | |
| Phenotyping Nontuberculous Mycobacterial Lung Disease: Comparative Analysis of Clinical and Imaging Features in a TB-Endemic Setting. | Feng Y, Guo J, Luo S, Zhang Z. | Infect Drug Resist | 10.2147/idr.s529466 | 2025 | | |
| Prevalence and clinical manifestations of cutaneous findings in patients with adult-onset immunodeficiency due to anti-interferon gamma autoantibodies: an eight-year retrospective study. | Pattanaprichakul P, Leeyaphan C, Angkasekwinai N, Bunyaratavej S, Senawong S, Sereeaphinan C, Munprom K. | Int J Dermatol | 10.1111/ijd.16870 | 2023 | | |
| Clinical Presentations and Species Spectrum of Nontuberculous Mycobacteria in Suspected Pulmonary Tuberculosis Cases. | Das S, Mohapatra PR, Rath S, Bhuniya S, Mishra B. | J Glob Infect Dis | 10.4103/jgid.jgid_152_24 | 2025 | | |
| Comorbidity of sarcoidosis and non-tuberculosis mycobacteria: a case description. | Dai G, Yin C, Chen S, Gao W, Tang X, Wang T, Zeng Y. | Quant Imaging Med Surg | 10.21037/qims-24-1207 | 2024 | | |
| AgNP-Containing Niosomes Functionalized with Fucoidan Potentiated the Intracellular Killing of Mycobacterium abscessus in Macrophages. | Nino-Martinez N, Audreyartha K, Cheung K, Parra SM, Martinez-Castanon G, Bach H. | Int J Mol Sci | 10.3390/ijms26031366 | 2025 | | |
| Primary cutaneous infections with non-tuberculous mycobacteria: a report of 6 cases. | Yao QH, Zhi HL, Xia XJ, Liu ZH. | BMC Infect Dis | 10.1186/s12879-024-10134-4 | 2024 | | |
| Pathogenicity | The autophagy-targeting compound V46 enhances antimicrobial responses to Mycobacteroides abscessus by activating transcription factor EB. | Sapkota A, Park EJ, Kim YJ, Heo JB, Nguyen TQ, Heo BE, Kim JK, Lee SH, Kim SI, Choi YJ, Roh T, Jeon SM, Jang M, Heo HJ, Whang J, Paik S, Yuk JM, Kim JM, Song GY, Jang J, Jo EK. | Biomed Pharmacother | 10.1016/j.biopha.2024.117313 | 2024 | |
| Disseminated nontuberculous mycobacterial infection in the context of interferon-gamma autoantibody syndrome: A case report and review of the literature. | Jordan V, Pickles R. | Eur J Microbiol Immunol (Bp) | 10.1556/1886.2024.00123 | 2025 | | |
| Mycobacteroides abscessus: Identification and Treatment Challenges. | Ferguson B. | J Clin Aesthet Dermatol | 2025 | | ||
| Unveiling Mycobacterium fortuitum Lung Disease: A Case Linked to Pedicure Practices. | Mangione Leon IY, Alashi L, Munoz Monaco G, Gomez de Ziegler C. | Cureus | 10.7759/cureus.84758 | 2025 | | |
| Polycationic phosphorous dendrimer potentiates multiple antibiotics against drug-resistant mycobacterial pathogens. | Imran M, Singh S, Ahmad MN, Malik P, Mukhopadhyay A, Yadav KS, Gupta UD, Mugale MN, Mitra K, Srivastava KK, Chopra S, Mignani S, Apartsin E, Majoral JP, Dasgupta A. | Biomed Pharmacother | 10.1016/j.biopha.2024.116289 | 2024 | | |
| Macrolide resistance due to erm(55). | Alexander DC, Farquhar T, Adams JME, Suchan DM, Workman SD, Wallace RJ, Brown-Elliott BA, El-Halfawy OM, Cameron ADS. | Microbiol Spectr | 10.1128/spectrum.02397-24 | 2025 | | |
| Non-Tuberculous Mycobacterial Cervicofacial Lymphadenitis in Children-10-Year Experience in a Tertiary Pediatric Center. | Leow O, Aoyama R, Loh WS, Shih E, Tay SY, Chew KL, Chew KL, Shen L, Chan SM. | J Pediatric Infect Dis Soc | 10.1093/jpids/piad043 | 2023 | | |
| Clinical Characteristics of Nontuberculous Mycobacterial Positivity Occurring During Multidrug-Resistant Tuberculosis Treatment: A Retrospective Study. | Wang M, Khan MT, Yang Z, Feng Z, Zhang H, Yuan Y, Wu D, Chen Z, Kuang H, Tan S. | Trop Med Infect Dis | 10.3390/tropicalmed10030083 | 2025 | | |
| Sinonasal Disease in Pediatric Patients With Cystic Fibrosis and the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) I1234V Mutation in Qatar. | Odeh M, Al-Naimi AR, Younes A. | Cureus | 10.7759/cureus.88481 | 2025 | | |
| The Epidemiology of Nontuberculous Mycobacteria in Cystic Fibrosis. | Sotiropoulou A, Loukou I, Vliora C, Douros K, Moustaki M. | Children (Basel) | 10.3390/children12091270 | 2025 | | |
| Genetics | Population genetic analysis of clinical Mycobacterium abscessus complex strains in China. | Li X, Zhu Y, Lu Y, Wu K, Che Y, Wang X, Wang W, Gao J, Gao J, Liu Z, Zhou Z. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1496896 | 2024 | |
| Development of multiplex real-time PCR for detection of clarithromycin resistance genes for the Mycobacterium abscessus group. | Pedace CS, Goncalves MG, Souza AR, Dos Santos Simeao FC, de Carvalho NFG, Gallo JF, Chimara E. | J Med Microbiol | 10.1099/jmm.0.001670 | 2023 | | |
| Effect of Panax quinquefolius extract on Mycobacterium abscessus biofilm formation. | He Z, Xu X, Wang C, Li Y, Dong B, Li S, Zeng J. | Biofouling | 10.1080/08927014.2023.2166405 | 2023 | | |
| sRNA21, a novel small RNA, protects Mycobacterium abscessus against oxidative stress. | Tan Z, Fan J, He S, Zhang Z, Chu H. | J Gene Med | 10.1002/jgm.3492 | 2023 | | |
| Secondary spontaneous pneumothorax in a patient with resistant Mycobacterium abscessus infection and systemic sclerosis-associated interstitial lung disease: A case report. | Nishizawa Y, Katsura H, Sasaki Y, Kudo R, Kizuki A, Horimoto A, Ishikawa M, Takagi K, Kikuchi K, Sakura H, Nitta K, Hoshino J, Ogawa T. | Respir Med Case Rep | 10.1016/j.rmcr.2023.101941 | 2023 | | |
| A Case of Silent Mycobacterial Endocarditis Masked as Refractory Hyperparathyroidism. | Hurley J, Arora G, Ficenec S, Khoury J, Athas D. | Cureus | 10.7759/cureus.94657 | 2025 | | |
| Pathogenicity | Insights on the Pathogenesis of Mycobacterium abscessus Infection in Patients with Cystic Fibrosis. | Basher M, Gur M, Meir M. | J Clin Med | 10.3390/jcm14103492 | 2025 | |
| Triple antimicrobial combinations with potent synergistic activity against M. abscessus. | Huang Y, Chiaraviglio L, Bode-Sojobi I, Kirby JE. | Antimicrob Agents Chemother | 10.1128/aac.01828-24 | 2025 | | |
| Pulmonary valve infective endocarditis caused by Mycobacterium abscessus. | Olatidoye OA, Samat SH, Yin K, Bates MJ. | J Cardiothorac Surg | 10.1186/s13019-023-02336-9 | 2023 | | |
| Identification of biomarkers associated with ferroptosis in macrophages infected with Mycobacterium abscessus using bioinformatic tools. | Qian J, Lu C, Meng K, Xu Z, Xue H, Yang W. | PLoS One | 10.1371/journal.pone.0314114 | 2025 | | |
| Mycobacterium abscessus persistence in the face of Pseudomonas aeruginosa antagonism. | Gupta R, Schuster M, Rohde KH. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1569331 | 2025 | | |
| Clinical Characteristics of Patients with Nontuberculous Mycobacterium Pulmonary Disease in Fuyang, China: A Retrospective Study. | Wang X, Li T, Liu Y, Zhu Y, Chen L, Gao Y. | Infect Drug Resist | 10.2147/idr.s475652 | 2024 | | |
| Diagnostic value of nanopore sequencing technology in nontuberculous mycobacterial pulmonary disease. | Lin WH, Tang F, Liu SS. | Am J Transl Res | 10.62347/hhrh8076 | 2024 | | |
| Intervention strategy for Rapid Grower Mycobacteria outbreak among post-laparoscopic surgical site infection patients in a tertiary care hospital. | Pal N, Ray R, Kundu S, Maiti PK. | Indian J Med Res | 10.25259/ijmr_138_24 | 2024 | | |
| Prolonged Survival Following Intra-abdominal Mycobacterium abscessus Infection Without Antimicrobial Therapy or Surgical Intervention. | Tiwari A, Geringer MR, Barsoumian A, Masella P, Vreeland TJ, Clifton GT. | Am Surg | 10.1177/00031348221146935 | 2023 | | |
| Enzymology | Mycobacterium abscessus Cluster in Cardiac Surgery Patients Potentially Attributable to a Commercial Water Purification System. | Klompas M, Akusobi C, Boyer J, Woolley A, Wolf ID, Tucker R, Rhee C, Fiumara K, Pearson M, Morris CA, Rubin E, Baker MA. | Ann Intern Med | 10.7326/m22-3306 | 2023 | |
| Mycobacteria in Organ Transplant Recipients. | Narsana N, Alejandra Perez M, Subramanian A. | Infect Dis Clin North Am | 10.1016/j.idc.2023.04.004 | 2023 | | |
| Clinical spectrum of extrapulmonary non-tuberculous mycobacterial disease in immunocompetent patients: a case series. | Yadav P, Meena DS, Kumar D, John N, Kaur N, Kombade S, Bohra GK, Tiwari S, Nag V. | Germs | 10.18683/germs.2024.1431 | 2024 | | |
| Multifaceted roles of mycobacterial HflX: ribosome splitting, rRNA disordering, and drug resistance. | Majumdar S, Ghosh P, Agrawal RK. | Biochem Soc Trans | 10.1042/bst20253084 | 2025 | | |
| Infection du cuir chevelu à Mycobacterium abscessus après une greffe capillaire subie en Amérique centrale. | Chow I, Chan S, Lin M, Peters L. | CMAJ | 10.1503/cmaj.230794-f | 2023 | | |
| Refractory Infection of Mycobacterium abscessus: Skin and Soft Tissue Infection Recurred under Combination Therapy of Surgery and Outpatient Antibiotics. | Yamada A, Yukawa K, Eguchi T. | J Plast Reconstr Surg | 10.53045/jprs.2023-0055 | 2024 | | |
| It takes two to tango! Stability of drugs affecting efficacy against Mycobacterium abscessus. | Singh S, Srivastava S. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2023.107060 | 2024 | | |
| Mycobacterium abscessus Pneumonia in an Immunonormal Infant. | Sands A, Klepper E, Bolton M. | Pediatr Infect Dis J | 10.1097/inf.0000000000003681 | 2022 | | |
| Beauty's Betrayal: Mycobacterium abscessus Case Series Following Aesthetic Procedures in the Brazilian Amazon. | Carbonell RCC, Oliveira LLF, Galan LEB, Filardi ETM, Lins ABM, Nattrodt JJM, Dantas DSM, Bernardi ACA, Cerni FA, Pucca MB. | Infect Dis Rep | 10.3390/idr16040055 | 2024 | | |
| Metabolism | Restriction of mitochondrial oxidation of glutamine or fatty acids enhances intracellular growth of Mycobacterium abscessus in macrophages. | Kim HW, Lee JW, Yoon HS, Park HW, Lee YI, Lee SK, Whang J, Kim JS. | Virulence | 10.1080/21505594.2025.2454323 | 2025 | |
| Clinical characteristics and outcomes of tuberculosis and non-tuberculous mycobacteria infections: a population-based study of concurrent and sequential infections. | Fei ZT, Zhou DP, Huang W, Liu P, Lu QP, Li H, Yang Y, Ye D, Liu XH, Xia L. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-025-05151-3 | 2025 | | |
| Beyond the Needle: Unmasking Atypical Mycobacteria in Postvaccination Abscesses in Children. | Shah A, Joshi DN, Shah A. | J Indian Assoc Pediatr Surg | 10.4103/jiaps.jiaps_262_23 | 2024 | | |
| Preclinical murine models to study lung infection with Mycobacterium abscessus complex. | Nicola F, Cirillo DM, Lore NI. | Tuberculosis (Edinb) | 10.1016/j.tube.2022.102301 | 2023 | | |
| Nontuberculous Mycobacterial Infection of Larynx and Cervical Trachea. | Lau RJ, Lackey TG, Samedi V, Fink DS. | Ann Otol Rhinol Laryngol | 10.1177/00034894231161871 | 2023 | | |
| Deciphering the diversity and assemblage mechanisms of nontuberculous mycobacteria community in four drinking water distribution systems with different disinfectants. | Yang J, Hu Y, Zhang Y, Zhou S, Meng D, Xia S, Wang H. | Sci Total Environ | 10.1016/j.scitotenv.2023.168176 | 2024 | | |
| Fate of in vitro cultured Mycobacterium abscessus populations when exposed to moxifloxacin. | Salina EG, Martini BA, Sorokin VV, Mulyukin AL. | Front Microbiol | 10.3389/fmicb.2024.1494147 | 2024 | | |
| Notes from the Field: Mycobacterium abscessus Outbreak Related to Contaminated Water Among Ventilator-Dependent Residents of a Pediatric Facility - Pennsylvania, 2022. | Sinkevitch JN, Paoline J, Smee A, Jones S, Spicer K, Gable P, Houston H, Stevens V, Bicking Kinsey C. | MMWR Morb Mortal Wkly Rep | 10.15585/mmwr.mm7242a5 | 2023 | | |
| Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panel. | Luong ML, Nakamachi Y, Silveira FP, Morrissey CO, Danziger-Isakov L, Verschuuren EAM, Wolfe CR, Hadjiliadis D, Chambers DC, Patel JK, Dellgren G, So M, Verleden GM, Blumberg EA, Vos R, Perch M, Holm AM, Mueller NJ, Chaparro C, Husain S. | Transpl Infect Dis | 10.1111/tid.14251 | 2024 | | |
| Long-term Outcomes of Adjunctive Lung Resection for Nontuberculous Mycobacteria Pulmonary Disease. | Kang N, Jhun BW. | Open Forum Infect Dis | 10.1093/ofid/ofae345 | 2024 | | |
| Pathogenicity | Divergent host humoral innate immune response to the smooth-to-rough adaptation of Mycobacterium abscessus in chronic infection. | Wheeler EA, Lenhart-Pendergrass PM, Rysavy NM, Poch KR, Caceres SM, Calhoun KM, Serban KA, Nick JA, Malcolm KC. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1445660 | 2025 | |
| Pathogenicity | Infectious Granuloma With Mycobacterium abscessus After Facial Injection of Botulinum Toxin: A Case Report. | Li C, Shen C, Zhang W. | J Craniofac Surg | 10.1097/scs.0000000000009790 | 2024 | |
| Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720. | Winthrop KL, Flume P, Hamed KA. | Expert Rev Anti Infect Ther | 10.1080/14787210.2023.2270158 | 2023 | | |
| Ferritin from Mycobacterium abscessus is involved in resistance to antibiotics and oxidative stress. | Pereira MMR, de Oliveira FM, da Costa AC, Junqueira-Kipnis AP, Kipnis A. | Appl Microbiol Biotechnol | 10.1007/s00253-023-12420-8 | 2023 | | |
| Oral beta-lactam combinations are effective in vitro against Mycobacterium avium, regardless of clarithromycin susceptibility. | Yoshikawa M, Nishimura T, Misawa K, Shimamura R, Suzuki K, Kashimura S, Igarashi Y, Enoki Y, Taguchi K, Hasegawa N, Namkoong H, Matsumoto K. | Microbiol Spectr | 10.1128/spectrum.02012-25 | 2025 | | |
| Liposomal amikacin and Mycobacterium abscessus: intimate interactions inside eukaryotic cells. | Le Moigne V, Blouquit-Laye S, Desquesnes A, Girard-Misguich F, Herrmann JL. | J Antimicrob Chemother | 10.1093/jac/dkac348 | 2022 | | |
| Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines. | Ku JH, Henkle E, Aksamit TR, Barker A, Brunton AE, Winthrop KL, Bronchiectasis and NTM Research Registry investigators. | Clin Infect Dis | 10.1093/cid/ciac788 | 2023 | | |
| Mining of the Novel Virulent ATP-Binding Cassette Importers in Mycobacterium abscessus by Comparative Genomic Strategy. | Xue S, Ma J, Li SS, Fan S, Cai Y, Li J, Fu X, Deng Z, Sun QH, Sun YC, Ma W. | Microb Drug Resist | 10.1089/mdr.2021.0450 | 2022 | | |
| Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps. | Mudde SE, Schildkraut JA, Ammerman NC, de Vogel CP, de Steenwinkel JEM, van Ingen J, Bax HI. | J Glob Antimicrob Resist | 10.1016/j.jgar.2022.10.015 | 2022 | | |
| A case of mediastinal abscess and infected aortic aneurysm caused by dissemination of Mycobacterium abscessus subsp. massiliense pulmonary disease. | Matsumoto Y, Murata M, Takayama K, Yamasaki S, Hiramine S, Toyoda K, Kibe Y, Nishida R, Kimura S, Sonoda H, Shiose A, Shimono N. | J Infect Chemother | 10.1016/j.jiac.2022.09.017 | 2023 | | |
| Identification of and discrimination between the Mycobacterium abscessus complex and Mycobacterium avium complex directly from sputum using quadruplex real-time PCR. | Dziedzinska R, Okunkova J, Kralik P, Svobodova J, Mala M, Slana I. | J Med Microbiol | 10.1099/jmm.0.001611 | 2022 | | |
| Investigating bacterial infections in Galleria mellonella larvae: Insights into pathogen dissemination and behavior. | Admella J, Torrents E. | J Invertebr Pathol | 10.1016/j.jip.2023.107975 | 2023 | | |
| Distinct lung microbiota community states are associated with pulmonary nontuberculous mycobacterial disease prognosis. | Chen Y, Miao Q, Bao R, Qu H, Shen J, Li N, Luan S, Yin X, Pan J, Hu B. | BMC Microbiol | 10.1186/s12866-025-04420-7 | 2025 | | |
| Application value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid in pathogen detection and diagnostic efficiency of acute exacerbation of bronchiectasis. | He Z, Kong J, Su Q, Lin J. | Am J Transl Res | 10.62347/wolq1347 | 2025 | | |
| Amikacin@SiO2 core@shell nanocarriers to treat pulmonal bacterial infections. | Rutschmann M, Redinger N, Schaible UE, Feldmann C. | J Mater Chem B | 10.1039/d2tb02609k | 2023 | | |
| CT findings as predictive factors for treatment failure in Mycobacterium abscessus complex lung disease: a retrospective cohort study. | Chiang PY, Huang YS, Huang YC, Lee MY, Kang VJ, Shu CC, Chang YC. | Jpn J Radiol | 10.1007/s11604-024-01570-y | 2024 | | |
| Series 1: The Use of hsp65- and erm(41)-Targeted Amplicon Sequencing in the Diagnostic Workflow for Non-Tuberculous Mycobacteria. | Lee T, Cabrera A, Kolehmainen K, Hird T, Jorgensen D, O'Dwyer A, Fornika D, KhunKhun RK, Rodrigues M, Prystajecky N, Tyson J, Sekirov I, Zlosnik JEA. | Trop Med Infect Dis | 10.3390/tropicalmed10070192 | 2025 | | |
| Pulmonary Mycobacterium abscessus infection treated in combination with inhaled tigecycline. | Pedersen AA, Floe A, Lokke A, Hilberg O. | BMJ Case Rep | 10.1136/bcr-2023-255383 | 2023 | | |
| Lymphangioleiomyomatosis Showing the Development of Mycobacterium abscessus subsp. massiliense Infection during Sirolimus Therapy. | Yanagisawa A, Takimoto T, Kurahara Y, Tsuyuguchi K, Yoshida S, Hirose M, Inoue Y, Arai T. | Intern Med | 10.2169/internalmedicine.2847-23 | 2024 | | |
| In vitro synergy between manuka honey and amikacin against Mycobacterium abscessus complex shows potential for nebulisation therapy. | Nolan VC, Harrison J, Cox JAG. | Microbiology (Reading) | 10.1099/mic.0.001237 | 2022 | | |
| Mycobacterium gordonae: the canary in the coal mine? | Condit D, Avery L, Daley CL, Metersky M. | J Thorac Dis | 10.21037/jtd-23-1648 | 2024 | | |
| Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel. | Hershko Y, Adler A. | Microb Drug Resist | 10.1089/mdr.2023.0024 | 2023 | | |
| Quantifying the effectiveness of ultraviolet-C light at inactivating airborne Mycobacterium abscessus. | Nguyen TT, He C, Carter R, Ballard EL, Smith K, Groth R, Jaatinen E, Kidd TJ, Thomson RM, Tay G, Johnson GR, Bell SC, Knibbs LD. | J Hosp Infect | 10.1016/j.jhin.2022.10.008 | 2023 | | |
| Epidemiology, microbiology and clinical impacts of non-tuberculous mycobacteria in adult patients with cystic fibrosis. | Orlos Z, Lorinczi LK, Antus B, Barta I, Miklos Z, Horvath I. | Heliyon | 10.1016/j.heliyon.2024.e41324 | 2025 | | |
| Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution. | Froberg G, Maurer FP, Chryssanthou E, Fernstrom L, Benmansour H, Boarbi S, Mengshoel AT, Keller PM, Viveiros M, Machado D, Fitzgibbon MM, Mok S, Werngren J, Cirillo DM, Alcaide F, Hyyrylainen HL, Aubry A, Andres S, Nadarajan D, Svensson E, Turnidge J, Giske CG, Kahlmeter G, Cambau E, van Ingen J, Schon T, EUCAST AMST and ESCMYC study groups. | Clin Microbiol Infect | 10.1016/j.cmi.2023.02.007 | 2023 | | |
| Pathogenicity | Cell Death Mechanisms in Mycobacterium abscessus Infection: A Double-Edged Sword. | Prata RBDS, Pinheiro RO. | Pathogens | 10.3390/pathogens14040391 | 2025 | |
| In vitro effects of diazabicyclooctane beta-lactamase inhibitors relebactam and nacubactam against three subspecies of Mycobacterium abscessus complex. | Misawa K, Nishimura T, Kashimura S, Enoki Y, Taguchi K, Uno S, Uwamino Y, Matsumoto K, Hasegawa N. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2022.106669 | 2022 | | |
| [Analysis of time for diagnosis of nontuberculous mycobacterial lung disease and its associated factors in a tuberculosis-designated hospital in Shanghai]. | Zheng XB, He YF, Wang L, Sun Q, Shen XN, Wu XC, Yang JH, Yao L, Cui HY, Xu B, Yu FY, Sha W. | Zhonghua Jie He He Hu Xi Za Zhi | 10.3760/cma.j.cn112147-20230111-00018 | 2023 | | |
| Pathogenicity | Phage-mediated TLR2 signaling attenuates intracellular Mycobacterium abscessus survival in macrophages. | Kapoor H, Maves AM, Bowder MA, Danelishvili L. | Sci Rep | 10.1038/s41598-025-07320-y | 2025 | |
| Genomic epidemiology of Mycobacterium abscessus at an adult cystic fibrosis programme reveals low potential for healthcare-associated transmission. | Gross JE, Finklea JD, Caceres SM, Poch KR, Hasan NA, Jia F, Epperson LE, Lipner EM, Vang CK, Honda JR, Strand MJ, Nogueira de Moura VC, Daley CL, Strong M, Nick JA. | ERJ Open Res | 10.1183/23120541.00165-2024 | 2024 | | |
| Nontuberculous mycobacteria remodel lung microbiota in cystic fibrosis-associated respiratory infections. | Hardman M, Higgi S, Hanson L, Schutz K, Wargo MJ, Teneback CC, Daniels TWV, van der Gast C, Rivett DW. | Microbiol Spectr | 10.1128/spectrum.00382-25 | 2025 | | |
| Mycobacterium abscessus: insights from a bioinformatic perspective. | Sur S, Patra T, Karmakar M, Banerjee A. | Crit Rev Microbiol | 10.1080/1040841x.2022.2082268 | 2023 | | |
| Evaluation and activity of new porphyrin-peptide cage-type conjugates for the photoinactivation of Mycobacterium abscessus. | Alcaraz M, Lyonnais S, Ghosh C, Aguilera-Correa JJ, Richeter S, Ulrich S, Kremer L. | Microbiol Spectr | 10.1128/spectrum.00006-24 | 2024 | | |
| Non-tuberculous mycobacteria disease pre-lung transplantation: A systematic review of the treatment regimens and duration pre- and post-transplant. | van Gemert JP, Ravensbergen SJ, Verschuuren EAM, Kerstjens HAM, Willemse BWM, van Ingen J, Hoefsloot W, Gan T, Akkerman OW. | Transplant Rev (Orlando) | 10.1016/j.trre.2023.100800 | 2023 | | |
| Pulmonary Mycobacterium abscessus Infection: A Pathogen in Disguise. | Waugh KM, Wajahat R. | Cureus | 10.7759/cureus.46897 | 2023 | | |
| Successful long-term management for postoperative sternal infection with multiple disseminated lymphadenitis caused by Mycobacterium abscessus. | Yanagihara T, Kawamura T, Minagi K, Sekine Y, Sugai K, Ichimura H, Sato Y. | Surg Case Rep | 10.1186/s40792-023-01730-8 | 2023 | | |
| Epidemiology of nontuberculous mycobacteria in the Finger Lakes region of New York. | Croix M, Dumyati G, Adams A, Levy P, Lesho E, Hardy D, Munsiff S. | J Clin Tuberc Other Mycobact Dis | 10.1016/j.jctube.2024.100483 | 2024 | | |
| Clinical value of quantitative PCR in diagnosis of suspected mycobacterial pulmonary infections. | Chen J, Chen C, Xie Y, Xu G, Lin M, Gong X, Zhang X, Chen X, Chen J, Zhang L, He G. | BMC Infect Dis | 10.1186/s12879-025-11935-x | 2025 | | |
| Skin and soft tissue infections due to rapidly growing mycobacteria. | Sepulcri C, Vena A, Bassetti M. | Curr Opin Infect Dis | 10.1097/qco.0000000000000905 | 2023 | | |
| Pathogenicity | Predicting Pulmonary Exacerbations in Cystic Fibrosis Using Inflammation-Based Scoring Systems. | Reitmeier RS, Gotschke M, Walter J, Gotschke J, Schlatzer J, Kauffmann-Guerrero D, Behr J, Tufman A, Mertsch P. | Diagnostics (Basel) | 10.3390/diagnostics15212761 | 2025 | |
| In vitro susceptibility of nontuberculous mycobacteria in China. | Ren W, Tan Y, Ma Z, Shang Y, Li S, Zhang X, Wang W, Yao C, Yuan J, Li L, Pang Y. | BMC Infect Dis | 10.1186/s12879-024-09016-6 | 2024 | | |
| The gene MAB_2362 is responsible for intrinsic resistance to various drugs and virulence in Mycobacterium abscessus by regulating cell division. | Ju Y, Li L, Zhang J, Yusuf B, Zeng S, Fang C, Tian X, Han X, Ding J, Zhang H, Ma W, Wang S, Chen X, Zhang T. | Antimicrob Agents Chemother | 10.1128/aac.00433-24 | 2025 | | |
| Mycobacterium abscessus Meningitis Associated with Stem Cell Treatment During Medical Tourism. | Wolf AB, Money KM, Chandnani A, Daley CL, Griffith DE, Chauhan L, Coffman N, Piquet AL, Tyler KL, Zimmer SM, Montague BT, Mann S, Pastula DM. | Emerg Infect Dis | 10.3201/eid2908.230317 | 2023 | | |
| Exploring a Rare Association: Systematic Review of Hypercalcemia in Nontuberculous Mycobacterial Infections. | Cohen R, Ostrovsky V, Zornitzki L, Elbirt D, Zornitzki T. | Microorganisms | 10.3390/microorganisms13040773 | 2025 | | |
| Risk Factors for Treatment Failure in Skin and Soft Tissue Infections Caused by Nontuberculous Mycobacteria. | Huang CH, Hsiao FY, Wang TH. | Ann Plast Surg | 10.1097/sap.0000000000003356 | 2023 | | |
| Analysis of nontuberculous mycobacterial infections in Saudi children from a tertiary care hospital perspective. | Abukhalid N, Alzahrani N, Alsager K, Alsowailmi B, Albawardi A. | J Clin Tuberc Other Mycobact Dis | 10.1016/j.jctube.2025.100554 | 2025 | | |
| Efficacy and Mode of Action of a Direct Inhibitor of Mycobacterium abscessus InhA. | Alcaraz M, Roquet-Baneres F, Leon-Icaza SA, Abendroth J, Boudehen YM, Cougoule C, Edwards TE, Kremer L. | ACS Infect Dis | 10.1021/acsinfecdis.2c00314 | 2022 | | |
| Managing Complicated Nontuberculous Mycobacteria Infections in Plastic Surgery. | Garcia-Ruza M, Blanco J, Campusano K, Silva D, Claro F, de Waard JH. | Plast Reconstr Surg Glob Open | 10.1097/gox.0000000000006254 | 2024 | | |
| Eradicating Pulmonary Mycobacterium abscessus: The Promise of Dual beta-Lactam Therapy. | Alahmdi B, Dousa KM, Kurz SG, Kaufman A, Bonomo RA, Taimur S. | Open Forum Infect Dis | 10.1093/ofid/ofad312 | 2023 | | |
| In vitro activity of rifabutin against Mycobacterium abscessus, clinical isolates. | Chen J, Zhang H, Guo Q, He S, Xu L, Zhang Z, Ma J, Chu H. | Clin Exp Pharmacol Physiol | 10.1111/1440-1681.13651 | 2022 | | |
| Loss of LpqM proteins in Mycobacterium abscessus is associated with impaired intramacrophage survival. | Boudehen Y-M, Daher W, Roquet-Baneres F, Kremer L. | Microbiol Spectr | 10.1128/spectrum.03837-23 | 2024 | | |
| Biochemical, structural, and functional studies reveal that MAB_4324c from Mycobacterium abscessus is an active tandem repeat N-acetyltransferase. | Alsarraf HMAB, Ung KL, Johansen MD, Dimon J, Olieric V, Kremer L, Blaise M. | FEBS Lett | 10.1002/1873-3468.14360 | 2022 | | |
| Surgical Treatment for Cutaneous Mycobacterium abscessus Infection Caused by Injections of Hyaluronic Acid. | Liu Y, Chen Y. | Clin Cosmet Investig Dermatol | 10.2147/ccid.s394594 | 2023 | | |
| Pediatric Non-Cystic Fibrosis Pulmonary Nontuberculous Mycobacterium Infections: A Global Population Based Study. | Gad El Sayed MBMZ, Tai D, Yu L, Novak D, Dosanjh A. | Pediatric Health Med Ther | 10.2147/phmt.s515071 | 2025 | | |
| Identification of Mycobacterium abscessus using the peaks of ribosomal protein L29, L30 and hemophore-related protein by MALDI-MS proteotyping. | Takei S, Teramoto K, Sekiguchi Y, Ihara H, Tohya M, Iwamoto S, Tanaka K, Khasawneh A, Horiuchi Y, Misawa S, Naito T, Kirikae T, Tada T, Tabe Y. | Sci Rep | 10.1038/s41598-024-61549-7 | 2024 | | |
| A 40-Year-Old Female With Mycobacterium abscessus Successfully Treated With a Dual Beta-Lactam Combination. | Moguillansky N, DeSear K, Dousa KM. | Cureus | 10.7759/cureus.40993 | 2023 | | |
| Polymicrobial infection in cystic fibrosis and future perspectives for improving Mycobacterium abscessus drug discovery. | Baker EJ, Allcott G, Cox JAG. | NPJ Antimicrob Resist | 10.1038/s44259-024-00060-5 | 2024 | | |
| Efflux pump effects on levofloxacin resistance in Mycobacterium abscessus. | Teng T, Chen S, Huo F, Jia J, Zhao L, Jiang G, Wang F, Chu N, Huang H. | Antimicrob Agents Chemother | 10.1128/aac.01348-23 | 2024 | | |
| Resolution of lobe collapse in a child with cystic fibrosis with Mycobacterium abscessus using serial intrabronchial rhDNase. | Xuereb J, Sammut P, Vella C, Balfour-Lynn IM. | Pediatr Pulmonol | 10.1002/ppul.25902 | 2022 | | |
| Scalp Infection Caused by Mycobacterium abscessus Manifested as Patchy Alopecia in an Immunocompetent Female. | Zhang X, Feng Y, Li D, Han J, Shi D. | Infect Drug Resist | 10.2147/idr.s416974 | 2023 | | |
| Case Report: Linezolid-associated toxic optic neuropathy in patients with pulmonary tuberculosis: case series and mini review. | Yun HJ, Kim SJ, Han KE, Choi EJ, Lee JE. | Front Pharmacol | 10.3389/fphar.2025.1547236 | 2025 | | |
| Systematic literature review of the diagnosis, prognosis, and treatment of peritoneal dialysis-related infection caused by nontuberculous mycobacteria. | Kadota N, Ishikawa K, Kubono Y, Konishi K, Fujimaru T, Ito Y, Nagahama M, Taki F, Kawai F, Mori N, Nakayama M. | BMC Nephrol | 10.1186/s12882-024-03841-2 | 2024 | | |
| Comparative analysis of non-tuberculous mycobacterial lung disease and lung colonization: a case-control study. | Chen S, Zhong J, Yang Q, Song X, Zhang L, Ruan G, Zhou B, Shi X, Liu X. | BMC Infect Dis | 10.1186/s12879-024-10067-y | 2024 | | |
| Comparing NGS-Based identification of bloodstream infections to traditional culture methods for enhanced ICU care: a comprehensive study. | Wang W, Chauhan V, Luo Y, Sharma S, Li C, Chen H. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1454549 | 2024 | | |
| Pathogenicity | The diversity of clinical Mycobacterium abscessus isolates in morphology, glycopeptidolipids and infection rates in a macrophage model. | Pichler V, Dalkilic L, Shoaib G, Shapira T, Rankine-Wilson L, Boudehen YM, Chao JD, Sexton D, Prieto M, Quon BS, Tocheva EI, Kremer L, Hsiao W, Av-Gay Y. | J Med Microbiol | 10.1099/jmm.0.001869 | 2024 | |
| Effect of Ultraviolet-c (UVc) light and ozone on the survival of Mycobacterium abscessus complex organisms associated with cystic fibrosis. | Moore JE, Millar BC. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_87_22 | 2022 | | |
| Mycobacterium abscessus Virulence Factors: An Overview of Un-Explored Therapeutic Options. | Cocorullo M, Stamilla A, Recchia D, Marturano MC, Maci L, Stelitano G. | Int J Mol Sci | 10.3390/ijms26073247 | 2025 | | |
| Mutations in Genes Encoding 23S rRNA and FadD32 May be Associated with Linezolid Resistance in Mycobacteroides abscessus. | Ng HF, Ngeow YF. | Microb Drug Resist | 10.1089/mdr.2022.0068 | 2023 | | |
| Bacillus thuringiensis Bacteremia in a 30-Year-Old Intravenous Drug User: A Report of a Rare Case. | Barakat S, Kim H, Dankar R, Hewlett C. | Cureus | 10.7759/cureus.71704 | 2024 | | |
| EmbB and EmbC regulate the sensitivity of Mycobacterium abscessus to echinomycin. | He J, Gao Y, Wang J, Hameed HMA, Wang S, Fang C, Tian X, Zhang J, Han X, Ju Y, Tan Y, Ma J, Ju J, Hu J, Liu J, Zhang T. | mLife | 10.1002/mlf2.12139 | 2024 | | |
| Disseminated Mycobacterium kansasii disease complicating Talaromyces marneffei infection in patient with anti-IFN-gamma autoantibodies: a case report. | Wei S, Meng D, Qin J, Mo S, Jiang Z, Zhang P. | BMC Infect Dis | 10.1186/s12879-025-11535-9 | 2025 | | |
| Long-term use of triple antibiotic-induced black hairy tongue: A case report. | Sun KW, Yang ZC. | SAGE Open Med Case Rep | 10.1177/2050313x231204136 | 2023 | | |
| Pseudomonas aeruginosa pqs Quorum Sensing Mediates Interaction with Mycobacterium abscessus In Vitro. | Long Y, Li Z, Li M, Lu P, Deng Y, Wu P, Li X, Qin G, Huang J, Gao W, Li G, Jia T, Yang L. | Microorganisms | 10.3390/microorganisms13010116 | 2025 | | |
| Prevalence of nontuberculous mycobacteria and the emergence of rare species in Henan Province, China. | Hongmei S, Ruixia L, Jiankang L, Han W, Chang Z, Yan MY, Kang WZ, Li LF, Zhi DC, Xin L. | Epidemiol Infect | 10.1017/s095026882400061x | 2024 | | |
| Cutaneous Mycobacterium Abscessus Infection Following Plastic Surgery: Three Case Reports. | Shen H, Zhang Q, Peng L, Ma W, Guo J. | Clin Cosmet Investig Dermatol | 10.2147/ccid.s445175 | 2024 | | |
| Colloidal silver against macrophage infections and biofilms of atypical mycobacteria. | Feizi S, Cooksley CM, Ramezanpour M, Nepal R, Psaltis AJ, Wormald PJ, Vreugde S. | Biometals | 10.1007/s10534-023-00494-w | 2023 | | |
| Stress-induced non-replicating Mycobacterium smegmatis incorporates exogenous fatty acids into glycopeptidolipids. | Ratna S, Daniel J. | Microb Pathog | 10.1016/j.micpath.2022.105943 | 2023 | | |
| Glycopeptidolipid glycosylation controls surface properties and pathogenicity in Mycobacterium abscessus. | Daher W, Leclercq LD, Johansen MD, Hamela C, Karam J, Trivelli X, Nigou J, Guerardel Y, Kremer L. | Cell Chem Biol | 10.1016/j.chembiol.2022.03.008 | 2022 | | |
| Pathogenicity | Pathogenicity and virulence of Mycobacterium abscessus. | Soverina S, Gilliland HN, Olive AJ. | Virulence | 10.1080/21505594.2025.2508813 | 2025 | |
| In vitro study of the effect of ALA-PDT on Mycobacterium abscessus and its antibiotic susceptibility. | Yue C, Wang L, Wang X, Cen R, Chen J, Li L, Yang W, Tan Y, Lei X. | Photodiagnosis Photodyn Ther | 10.1016/j.pdpdt.2022.102802 | 2022 | | |
| A novel chemogenomic discovery platform identifies bioactive hits with rapid bactericidal activity against Mycobacteroides Abscessus. | Makafe GG, Cole L, Roberts A, Muncil S, Patwardhan A, Bernacki D, Chojnacki M, Weinrick B, Sheinerman F. | Tuberculosis (Edinb) | 10.1016/j.tube.2023.102317 | 2023 | | |
| Evaluation of a Commercial Multiplex Real-Time PCR with Melting Curve Analysis for the Detection of Mycobacterium tuberculosis Complex and Five Nontuberculous Mycobacterial Species. | Kim KJ, Chang Y, Yun SG, Nam MH, Cho Y. | Microorganisms | 10.3390/microorganisms13010026 | 2024 | | |
| In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United States. | Hunkins JJ, de-Moura VC, Eddy JJ, Daley CL, Khare R. | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2022.115882 | 2023 | | |
| Mycobacterium tuberculosis - atpE gene profile of bedaquiline-treated pulmonary tuberculosis patients at the referral hospital Dr. Soetomo, Indonesia. | Setyawan MF, Mertaniasih NM, Soedarsono S, Nuha Z, Maladan Y, Matsumoto S. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_40_23 | 2023 | | |
| [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria]. | Ozkaratas MH, Arslan N, Esen N, Ozkutuk AA. | Mikrobiyol Bul | 10.5578/mb.20239917 | 2023 | | |
| Discovery of Biofilm-Inhibiting Compounds to Enhance Antibiotic Effectiveness Against M. abscessus Infections. | Dzalamidze E, Gorzynski M, Vande Voorde R, Nelson D, Danelishvili L. | Pharmaceuticals (Basel) | 10.3390/ph18020225 | 2025 | | |
| Pathogenicity | Cutaneous nontuberculous mycobacterial infections in Japan: Review of the Japanese literature. | Fujishima C, Tahara J, Munemoto S, Hioki C, Sasaki H, Yoshida H, Matsuo H, Miyamoto Y, Ishii N, Kudo H. | J Dermatol | 10.1111/1346-8138.16531 | 2022 | |
| Identification of essential oils with strong activity against stationary phase Mycobacterium abscessus. | Cao D, Jiang X, Wu T, Xiang Y, Liu J, Li Z, Yuan X, Bi K, Dong X, Tonjum T, Xu K, Zhang Y. | Heliyon | 10.1016/j.heliyon.2024.e27073 | 2024 | | |
| Non-Mycobacteria Tuberculosis in Africa: A Literature Review. | Ojo OT, Odeyemi AO. | Ethiop J Health Sci | 10.4314/ejhs.v33i5.21 | 2023 | | |
| Nontuberculous Mycobacterial Infection of Facial Implant Following Cosmetic Surgery Abroad. | Brummund D, Chang A, Michienzi J. | Eplasty | 2024 | | ||
| Direct identification of Mycobacterium species from liquid medium (MGIT) using FastPrep-2 bead beating system and MALDI-TOF mass spectrometry technology: a comparison with solid media and PCR-based method. | Bazzi AM, Sunki AA, Hamdi MJ, Khaldi AO, Al-Tawfiq JA. | Pract Lab Med | 10.1016/j.plabm.2025.e00479 | 2025 | | |
| Treatment outcome of continuation of intravenous amikacin for Mycobacterium abscessus pulmonary disease with a persistent culture positivity after the treatment initiation. | Park YE, Park SY, Jhun BW, Park Y, Kang YA, Park J, Kwak N, Yim JJ, Shim TS, Jo KW. | J Infect Chemother | 10.1016/j.jiac.2022.03.026 | 2022 | | |
| Genetics | Characterization of Prophages and Their Genetic Cargo in Clinical M. abscessus Isolates. | Luan S, Chen Y, Li N, Miao Q, Pan J, Hu B. | Microorganisms | 10.3390/microorganisms13092028 | 2025 | |
| Remote disruption of intestinal homeostasis by Mycobacterium abscessus is detrimental to Drosophila survival. | Toure H, Durand N, Rincheval V, Girard-Misguich F, Guenal I, Herrmann JL, Szuplewski S. | Sci Rep | 10.1038/s41598-024-80994-y | 2024 | | |
| Multicenter, retrospective cohort study of antimycobacterial treatment-related harms among patients with non-tuberculosis Mycobacterium infections in the United States. | Veve MP, Kenney RM, Aljundi AM, Dierker MS, Athans V, Shallal AB, Patel N. | Antimicrob Agents Chemother | 10.1128/aac.01596-24 | 2025 | | |
| Nontuberculous mycobacterial abscess of lacrimal sac and eyelid debridement: Case report. | Matsuo T, Tanaka T, Yamada K, Nose M, Tanimoto Y. | Clin Case Rep | 10.1002/ccr3.8364 | 2023 | | |
| Non-tuberculous Mycobacterium Rhinosinusitis in an Immunocompetent Patient. | Tomlinson MG, Chidarala S, Lobo BC, Kalyatanda GS. | Cureus | 10.7759/cureus.44002 | 2023 | | |
| A complicated infection by cutaneous Nocardia wallacei and pulmonary Mycobacterium abscessus in a Chinese immunocompetent patient: a case report. | Qin L, Wang S, Zheng Z, Zhang W, Qu Q, Li J, Tan Y, Cao L. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1229298 | 2023 | | |
| Colonization or coinfection? A case report of Mycobacterium avium complex detected in a patient with pulmonary tuberculosis. | Bui TI, Rowe J, Eberly AR. | ASM Case Rep | 10.1128/asmcr.00081-24 | 2025 | | |
| Raloxifene prevents intracellular invasion of pathogenic bacteria through modulation of cell metabolic pathways. | Chang J, Kim J, Lee W. | J Antimicrob Chemother | 10.1093/jac/dkac069 | 2022 | | |
| Mycobacterium abscessus Periprosthetic Hip Infection Complicated by Superimposed Polymicrobial Infection: A Case Report. | Genovese N, Auld T, Dever LL, Rossman SR. | JBJS Case Connect | 10.2106/jbjs.cc.21.00058 | 2021 | | |
| Use of Omadacycline as a Component of Mycobacterium Abscessus Eradication in an Adolescent With Cystic Fibrosis. | Tucker MK, Droemer L, Condren M. | J Pediatr Pharmacol Ther | 10.5863/1551-6776-28.2.172 | 2023 | | |
| Genetics | Genome synthesis, assembly, and rebooting of therapeutically useful high G+C% mycobacteriophages. | Ko CC, Sikkema AP, Lauer MJ, Amarh ED, Garlena RA, Russell DA, Chew N, Li T, Harrison IM, Ellefson J, Hatfull GF, Lohman GJS. | Proc Natl Acad Sci U S A | 10.1073/pnas.2523871122 | 2025 | |
| Phylogeny | The clinical impact of 16S ribosomal RNA PCR and sequencing in the identification of bacterial infections: a 7-year report from a Lebanese tertiary care center. | Youssef N, Boutros CF, Dakroub F, Akl F, Reslan L, Finianos M, Moumneh MBM, Dargham TB, Zein ZE, Haddara A, Korman R, Khafaja S, Matar G, Araj GF, Dbaibo GS. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1619640 | 2025 | |
| Phenotype | Environment in the lung of cystic fibrosis patients stimulates the expression of biofilm phenotype in Mycobacterium abscessus. | Keefe BF, Bermudez LE. | J Med Microbiol | 10.1099/jmm.0.001467 | 2022 | |
| Osteomyelitis in the Left First Toe Due to Mycobacterium abscessus after an Injury. | Yagi Y, Suga H, Takushima A. | J Plast Reconstr Surg | 10.53045/jprs.2022-0040 | 2023 | | |
| Trehalose polyphleates participate in Mycobacterium abscessus fitness and pathogenesis. | Malmsheimer S, Daher W, Tasrini Y, Hamela C, Aguilera-Correa JJ, Chalut C, Hatfull GF, Kremer L. | mBio | 10.1128/mbio.02970-24 | 2024 | | |
| Evaluation of a novel ELISA test using synthetic mycolic acid antigens for serodiagnosis of non-tuberculous mycobacterial (NTM) infections. | Bashford J, Flowers W, Haworth C, Ryan J, Cervi A, Dulayymi JRA, Mason PS, Plank A, Baird M, Floto A. | Thorax | 10.1136/thorax-2022-218800 | 2023 | | |
| Mycobacterium abscessus skin and soft tissue infection following autologous fat grafting in Kurdistan treated with an antibiotic combination including Imipenem-Relebactam and Rifabutin. | Beech AJ, Weinberg SE, Mortimer AE, Lynch F, Bedford J, Calisti G. | J Clin Tuberc Other Mycobact Dis | 10.1016/j.jctube.2023.100381 | 2023 | | |
| [Effects of four efflux pump inhibitors on the activities of clarithromycin against Mycobacterium abscessus]. | Teng TL, Shang YY, Huang HR, Chu NH, Chen ST. | Zhonghua Jie He He Hu Xi Za Zhi | 10.3760/cma.j.cn112147-20210923-00669 | 2022 | | |
| An Integrated Mycobacterial CT Imaging Dataset with Multispecies Information. | Han Z, Zhang Y, Ding W, Zhao X, Jia B, Liu T, Wan L, Xing Z. | Sci Data | 10.1038/s41597-025-04838-8 | 2025 | | |
| Nontuberculous mycobacteria testing and culture positivity in the United States. | Marshall JE, Mercaldo RA, Lipner EM, Prevots DR. | BMC Infect Dis | 10.1186/s12879-024-09059-9 | 2024 | | |
| Current perspectives on infections following refractive kerato-lenticule extraction (KLex) surgery. | Anitha V, Christy JS, Vanathi M, Manohar D, Tandon R, Ravindran M. | Indian J Ophthalmol | 10.4103/ijo.ijo_2280_24 | 2025 | | |
| Molecular Identification of Strains within the Mycobacterium abscessus Complex and Determination of Resistance to Macrolides and Aminoglycosides. | Kania K, Wojcik K, Czekajewska J, Grzesiak M, Klesiewicz K. | Pol J Microbiol | 10.33073/pjm-2023-048 | 2023 | | |
| Mycobacterium abscessus causing native aortic valve endocarditis post stenting. | Sondhi A, Singh P, Anand KB, Ghosh A, Lall M, Sen S. | Med J Armed Forces India | 10.1016/j.mjafi.2022.09.008 | 2024 | | |
| Enzymology | Intrapulmonary pharmacokinetics of SPR719 following oral administration of SPR720 to healthy volunteers. | Rodvold KA, Gotfried MH, Ussery XT, Wong SL, Hamed KA. | Antimicrob Agents Chemother | 10.1128/aac.01103-24 | 2024 | |
| Medical Tourism in Plastic Surgery: A Case Series of Complications. | Koussayer B, Blount T, Alkaelani MT, Le NK, Al Bayati MJ, Moffitt J, Troy J. | Eplasty | 2024 | | ||
| Pathogenicity | Mycobacterium abscessus cell wall and plasma membrane characterization by EPR spectroscopy and effects of amphotericin B, miltefosine and nerolidol. | Alonso L, Pimenta LKL, Kipnis A, Alonso A. | Biochim Biophys Acta Biomembr | 10.1016/j.bbamem.2022.183872 | 2022 | |
| Treatment for non-tuberculous mycobacteria: challenges and prospects. | Conyers LE, Saunders BM. | Front Microbiol | 10.3389/fmicb.2024.1394220 | 2024 | | |
| [Mycobacterium abscessus, a model of resistance to multiple antibiotic classes]. | Illouz M, Alcaraz M, Roquet-Baneres F, Kremer L. | Med Sci (Paris) | 10.1051/medsci/2021164 | 2021 | | |
| Pathogenicity | Clinical characteristics and an evaluation of predictors for a favourable outcome of Mycobacterium abscessus otomastoiditis: a systematic review and meta-analysis of individual participant data. | Manders J, Leow T, van Aerde K, Hol M, Kunst D, Pegge S, Jansen T, van Ingen J, Bekkers S. | Int J Infect Dis | 10.1016/j.ijid.2022.01.017 | 2022 | |
| Efflux pumps and membrane permeability contribute to intrinsic antibiotic resistance in Mycobacterium abscessus. | McGowen K, Funck T, Wang X, Zinga S, Wolf ID, Akusobi C, Denkinger CM, Rubin EJ, Sullivan MR. | PLoS Pathog | 10.1371/journal.ppat.1013027 | 2025 | | |
| Phylogeny | Development of a nucleic acid chromatography assay for the detection of commonly isolated rapidly growing mycobacteria. | Igarashi Y, Chikamatsu K, Sano S, Miyamoto S, Aono A, Osugi A, Morishige Y, Murase Y, Yamada H, Takaki A, Mitarai S. | J Med Microbiol | 10.1099/jmm.0.001464 | 2021 | |
| Genetics | Diagnostic value of bronchoalveolar lavage fluid metagenomic next-generation sequencing for pulmonary infections in patients with connective tissue disease: A retrospective study. | Wang H, Zhao B. | Sci Rep | 10.1038/s41598-025-02472-3 | 2025 | |
| Nontuberculous mycobacteria isolation from sputum specimens: A retrospective analysis of 1061 cases. | Babalik A, Koc EN, Sekerbey HG, Donmez GE, Balikci A, Kilicaslan Z. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_10_23 | 2023 | | |
| Small molecule inhibitors of the fosfomycin resistance enzyme FosM from Mycobacterium abscessus. | Chiasson S, Smith T, Bello L, Chandrika NT, Green KD, Garneau-Tsodikova S, Thompson MK. | Biochim Biophys Acta Gen Subj | 10.1016/j.bbagen.2023.130444 | 2023 | | |
| Mycobacterium chelonae infection of a cardiovascular bioprosthesis linked to a recent outbreak. | Kessel J, Braner A, Diricks M, Walther T, Holubec T, Werner R, Hogardt M, Wichelhaus TA, Niemann S, Moter A, Friesen I, Wetzstein N. | Infection | 10.1007/s15010-025-02534-8 | 2025 | | |
| Antibacterial peptide RP557 increases the antibiotic sensitivity of Mycobacterium abscessus by inhibiting biofilm formation. | Li B, Zhang Y, Guo Q, He S, Fan J, Xu L, Zhang Z, Wu W, Chu H. | Sci Total Environ | 10.1016/j.scitotenv.2021.151855 | 2022 | | |
| Intra-abdominal Abscess Caused by Mycobacteroides abscessus in a Peritoneal Dialysis Patient: A Case Report. | Muraki N, Asahina K, Hori K, Inanaga R, Matsui K, Shinozaki M. | Intern Med | 10.2169/internalmedicine.4048-24 | 2025 | | |
| Cosmetic operative care abroad leads to a multidrug-resistant Mycobacterium abscessus infection in a patient: a case report. | Motawea KR, Rabea RK, Elhalag RH, Goodloe J, Awad DM, Kaur M, Awad AK, Swed S, Varney J. | J Med Case Rep | 10.1186/s13256-022-03678-z | 2022 | | |
| Phenotype | Exposure of Mycobacteriodes abscessus clones to mucin affects bacterial phenotype. | Leestemaker-Palmer A, Ong T, Bermudez LE. | Sci Rep | 10.1038/s41598-024-84451-8 | 2025 | |
| Growth medium and nitric oxide alter Mycobacterium abscessus morphotype and virulence. | Nandanwar N, Gibson JE, Neely MN. | Microbiol Res | 10.1016/j.micres.2021.126887 | 2021 | | |
| Mycobacterium abscessus Causes Highly Resistant Infection as a Breast Abscess. | Coggins JM, Obi A, Badders J, Roy K, Duncan R, Silva C. | Cureus | 10.7759/cureus.38450 | 2023 | | |
| Cu-promoted synthesis of triclosan-Mannich and Glaser adducts: anti-mycobacterial evaluation with in silico validations. | Shekhar, Alcaraz M, Anand A, Sharma RK, Kremer L, Kumar V. | Future Med Chem | 10.4155/fmc-2023-0298 | 2024 | | |
| [In vitro evaluation of the antibacterial activity of nemonoxacin against Mycobacterium abscessus]. | Li B, Guo Q, Chu HQ. | Zhonghua Jie He He Hu Xi Za Zhi | 10.3760/cma.j.cn112147-20210507-00311 | 2021 | | |
| Enzymology | Painful Purulent Nodules Caused by Mycobacterium at Site of Lipodissolve Injections. | Kaur H, Reyes-Barron C, Sipprell WH, Cameron A, Louie T, Tsai PR, Scott G. | Am J Dermatopathol | 10.1097/dad.0000000000002118 | 2022 | |
| Characterization of Mycobacterium abscessus colony-biofilms based on bi-dimensional images. | Aguilera-Correa JJ, Boudehen YM, Kremer L. | Antimicrob Agents Chemother | 10.1128/aac.00402-23 | 2023 | | |
| Enzymology | Biocatalytic valorization of lignin subunit: Screening a carboxylic acid reductase with high substrate preference to syringyl functional group. | Lee HS, Park J, Yeon YJ. | Enzyme Microb Technol | 10.1016/j.enzmictec.2022.110099 | 2022 | |
| RshA mutations contributing to tigecycline resistance in Mycobacteroides abscessus. | Aw KM, Ng HF, Lee CL, Zin T, Ngeow YF. | J Med Microbiol | 10.1099/jmm.0.001547 | 2022 | | |
| Intracranial infection caused by Mycobacterium rhodesiae with specific imaging findings and good response to medication: a case report and literature review. | Chen S, Sun W, Liu R, Yao L, Peng Q. | Front Med (Lausanne) | 10.3389/fmed.2024.1414369 | 2024 | | |
| Mycobacterium abscessus infection in a patient with ornithine transcarbamylase deficiency and liver transplant. | Li YM, Desai K, Saad AG, Galimberti FV. | Pediatr Dermatol | 10.1111/pde.14646 | 2021 | | |
| Amino acid 17 in QRDR of Gyrase A plays a key role in fluoroquinolones susceptibility in mycobacteria. | Wang S, Zhang J, Hameed HMA, Ding J, Guan P, Fang X, Peng J, Su B, Ma S, Tan Y, M Cook G, Zhang G, Lin Y, Zhong N, Hu J, Liu J, Zhang T. | Microbiol Spectr | 10.1128/spectrum.02809-23 | 2023 | | |
| Mycobacterium abscessus and Mycobacterium massiliense exhibit distinct host and organ specificity: a cross-sectional study. | Hsu JY, Cheng A, Ku CC, Chen YC, Wang JT, Hsieh TW, Sheng WH, Chang SC, Wu UI. | Int J Infect Dis | 10.1016/j.ijid.2021.12.348 | 2022 | | |
| CLINICAL CHARACTERISTICS AND VISUAL OUTCOMES IN ENDOPHTHALMITIS AFTER KERATOPROSTHESIS IMPLANTATION. | Lee T, Robbins CB, Wisely CE, Grewal DS, Daluvoy MB, Fekrat S. | Retina | 10.1097/iae.0000000000003300 | 2022 | | |
| Pathogenicity | Clinical Whole Genome Sequencing for Clarithromycin and Amikacin Resistance Prediction and Subspecies Identification of Mycobacterium abscessus. | Realegeno S, Mirasol R, Garner OB, Yang S. | J Mol Diagn | 10.1016/j.jmoldx.2021.07.023 | 2021 | |
| Synthesis and Biological Characterization of Fluorescent Cyclipostins and Cyclophostin Analogues: New Insights for the Diagnosis of Mycobacterial-Related Diseases. | Sarrazin M, Martin BP, Avellan R, Gnawali GR, Poncin I, Le Guenno H, Spilling CD, Cavalier JF, Canaan S. | ACS Infect Dis | 10.1021/acsinfecdis.2c00448 | 2022 | | |
| Cyclophostin and Cyclipostins analogues counteract macrolide-induced resistance mediated by erm(41) in Mycobacterium abscessus. | Sarrazin M, Poncin I, Fourquet P, Audebert S, Camoin L, Denis Y, Santucci P, Spilling CD, Kremer L, Le Moigne V, Herrmann JL, Cavalier JF, Canaan S. | J Biomed Sci | 10.1186/s12929-024-01091-w | 2024 | | |
| The synergetic effect of sitafloxacin-arbekacin combination in the Mycobacterium abscessus species. | Watanabe J, Ihara H, Takei S, Nakamura A, Fujimoto Y, Handoh T, Kurokawa K, Arai Y, Shibayama K, Sumiyoshi I, Ochi Y, Okabe T, Misawa S, Togo S, Naito T, Tabe Y, Miida T, Takahashi K. | Sci Rep | 10.1038/s41598-023-29021-0 | 2023 | | |
| Mycobacterium abscessus pulmonary disease presenting with spontaneous pneumomediastinum and subcutaneous emphysema in childhood acute lymphoblastic leukemia: a case report and literature review. | Liu W, Chu J, Xie Z, Yang L, Huang L, Tu S, Cai H, Wu Z, Wei A, Liu C, Cheng Y, Zhang K, Wang N. | BMC Pediatr | 10.1186/s12887-023-04199-4 | 2023 | | |
| From Triumph to Trial: A Case Study of Non-Tuberculous Mycobacterium After Tetralogy of Fallot (TOF) Correction in an Immunocompetent Child. | Khan S, Ali Y, Baig KS, Hussain U, Ali Z. | Cureus | 10.7759/cureus.62207 | 2024 | | |
| Treatment of Mycobacterium abscessus Pulmonary Disease. | Griffith DE, Daley CL. | Chest | 10.1016/j.chest.2021.07.035 | 2022 | | |
| Mycobacterium abscessus Complex Osteomyelitis of the Wrist. | Alter N, Trenschel RW, Schwartz G, Sharan J, Boyle RP, Shoja MM. | Cureus | 10.7759/cureus.32593 | 2022 | | |
| Pulmonary Mycobacterium abscessus Infection in an 11-Year-Old Child, Successfully Treated with Inhaled/Parenteral Amikacin: A Case Report and Review of Literature. | Deniz M, Ramasli Gursoy T, Tapisiz A, Tezer H, Aslan AT. | J Trop Pediatr | 10.1093/tropej/fmab031 | 2021 | | |
| Misdiagnosis of non-tuberculous mycobacteria as tuberculous by the GeneXpert MTB/RIF Ultra: Fact or fiction? | Opperman CJ, Ntshangase Z, Gumede M, Singh S, Ghebrekristos Y, Warren R, Goosen W. | S Afr J Infect Dis | 10.4102/sajid.v39i1.576 | 2024 | | |
| Streptococcus salivarius pneumonia-associated pneumomediastinum: a case report and literature review. | Chen Z, Xiang K, Wang K, Liu B. | BMC Infect Dis | 10.1186/s12879-024-10138-0 | 2024 | | |
| Use of epigenetically modified bacteriophage and dual beta-lactams to treat a Mycobacterium abscessus sternal wound infection. | Cristinziano M, Shashkina E, Chen L, Xiao J, Miller MB, Doligalski C, Coakley R, Lobo LJ, Footer B, Bartelt L, Abad L, Russell DA, Garlena R, Lauer MJ, Viland M, Kaganovsky A, Mowry E, Jacobs-Sera D, van Duin D, Kreiswirth BN, Hatfull GF, Friedland A. | Nat Commun | 10.1038/s41467-024-54666-4 | 2024 | | |
| Mycobacterium abscessus Pneumonia in Severe Alcoholism. | Acharya S, Anwar S, Medina Y, Thapa S, Glaser A. | Cureus | 10.7759/cureus.26251 | 2022 | | |
| A simple, efficient and cost-effective method for medium- to longterm maintenance and storage of Mycobacterium abscessus complex organisms. | Moore JE, Millar BC. | J Microbiol Methods | 10.1016/j.mimet.2021.106295 | 2021 | | |
| Mycobacterium abscessus subsp. massiliense: Biofilm Formation, Host Immune Response, and Therapeutic Strategies. | Lira RLS, Nogueira FAB, Campos RFPC, Ferreira DRM, Roxo PLBT, de Azevedo CCS, Gimenes ECM, Bastos RLC, Nascimento CEC, Nunes FDO, Marques MCP, Campos CDL, Martinez CG, Zagmignan A, Silva LCN, Ribeiro RM, de Azevedo Dos Santos APS, Carvalho RC, de Sousa EM. | Microorganisms | 10.3390/microorganisms13020447 | 2025 | | |
| Contezolid in complicated skin and soft tissue infection. | Kaul G, Dasgupta A, Chopra S. | Drugs Today (Barc) | 10.1358/dot.2022.58.7.3389002 | 2022 | | |
| Chronic intractable nontuberculous mycobacterial-infected wound after acupuncture therapy in the elbow joint: A case report. | Kim JH, Koh IC, Lim SY, Kang SH, Kim H. | World J Clin Cases | 10.12998/wjcc.v12.i36.6926 | 2024 | | |
| Treatment outcomes in NTM-PD in a high TB burden context. | Kang S, Schmidt JE, Chen I, Tiberi S. | IJTLD Open | 10.5588/ijtldopen.24.0413 | 2024 | | |
| Patient with Adult T-cell Leukemia and Lung Infection Caused by Mycobacterium abscessus: Successful Treatment with Intensive Chemotherapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation. | Azumi H, Kubo M, Otani A, Ochi S, Kobayashi S, Miyataka Y, Nakamura F, Yagi H. | Intern Med | 10.2169/internalmedicine.1181-22 | 2024 | | |
| Radiographic severity and treatment outcome of Mycobacterium abscessus complex pulmonary disease. | Park J, Yoon SH, Kim JY, Gu KM, Kwak N, Yim JJ. | Respir Med | 10.1016/j.rmed.2021.106549 | 2021 | | |
| GrcC1 mediates low-level resistance to multiple drugs in M. marinum, M. abscessus, and M. smegmatis. | Fang C, Zhang H, He J, Tian X, Zeng S, Han X, Wang S, Yusuf B, Hu J, Zhong N, Gao Y, Hameed HMA, Zhang T. | Microbiol Spectr | 10.1128/spectrum.02289-24 | 2025 | | |
| The future approach for the management of acute bacterial skin and skin structure infections. | Tiseo G, Falcone M. | Curr Opin Infect Dis | 10.1097/qco.0000000000001092 | 2025 | | |
| Pharmacokinetics of Omadacycline in Adults with Cystic Fibrosis. | Sanders M, Hong E, Chung PS, Rao AP, Beringer P. | Clin Pharmacokinet | 10.1007/s40262-024-01440-w | 2024 | | |
| Metabolism | A proteomic and functional view of intrabacterial lipid inclusion biogenesis in mycobacteria. | Dargham T, Aguilera-Correa JJ, Avellan R, Mallick I, Celik L, Santucci P, Brasseur G, Poncin I, Point V, Audebert S, Camoin L, Daher W, Cavalier J-F, Kremer L, Canaan S. | mBio | 10.1128/mbio.01475-24 | 2025 | |
| Deletion of ESX-3 and ESX-4 secretion systems in Mycobacterium abscessus results in highly impaired pathogenicity. | Daher W, Le Moigne V, Tasrini Y, Parmar S, Sexton DL, Aguilera-Correa JJ, Berdal V, Tocheva EI, Herrmann JL, Kremer L. | Commun Biol | 10.1038/s42003-025-07572-4 | 2025 | | |
| Formation of Mycobacterium abscessus colonies in cellular culture in an in vitro infection model. | Lopez-Medrano R, Retuerto-Guerrero M, Blanco-Conde S, Moran-Fernandez MB, Rivero-Lezcano OM. | MethodsX | 10.1016/j.mex.2024.102667 | 2024 | | |
| Nontuberculous mycobacteria in cystic fibrosis. | Nick JA, Daley CL, Lenhart-Pendergrass PM, Davidson RM. | Curr Opin Pulm Med | 10.1097/mcp.0000000000000816 | 2021 | | |
| Genetics | Nasopharyngeal Mycobacterium abscessus Infection: A Case Report and Literature Review. | Kaji M, Namkoong H, Nagao G, Azekawa S, Nakagawara K, Tanaka H, Morita A, Asakura T, Kamata H, Uwamino Y, Yoshida M, Fukunaga K, Hasegawa N. | Infect Drug Resist | 10.2147/idr.s415197 | 2023 | |
| Case Report: Multiple Scalp Abscesses due to Mycobacterium abscessus Infection Following Triamcinolone Injection in an Immunocompetent Person. | Mohanty M, Mishra B, Sirka CS, Mohapatra PR. | Am J Trop Med Hyg | 10.4269/ajtmh.22-0126 | 2022 | | |
| Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections. | Mingora CM, Bullington W, Faasuamalie PE, Levin A, Porter G, Stadnick R, Varley CD, Addrizzo-Harris D, Daley CL, Olivier KN, Winthrop KL, Dorman SE, Flume PA. | Open Forum Infect Dis | 10.1093/ofid/ofad335 | 2023 | | |
| A Rare Insidious Case of Skin and Soft Tissue Infection Due to Mycobacterium abscessus: A Case Report. | Cardenas DD, Yasmin T, Ahmed S. | Cureus | 10.7759/cureus.25725 | 2022 | | |
| Clinical Efficacy of Serum Antiglycopeptidolipid Core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort Study. | Choi H, Hughes C, Eke Z, Shuttleworth M, Shteinberg M, Polverino E, Goeminne PC, Welte T, Blasi F, Shoemark A, Long MB, Aliberti S, Haworth CS, Ringshausen FC, Loebinger MR, Lorent N, Chalmers JD. | Chest | 10.1016/j.chest.2024.10.029 | 2025 | | |
| Genetics | Subspecies Distribution and Antimicrobial Susceptibility Testing of Mycobacterium abscessus Clinical Isolates in Madrid, Spain: a Retrospective Multicenter Study. | Ruedas-Lopez A, Tato M, Broncano-Lavado A, Esteban J, Ruiz-Serrano MJ, Sanchez-Cueto M, Toro C, Domingo D, Cacho J, Barrado L, Lopez-Roa P. | Microbiol Spectr | 10.1128/spectrum.05041-22 | 2023 | |
| The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission. | Dedrick RM, Abad L, Storey N, Kaganovsky AM, Smith BE, Aull HA, Cristinziano M, Morkowska A, Murthy S, Loebinger MR, Hatfull GF, Satta G. | Clin Microbiol Infect | 10.1016/j.cmi.2023.06.026 | 2023 | | |
| Clofazimine susceptibility testing of Mycobacterium avium complex and Mycobacterium abscessus: a meta-analysis study. | Hajikhani B, Nasiri MJ, Hosseini SS, Khalili F, Karimi-Yazdi M, Hematian A, Nojookambari NY, Goudarzi M, Dadashi M, Mirsaeidi M. | J Glob Antimicrob Resist | 10.1016/j.jgar.2021.06.002 | 2021 | | |
| Primary cutaneous Mycobacteria avium complex infection in a systemic lupus erythematosus patient: A case report and review. | Yao QH, Xia XJ, Xu JZ, Shen H, Yang Y, Liu ZH. | Medicine (Baltimore) | 10.1097/md.0000000000041450 | 2025 | | |
| Survival of Mycobacterium abscessus complex organisms on coins. | Moore JE, Millar BC. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_138_21 | 2021 | | |
| Metabolism | Orphan response regulator NnaR is critical for nitrate and nitrite assimilation in Mycobacterium abscessus. | Simcox BS, Rohde KH. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1411333 | 2024 | |
| Serological biomarkers for the diagnosis of Mycobacterium abscessus infections in cystic fibrosis patients. | Le Moigne V, Roux AL, Mahoudo H, Christien G, Ferroni A, Dumitrescu O, Lina G, Bouchara JP, Plesiat P, Gaillard JL, Canaan S, Hery-Arnaud G, Herrmann JL. | J Cyst Fibros | 10.1016/j.jcf.2021.08.019 | 2022 | | |
| Anti-IFN-gamma Autoantibody Syndrome Presenting with Disseminated Nontuberculous Mycobacteria Infections: A Case Series of Therapeutic Implications and Review of Literature. | Cheng B, Bajwa B, Choi S, Martin H, Miao T, Werry D, Perlman M, Mirzanejad Y. | Trop Med Infect Dis | 10.3390/tropicalmed10070202 | 2025 | | |
| Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis. | Mir M, Soto F, Gomez PAA, Arroyo RDR, Suresh A, Su A, Gan Q, Stewart J, Adachi R, Balachandran DD, Bashoura L, Casal RF, Dickey BF, Eapen GA, Evans SE, Grosu H, Jimenez CA, Lin J, Ost DE, Sabath BF, Shannon VR, Naing A, Gao J, Wu J, Suresh K, Faiz SA, Altan M, Sheshadri A. | Front Med (Lausanne) | 10.3389/fmed.2025.1582714 | 2025 | | |
| Outcomes of Surgical Treatment for Mycobacterium abscessus Complex Pulmonary Disease. | Togo T, Atsumi J, Hiramatsu M, Shimoda K, Morimoto K, Shiraishi Y. | Ann Thorac Surg | 10.1016/j.athoracsur.2021.03.088 | 2022 | | |
| Omadacycline for the treatment of Mycobacterium abscessus infections: Case series and review of the literature. | Siddiqa A, Khan S, Rodriguez GD, Urban C, Segal-Maurer S, Turett G. | IDCases | 10.1016/j.idcr.2023.e01703 | 2023 | | |
| Disseminated Mycobacterium abscessus subspecies massiliense infection and subsequent prosthetic joint infection in a hemodialysis patient: A case report. | Tsuruyama Y, Mori N, Fujisawa T, Katayama M. | J Infect Chemother | 10.1016/j.jiac.2021.05.003 | 2021 | | |
| Case series of Rapidly growing Mycobacterial Post-operative surgical site infection in kidney transplant recipients. | Masalmani MA, Hashim SMA, Ittaman A, Abu Jarir SS, Abukhattab M, Soub HA, Suwaidi ZA, Fadhil R, Ali O. | IDCases | 10.1016/j.idcr.2022.e01640 | 2022 | | |
| Clofazimine for treatment of multidrug-resistant non-tuberculous mycobacteria. | Pfaeffle HOI, Alameer RM, Marshall MH, Houpt ER, Albon DP, Heysell SK. | Pulm Pharmacol Ther | 10.1016/j.pupt.2021.102058 | 2021 | | |
| T9-T10 Osteomyelitis, Epidural Abscess and Cord Compression Secondary to Mycobacterium abscessus: A Case Report. | Davis MA, Antony S. | Infect Disord Drug Targets | 10.2174/1871526520666200428095022 | 2021 | | |
| Cell-free DNA next-generation sequencing for Mycobacterium tuberculosis obtained from plasma of children with active tuberculosis. | Quan S, Tian X, Sun Y, Qi H, Jiao W, Sun B, Xu F, Fang M, Yang X, Zeng X, Duan K, Wang J, Fu X, Duan L, Sun L, Shen A. | BMC Pediatr | 10.1186/s12887-025-05526-7 | 2025 | | |
| Adhesion and Colonization Intensity of Staphylococcus epidermidis, Pseudomonas aeruginosa, and Candida albicans on Smooth, Micro-Textured, and Macro-Textured Silicone Biomaterials. | Jursevics K, Skadins I, Krasilnikova J, Lece A, Skesters A, Jursevics E. | J Funct Biomater | 10.3390/jfb16090322 | 2025 | | |
| Mycobacterium abscessus peritonitis and ventriculitis associated with ventriculoperitoneal shunt. | Clabots D, Serrat A. | IDCases | 10.1016/j.idcr.2022.e01445 | 2022 | | |
| A Case of Cystic Neutrophilic Granulomatous Mastitis in Which Mycobacteroides abscessus Was Detected. | Yamazaki H, Ito Y, Goto K, Kasami M. | Surg Case Rep | 10.70352/scrj.cr.24-0115 | 2025 | | |
| A Silent Threat Unveiled: Mycobacterium gordonae Catheter-Related Peritonitis in a Patient on Peritoneal Dialysis. | Hein MA, Parinyasiri U, Wannigama DL, Udomsantisuk N, Kanjanabuch T. | Cureus | 10.7759/cureus.76280 | 2024 | | |
| The use of dual beta-lactams to restore susceptibility of Mycobacterium avium complex. | Al-Jabri MY, Dousa KM, Wilson BM, Bonomo RA. | JAC Antimicrob Resist | 10.1093/jacamr/dlae142 | 2024 | | |
| Brazilian Butt Lift Gone Wrong: A Case Series of Non-Tuberculous Mycobacterial Gluteal Infection After Brazilian Butt Lifts. | Bies JJ, Allen JC, Barsi ZE, Hassan M, Prakash S, Aguilar MP, Meza A, Peralta DP. | Cureus | 10.7759/cureus.49881 | 2023 | | |
| The burden of mycobacteria species among children from postvaccination abscess in Southern India. | Kavitha K, Ragunathan L, Elantheriyan P, Gopalakrishnan K, Gopala KA, Balamurugan ID, Navya RR, Marcella SS, Venkatachalam GK. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_190_21 | 2021 | | |
| Antimicrobial susceptibility profiles of Mycobacterium abscessus complex isolates from respiratory specimens in Shanghai, China. | Guo Q, Wei J, Zou W, Li Q, Qian X, Zhu Z. | J Glob Antimicrob Resist | 10.1016/j.jgar.2021.02.024 | 2021 | | |
| Atypical Mycobacterium Skin Infection in a Heart Transplant Patient. | Calkins D, Cabrera Cancio MR, Mayer CA, Mackie B. | Cureus | 10.7759/cureus.72887 | 2024 | | |
| Extrapulmonary Coinfection Caused by Pneumocystis jirovecii and Histoplasma capsulatum in an Adult With Human Immunodeficiency Virus Infection: A Case Report. | Rondon-Carvajal J, Gil-Gonzalez M, Ruiz-Giraldo S, Pinzon M, Gomez-Velasquez JC. | Cureus | 10.7759/cureus.76808 | 2025 | | |
| Epidemiological Characteristics of Nontuberculous Mycobacterial Pulmonary Disease in South Korea: A Meta-analysis of Individual Participant Data. | Lee G, Kim S, Chang S, Sohn H, Kang YA, Park Y. | Tuberc Respir Dis (Seoul) | 10.4046/trd.2023.0193 | 2024 | | |
| Genetics | Massive and Lengthy Clonal Nosocomial Expansion of Mycobacterium abscessus subsp. massiliense among Patients Who Are Ventilator Dependent without Cystic Fibrosis. | Komiya K, Yoshida M, Uchida S, Takikawa S, Yamasue M, Matsumoto T, Morishige Y, Aono A, Hiramatsu K, Yamaoka Y, Nishizono A, Ato M, Kadota JI, Mitarai S. | Microbiol Spectr | 10.1128/spectrum.04908-22 | 2023 | |
| Enzymology | Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease. | Singh S, Wang JY, Heysell SK, McShane PJ, Wadle C, Shankar P, Huang HL, Pasipanodya J, Boorgula GD, Philley JV, Gumbo T, Srivastava S. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2023.106847 | 2023 | |
| Genetics | Beyond phenotype: The genomic heterogeneity of co-infecting Mycobacterium abscessus smooth and rough colony variants in cystic fibrosis patients. | Gutierrez AV, Baron SA, Sardi FS, Saad J, Coltey B, Reynaud-Gaubert M, Drancourt M. | J Cyst Fibros | 10.1016/j.jcf.2021.02.002 | 2021 | |
| Pulmonary Mycobacterium abscessus and response to treatment in an outpatient setting: Case series. | Gopalaswamy R, Padmapriyadarsini C, Sekar K, Vijayaragavan V, Bhavani PK, Lokanathan LM, Anandakrishnan S, Sivaramakrishnan G. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_22_21 | 2021 | | |
| Disseminated Mycobacterium Chelonae infection in an immunocompromised adult: An uncommon etiology of skin infection. | Amare B, Mangano A, Sarker M, Adhikari S. | IDCases | 10.1016/j.idcr.2024.e02132 | 2025 | | |
| Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010-2019). | Marshall JE, Mercaldo RA, Lipner EM, Prevots DR. | BMC Infect Dis | 10.1186/s12879-023-08468-6 | 2023 | | |
| Addison's disease triggered by infection with mycobacterium abscessus, but not by adrenal tuberculosis or MAC pulmonary disease, in a subject with type 2 diabetes mellitus: case report. | Kaneto H, Tatsumi F, Ohnishi M, Iwamoto Y, Katakura Y, Shimoda M, Nakanishi S, Kaku K, Mune T. | BMC Endocr Disord | 10.1186/s12902-022-01178-1 | 2022 | | |
| Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. | Friedland AE, Maziarz EK, Wolfe CR, Patel CB, Patel P, Milano CA, Schroder JN, Daneshmand MA, Wallace RJ, Alexander BD, Baker AW. | Am J Transplant | 10.1016/j.ajt.2023.04.009 | 2023 | | |
| Challenges in Perioperative Cerebral Oximetry Monitoring: A Case of Clofazimine-Induced Skin Pigmentation Interference. | Silva R, Veiga J, Barbosa J, Oliveira C, Carvalho F. | Cureus | 10.7759/cureus.42988 | 2023 | | |
| Genetics | Reinfection or relapse? A case study of whole genome sequencing guided genomic characterization of Mycobacterium abscessus chronic infection in a cystic fibrosis patient. | Chawla R, von Bredow B, Deville J, Yang S. | IDCases | 10.1016/j.idcr.2022.e01491 | 2022 | |
| Mycobacterium abscessus urinary tract infection in an immunocompetent host: A case report and literature review. | Al-Mashdali AF, Ali GA, Taha NM, Goravey W, Omrani AS. | IDCases | 10.1016/j.idcr.2022.e01538 | 2022 | | |
| Description of wylie-stanley agar for the recovery of mycobacterium abscessus. | Moore JE, Murphy A, Millar BC. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_83_21 | 2021 | | |
| Escherichia coli Necrotizing Fasciitis After Abdominoplasty Combined With Liposuction: A Report of a Case and Review of the Literature. | Aoun CB, Zeaiter N, Moukawam E, Hassan M, Hreibeh W. | Cureus | 10.7759/cureus.86261 | 2025 | | |
| Genetics | Genome-Scale Characterization of Mycobacterium abscessus Complex Isolates from Portugal. | Carneiro S, Pinto M, Silva S, Santos A, Rodrigues I, Santos D, Duarte S, Vieira L, Gomes JP, Macedo R. | Int J Mol Sci | 10.3390/ijms242015402 | 2023 | |
| Extrapulmonary Nontuberculous Mycobacteria Infection: The New-Age Neglected Infectious Disease. | Rath S, Firdaus S, Nayak G, Mohanty M. | Cureus | 10.7759/cureus.81017 | 2025 | | |
| Exploring Benzo[h]chromene Derivatives as Agents against Protozoal and Mycobacterial Infections. | Pertino MW, F de la Torre A, Schmeda-Hirschmann G, Vega Gomez C, Rolon M, Coronel C, Rojas de Arias A, Molina-Torres CA, Vera-Cabrera L, Viveros-Valdez E. | Pharmaceuticals (Basel) | 10.3390/ph17101375 | 2024 | | |
| Recurrent Osteomyelitis Caused by Mycobacterium abscessus Necessitating Surgical Decompression and Revision Surgery With Interbody Fusion. | Bashti M, Kumar V, Cote I, Peterson EC, Basil GW. | Cureus | 10.7759/cureus.33668 | 2023 | | |
| Clinical presentations of nontuberculous mycobacteria as suspected and drug-resistant tuberculosis: Experience from a tertiary care center in Eastern India. | Das S, Mishra B, Mohapatra PR, Preetam C, Rath S. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_68_22 | 2022 | | |
| A Case Report on Mycobacterium abscessus: An Emerging Pathogen. | Chohan A, Choudhury S, Taweesedt PT, Dadhwal R, Vakil AP, Ali Z, Franco R. | Cureus | 10.7759/cureus.23072 | 2022 | | |
| Plasmid-mediated drug resistance in mycobacteria: the tip of the iceberg? | Derbyshire KM, Salfinger M. | J Clin Microbiol | 10.1128/jcm.00628-23 | 2023 | | |
| Pathogenicity | Comparison of drug-susceptibility patterns and gene sequences associated with clarithromycin and azithromycin resistance in Mycobacterium abscessus complex isolates and evaluation of the accumulation of intrinsic macrolide resistance. | Yoshida S, Tsuyuguchi K, Kobayashi T, Inoue Y, Suzuki K. | J Med Microbiol | 10.1099/jmm.0.001326 | 2021 | |
| Strain Identification and Drug Resistance Analysis of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry in Nontuberculous Mycobacterial Lung Disease. | Shi J, Gao G, Pan J, Wu LP, Ning H, Wu Z, Ye X, Jiang X. | Infect Drug Resist | 10.2147/idr.s405563 | 2023 | | |
| Mixed infection of three nontuberculous mycobacteria species identified by metagenomic next-generation sequencing in a patient with peritoneal dialysis-associated peritonitis: a rare case report and literature review. | Chen X, Zhu J, Liu Z, Ye J, Yang L, Zhang Z. | BMC Nephrol | 10.1186/s12882-023-03156-8 | 2023 | | |
| Pathogenicity | Rapid macrolide and amikacin resistance testing for Mycobacterium abscessus in people with cystic fibrosis. | Bordin A, Pandey S, Coulter C, Syrmis M, Pardo C, Hackett H, Bell SC, Wainwright CE, Nimmo GR, Jennison AV, Clark JE, Whiley DM. | J Med Microbiol | 10.1099/jmm.0.001349 | 2021 | |
| Effectiveness and safety of regimens containing linezolid for treatment of Mycobacterium abscessus pulmonary Disease. | Cheng LP, Zhang Q, Lou H, Shen XN, Qu QR, Cao J, Wei W, Sha W, Sun Q. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-023-00655-2 | 2023 | | |
| Rare extension of pancreatic pseudocyst with Mycobacterium abscessus into the iliopsoas muscle. | Mark JD, Park T, Velez Quinones V, Isaac S. | BMJ Case Rep | 10.1136/bcr-2022-252777 | 2022 | | |
| In vitro susceptibility of Mycobacterium abscessus complex and feasibility of standardizing treatment regimens. | Chew KL, Octavia S, Go J, Ng S, Tang YE, Soh P, Yong J, Jureen R, Lin RTP, Yeoh SF, Teo J. | J Antimicrob Chemother | 10.1093/jac/dkaa520 | 2021 | | |
| [Mycobacterium abscessus and Mycobacterium tuberculosis coinfection in a patient with exogenous Cushing syndrome and other comorbilities]. | Patron-Ordonez G, Llanos-Tejada F, Benites-Gamboa D, Espinoza-Chiong C. | Rev Peru Med Exp Salud Publica | 10.17843/rpmesp.2020.374.5296 | 2020 | | |
| Catheter-related infections caused by Mycobacterium abscessus in a patient with motor neurone disease: A case report. | Pan SF, Zhang YY, Wang XZ, Sun JJ, Song SL, Tang YR, Wang JL. | World J Clin Cases | 10.12998/wjcc.v10.i15.5082 | 2022 | | |
| Multicentre retrospective observational study for development and validation of MAC prognostic score model. | Takeda K, Takazono T, Ide S, Yoshida M, Iwanaga N, Hosogaya N, Tsukamoto Y, Irifune S, Suyama T, Mihara T, Kondo A, Kobayashi T, Fukuda Y, Sasaki E, Sawai T, Higashiyama Y, Hashiguchi K, Hanaka M, Ii T, Fukushima K, Komiya K, Miyazaki T, Yatera K, Izumikawa K, Furumoto A, Yanagihara K, Mukae H. | Sci Rep | 10.1038/s41598-025-14348-7 | 2025 | | |
| Molecular assessment of mycobacterial burden in the treatment of nontuberculous mycobacterial disease. | Ellis HC, Moffatt MF, Churchward C, Cuthbertson L, Cookson WOC, Loebinger MR. | ERJ Open Res | 10.1183/23120541.00435-2022 | 2023 | | |
| Outcomes of Nontuberculous Mycobacterial Keratitis After Clear Corneal Incision Phacoemulsification Surgery: A Case Series of 6 Eyes in South Florida. | Chhaya N, Zhu A, Shaik N, Weiss M, Miller D, Tonk RS, Koo EH. | Cornea | 10.1097/ico.0000000000002976 | 2022 | | |
| First report of disseminated Mycobacterium abscessus in an immunocompetent adult patient in Oman. | Al Mamari A, Al Tamtami W, Al A'amri K, Al Lawati H, Al Kalbani S, Al Muqbali I. | IJID Reg | 10.1016/j.ijregi.2022.01.010 | 2022 | | |
| Outcomes of Short-Term Tigecycline-Containing Regimens for Mycobacterium abscessus Pulmonary Disease. | Kim SR, Jang M, Kim SY, Kim DH, Jhun BW. | Antimicrob Agents Chemother | 10.1128/aac.00774-22 | 2022 | | |
| Story of an Abscess: A Case of Mycobacterium abscessus Infection in an Immunocompetent Patient. | Maheshwarappa HM, Machanalli G, Thilakchand KR, Tejaswini DD. | Indian J Crit Care Med | 10.5005/jp-journals-10071-24182 | 2022 | | |
| High Prevalence of Nontuberculous Mycobacteria in Cystic Fibrosis Patients in Tropical French Reunion Island. | Ho D, Belmonte O, Andre M, Gazaille V, Perisson C, Gachelin E, Allyn J, Payet A, Coolen-Allou N. | Pediatr Infect Dis J | 10.1097/inf.0000000000002999 | 2021 | | |
| Phylogeny | Optimized analysis parameters of variant calling for whole genome-based phylogeny of Mycobacteroides abscessus. | Kaewprasert O, Tongsima S, Ong RT, Faksri K. | Arch Microbiol | 10.1007/s00203-022-02792-2 | 2022 | |
| Cultivation | Improved detection of mycobacteria in CF and tissue samples grown in mycobacteria growth indicator tube incubated at 30°C compared to conventional growth conditions of liquid and solid media. | Kehrmann J, Stumpf AL, Dragaqina A, Buer J. | J Clin Microbiol | 10.1128/jcm.00683-24 | 2024 | |
| Application of metagenomic next-generation sequencing in the diagnosis of pathogens in patients with diabetes complicated by community-acquired pneumonia. | Chen HB, Liu J, Zhang Y, Huang H, Wang LN. | Open Life Sci | 10.1515/biol-2022-1048 | 2025 | | |
| Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China. | Wen S, Gao X, Zhao W, Huo F, Jiang G, Dong L, Zhao L, Wang F, Yu X, Huang H. | Int J Infect Dis | 10.1016/j.ijid.2021.06.055 | 2021 | | |
| Genetics | Population structure of Mycobacterium avium subsp. hominissuis provides new insights into genomic evolution. | Olawoye IB, Alexander D, Guthrie JL. | Microb Genom | 10.1099/mgen.0.001543 | 2025 | |
| Enzymology | Role of Therapeutic Drug Monitoring in the Treatment of Persistent Mycobacterium abscessus Central Nervous System Infection: A Case Report and Review of the Literature. | Wu EL, Al-Heeti O, Hoff BM, Williams JL, Krueger KM, Santoiemma PP, Rhodes NJ. | Open Forum Infect Dis | 10.1093/ofid/ofac392 | 2022 | |
| Bilateral Nontuberculous Mycobacterial Otitis Media: A Case Report. | Kajiwara R, Yamamoto K, Ohira S, Wada K. | J Int Adv Otol | 10.5152/iao.2024.231187 | 2024 | | |
| Virulent Mycobacterium avium subspecies hominissuis subverts macrophages during early stages of infection. | Ndzeidze R, Leestemaker-Palmer A, Danelishvili L, Bermudez LE. | Microbiology (Reading) | 10.1099/mic.0.001133 | 2022 | | |
| Liver Mass Caused by Mycobacterium fortuitum: A Rare Case Diagnosed by EUS-FNA. | Jao YS, Martinez L, Carlo VJ, Micames CG. | ACG Case Rep J | 10.14309/crj.0000000000001083 | 2023 | | |
| Antibacterial activity of fungus comb extracts from Senegalese fungus-farming termites | Gaye M, Zinai A, Armstrong N, Herbette G, Monnier V, Bassene H, Diatta G, Sambou M, Sokhna C, Raoult D, Fenollar F, Mediannikov O. | AMB Express | 2025 | | ||
| Mycobacterium chelonae soft-tissue infection in an immunocompetent child. | Bosman AG, Beer J, Grimwood K. | J Paediatr Child Health | 10.1111/jpc.16310 | 2023 | | |
| Modulation of a Mycobacterial ADP-Ribosyltransferase to Augment Rifamycin Antibiotic Resistance. | Zheng M, Lupoli TJ. | ACS Infect Dis | 10.1021/acsinfecdis.1c00297 | 2021 | | |
| Rapid Mycobacterium abscessus antimicrobial susceptibility testing based on antibiotic treatment response mapping via Raman Microspectroscopy. | Ren W, Mao Y, Li S, Gao B, Fu X, Liu X, Zhu P, Shang Y, Li Y, Ma B, Sun L, Xu J, Pang Y. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-023-00644-5 | 2023 | | |
| CFTR Modulator Therapy in an Individual With Cystic Fibrosis Caused by a N1303K CFTR Variant and Infected With Mycobacterium abscessus. | Elson EC, Capel P, Haynes J, Duehlmeyer S, Fischer M, Escobar H. | J Pediatr Pharmacol Ther | 10.5863/1551-6776-27.4.396 | 2022 | | |
| Thoracoscopic right middle lobectomy for Mycobacterium abscessus in a young patient suspected of having congenital immunodeficiency. | Sekihara K, Hirai H, Sumiya R, Momose N, Sugimura A, Nagasaka S. | Asian J Endosc Surg | 10.1111/ases.12828 | 2021 | | |
| Concurrent Zoster Sine Herpete and Hepatosplenic Fungal Infection in a Cancer Patient: A Case Report. | Pearson EM, Handley G, Greene J. | Cureus | 10.7759/cureus.72117 | 2024 | | |
| Pathogenicity | [In vitro evaluation of the antibacterial activity of nemonoxacin against Mycobacterium tuberculosis, Mycobacterium intracellulare and Mycobacterium abscessus]. | Jiang GL, Wang F, Xue Y, Jia JN, Huang HR. | Zhonghua Jie He He Hu Xi Za Zhi | 10.3760/cma.j.cn112147-20200813-00896 | 2020 | |
| Clinical Characteristics and Prognosis of Patients with Severe Pneumonia with Neurological Dysfunction: A Regional Multicenter Retrospective Study in Mainland China | Zhu Y, Jia Y, Zhang C, Li H, Ding P, Huang L, Wang G, Cai H, Yu W. | Infect Drug Resist | 2025 | | ||
| Clinical analysis and risk factors associated with poor prognosis in nontuberculous mycobacterial infection. | Chai J, Zhang S, Ma C, Mei Q, Liu T, Liu J, Liu Y, Zhu H. | Virulence | 10.1080/21505594.2025.2459313 | 2025 | | |
| Refractory Peritonitis and Small Bowel Ileus: A Case of Encapsulating Peritoneal Sclerosis Secondary to Mycobacterium abscessus Peritonitis. | Rouhani S, Adunuri N. | Eur J Case Rep Intern Med | 10.12890/2022_003173 | 2022 | | |
| Pathogenicity | A review of current and promising nontuberculous mycobacteria antibiotics. | Cantelli CR, Dassonville-Klimpt A, Sonnet P. | Future Med Chem | 10.4155/fmc-2021-0048 | 2021 | |
| Nontuberculous Mycobacteria. | Tan S, Kasperbauer S. | Semin Respir Crit Care Med | 10.1055/s-0041-1730997 | 2021 | | |
| A Target Engagement Assay to Assess Uptake, Potency, and Retention of Antibiotics in Living Bacteria. | Fanti RC, Vasconcelos SNS, Catta-Preta CMC, Sullivan JR, Riboldi GP, Dos Reis CV, Ramos PZ, Edwards AM, Behr MA, Counago RM. | ACS Infect Dis | 10.1021/acsinfecdis.2c00073 | 2022 | | |
| Airway Microbiome in Children with Cystic Fibrosis: A Review of Microbial Shifts and Therapeutic Impacts. | Buruiana G, Sima CM, Anton-Paduraru DT, Badescu AC, Lunca C, Duhaniuc A, Dorneanu OS. | Medicina (Kaunas) | 10.3390/medicina61091605 | 2025 | | |
| A dTDP-L-rhamnose 4-epimerase required for glycopeptidolipid biosynthesis in Mycobacterium abscessus. | Aguilera-Correa JJ, Wei F, Leclercq LD, Tasrini Y, Mullapudi E, Daher W, Nakajima K, Canaan S, Herrmann JL, Wilmanns M, Guerardel Y, Wen L, Kremer L. | J Biol Chem | 10.1016/j.jbc.2024.107852 | 2024 | | |
| Anti-Infection of Nasopharyngeal Carcinoma Combined with Non-Tuberculous Mycobacteria: A Case Report and Literature Review. | Li Q, Guan W, Zhang J, Chen M, Zou Y. | Infect Drug Resist | 10.2147/idr.s475377 | 2024 | | |
| Application of metagenomic next-generation sequencing in the diagnosis and treatment of acute pneumonia caused by Tropheryma whipplei. | Huo Y, Wu C, Ma D. | BMC Pulm Med | 10.1186/s12890-025-03657-2 | 2025 | | |
| Disseminated Mycobacterium abscessus Infection in a Burn Patient. | Hsu EH, Young S, Clayton N, Lee J, Hauser N, Penn B, Sen S. | J Burn Care Res | 10.1093/jbcr/irac013 | 2022 | | |
| Successful surgical intervention for acute pyothorax caused by methicillin-resistant Staphylococcus aureus thoracic pyogenic spondylitis: a case report. | Kitamura N, Shimada Y, Futakawa H, Makino H, Takegoshi Y, Kawasuji H, Tanabe K, Ojima T, Shimoyama K, Yamamoto Y, Kawaguchi Y, Tsuchiya T. | Gen Thorac Cardiovasc Surg Cases | 10.1186/s44215-024-00138-6 | 2024 | | |
| Yield of routine mycobacterial culture of osteoarticular specimens in a tertiary orthopaedic hospital in England, 2017-2022. | Yates TA, Vahesan O, Warren S, Scobie A. | J Bone Jt Infect | 10.5194/jbji-9-217-2024 | 2024 | | |
| Lefamulin harbors promising anti-tuberculosis activity against multidrug-resistant Mycobacterium tuberculosis isolates. | Wu J, Ji Y, Zhang W, Chen S, Dong Y, Yu X. | Microbiol Spectr | 10.1128/spectrum.02250-25 | 2025 | | |
| Identification and Antimicrobial Susceptibilities for Patients with Non-tuberculous Mycobacteria Infection in Jeju Island: Single-Center Retrospective Study. | Kim M, Heo ST, Lee J, Lee JH, Kim M, Kim C, Seong GM, Kang MJ, Yoo JR. | Infect Chemother | 10.3947/ic.2023.0052 | 2024 | | |
| Metabolism | Altered serine metabolism promotes drug tolerance in Mycobacterium abscessus via a WhiB7-mediated adaptive stress response. | Bernard C, Liu Y, Larrouy-Maumus G, Guilhot C, Cam K, Chalut C. | Antimicrob Agents Chemother | 10.1128/aac.01456-23 | 2024 | |
| A child with acute myeloid leukemia complicated by calcaneal osteomyelitis due to Mycobacterium abscessus infection after induction chemotherapy successfully salvaged with bedaquiline and clofazimine. | Chan WY, Ho PL, To KK, Lam AY, Ho KW, Lau TW, So NL, Ha SY. | Int J Infect Dis | 10.1016/j.ijid.2020.10.102 | 2021 | | |
| Structural analysis of the N-acetyltransferase Eis1 from Mycobacterium abscessus reveals the molecular determinants of its incapacity to modify aminoglycosides. | Ung KL, Kremer L, Blaise M. | Proteins | 10.1002/prot.25997 | 2021 | | |
| Evaluation of targeted next-generation sequencing for microbiological diagnosis of acute lower respiratory infection. | Yang F, Jiang L, Cao Q, Yi M, Zhao Q. | Front Microbiol | 10.3389/fmicb.2025.1615965 | 2025 | | |
| Metabolism | Intracellular glutamine fluctuates with nitrogen availability and regulates Mycobacterium smegmatis biofilm formation. | Varner E, Meyer M, Whalen J, Wang Y-H, Rodriguez C, Malik I, Mullet SJ, Gelhaus SL, DePas WH. | J Bacteriol | 10.1128/jb.00252-25 | 2025 | |
| Mycobacterium Abscessus: A Rare Cause of Peri-Ductal Mastitis in Endemic Regions. | Shaikh A, Vohra LM. | J Coll Physicians Surg Pak | 10.29271/jcpsp.2020.05.537 | 2020 | | |
| A laboratory-based analysis of rapidly growing mycobacteria in Northwest Paulista, Sao Paulo, Brazil. | Silveira Paro Pedro HD, Tonelli Nardi SM, Ule Belotti NC, Tegon de Freitas AC, de Souza NG, Chimara E. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_65_21 | 2021 | | |
| A universal, high-quality, and high-yield DNA purification method for mycobacteria, including Mycobacterium tuberculosis: large-scale assessment of the chloroform-bead method. | Murase Y, Hosoya M, Morishige Y, Shimomura Y, Nagai M, Tamaru A, Takaki A, Mitarai S, Japan Tuberculosis Genotyping Group (2023), Japan Tuberculosis Genotyping Group. | Microbiol Spectr | 10.1128/spectrum.00765-25 | 2025 | | |
| ADP-ribosylation-resistant rifabutin analogs show improved bactericidal activity against drug-tolerant M. abscessus in caseum surrogate. | Xie M, Ganapathy US, Lan T, Osiecki P, Sarathy JP, Dartois V, Aldrich CC, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.00381-23 | 2023 | | |
| Notes from the Field: Nontuberculous Mycobacteria Infections After Cosmetic Surgery Procedures in Florida - Nine States, 2022-2023. | Saunders KE, Reyes JM, Cyril L, Mitchell M, Colter S, Erskine J, McNamara KX, Hunter JC, Perkins KM, Charles A. | MMWR Morb Mortal Wkly Rep | 10.15585/mmwr.mm7303a4 | 2024 | | |
| Infections Management in the Lung Transplant Setting in Italy: A Web-Survey. | Lombardi A, Grossi P, Mikulska M, Giannella M, Pascale R, Marinello S, Montagnani F, Seminari E, Corcione S, Bandera A, Bertani A, Mularoni A, Infection Prevention and Treatment Working Group of the LUNG-SITO study group. | Transpl Infect Dis | 10.1111/tid.14413 | 2025 | | |
| Atypical Mycobacteriosis Due to Mycobacterium abscessus subsp. massiliense: Our Experince. | Rodriguez-Cerdeira C, Hernandez-Castro R, Sanchez-Cardenas CD, Arenas R, Meza-Robles A, Toussaint-Caire S, Atoche-Dieguez C, Martinez-Herrera E. | Pathogens | 10.3390/pathogens11121399 | 2022 | | |
| Atypical mycobacterium infection following anterior cruciate ligament reconstruction. | Aier S, Kalra S, Varma M, Pandey V. | BMJ Case Rep | 10.1136/bcr-2022-253440 | 2023 | | |
| Genetics | Genomic analysis of prophages in 44 clinical strains of Pseudomonas aeruginosa isolated in Saudi Arabia. | Alsaadi A, Imam M, Alghamdi AA, Aljedani SS, Alsari A, Aljami H, Bosaeed M. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1563781 | 2025 | |
| O-Methylation of the Glycopeptidolipid Acyl Chain Defines Surface Hydrophobicity of Mycobacterium abscessus and Macrophage Invasion. | Daher W, Leclercq LD, Viljoen A, Karam J, Dufrene YF, Guerardel Y, Kremer L. | ACS Infect Dis | 10.1021/acsinfecdis.0c00490 | 2020 | | |
| Nontuberculous Mycobacterial Pulmonary Infection Among Lung Transplant Recipients. | Izhakian S, Frajman A, Mekiten O, Heching M, Pertzov B, Shtraichman O, Gershman E, Rozengarten D, Gorelik O, Kramer MR. | Exp Clin Transplant | 10.6002/ect.2021.0177 | 2021 | | |
| Exacerbation of nontuberculous mycobacterial pulmonary disease in a patient with advanced non-small-cell lung cancer during treatment with PD-1 inhibitor and chemotherapy. | Okamoto M, Kim YH, Ouchi A, Yamaoka T, Iwamoto N, Iwatsubo S, Matsumura K, Nakamura M, Kin Y, Shiina Y, Funada Y. | Respir Med Case Rep | 10.1016/j.rmcr.2021.101529 | 2021 | | |
| The frequency and related factors of non-tuberculosis mycobacteria infections among patients with cystic fibrosis. | Ademhan Tural D, Emiralioglu N, Ozsezen B, Saribas Z, Ozcan N, Alp A, Sunman B, Hizal M, Eryilmaz Polat S, Yalcin E, Dogru D, Ozcelik U, Kiper N. | Pediatr Int | 10.1111/ped.14688 | 2021 | | |
| Rapid and accurate identification and differentiation of Mycobacterium tuberculosis and non-tuberculous mycobacteria using PCR kits available in a high-burden setting. | Castro-Rodriguez B, Franco-Sotomayor G, Rodriguez-Pazmino AS, Cardenas-Franco GE, Orlando SA, Hermoso de Mendoza J, Parra-Vera H, Garcia-Bereguiain MA. | Front Public Health | 10.3389/fpubh.2024.1358261 | 2024 | | |
| Enzymology | Comparison of four agar media for the enumeration of the Mycobacterium abscessus complex. | Moore JE, Millar BC. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_110_20 | 2020 | |
| Pathogenicity | Dominant Negative TRAF3 Variant With Recurrent Mycobacterium abscessus Infection and Bronchiectasis. | Liew MF, Lim HF, Liang MC, Lim I, Tan Z, Tan RYM, Sam QH, Soe WM, Tay SH, Xu S, Chang MW, Foo R, Soong TW, Ravikumar S, Chai LYA. | Open Forum Infect Dis | 10.1093/ofid/ofac379 | 2022 | |
| Metagenomic next-generation sequencing of osteoarticular tissue for the diagnosis of suspected osteoarticular tuberculosis. | Yan G, Liu Z, Teng T, Dong W, Lan T, Fan J, Tang K, Qin S, Nie W. | Microbiol Spectr | 10.1128/spectrum.03598-23 | 2024 | | |
| Subcutaneous infection caused by Mycobacterium abscessus following cosmetic injections of botulinum toxin: A case report. | Deng L, Luo YZ, Liu F, Yu XH. | World J Clin Cases | 10.12998/wjcc.v10.i18.6141 | 2022 | | |
| Complete Genome Sequences of Four Mycobacteriophages Involved in Directed Evolution against Undisputed Mycobacterium abscessus Clinical Strains. | Cao Yao JC, Garcia Cehic D, Quer J, Mendez JN, Gorrin AD, Hevia LG, Fernandez MTT. | Microorganisms | 10.3390/microorganisms12020374 | 2024 | | |
| Exploring beta-lactam interactions with DacB1: unraveling optimal therapies for combating drug-resistant Mycobacterium tuberculosis. | Nantongo M, Nguyen DC, Shin E, Bethel CR, Taracila MA, Dousa KM, Li Q, Fletcher S, Kurz SG, Kreiswirth BN, Boom WH, Holland S, Rubin EJ, Bonomo RA. | mBio | 10.1128/mbio.01372-25 | 2025 | | |
| CRISPR Interference-Based Inhibition of MAB_0055c Expression Alters Drug Sensitivity in Mycobacterium abscessus. | Nguyen TQ, Heo BE, Park Y, Jeon S, Choudhary A, Moon C, Jang J. | Microbiol Spectr | 10.1128/spectrum.00631-23 | 2023 | | |
| Plasma cytokine levels as markers of pathogenesis and treatment response in patients with non-tuberculous mycobacterial pulmonary disease. | Zhao S, Zhang Z, Xu J, Zhou Z, Wu Y, Wu Y, Jiang G. | Braz J Med Biol Res | 10.1590/1414-431x2024e13755 | 2024 | | |
| Disseminated Mycobacterium abscessus infection as a cause of autosensitization. | Juhasz MLW, Rojek NW, Diamond C, Mandel D, Smith J. | JAAD Case Rep | 10.1016/j.jdcr.2021.08.002 | 2021 | | |
| Transition metal homoeostasis is key to metabolism and drug tolerance of Mycobacterium abscessus. | Liu Y, Murphy K, Fernandes N, Moore RET, Pennisi I, Williams R, Rehkamper M, Larrouy-Maumus G. | NPJ Antimicrob Resist | 10.1038/s44259-024-00042-7 | 2024 | | |
| Clinical risk factors related to treatment failure in Mycobacterium abscessus lung disease. | Fujiwara K, Furuuchi K, Aono A, Uesugi F, Shirai T, Nakamoto K, Shimada T, Mochizuki F, Tanaka Y, Iijima H, Yoshiyama T, Shiraishi Y, Kurashima A, Ohta K, Mitarai S, Morimoto K. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-020-04026-z | 2021 | | |
| Comparison of the efficacy of one-stage revision surgery guided by precise pathogen diagnosis and conventional two-stage revision for chronic knee periprosthetic joint infection | Xiao Z, Zeng J, Zhang Z, Wu B, Hong Z, Guo Y, Huang C, Huang Z, Wu Z, Zhang W, Fang X, Li W. | Arthroplasty | 2025 | | ||
| Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: A case report and literature review. | Bartolomeo K, Hassanein M, Vachharajani TJ. | J Vasc Access | 10.1177/11297298211015083 | 2022 | | |
| Post Cesarean Surgical Site Infection With Mycobacterium Abscessus Sp. Massiliense. | Nagpal R, Vanam HP, Dhingra H, Banswada RR. | J Family Reprod Health | 10.18502/jfrh.v16i2.9486 | 2022 | | |
| Clinical application of the urinary lipoarabinomannan (AIMLAM) test in PLHIV with TB | Lu J, Li X, Liu H, Dong X, Zhang S, Wu X, Yan F, Zhang Y, Wang X, Gao A, Dou J. | AIDS Res Ther | 2025 | | ||
| A one-year hospital system review of plasma next-generation sequencing in a mixed population. | Drake TC, Babic J, Wanger A, Chavez V. | Antimicrob Steward Healthc Epidemiol | 10.1017/ash.2024.460 | 2024 | | |
| Molecular characterization of Mycobacterium abscessus subspecies isolated from patients attending an Italian Cystic Fibrosis Centre. | Teri A, Sottotetti S, Arghittu M, Girelli D, Biffi A, D'Accico M, Dacco V, Gambazza S, Pizzamiglio G, Trovato A, Tortoli E, Colombo C, Cariani L. | New Microbiol | 2020 | | ||
| Biofilm formation is a risk factor for late and delayed complications of filler injection. | Zhang YL, Sun ZS, Hong WJ, Chen Y, Zhou YF, Luo SK. | Front Microbiol | 10.3389/fmicb.2023.1297948 | 2023 | | |
| Atypical mycobacterial keratitis: Clinical outcome in nonrefractive surgery cases. | Priyadarshini K, Priyadarshini SR, Sahu SK, Behera HS, Das S. | Indian J Ophthalmol | 10.4103/ijo.ijo_3338_23 | 2025 | | |
| Treatment for Mycobacterium abscessus complex-lung disease. | Weng YW, Huang CK, Sy CL, Wu KS, Tsai HC, Lee SS. | J Formos Med Assoc | 10.1016/j.jfma.2020.05.028 | 2020 | | |
| Diagnostic utility of auramine O smear microscopy for detecting non-tuberculous mycobacteria versus Mycobacterium tuberculosis complex in adult clinical samples: a 5-year retrospective study (2018-2022). | Atiya N, Ong LT, Loh TC, Wong CK, Abdullah A. | BMC Infect Dis | 10.1186/s12879-025-11298-3 | 2025 | | |
| Nanoparticulate beta-Cyclodextrin with Gallium Tetraphenylporphyrin Demonstrates in Vitro and in Vivo Antimicrobial Efficacy against Mycobacteroides abscessus and Mycobacterium avium. | Choi SR, Talmon GA, Britigan BE, Narayanasamy P. | ACS Infect Dis | 10.1021/acsinfecdis.0c00896 | 2021 | | |
| Diagnostic Utility of a Mycobacterium Multiplex PCR Detection Panel for Tuberculosis and Nontuberculous Mycobacterial Infections. | Uwamino Y, Aono A, Tomita Y, Morimoto K, Kawashima M, Kamata H, Sasaki Y, Nagai H, Hasegawa N, Mitarai S. | Microbiol Spectr | 10.1128/spectrum.05162-22 | 2023 | | |
| MALDI-TOF mass spectrometry from nucleic acid: development and evaluation of a novel platform for identification of mycobacteria and detection of genetic markers of resistance. | DeCurtis EK, Machado I, Kuss-Duerkop SK, Wang Y, Khare R. | Microbiol Spectr | 10.1128/spectrum.01638-24 | 2024 | | |
| Multiple Simultaneous Infections With Nontuberculous Mycobacteria in the Setting of GATA2 Mutation and Myelodysplastic Syndrome. | Tabaja H, Jensen KL, Rivera CG, Misra A, Pruthi RK, Vergidis P. | Open Forum Infect Dis | 10.1093/ofid/ofac309 | 2022 | | |
| Whole-Genome Sequences of Mycobacterium abscessus subsp. massiliense Isolates from Brazil. | Machado E, Oliveira FC, Silva Duarte R, Carvalho AC, Candido PHC, Conceicao EC, Gomes L, Vasconcellos SEG, Coelho FS, Vinhas S, Lourenco MC, Guimaraes ACR, Catanho M, Suffys PN. | Microbiol Resour Announc | 10.1128/mra.00361-21 | 2021 | | |
| An HPLC-based Assay to Study the Activity of Cyclic Diadenosine Monophosphate (C-di-AMP) Synthase DisA from Mycobacterium smegmatis. | Mahapa A, Gautam S, Rathore A, Chatterji D. | Bio Protoc | 10.21769/bioprotoc.5138 | 2024 | | |
| Skin and soft-tissue infections due to rapidly growing mycobacteria: An overview. | Kumar C, Shrivastava K, Singh A, Chauhan V, Varma-Basil M. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_110_21 | 2021 | | |
| The QcrB Inhibitors TB47 and Telacebec Do Not Potentiate the Activity of Clofazimine in Mycobacterium abscessus. | Sorayah R, Moraski GC, Barkan D, Pethe K. | Antimicrob Agents Chemother | 10.1128/aac.00964-21 | 2021 | | |
| Prevalence of Mycobacterium abscessus among the Patients with Nontuberculous Mycobacteria. | Ayoubi S, Aghajani J, Farnia P, Farnia P, Ghanavi J, Velayati AA. | Arch Iran Med | 2020 | | ||
| Vertebral osteomyelitis caused by Mycobacteroides abscessus subsp. abscessus resulting in spinal cord injury due to vertebral body fractures. | Omori K, Kitagawa H, Tadera K, Naka Y, Sakamoto S, Kamei N, Nomura T, Shigemoto N, Hattori N, Ohge H. | J Infect Chemother | 10.1016/j.jiac.2021.09.013 | 2022 | | |
| Mycobacterium abscessus Ventriculoperitoneal Shunt Infection. | Herrera D, Danyalian A, Kaswan D, Cohen N, Edelstein M, Rivero A, Solari PR. | Cureus | 10.7759/cureus.16356 | 2021 | | |
| Transcriptomic profiling of ceftriaxone-tolerant phenotypes of Neisseria gonorrhoeae reveals downregulation of ribosomal genes - a pilot study. | Manoharan-Basil SS, Balduck M, Gestels Z, Abdellati S, De Block T, Kenyon C. | Microbiol Spectr | 10.1128/spectrum.01207-25 | 2025 | | |
| Antibacterial efficacy of mycobacteriophages against virulent Mycobacterium tuberculosis. | Jeyasankar S, Kalapala YC, Sharma PR, Agarwal R. | BMC Microbiol | 10.1186/s12866-024-03474-3 | 2024 | | |
| Tigecycline Tango: A Case of Antibiotic-Induced Pancreatitis. | Maringanti BS, Ganipisetti VM, Jun SS, Flores MI. | Cureus | 10.7759/cureus.44538 | 2023 | | |
| Eradicating latent tuberculosis: use of interferon gamma release assay and isoniazid/rifapentine in people living with HIV/AIDS. | Monteiro MA, Apoliano CF, Martins JER, Sunada NO, Folgosi VA, Nascimento NAL, Chimara E, Veiga APR, Pereira LO, Andrade LCC, Tiberto L, Ferreira MD, Fonseca LAM, Duarte AJDS, Arakaki-Sanchez D, Hong MA, Casseb J. | Rev Inst Med Trop Sao Paulo | 10.1590/s1678-9946202567014 | 2025 | | |
| Rapid growth atypical mycobacteria infection associated with growth hormone injections: a case report. | Cardozo Lomaquiz CD, Frontanilla T, Scavone N, Fretes A, Torales N, Pereira ME, Mino de Kaspar H, Ortiz X, Henning R. | Access Microbiol | 10.1099/acmi.0.000280 | 2021 | | |
| Phylogeny | Outcome according to subspecies following lung transplantation in cystic fibrosis pediatric patients infected with Mycobacterium abscessus. | Kavaliunaite E, Harris KA, Aurora P, Dixon G, Shingadia D, Muthialu N, Spencer H. | Transpl Infect Dis | 10.1111/tid.13274 | 2020 | |
| Treatment for Mycobacterium abscessus Infection Associated with Fat Grafting. | Chen B, Song H, Xu M, Gao Q, Wang F, Wang J, Wu J. | Surg Infect (Larchmt) | 10.1089/sur.2019.270 | 2020 | | |
| Repurposing drugs for treatment of Mycobacterium abscessus: a view to a kill. | Gumbo T, Cirrincione K, Srivastava S. | J Antimicrob Chemother | 10.1093/jac/dkz523 | 2020 | | |
| Atypical Mycobacterium Abscessus Infection in Stable Chronic Lymphocytic Leukemia: A Case Report and Review of the Literature. | Rodriguez RR, Alhamad K, Ghosh S, Bihler E, Raj MS. | Cureus | 10.7759/cureus.20574 | 2021 | | |
| Coordinated conformational changes in P450 decarboxylases enable hydrocarbons production from renewable feedstocks. | Generoso WC, Alvarenga AHS, Simoes IT, Miyamoto RY, Melo RR, Guilherme EPX, Mandelli F, Santos CA, Prata R, Santos CRD, Colombari FM, Morais MAB, Pimentel Fernandes R, Persinoti GF, Murakami MT, Zanphorlin LM. | Nat Commun | 10.1038/s41467-025-56256-4 | 2025 | | |
| A first case report of nasopharyngeal Mycobacterium abscessus subspecies massiliense infection. | Oki Y, Hatakeyama H, Komatsu M, Isono Y, Ikemiyagi H, Tsukiji J, Higa R, Oridate N. | Eur J Med Res | 10.1186/s40001-021-00578-8 | 2021 | | |
| Pathogenicity | A stop-gain mutation in sigma factor SigH (MAB_3543c) may be associated with tigecycline resistance in Mycobacteroides abscessus. | Lee CL, Ng HF, Ngeow YF, Thaw Z. | J Med Microbiol | 10.1099/jmm.0.001378 | 2021 | |
| Therapeutic Perspectives and Mechanistic Insights of Phage Therapy in Allotransplantation. | Dery KJ, Gorski A, Miedzybrodzki R, Farmer DG, Kupiec-Weglinski JW. | Transplantation | 10.1097/tp.0000000000003565 | 2021 | | |
| Rapid Detection of Clarithromycin and Amikacin Resistance in Mycobacterium abscessus Complex by High-Resolution Melting Curve Analysis. | Li H, Mulati G, Shang Y, Yao C, Wang Y, Ren W, Xue Z, Li S, Pang Y. | Microbiol Spectr | 10.1128/spectrum.00574-22 | 2022 | | |
| Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis. | Burke A, Smith D, Coulter C, Bell SC, Thomson R, Roberts JA. | Clin Pharmacokinet | 10.1007/s40262-021-01010-4 | 2021 | | |
| The microbial etiology and resistance patterns of cosmetic tourism-related infections in Ireland. | Keane A, Feeley AA, Chee SY, Sheil F, O'Gorman J, O'Neill E, Cahill KC. | Ir J Med Sci | 10.1007/s11845-024-03800-8 | 2024 | | |
| Construction of a Mycobacterium smegmatis Promoter Library for Therapeutic and Environmental Applications. | Fang L, Nafziger EH, Guo M, Saha MS. | ACS Omega | 10.1021/acsomega.5c02222 | 2025 | | |
| Infection of a venous port - beware of the Mycobacterium. | Heng TH, Loh MHY, Chua YY, Tan BK, Tan BS. | J Radiol Case Rep | 10.3941/jrcr.v16i9.4587 | 2022 | | |
| Evaluation of nucleotide MALDI-TOF-MS for the identification of Mycobacterium species. | Zhu Y, Liu Z, Peng L, Liu B, Wu K, Zhang M, Wang X, Pan J. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1335104 | 2024 | | |
| Decoding host-microbe interactions with engineered human organoids. | Meirelles LA, Persat A. | EMBO J | 10.1038/s44318-025-00387-3 | 2025 | | |
| Clofazimine in Mycobacterium abscessus peritonitis: A pediatric case report. | Pinapala A, Koh LJ, Ng KH, Tambyah PA, Yap HK. | Perit Dial Int | 10.1177/0896860820909702 | 2021 | | |
| Pathogenicity | Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. | Johansen MD, Herrmann JL, Kremer L. | Nat Rev Microbiol | 10.1038/s41579-020-0331-1 | 2020 | |
| A Rare Case of Nontuberculous Mycobacterial Abscess Mimicking Brain Tumor in an Immunocompetent Patient. | Jung J, Shin I, Choi Y. | Brain Tumor Res Treat | 10.14791/btrt.2023.0019 | 2023 | | |
| Disseminated Mycobacterium abscessus infection and native valve endocarditis. | Rahi MS, Reyes SP, Parekh J, Gunasekaran K, Amoah K, Rudolph D. | Respir Med Case Rep | 10.1016/j.rmcr.2020.101331 | 2021 | | |
| Isolation and Antimicrobial Susceptibility of Nontuberculous Mycobacteria in a Tertiary Hospital in Korea, 2016 to 2020. | Kim KJ, Oh SH, Jeon D, Chang CL. | Tuberc Respir Dis (Seoul) | 10.4046/trd.2022.0115 | 2023 | | |
| Mycobacterium infection secondary to exogenous lipoid pneumonia caused by nasal drops: a case report and literature review. | Wang H, Lu S, Li H, Wang Y. | BMC Pulm Med | 10.1186/s12890-022-02265-8 | 2023 | | |
| Clinical and Experimental Determination of Protection Afforded by BCG Vaccination against Infection with Non-Tuberculous Mycobacteria: A Role in Cystic Fibrosis? | Warner S, Blaxland A, Counoupas C, Verstraete J, Zampoli M, Marais BJ, Fitzgerald DA, Robinson PD, Triccas JA. | Vaccines (Basel) | 10.3390/vaccines11081313 | 2023 | | |
| Pathogenicity | Pulmonary Nontuberculous Mycobacteria Infection in Bronchiectasis: A Narrative Review of Current Status and Future. | Fujita M. | Health Sci Rep | 10.1002/hsr2.70749 | 2025 | |
| Case Report: Endovascular repair of thoracoabdominal aneurysm aorta and generalized mycobacterial infection (clinical case). | Chernyavskiy M, Vanyurkin A, Verkhovskaya E, Panteleeva Y, Ryzhkova D, Basek I, Ryzhkov A, Mitrofanova L, Gulyaev D, Salogub G, Danilov I, Ovchinnikov D, Starshinova A, Kudlay D, Shlyakhto E. | Front Cardiovasc Med | 10.3389/fcvm.2025.1623403 | 2025 | | |
| Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases. | Lange C, Bottger EC, Cambau E, Griffith DE, Guglielmetti L, van Ingen J, Knight SL, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, Wagner D, Winthrop K, Daley CL, expert panel group for management recommendations in non-tuberculous mycobacterial pulmonary diseases. | Lancet Infect Dis | 10.1016/s1473-3099(21)00586-7 | 2022 | | |
| The usefulness of change in CT score for evaluating the activity of Mycobacterium abscessus (Mab) pulmonary disease (Mab-PD). | Shinfuku K, Hara H, Takasaka N, Ishikawa T, Araya J, Kuwano K. | PLoS One | 10.1371/journal.pone.0281103 | 2023 | | |
| Third-Generation Tetracyclines: Current Knowledge and Therapeutic Potential. | Kounatidis D, Dalamaga M, Grivakou E, Karampela I, Koufopoulos P, Dalopoulos V, Adamidis N, Mylona E, Kaziani A, Vallianou NG. | Biomolecules | 10.3390/biom14070783 | 2024 | | |
| Treating nontuberculous mycobacteria in children with cystic fibrosis: a multicentre retrospective study. | Saint GL, Thomas MF, Zainal Abidin N, Langley RJ, Brodlie M, McNamara P, NTM Collaborators Group. | Arch Dis Child | 10.1136/archdischild-2021-322177 | 2022 | | |
| Fever work-up unfolds a rare diagnosis of native valve endocarditis caused by Mycobacterium abscessus. | Sharma A, Mundi I, Behal K, Kaur N, Singh P, Mahant M. | Indian J Pathol Microbiol | 10.4103/ijpm.ijpm_19_19 | 2019 | | |
| Susceptibility of the Mycobacterium abscessus complex to drying: Implications for nebulizer hygiene in patients with cystic fibrosis. | Moore JE, Millar BC. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_62_20 | 2020 | | |
| Mycobacterium abscessus infections following injection of botulinum toxin. | Fang RY, Sun QN. | J Cosmet Dermatol | 10.1111/jocd.13094 | 2020 | | |
| A Report of Two Uncommon Cases of Mycobacterium chelonae with Localized and Disseminated Skin and Soft Tissue Infection. | Rueda Prada L, Gorasevic M, Gavrancic T, Rajani AJ, Sluzevich JC, Nair-Collins S, Durvasula RV. | Infect Dis Rep | 10.3390/idr17010013 | 2025 | | |
| Management of refractory Mycobacterium abscessus sternal infection following reoperative cardiac surgery. | Wojcik BM, Mitchell JD, Chong T, Rove JY. | Clin Case Rep | 10.1002/ccr3.4027 | 2021 | | |
| Drosophila melanogaster as an organism model for studying cystic fibrosis and its major associated microbial infections. | Toure H, Herrmann J-L, Szuplewski S, Girard-Misguich F. | Infect Immun | 10.1128/iai.00240-23 | 2023 | | |
| Pathogenicity | Efficacy of Moxifloxacin against Mycobacterium abscessus in Zebrafish Model in vivo. | Nie WJ, Xie ZY, Gao S, Teng TL, Zhou WQ, Shang YY, Jing W, Shi WH, Wang QF, Huang XR, Cai BY, Wang J, Wang J, Guo R, Ge QP, Nie LH, Han XQ, Du YD, Chu NH. | Biomed Environ Sci | 10.3967/bes2020.047 | 2020 | |
| Metabolism | Dps protein is related to resistance of Mycobacterium abscessus subsp. massiliense against stressful conditions. | de Alcantara NR, de Oliveira FM, Garcia W, Dos Santos OAL, Junqueira-Kipnis AP, Kipnis A. | Appl Microbiol Biotechnol | 10.1007/s00253-020-10586-z | 2020 | |
| DS86760016, a Leucyl-tRNA Synthetase Inhibitor, Is Active against Mycobacterium abscessus. | Nguyen TQ, Heo BE, Hanh BTB, Jeon S, Park Y, Choudhary A, Lee S, Kim TH, Moon C, Min SJ, Jang J. | Antimicrob Agents Chemother | 10.1128/aac.01567-22 | 2023 | | |
| Neurological manifestations of nontuberculous mycobacteria in adults: case series and review of the literature. | Mina Y, Kline A, Manion M, Hammoud DA, Wu T, Hogan J, Sereti I, Smith BR, Zerbe CS, Holland SM, Nath A. | Front Neurol | 10.3389/fneur.2024.1360128 | 2024 | | |
| Analysis of the Lipid Composition of Mycobacteria by Thin Layer Chromatography. | Guallar-Garrido S, Luquin M, Julian E. | J Vis Exp | 10.3791/62368 | 2021 | | |
| Population heterogeneity in Mycobacterium smegmatis and Mycobacterium abscessus. | Born SEM, Reichlen MJ, Bartek IL, Benoit JB, Frank DN, Voskuil MI. | Microbiology (Reading) | 10.1099/mic.0.001402 | 2023 | | |
| Nontuberculous Mycobacterial Lung Disease Management in Belgium: A Longitudinal Pharmacy Database Study. | Peeters E, Obradovic M, van der Laan R, Cai R, Lorent N. | Drugs Real World Outcomes | 10.1007/s40801-025-00507-9 | 2025 | | |
| A rapid and simple MALDI-TOF MS lipid profiling method for differentiating Mycobacterium ulcerans from Mycobacterium marinum. | Komine T, Fukano H, Yoshida M, Miyamoto Y, Nakaya M, Fujinaga A, Doke K, Hoshino Y. | J Clin Microbiol | 10.1128/jcm.01400-24 | 2025 | | |
| Phylogeny | [Mycobacterium abscessus complex representatives in patients with bronchopulmonary pathology: prevalence, peculiarities of cultivation and identification.] | Kalimulina KR, Ismatullin DD, Lyamin AV, Lyamin AV, Kondratenko OV, Kozlov AV, Zhestkov AV. | Klin Lab Diagn | 10.18821/0869-2084-2020-65-5-316-320 | 2020 | |
| In vitro activity of gepotidacin and comparator antimicrobials against isolates of nontuberculous mycobacteria (NTM). | Brown-Elliott BA, Bush G, Hughes MD, Rodriguez E, Weikel CA, Min SB, Wallace RJ. | Antimicrob Agents Chemother | 10.1128/aac.01684-23 | 2024 | | |
| Pediatric Mandible Reconstruction for Osteomyelitis During Largest Reported Mycobacterium Abscessus Outbreak. | Mueller MA, Kanack MD, Singh J, Jaffurs D, Vyas RM. | J Craniofac Surg | 10.1097/scs.0000000000006070 | 2020 | | |
| Secondary organizing pneumonia due to Mycobacterium abscessus lung disease: Case report and review of the literature. | Watanabe K, Miyake A, Kaneko T. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_134_19 | 2019 | | |
| Biotechnology | An Evaluation of the Antibacterial, Antileishmanial, and Cytotoxic Potential of the Secondary Metabolites of Streptomyces sp. ARH (A3). | de Azevedo VLS, Rosa FC, Dias LRL, Batista LA, Melo MC, Sales LAT, Branco AJM, Araujo TRR, de Miranda RCM, Alianca ASDS. | Microorganisms | 10.3390/microorganisms12030476 | 2024 | |
| Metabolism | Diagnosis of Mycobacterium abscessus/chelonae complex cutaneous infection: Correlation of tissue culture and skin biopsy. | Sardina LA, Kaw U, Jour G, Knabel D, Dyck RM, Procop GW, Bergfeld WF, Harrington S, Demkowicz R, Piliang MP. | J Cutan Pathol | 10.1111/cup.13623 | 2020 | |
| Cell Surface Remodeling of Mycobacterium abscessus under Cystic Fibrosis Airway Growth Conditions. | Wiersma CJ, Belardinelli JM, Avanzi C, Angala SK, Everall I, Angala B, Kendall E, de Moura VCN, Verma D, Benoit J, Brown KP, Jones V, Malcolm KC, Strong M, Nick JA, Floto RA, Parkhill J, Ordway DJ, Davidson RM, McNeil MR, Jackson M. | ACS Infect Dis | 10.1021/acsinfecdis.0c00214 | 2020 | | |
| Infectious complications related to medical tourism. | Pavli A, Maltezou HC. | J Travel Med | 10.1093/jtm/taaa210 | 2021 | | |
| Outcomes of pulmonary Mycobacterium abscessus infection. | Flight WG, Hough NE, Chapman SJ. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_3_20 | 2020 | | |
| Genomic and microbiological analyses of iron acquisition pathways among respiratory and environmental nontuberculous mycobacteria from Hawai'i. | Tan CG, Oberlag NM, McGowan AE, Dawrs SN, Chan YL, Strong M, Hasan NA, Honda JR. | Front Microbiol | 10.3389/fmicb.2023.1268963 | 2023 | | |
| Phylogeny | Identification of Mycobacterium abscessus species and subspecies using the Cas12a/sgRNA-based nucleic acid detection platform. | Xiao G, Zhang S, Liang Z, Li G, Fang M, Liu Y, Zhang J, Ou M, He X, Zhang T, Zeng C, Liu L, Zhang G. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-019-03757-y | 2020 | |
| Pediatric Ventriculoperitoneal Shunt Infection: The Role of Shunt Tract Debridement in Mycobacterium abscessus Eradication. | Abu-Ghname A, Davis MJ, Davies LW, Whitehead WE, Buchanan EP. | J Craniofac Surg | 10.1097/scs.0000000000006061 | 2020 | | |
| Neutrophil dysfunction in bronchiectasis: Pathophysiological insights and emerging targeted therapies. | Taha A. | Multidiscip Respir Med | 10.5826/mrm.2025.1034 | 2025 | | |
| Impact of relebactam-mediated inhibition of Mycobacterium abscessus BlaMab beta-lactamase on the in vitro and intracellular efficacy of imipenem. | Le Run E, Atze H, Arthur M, Mainardi JL. | J Antimicrob Chemother | 10.1093/jac/dkz433 | 2020 | | |
| Significance of early diagnosis and surgical management in treating Mycobacterium immunogenum-related pyogenic extensor tenosynovitis: a case report. | Okinaka T, Fujimura K, Hamasaki Y, Hasegawa Y, Matono T. | BMC Infect Dis | 10.1186/s12879-024-09249-5 | 2024 | | |
| Identification of Mycobacterium abscessus Subspecies by MALDI-TOF Mass Spectrometry and Machine Learning. | Rodriguez-Temporal D, Herrera L, Alcaide F, Domingo D, Hery-Arnaud G, van Ingen J, Van den Bossche A, Ingebretsen A, Beauruelle C, Terschlusen E, Boarbi S, Vila N, Arroyo MJ, Mendez G, Munoz P, Mancera L, Ruiz-Serrano MJ, Rodriguez-Sanchez B. | J Clin Microbiol | 10.1128/jcm.01110-22 | 2023 | | |
| Repurposing drugs to advance the treatment of Buruli ulcer. | Singh S, Yotsu R, Nuremberger E, Srivastava S. | Antimicrob Agents Chemother | 10.1128/aac.00029-25 | 2025 | | |
| Hypercalcaemia secondary to disseminated Mycobacterium abscessus and Mycobacterium fortuitum. | Kuthiah N, Chaozer E. | J R Coll Physicians Edinb | 10.4997/jrcpe.2019.309 | 2019 | | |
| Metabolism | Gallium Porphyrin and Gallium Nitrate Synergistically Inhibit Mycobacterial Species by Targeting Different Aspects of Iron/Heme Metabolism. | Choi SR, Switzer B, Britigan BE, Narayanasamy P. | ACS Infect Dis | 10.1021/acsinfecdis.0c00113 | 2020 | |
| Genetics | Glycopeptidolipid Genotype Correlates With the Severity of Mycobacterium abscessus Lung Disease. | Li B, Ye M, Zhao L, Guo Q, Chen J, Xu B, Zhan M, Zhang Y, Zhang Z, Chu H. | J Infect Dis | 10.1093/infdis/jiz475 | 2020 | |
| Enzymology | Prevention of transmission of Mycobacterium abscessus among patients with cystic fibrosis. | Gross JE, Martiniano SL, Nick JA. | Curr Opin Pulm Med | 10.1097/mcp.0000000000000621 | 2019 | |
| Pathogenicity | A Disseminated Mycobacterium Abscessus Infection in a Patient Affected by Pulmonary Graft versus Host Disease: Case Report with a Revision of Literature. | Bernardelli A, Schena A, Savoldi A, Colato C, Baretta V, D'Alessandro E, Zamboni G, Shoushtari Zadeh Naseri M, Favaro F, Peracchi M, Schena D, Andreini A, Cesaro S, Tecchio C. | J Clin Med | 10.3390/jcm11092410 | 2022 | |
| Mycobacterium abscessus bloodstream infection: Unexpected catheter tunnel infection localized by PET/CT. | Xie O, Khan S, Globan M, Lea K, Bajel A, Slavin M. | Transpl Infect Dis | 10.1111/tid.13147 | 2019 | | |
| Pathogenicity | Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease. | Fujiwara K, Uesugi F, Furuuchi K, Tanaka Y, Yoshiyama T, Saotome M, Ohta K, Mitarai S, Morimoto K. | Microbiol Spectr | 10.1128/spectrum.01928-21 | 2021 | |
| Synthesis and evaluation of Trehalose-Pks13 inhibitor conjugates targeting mycobacteria. | Kumbalathara A D USS, Bartolomeu Halicki PC, Kalera K, Swarts BM, Rohde KH, Sucheck SJ. | Carbohydr Res | 10.1016/j.carres.2025.109506 | 2025 | | |
| Finding the optimal regimen for Mycobacteroides abscessus treatment (FORMaT) in people with Mycobacteroides abscessus pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trial. | Jong T, Baird T, Barr HL, Bell S, Bigirumurame T, Brady K, Burke A, Byrnes J, Caudri D, Clark JE, Coin LJM, Goh F, Grimwood K, Hicks D, Jayawardana K, Joshi S, Lee K, Qvist T, Reid D, Rice M, Roberts JA, Rogers G, Shackleton C, Sly PD, Smyth AR, Stevens L, Stockwell R, Tarique A, Taylor S, Thomson R, Tiddens HAWM, Wang XF, Wason J, Wainwright C. | BMJ Open | 10.1136/bmjopen-2024-096188 | 2025 | | |
| Metagenomic next-generation sequencing assistance in identifying non-tuberculous mycobacterial infections. | Wang S, Xing L. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1253020 | 2023 | | |
| Phylogeny | A single-gene approach for the subspecies classification of Mycobacteroides abscessus. | Ng HF, Ngeow YF. | Pathog Dis | 10.1093/femspd/ftaa055 | 2020 | |
| Acupuncture-Associated Mycobacterium massiliense and Scedosporium Infections Superimposed by Tetanus. | Prasoppokakorn T. | Case Rep Infect Dis | 10.1155/2022/8918020 | 2022 | | |
| Silencing essential gene expression in Mycobacterium abscessus during infection. | Boudehen Y-M, Tasrini Y, Aguilera-Correa JJ, Alcaraz M, Kremer L. | Microbiol Spectr | 10.1128/spectrum.02836-23 | 2023 | | |
| Species identification and drug susceptibility testing of non-tuberculous mycobacteria by Line Probe Assay in Lambaréné, Gabon-a cross-sectional study. | Ndanga MED, Abdul JBPAA, Edoa JR, Ibinda GARM, Adegbite BR, Mevyann RC, Biyogho CM, Mahoumbou J, Manguinga S, Roguet NM, Lell B, Kremsner PG, Alabi AS, Grobusch MP, Adegnika AA. | BMC Infect Dis | 10.1186/s12879-023-08617-x | 2023 | | |
| Distribution characteristics of human herpes viruses in the lower respiratory tract and their impact on 30-day mortality in community-acquired pneumonia patients. | Ding Y, Liu G, Li Q, Zou L, Dai J, Chongsuvivatwong V. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1436509 | 2024 | | |
| Rifabutin Is Inactivated by Mycobacterium abscessus Arr. | Schafle D, Selchow P, Borer B, Meuli M, Rominski A, Schulthess B, Sander P. | Antimicrob Agents Chemother | 10.1128/aac.02215-20 | 2021 | | |
| Phage Therapy: An Alternative Approach to Combating Multidrug-Resistant Bacterial Infections in Cystic Fibrosis. | Cocorullo M, Stelitano G, Chiarelli LR. | Int J Mol Sci | 10.3390/ijms25158321 | 2024 | | |
| An Artefactual Cluster of Mycobacterium abscessus Pneumonia among Cancer Patients Arising from Contamination. | Diella G, Caggiano G, Triggiano F, Lopuzzo M, Apollonio F, Mastria M, Ronga L, Bonadonna L, Lucentini L, Pece A, Milella P, Montagna MT. | Pathogens | 10.3390/pathogens11010108 | 2022 | | |
| Mycobacterium abscessus felon complicated with osteomyelitis: not an ordinary nail salon visit. | Gonzales Zamora JA, Villar Astete A. | Acta Clin Belg | 10.1080/17843286.2019.1637390 | 2020 | | |
| Comparative evaluation of five beta-Lactamase inhibitors in combination with beta-Lactams against multidrug-resistant Mycobacterium tuberculosis in vitro. | Shi J, Zheng D, Su R, Ma X, Zhu Y, Wang S, Chang W, Sun D. | BMC Infect Dis | 10.1186/s12879-025-10730-y | 2025 | | |
| Pneumonia due to Mycobacterium cosmeticum in a patient with systemic sclerosis: A case report. | Hu Y, Zhang C, Jia L. | Clin Case Rep | 10.1002/ccr3.7464 | 2023 | | |
| A case of a preschool child with a successful kidney transplant following the long-term administration of antibiotics to treat peritoneal dialysis-related ESI/peritonitis by Mycobacterium abscessus. | Nakano S, Yamamura-Miyazaki N, Michigami T, Yazawa K, Yanagihara I, Yamamoto K. | CEN Case Rep | 10.1007/s13730-022-00689-z | 2022 | | |
| Metabolism | Transposon mutagenesis in Mycobacterium abscessus identifies an essential penicillin-binding protein involved in septal peptidoglycan synthesis and antibiotic sensitivity. | Akusobi C, Benghomari BS, Zhu J, Wolf ID, Singhvi S, Dulberger CL, Ioerger TR, Rubin EJ | Elife | 10.7554/eLife.71947 | 2022 | |
| Pathogenicity | Rapid and Accurate Differentiation of Mycobacteroides abscessus Complex Species by Liquid Chromatography-Ultra-High-Resolution Orbitrap Mass Spectrometry. | Bajaj AO, Slechta ES, Barker AP | Front Cell Infect Microbiol | 10.3389/fcimb.2022.809348 | 2022 | |
| Pathogenicity | Comparison of Isogenic Strains Shows No Evidence of Altered Nosocomial Transmission-Competency of Rough, GPL-Negative Mycobacterium abscessus Strains. | Meir M, Foreman M, Bar-Oz M, Naor N, Rozenblit A, Barkan D | Microbiol Spectr | 10.1128/spectrum.01990-21 | 2022 | |
| Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus. | Bich Hanh BT, Quang NT, Park Y, Heo BE, Jeon S, Park JW, Jang J | Front Pharmacol | 10.3389/fphar.2021.790767 | 2021 | | |
| Pathogenicity | Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus. | Sudadech P, Roytrakul S, Kaewprasert O, Sirichoat A, Chetchotisakd P, Kanthawong S, Faksri K | PLoS One | 10.1371/journal.pone.0260003 | 2021 | |
| Pathogenicity | RNA Sequencing Elucidates Drug-Specific Mechanisms of Antibiotic Tolerance and Resistance in Mycobacterium abscessus. | Schildkraut JA, Coolen JPM, Burbaud S, Sangen JJN, Kwint MP, Floto RA, Op den Camp HJM, Te Brake LHM, Wertheim HFL, Neveling K, Hoefsloot W, van Ingen J | Antimicrob Agents Chemother | 10.1128/AAC.01509-21 | 2021 | |
| Photo-damage promoted by tetra-cationic palladium(II) porphyrins in rapidly growing mycobacteria. | Rossi GG, Guterres KB, Moreira KS, Burgo TAL, de Campos MMA, Iglesias BA | Photodiagnosis Photodyn Ther | 10.1016/j.pdpdt.2021.102514 | 2021 | | |
| Genetics | Genome-Wide Essentiality Analysis of Mycobacterium abscessus by Saturated Transposon Mutagenesis and Deep Sequencing. | Rifat D, Chen L, Kreiswirth BN, Nuermberger EL | mBio | 10.1128/mBio.01049-21 | 2021 | |
| Pathogenicity | Secretome characterization of clinical isolates from the Mycobacterium abscessus complex provides insight into antigenic differences. | Cornejo-Granados F, Kohl TA, Sotomayor FV, Andres S, Hernandez-Pando R, Hurtado-Ramirez JM, Utpatel C, Niemann S, Maurer FP, Ochoa-Leyva A | BMC Genomics | 10.1186/s12864-021-07670-7 | 2021 | |
| Genetics | Genome Sequence of Mycobacterium abscessus Phage phiT45-1. | Amarh ED, Gauthier CH, Dedrick RM, Garlena RA, Russell DA, Jacobs-Sera D, Zack KM, Hatfull GF | Microbiol Resour Announc | 10.1128/MRA.00155-21 | 2021 | |
| Peripheral tetra-cationic Pt(II) porphyrins photo-inactivating rapidly growing mycobacteria: First application in mycobacteriology. | Rossi GG, Guterres KB, da Silveira CH, Moreira KS, Burgo TAL, Iglesias BA, de Campos MMA | Microb Pathog | 10.1016/j.micpath.2020.104455 | 2020 | | |
| Stress | Tigecycline resistance may be associated with dysregulated response to stress in Mycobacterium abscessus. | Ng HF, Ngeow YF, Yap SF, Zin T, Tan JL | Int J Med Microbiol | 10.1016/j.ijmm.2019.151380 | 2019 | |
| Phylogeny | Mycobacterium abscessus infection in the stomach of patients with various gastric symptoms. | Chouhan D, Barani Devi T, Chattopadhyay S, Dharmaseelan S, Nair GB, Devadas K, Radhakrishna Pillai M | PLoS Negl Trop Dis | 10.1371/journal.pntd.0007799 | 2019 | |
| Pathogenicity | Inhibition of Mycobacterium abscessus, M. chelonae, and M. fortuitum biofilms by Methylobacterium sp. | Garcia-Coca M, Rodriguez-Sevilla G, Perez-Domingo A, Aguilera-Correa JJ, Esteban J, Munoz-Egea MC | J Antibiot (Tokyo) | 10.1038/s41429-019-0232-6 | 2019 | |
| Pathogenicity | The differential effect of clarithromycin and azithromycin on induction of macrolide resistance in Mycobacterium abscessus. | Schildkraut JA, Pennings LJ, Ruth MM, de Brouwer AP, Wertheim HF, Hoefsloot W, de Jong A, van Ingen J | Future Microbiol | 10.2217/fmb-2018-0310 | 2019 | |
| Enzymology | Auranofin Activity Exposes Thioredoxin Reductase as a Viable Drug Target in Mycobacterium abscessus. | Ruth MM, van Rossum M, Koeken VACM, Pennings LJ, Svensson EM, Ruesen C, Bowles EC, Wertheim HFL, Hoefsloot W, van Ingen J | Antimicrob Agents Chemother | 10.1128/AAC.00449-19 | 2019 | |
| Phylogeny | Antimicrobial properties of basidiomycota macrofungi to Mycobacterium abscessus isolated from patients with cystic fibrosis. | Millar BC, Nelson D, Moore RE, Rao JR, Moore JE | Int J Mycobacteriol | 10.4103/ijmy.ijmy_167_18 | 2019 | |
| Pathogenicity | Dual beta-Lactam Combinations Highly Active against Mycobacterium abscessus Complex In Vitro. | Pandey R, Chen L, Manca C, Jenkins S, Glaser L, Vinnard C, Stone G, Lee J, Mathema B, Nuermberger EL, Bonomo RA, Kreiswirth BN | mBio | 10.1128/mBio.02895-18 | 2019 | |
| Pathogenicity | In Vitro Synergism of Rifabutin with Clarithromycin, Imipenem, and Tigecycline against the Mycobacterium abscessus Complex. | Cheng A, Tsai YT, Chang SY, Sun HY, Wu UI, Sheng WH, Chen YC, Chang SC | Antimicrob Agents Chemother | 10.1128/AAC.02234-18 | 2019 | |
| Pathogenicity | A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria. | Ruth MM, Sangen JJN, Remmers K, Pennings LJ, Svensson E, Aarnoutse RE, Zweijpfenning SMH, Hoefsloot W, Kuipers S, Magis-Escurra C, Wertheim HFL, van Ingen J | J Antimicrob Chemother | 10.1093/jac/dky526 | 2019 | |
| Pathogenicity | Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus. | Kirkwood ZI, Millar BC, Downey DG, Moore JE | Int J Mycobacteriol | 10.4103/ijmy.ijmy_142_18 | 2018 | |
| Phylogeny | A proteomics approach for the identification of species-specific immunogenic proteins in the Mycobacterium abscessus complex. | Steindor M, Nkwouano V, Stefanski A, Stuehler K, Ioerger TR, Bogumil D, Jacobsen M, Mackenzie CR, Kalscheuer R | Microbes Infect | 10.1016/j.micinf.2018.10.006 | 2018 | |
| Genetics | A mutation in anti-sigma factor MAB_3542c may be responsible for tigecycline resistance in Mycobacterium abscessus. | Ng HF, Tan JL, Zin T, Yap SF, Ngeow YF | J Med Microbiol | 10.1099/jmm.0.000857 | 2018 | |
| Pathogenicity | Antimycobacterial activity of veterinary antibiotics (Apramycin and Framycetin) against Mycobacterium abscessus: Implication for patients with cystic fibrosis. | Moore JE, Koulianos G, Hardy M, Misawa N, Millar BC | Int J Mycobacteriol | 10.4103/ijmy.ijmy_73_18 | 2018 | |
| Pathogenicity | In Vitro and Intracellular Activity of Imipenem Combined with Rifabutin and Avibactam against Mycobacterium abscessus. | Le Run E, Arthur M, Mainardi JL | Antimicrob Agents Chemother | 10.1128/AAC.00623-18 | 2018 | |
| Pathogenicity | Activity of Rifabutin and Hemi-synthetic Derivatives Against Mycobacterium abscessus. | Ramis IB, Figueiredo R, Ramos DF, Halicki PCB, von Groll A, Viveiros M, do Ceu Costa M, da Silva PEA | Med Chem | 10.2174/1573406414666171204102633 | 2018 | |
| Pathogenicity | Antibiofilm activity of nanoemulsions of Cymbopogon flexuosus against rapidly growing mycobacteria. | Rossi GG, Guterres KB, Bonez PC, da Silva Gundel S, Aggertt VA, Siqueira FS, Ourique AF, Wagnerd R, Klein B, Santos RCV, de Campos MMA | Microb Pathog | 10.1016/j.micpath.2017.11.002 | 2017 | |
| Pathogenicity | In Vitro Evaluation of Povidone-Iodine and Chlorhexidine against Outbreak and Nonoutbreak Strains of Mycobacterium abscessus Using Standard Quantitative Suspension and Carrier Testing. | Cheng A, Sun HY, Tsai YT, Wu UI, Chuang YC, Wang JT, Sheng WH, Hsueh PR, Chen YC, Chang SC | Antimicrob Agents Chemother | 10.1128/AAC.01364-17 | 2017 | |
| Clinical Mycobacterium abscessus strain inhibits autophagy flux and promotes its growth in murine macrophages. | Kim SW, Subhadra B, Whang J, Back YW, Bae HS, Kim HJ, Choi CH | Pathog Dis | 10.1093/femspd/ftx107 | 2017 | | |
| Metabolism | Effect of beta-lactamase production and beta-lactam instability on MIC testing results for Mycobacterium abscessus. | Rominski A, Schulthess B, Muller DM, Keller PM, Sander P | J Antimicrob Chemother | 10.1093/jac/dkx284 | 2017 | |
| galK-based suicide vector mediated allelic exchange in Mycobacterium abscessus. | Gregoire SA, Byam J, Pavelka MS | Microbiology (Reading) | 10.1099/mic.0.000528 | 2017 | | |
| Pathogenicity | Increased survival and proliferation of the epidemic strain Mycobacterium abscessus subsp. massiliense CRM0019 in alveolar epithelial cells. | Ribeiro GM, Matsumoto CK, Real F, Teixeira D, Duarte RS, Mortara RA, Leao SC, de Souza Carvalho-Wodarz C | BMC Microbiol | 10.1186/s12866-017-1102-7 | 2017 | |
| Pathogenicity | Rifabutin Is Active against Mycobacterium abscessus Complex. | Aziz DB, Low JL, Wu ML, Gengenbacher M, Teo JWP, Dartois V, Dick T | Antimicrob Agents Chemother | 10.1128/AAC.00155-17 | 2017 | |
| Enzymology | Intrinsic rifamycin resistance of Mycobacterium abscessus is mediated by ADP-ribosyltransferase MAB_0591. | Rominski A, Roditscheff A, Selchow P, Bottger EC, Sander P | J Antimicrob Chemother | 10.1093/jac/dkw466 | 2016 | |
| Pathogenicity | Identification of antimicrobial activity among new sulfonamide metal complexes for combating rapidly growing mycobacteria. | Agertt VA, Bonez PC, Rossi GG, Flores Vda C, Siqueira Fdos S, Mizdal CR, Marques LL, de Oliveira GN, de Campos MM | Biometals | 10.1007/s10534-016-9951-3 | 2016 | |
| Pathogenicity | Bactericidal and intracellular activity of beta-lactams against Mycobacterium abscessus. | Lefebvre AL, Dubee V, Cortes M, Dorchene D, Arthur M, Mainardi JL | J Antimicrob Chemother | 10.1093/jac/dkw022 | 2016 | |
| Pathogenicity | Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus. | Abdalla MY, Switzer BL, Goss CH, Aitken ML, Singh PK, Britigan BE | Antimicrob Agents Chemother | 10.1128/AAC.00331-15 | 2015 | |
| Genetics | Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs. | Brown-Elliott BA, Vasireddy S, Vasireddy R, Iakhiaeva E, Howard ST, Nash K, Parodi N, Strong A, Gee M, Smith T, Wallace RJ Jr | J Clin Microbiol | 10.1128/JCM.02950-14 | 2015 | |
| Metabolism | Aminoglycoside-modifying enzymes determine the innate susceptibility to aminoglycoside antibiotics in rapidly growing mycobacteria. | Maurer FP, Bruderer VL, Castelberg C, Ritter C, Scherbakov D, Bloemberg GV, Bottger EC | J Antimicrob Chemother | 10.1093/jac/dku550 | 2015 | |
| Genetics | Genome sequencing of Mycobacterium abscessus isolates from patients in the united states and comparisons to globally diverse clinical strains. | Davidson RM, Hasan NA, Reynolds PR, Totten S, Garcia B, Levin A, Ramamoorthy P, Heifets L, Daley CL, Strong M | J Clin Microbiol | 10.1128/JCM.01144-14 | 2014 | |
| Phylogeny | A phylogenomic approach to bacterial subspecies classification: proof of concept in Mycobacterium abscessus. | Tan JL, Khang TF, Ngeow YF, Choo SW | BMC Genomics | 10.1186/1471-2164-14-879 | 2013 | |
| Pathogenicity | Bacterial adherence to different meshes used in abdominal surgery. | Perez-Tanoira R, Isea-Pena MC, Celdran A, Garcia-Vasquez C, Esteban J | Surg Infect (Larchmt) | 10.1089/sur.2013.032 | 2013 | |
| Enzymology | Characterization of broad-spectrum Mycobacterium abscessus class A beta-lactamase. | Soroka D, Dubee V, Soulier-Escrihuela O, Cuinet G, Hugonnet JE, Gutmann L, Mainardi JL, Arthur M | J Antimicrob Chemother | 10.1093/jac/dkt410 | 2013 | |
| Metabolism | Insertion site and distribution of a genomic island conferring DNA phosphorothioation in the Mycobacterium abscessus complex. | Howard ST, Newman KL, McNulty S, Brown-Elliott BA, Vasireddy R, Bridge L, Wallace RJ | Microbiology (Reading) | 10.1099/mic.0.070318-0 | 2013 | |
| Pathogenicity | New rapid scheme for distinguishing the subspecies of the Mycobacterium abscessus group and identifying Mycobacterium massiliense isolates with inducible clarithromycin resistance. | Shallom SJ, Gardina PJ, Myers TG, Sebastian Y, Conville P, Calhoun LB, Tettelin H, Olivier KN, Uzel G, Sampaio EP, Holland SM, Zelazny AM | J Clin Microbiol | 10.1128/JCM.01132-13 | 2013 | |
| Genetics | Mycobacterium abscessus multispacer sequence typing. | Sassi M, Ben Kahla I, Drancourt M | BMC Microbiol | 10.1186/1471-2180-13-3 | 2013 | |
| Cultivation | Comparative study with two different enrichments in the culture media used in the disinfectant efficacy assay. | Sabagh BP, Souto Ada S, Reis LM, Silva SA, Pereira DC, Neves Mde C, Pinheiro RR, Duarte RS, Miyazaki NH, Boas MH | J Microbiol Methods | 10.1016/j.mimet.2011.12.004 | 2011 | |
| Transcriptome | Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains. | Macheras E, Roux AL, Bastian S, Leao SC, Palaci M, Sivadon-Tardy V, Gutierrez C, Richter E, Rusch-Gerdes S, Pfyffer G, Bodmer T, Cambau E, Gaillard JL, Heym B | J Clin Microbiol | 10.1128/JCM.01274-10 | 2010 | |
| Enzymology | Diversity of pulsed-field gel electrophoresis patterns of Mycobacterium abscessus type 2 clinical isolates. | Matsumoto CK, Chimara E, Bombarda S, Duarte RS, Leao SC | J Clin Microbiol | 10.1128/JCM.01665-10 | 2010 | |
| Metabolism | Comparative analysis of immune responses to Mycobacterium abscessus infection and its antigens in two murine models. | Jeon BY, Kwak J, Lee SS, Cho S, Won CJ, Kim JM, Shin SJ | J Microbiol | 10.1007/s12275-009-0139-1 | 2009 | |
| Metabolism | Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessus. | Ripoll F, Pasek S, Schenowitz C, Dossat C, Barbe V, Rottman M, Macheras E, Heym B, Herrmann JL, Daffe M, Brosch R, Risler JL, Gaillard JL | PLoS One | 10.1371/journal.pone.0005660 | 2009 | |
| Genetics | Genomics of glycopeptidolipid biosynthesis in Mycobacterium abscessus and M. chelonae. | Ripoll F, Deshayes C, Pasek S, Laval F, Beretti JL, Biet F, Risler JL, Daffe M, Etienne G, Gaillard JL, Reyrat JM | BMC Genomics | 10.1186/1471-2164-8-114 | 2007 | |
| Hypervirulence of a rough variant of the Mycobacterium abscessus type strain. | Catherinot E, Clarissou J, Etienne G, Ripoll F, Emile JF, Daffe M, Perronne C, Soudais C, Gaillard JL, Rottman M | Infect Immun | 10.1128/IAI.00835-06 | 2006 | | |
| Enzymology | Multicenter evaluation of mycobacteria identification by PCR restriction enzyme analysis in laboratories from Latin America and the Caribbean. | Leao SC, Bernardelli A, Cataldi A, Zumarraga M, Robledo J, Realpe T, Mejia GI, da Silva Telles MA, Chimara E, Velazco M, Fernandez J, Rodrigues PA, Guerrero MI, Leon CI, Porras TB, Rastogi N, Goh KS, Suffys P, da Silva Rocha A, dos Santos Netto D, Ritacco V, Lopez B, Barrera L, Palomino JC, Martin A, Portaels F | J Microbiol Methods | 10.1016/j.mimet.2004.11.015 | 2004 | |
| Enzymology | Pulsed-field gel electrophoresis study of Mycobacterium abscessus isolates previously affected by DNA degradation. | Zhang Y, Yakrus MA, Graviss EA, Williams-Bouyer N, Turenne C, Kabani A, Wallace RJ Jr | J Clin Microbiol | 10.1128/JCM.42.12.5582-5587.2004 | 2004 | |
| Pathogenicity | [Investigation of drug-resistance to rifampin and rpoB gene sequence analysis of Mycobacterium abscessus]. | Sha W, Weng XH, Xiao HP, He GJ | Zhonghua Jie He He Hu Xi Za Zhi | 2003 | | |
| Pathogenicity | A polymorphic region in Mycobacterium abscessus contains a novel insertion sequence element. | Howard ST, Byrd TF, Lyons CR | Microbiology (Reading) | 10.1099/00221287-148-10-2987 | 2002 | |
| Enzymology | DNA polymorphism of Mycobacterium abscessus analyzed by infrequent-restriction-site polymerase chain reaction. | Su LH, Chia JH, Leu HS, Cheng SW, Kuo AJ, Sun CF, Wu TL | Chang Gung Med J | 2000 | | |
| Phylogeny | Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to species status: Mycobacterium abscessus comb. nov. | Kusunoki S, Ezaki T | Int J Syst Bacteriol | 10.1099/00207713-42-2-240 | 1992 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive8416.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License